Title,URL,Time Published,Authors,Summary,Banner Image,Source,Category Within Source,Source Domain,Topics,Overall Sentiment Score,Overall Sentiment Label,Ticker Sentiment
5 Large Drug Stocks to Watch From a Thriving Industry,https://www.zacks.com/commentary/2101789/5-large-drug-stocks-to-watch-from-a-thriving-industry,20230531T134200,['Zacks Investment Research'],"Drug/biotech companies are likely to see significant advances in innovation in 2023. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), J&J (JNJ), Novo Nordisk (NVO), Roche (RHHBY) and Novartis (NVS) are worth retaining in your portfolio.",https://staticx-tuner.zacks.com/images/articles/main/d7/2114.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.980922'}, {'topic': 'Earnings', 'relevance_score': '0.980716'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.769861'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.18535,Somewhat-Bullish,"[{'ticker': 'GOOG', 'relevance_score': '0.025845', 'ticker_sentiment_score': '0.027075', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HZNP', 'relevance_score': '0.051663', 'ticker_sentiment_score': '0.028062', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.128684', 'ticker_sentiment_score': '0.162395', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.051663', 'ticker_sentiment_score': '0.170943', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.179407', 'ticker_sentiment_score': '0.167316', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SGEN', 'relevance_score': '0.025845', 'ticker_sentiment_score': '0.027075', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.025845', 'ticker_sentiment_score': '0.027075', 'ticker_sentiment_label': 'Neutral'}]"
Next AI winners are not your usual suspects,https://www.foxbusiness.com/markets/next-ai-winners-not-usual-suspects,20230531T120307,[],The rapid rise of technologies is driving movement in financial markets and some companies that stand to benefit from it may not be the traditional tech names that typically come up in AI discussions.,https://cf-images.us-east-1.prod.boltdns.net/v1/static/854081161001/5f642d8b-8186-46e3-b036-657aaa5c4265/8eba3234-8fda-44b1-ae70-caa138ed8f65/1280x720/match/image.jpg,Fox Business News,n/a,www.foxbusiness.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '0.650727'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",0.351194,Bullish,"[{'ticker': 'GH', 'relevance_score': '0.063425', 'ticker_sentiment_score': '0.083038', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.063425', 'ticker_sentiment_score': '0.112073', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.12645', 'ticker_sentiment_score': '0.149751', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WEN', 'relevance_score': '0.063425', 'ticker_sentiment_score': '0.244208', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MDNDF', 'relevance_score': '0.063425', 'ticker_sentiment_score': '0.244208', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HCA', 'relevance_score': '0.063425', 'ticker_sentiment_score': '0.083038', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.063425', 'ticker_sentiment_score': '0.083038', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NKE', 'relevance_score': '0.063425', 'ticker_sentiment_score': '0.187242', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BHP', 'relevance_score': '0.063425', 'ticker_sentiment_score': '0.133108', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.063425', 'ticker_sentiment_score': '0.083038', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DPZ', 'relevance_score': '0.063425', 'ticker_sentiment_score': '0.244208', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.063425', 'ticker_sentiment_score': '0.112073', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSNLF', 'relevance_score': '0.063425', 'ticker_sentiment_score': '0.167185', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DMPZF', 'relevance_score': '0.063425', 'ticker_sentiment_score': '0.244208', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'RIO', 'relevance_score': '0.063425', 'ticker_sentiment_score': '0.133108', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EQIX', 'relevance_score': '0.063425', 'ticker_sentiment_score': '0.141124', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMG', 'relevance_score': '0.063425', 'ticker_sentiment_score': '0.244208', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HD', 'relevance_score': '0.063425', 'ticker_sentiment_score': '0.187242', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WMT', 'relevance_score': '0.12645', 'ticker_sentiment_score': '0.1591', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Should You Invest in the Fidelity MSCI Health Care Index ETF  ( FHLC ) ?,https://www.zacks.com/stock/news/2101734/should-you-invest-in-the-fidelity-msci-health-care-index-etf-fhlc,20230531T102008,['Zacks Investment Research'],Sector ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default290.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}]",0.282445,Somewhat-Bullish,"[{'ticker': 'UNH', 'relevance_score': '0.128135', 'ticker_sentiment_score': '0.051111', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.128135', 'ticker_sentiment_score': '0.051111', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.128135', 'ticker_sentiment_score': '0.051111', 'ticker_sentiment_label': 'Neutral'}]"
Best Of: Inside Johnson & Johnson's bankruptcy two-step,https://www.ft.com/content/aae0a7f0-ad08-437d-adba-3fa883b5be66,20230531T040956,[],"This is an audio transcript of the Behind the Money podcast episode: 'Best Of: Inside Johnson & Johnson's bankruptcy two-step' Hey, everyone. Just to note that we're taking a break this week. So instead, today we're resharing one of our episodes. Now be sure to stick around till the end.",https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2Fda0eadb6-6258-4ce0-95e0-01a41c13f9be.jpg?fit=scale-down&source=next&width=700,Financial Times,GoogleRSS,www.ft.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.105801,Neutral,"[{'ticker': 'TT', 'relevance_score': '0.008666', 'ticker_sentiment_score': '0.039135', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TRMNF', 'relevance_score': '0.008666', 'ticker_sentiment_score': '-0.060589', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSSMY', 'relevance_score': '0.008666', 'ticker_sentiment_score': '0.042632', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.155007', 'ticker_sentiment_score': '-0.035439', 'ticker_sentiment_label': 'Neutral'}]"
Best Of: Inside Johnson & Johnson's bankruptcy two-step,https://www.ft.com/content/08388420-cf6d-47e1-bd22-7a2b1504aa89,20230531T040000,[],"This week, we're revisiting an episode from last year.",https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fnext-video-editor-images.s3.ap-northeast-1.amazonaws.com%2F5a967e3c-3297-47a2-8f17-fdcb8f8cfb50?source=next-opengraph&fit=scale-down&width=900,Financial Times,Companies,www.ft.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.28199,Somewhat-Bearish,"[{'ticker': 'JNJ', 'relevance_score': '0.295867', 'ticker_sentiment_score': '-0.211099', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
Johnson & Johnson  ( JNJ )  Stock Moves 0.01%: What You Should Know,https://www.zacks.com/stock/news/2101628/johnson-johnson-jnj-stock-moves-001-what-you-should-know,20230530T214517,['Zacks Investment Research'],"In the latest trading session, Johnson & Johnson (JNJ) closed at $154.37, marking a +0.01% move from the previous day.",https://staticx-tuner.zacks.com/images/default_article_images/default134.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.95493'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.221009,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.617188', 'ticker_sentiment_score': '0.330766', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Johnson & Johnson Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/05/32633618/johnson-johnson-unusual-options-activity,20230530T194646,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 14 strange trades. If we consider the specifics of each trade, it is accurate to state that 35% of the investors opened trades with ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.155935,Somewhat-Bullish,"[{'ticker': 'C', 'relevance_score': '0.136113', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.696319', 'ticker_sentiment_score': '0.056816', 'ticker_sentiment_label': 'Neutral'}]"
Nvidia Becomes Ninth Company To Hit $1 Trillion Market Cap - Who Could Be Next To Join Elusive Club? - NVIDIA  ( NASDAQ:NVDA ) ,https://www.benzinga.com/news/23/05/32630114/nvidia-becomes-ninth-company-to-hit-1-trillion-market-cap-who-could-be-next-to-join-elusive-club,20230530T182011,['Chris Katje'],A surge in price for shares of Nvidia Corporation NVDA after the company's quarterly earnings results and guidance has put the semiconductor company in the elusive $1 trillion market capitalization club. Here's a look at the past and current members of the club and who could be next to join.,https://cdn.benzinga.com/files/images/story/2023/05/30/nvidia_bull_chart.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.938793'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.189774,Somewhat-Bullish,"[{'ticker': 'GOOG', 'relevance_score': '0.042271', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.126339', 'ticker_sentiment_score': '0.112356', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.509206', 'ticker_sentiment_score': '0.198336', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.167904', 'ticker_sentiment_score': '0.022114', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVX', 'relevance_score': '0.084423', 'ticker_sentiment_score': '0.276216', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BRK-A', 'relevance_score': '0.042271', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.042271', 'ticker_sentiment_score': '0.220918', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TCTZF', 'relevance_score': '0.084423', 'ticker_sentiment_score': '0.105261', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.084423', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSM', 'relevance_score': '0.084423', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.126339', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.328455', 'ticker_sentiment_score': '0.243474', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AZN', 'relevance_score': '0.084423', 'ticker_sentiment_score': '0.230557', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'XOM', 'relevance_score': '0.126339', 'ticker_sentiment_score': '0.273531', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.042271', 'ticker_sentiment_score': '0.220918', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PCCYF', 'relevance_score': '0.042271', 'ticker_sentiment_score': '0.129274', 'ticker_sentiment_label': 'Neutral'}]"
Kenvue's Growth Forecast: Exploring The Future Of Johnson & Johnson's Carve-Out - Kenvue  ( NYSE:KVUE ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/05/32630411/kenvues-growth-forecast-exploring-the-future-of-johnson-johnsons-carve-out,20230530T175727,['Lekha Gupta'],"RBC Capital Markets analyst Nik Modi initiated coverage on Kenvue Inc KVUE with an Outperform rating and a price target of $29. Kenvue is Johnson & Johnson's JNJ consumer-healthcare business carve-out, which debuted on the U.S. stock exchange earlier this month.",https://cdn.benzinga.com/files/images/story/2023/05/30/kvue.png?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.858979'}]",0.392503,Bullish,"[{'ticker': 'ICNB', 'relevance_score': '0.15347', 'ticker_sentiment_score': '0.320201', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KVUE', 'relevance_score': '0.666827', 'ticker_sentiment_score': '0.589607', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.301315', 'ticker_sentiment_score': '0.506045', 'ticker_sentiment_label': 'Bullish'}]"
"Ruling clears way for Purdue Pharma to settle opioid claims, protect Sacklers from lawsuits",https://apnews.com/article/opioid-crisis-purdue-settlement-bankruptcy-sackler-9d1f39c52d8d0f4f0c79960d930a5b84,20230530T144240,[],"Ruling clears way for Purdue Pharma to settle opioid claims, protect ... The Associated Press ...",https://storage.googleapis.com/afs-prod/media/6f73a4d85cab4edba5365792b025885c/3000.webp,Associated Press,Business,apnews.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}]",-0.019623,Neutral,"[{'ticker': 'CVS', 'relevance_score': '0.054483', 'ticker_sentiment_score': '-0.031', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAH', 'relevance_score': '0.054483', 'ticker_sentiment_score': '-0.031', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.054483', 'ticker_sentiment_score': '-0.031', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.054483', 'ticker_sentiment_score': '-0.031', 'ticker_sentiment_label': 'Neutral'}]"
Ceramedix Joins Johnson & Johnson Innovation - JLABS as a Resident Company,https://www.benzinga.com/pressreleases/23/05/n32622393/ceramedix-joins-johnson-johnson-innovation-jlabs-as-a-resident-company,20230530T121700,['PRNewswire'],"NEW YORK, May 30, 2023 /PRNewswire/ -- Ceramedix, Inc., a privately-held biotherapeutics company developing a new class of antibody-based drugs designed with the aim to address novel disease targets involving the microvasculature, today announced it has joined Johnson & Johnson Innovation - ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.236745,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.294682', 'ticker_sentiment_score': '0.310661', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Ceramedix Joins Johnson & Johnson Innovation - JLABS as a Resident Company,https://www.prnewswire.com/news-releases/ceramedix-joins-johnson--johnson-innovation--jlabs-as-a-resident-company-301836181.html,20230530T121700,"['Inc.', 'Ceramedix']",Ceramedix Joins Johnson & Johnson Innovation - JLABS as a ... PR ...,https://mma.prnewswire.com/media/2086791/Ceramedix_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.239441,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.210274', 'ticker_sentiment_score': '0.225926', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Here's Why You Should Retain Integra  ( IART )  Stock Now,https://www.zacks.com/stock/news/2101232/heres-why-you-should-retain-integra-iart-stock-now,20230530T120700,['Zacks Investment Research'],Investors continue to be optimistic about Integra Lifesciences (IART) based on the prospect of its CSS segment and ample liquidity to support M&A strategies.,https://staticx-tuner.zacks.com/images/articles/main/d6/2257.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.988787'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}]",0.170734,Somewhat-Bullish,"[{'ticker': 'ZBH', 'relevance_score': '0.221616', 'ticker_sentiment_score': '0.094392', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HOLX', 'relevance_score': '0.17813', 'ticker_sentiment_score': '0.004317', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDXG', 'relevance_score': '0.044885', 'ticker_sentiment_score': '0.047625', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNN', 'relevance_score': '0.044885', 'ticker_sentiment_score': '0.047625', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SYK', 'relevance_score': '0.044885', 'ticker_sentiment_score': '0.047625', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSSMY', 'relevance_score': '0.044885', 'ticker_sentiment_score': '0.047625', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.044885', 'ticker_sentiment_score': '0.047625', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IART', 'relevance_score': '0.089629', 'ticker_sentiment_score': '0.165746', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PEN', 'relevance_score': '0.13409', 'ticker_sentiment_score': '0.088106', 'ticker_sentiment_label': 'Neutral'}]"
Should iShares Core High Dividend ETF  ( HDV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2101184/should-ishares-core-high-dividend-etf-hdv-be-on-your-investing-radar,20230530T102006,['Zacks Investment Research'],Style Box ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default244.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.249472,Somewhat-Bullish,"[{'ticker': 'BLK', 'relevance_score': '0.061949', 'ticker_sentiment_score': '0.117033', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MORN', 'relevance_score': '0.123526', 'ticker_sentiment_score': '0.195615', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VZ', 'relevance_score': '0.123526', 'ticker_sentiment_score': '0.068619', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.123526', 'ticker_sentiment_score': '0.068619', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.123526', 'ticker_sentiment_score': '0.068619', 'ticker_sentiment_label': 'Neutral'}]"
"The Zacks Analyst Blog Highlights InMode, Johnson & Johnson, Intuitive Surgical and GE HealthCare",https://www.zacks.com/stock/news/2101176/the-zacks-analyst-blog-highlights-inmode-johnson-johnson-intuitive-surgical-and-ge-healthcare,20230530T101500,['Zacks Investment Research'],"InMode, Johnson & Johnson, Intuitive Surgical and GE HealthCare are included in this Analyst Blog.",https://staticx-tuner.zacks.com/images/articles/main/e3/1178.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.890401'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.905476'}]",0.29684,Somewhat-Bullish,"[{'ticker': 'GEHC', 'relevance_score': '0.157483', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.40375', 'ticker_sentiment_score': '0.423087', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'INMD', 'relevance_score': '0.40375', 'ticker_sentiment_score': '0.256965', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.40375', 'ticker_sentiment_score': '0.274014', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Idorsia announces a change to commercial leadership,https://www.globenewswire.com/news-release/2023/05/30/2677964/0/en/Idorsia-announces-a-change-to-commercial-leadership.html,20230530T050000,['Idorsia Pharmaceuticals Ltd'],Ad hoc announcement pursuant to Art. 53 LR ...,https://ml-eu.globenewswire.com/Resource/Download/bb724119-468d-4b1d-8206-3c2175d07f2b,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.235088,Somewhat-Bullish,"[{'ticker': 'IDRSF', 'relevance_score': '0.660868', 'ticker_sentiment_score': '0.602969', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.058615', 'ticker_sentiment_score': '0.030025', 'ticker_sentiment_label': 'Neutral'}]"
Pain Relief Therapeutics Market to Grow Significantly by 2029- Brandessence Market Research,https://www.prnewswire.com/news-releases/pain-relief-therapeutics-market-to-grow-significantly-by-2029--brandessence-market-research-301836608.html,20230529T151500,['Brandessence Market Research and Consulting Private Limited'],Pain Relief Therapeutics Market to Grow Significantly by 2029 ... PR ...,https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Earnings', 'relevance_score': '0.214378'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.046836,Neutral,"[{'ticker': 'CARA', 'relevance_score': '0.023487', 'ticker_sentiment_score': '0.099264', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABT', 'relevance_score': '0.023487', 'ticker_sentiment_score': '0.099264', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAYZF', 'relevance_score': '0.023487', 'ticker_sentiment_score': '0.099264', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.046953', 'ticker_sentiment_score': '0.122326', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.023487', 'ticker_sentiment_score': '0.099264', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.046953', 'ticker_sentiment_score': '0.130099', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.023487', 'ticker_sentiment_score': '0.099264', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:UZS', 'relevance_score': '0.023487', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Intraocular Lens  ( IOL )  Market to Grow Phenomenally by 2029- Brandessence Market Research,https://www.prnewswire.com/news-releases/intraocular-lens-iol-market-to-grow-phenomenally-by-2029--brandessence-market-research-301836613.html,20230529T150000,['Brandessence Market Research and Consulting Private Limited'],Intraocular Lens ( IOL ) Market to Grow Phenomenally by 2029 ... PR ...,https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.287418,Somewhat-Bullish,"[{'ticker': 'ALC', 'relevance_score': '0.044801', 'ticker_sentiment_score': '0.126747', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HOCPF', 'relevance_score': '0.02241', 'ticker_sentiment_score': '0.143154', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.02241', 'ticker_sentiment_score': '0.122751', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.044801', 'ticker_sentiment_score': '0.135743', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STAA', 'relevance_score': '0.02241', 'ticker_sentiment_score': '0.143154', 'ticker_sentiment_label': 'Neutral'}]"
Coronary Stents Market to Witness Phenomenal Gains by 2029- Brandessence Market Research,https://www.prnewswire.com/news-releases/coronary-stents-market-to-witness-phenomenal-gains-by-2029--brandessence-market-research-301836605.html,20230529T144500,['Brandessence Market Research and Consulting Private Limited'],Coronary Stents Market to Witness Phenomenal Gains by 2029 ... PR ...,https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.108179'}]",0.243632,Somewhat-Bullish,"[{'ticker': 'BSX', 'relevance_score': '0.020615', 'ticker_sentiment_score': '0.039405', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TRUMF', 'relevance_score': '0.020615', 'ticker_sentiment_score': '0.039405', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BDX', 'relevance_score': '0.020615', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.020615', 'ticker_sentiment_score': '0.121535', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAH', 'relevance_score': '0.020615', 'ticker_sentiment_score': '0.039405', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.041216', 'ticker_sentiment_score': '0.051807', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCRPF', 'relevance_score': '0.020615', 'ticker_sentiment_score': '0.039405', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.020615', 'ticker_sentiment_score': '0.121535', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:UZS', 'relevance_score': '0.020615', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Arthroscopy Market to Showcase Remarkable Growth by 2029- Brandessence Market Research,https://www.prnewswire.com/news-releases/arthroscopy-market-to-showcase-remarkable-growth-by-2029--brandessence-market-research-301836603.html,20230529T143000,['Brandessence Market Research and Consulting Private Limited'],Arthroscopy Market to Showcase Remarkable Growth by 2029 ... PR ...,https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Earnings', 'relevance_score': '0.796627'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.219654,Somewhat-Bullish,"[{'ticker': 'ZBH', 'relevance_score': '0.02105', 'ticker_sentiment_score': '0.037784', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNN', 'relevance_score': '0.02105', 'ticker_sentiment_score': '0.037784', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SYK', 'relevance_score': '0.042085', 'ticker_sentiment_score': '0.050023', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSSMY', 'relevance_score': '0.02105', 'ticker_sentiment_score': '0.037784', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.042085', 'ticker_sentiment_score': '0.122174', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IART', 'relevance_score': '0.02105', 'ticker_sentiment_score': '0.068648', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.02105', 'ticker_sentiment_score': '0.037784', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CNMD', 'relevance_score': '0.02105', 'ticker_sentiment_score': '0.037784', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.02105', 'ticker_sentiment_score': '0.121847', 'ticker_sentiment_label': 'Neutral'}]"
Here is What to Know Beyond Why Johnson & Johnson  ( JNJ )  is a Trending Stock,https://www.zacks.com/stock/news/2100815/here-is-what-to-know-beyond-why-johnson-johnson-jnj-is-a-trending-stock,20230529T130011,['Zacks Investment Research'],"Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",https://staticx-tuner.zacks.com/images/default_article_images/default307.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}]",0.226713,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.482078', 'ticker_sentiment_score': '0.107154', 'ticker_sentiment_label': 'Neutral'}]"
How - and Why - to Give to Your Grandkids,https://www.kiplinger.com/personal-finance/family-savings/how-and-why-to-give-to-your-grandkids,20230529T110058,['David Rodeck'],"Over the next couple of decades, Americans - mostly aging Baby Boomers and Gen Xers - are expected to pass along about $73 trillion in wealth to their heirs. They will give another $12 trillion to charity.",https://cdn.mos.cms.futurecdn.net/VHteDKEjjZRc6UoP29HVfF-415-80.jpg,Kiplinger,n/a,www.kiplinger.com,"[{'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.999999'}]",0.195308,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.016738', 'ticker_sentiment_score': '-0.119947', 'ticker_sentiment_label': 'Neutral'}]"
Lung Cancer Therapies Market to Amplify Significantly over 2022-2029 - Brandessence Market Research,https://www.prnewswire.com/news-releases/lung-cancer-therapies-market-to-amplify-significantly-over-2022-2029---brandessence-market-research-301836472.html,20230529T102600,['Brandessence Market Research And Consulting Private Limited'],Lung Cancer Therapies Market to Amplify Significantly over 2022 ... PR ...,https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.119358,Neutral,"[{'ticker': 'AZN', 'relevance_score': '0.023579', 'ticker_sentiment_score': '0.074359', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.070656', 'ticker_sentiment_score': '0.127303', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SKXJF', 'relevance_score': '0.023579', 'ticker_sentiment_score': '0.074359', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SGEN', 'relevance_score': '0.023579', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSKYF', 'relevance_score': '0.023579', 'ticker_sentiment_score': '0.074359', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.070656', 'ticker_sentiment_score': '0.123983', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.023579', 'ticker_sentiment_score': '0.074359', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.023579', 'ticker_sentiment_score': '0.074359', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:UZS', 'relevance_score': '0.023579', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Is WisdomTree U.S. Quality Dividend Growth ETF  ( DGRW )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2100737/is-wisdomtree-us-quality-dividend-growth-etf-dgrw-a-strong-etf-right-now,20230529T102008,['Zacks Investment Research'],Smart Beta ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default193.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999953'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.304491,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.114137', 'ticker_sentiment_score': '0.066424', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.114137', 'ticker_sentiment_score': '0.066424', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MORN', 'relevance_score': '0.057215', 'ticker_sentiment_score': '0.186069', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WT', 'relevance_score': '0.333257', 'ticker_sentiment_score': '0.346328', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.114137', 'ticker_sentiment_score': '0.066424', 'ticker_sentiment_label': 'Neutral'}]"
US Default Looks To Be Avoided At Eleventh Hour - Here's What Investors Should Know,https://www.forbes.com/sites/qai/2023/05/29/us-default-looks-to-be-avoided-at-eleventh-hourheres-what-investors-should-know/,20230529T090036,['Q.ai - Powering a Personal Wealth Movement'],"All in all, the atmosphere of uncertainty and this close call on the U.S. default have many investors wondering how to shore up their portfolios.",https://imageio.forbes.com/specials-images/imageserve/64745a6e309f1118f19811f3/0x0.jpg?format=jpg&width=1200,Forbes,Money,www.forbes.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999862'}]",0.05632,Neutral,"[{'ticker': 'DUK', 'relevance_score': '0.109956', 'ticker_sentiment_score': '0.007953', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.109956', 'ticker_sentiment_score': '-0.035525', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.073434', 'ticker_sentiment_score': '0.122006', 'ticker_sentiment_label': 'Neutral'}]"
Want to Grow Richer? These Stocks Have Doubled in the Past 5 Years,https://www.fool.com/investing/2023/05/28/want-to-grow-richer-these-stocks-have-doubled-in-5/,20230528T131500,['Kody Kester'],These two pharmaceutical companies have created value for shareholders.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F733859%2Fa-pharmacist-serves-a-customer.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.983783'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}]",0.324069,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.147366', 'ticker_sentiment_score': '0.116756', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.422661', 'ticker_sentiment_score': '0.463723', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.147366', 'ticker_sentiment_score': '0.116756', 'ticker_sentiment_label': 'Neutral'}]"
Buy the Dip On These Warren Buffett Stocks,https://www.fool.com/investing/2023/05/28/buy-the-dip-on-these-warren-buffett-stocks/,20230528T093000,['Adria Cimino'],You'll want to follow Buffett's lead and hold on to these stocks forever.,https://media.ycharts.com/charts/6b0c95d52d8a74d977ffa7e7e1f65e65.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.976913'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.401515,Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.068698', 'ticker_sentiment_score': '0.06418', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TRMNF', 'relevance_score': '0.068698', 'ticker_sentiment_score': '0.341583', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KO', 'relevance_score': '0.509589', 'ticker_sentiment_score': '0.501662', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'BRK-A', 'relevance_score': '0.068698', 'ticker_sentiment_score': '0.265652', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.204072', 'ticker_sentiment_score': '0.191842', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
US-China relations continue to thaw as trade officials meet in Detroit,https://www.scmp.com/news/china/diplomacy/article/3222006/us-china-relations-continue-thaw-meeting-between-trade-officials-detroit,20230526T191843,['Khushboo Razdan'],Chinese Commerce Minister Wang Wentao and US Trade Representative Katherine Tai hold talks on the margin of the Asia-Pacific Economic Cooperation session.,"https://img.i-scmp.com/cdn-cgi/image/fit=contain,width=425,format=auto/sites/default/files/styles/768x768/public/d8/images/canvas/2023/05/27/4768411f-80f9-438e-a43f-5b45ecd69aec_fb3b6a21.jpg?itok=BCrgT-2I&v=1685128718",South China Morning Post,Business,www.scmp.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",-0.07173,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.061473', 'ticker_sentiment_score': '0.067003', 'ticker_sentiment_label': 'Neutral'}]"
Cummins spinoff Atmus Filtration's stock soars 14% in trading debut,https://www.marketwatch.com/story/atmus-filtrations-stock-soars-14-in-trading-debut-d746dc8a,20230526T182800,['Ciara Linnane'],"Atmus makes products for commercial vehicles and agriculture, construction, mining and power-generation vehicles and equipment.",https://images.mktw.net/im-789891/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'IPO', 'relevance_score': '0.769861'}, {'topic': 'Financial Markets', 'relevance_score': '0.992549'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.074302,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.377142', 'ticker_sentiment_score': '0.257162', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.194242', 'ticker_sentiment_score': '0.056127', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMI', 'relevance_score': '0.377142', 'ticker_sentiment_score': '0.083635', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.194242', 'ticker_sentiment_score': '0.056127', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.194242', 'ticker_sentiment_score': '0.058835', 'ticker_sentiment_label': 'Neutral'}]"
Bristol Myers  ( BMY )  Thrombosis Drug Gets Fast Track Designation,https://www.zacks.com/stock/news/2100517/bristol-myers-bmy-thrombosis-drug-gets-fast-track-designation,20230526T163200,['Zacks Investment Research'],"Bristol Myers (BMY) obtains Fast Track Designation from the FDA for milvexian, which is being developed in collaboration with Johnson and Johnson's Janssen.",https://staticx-tuner.zacks.com/images/default_article_images/default72.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.089983,Neutral,"[{'ticker': 'LGND', 'relevance_score': '0.302429', 'ticker_sentiment_score': '0.111267', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.123526', 'ticker_sentiment_score': '-0.029656', 'ticker_sentiment_label': 'Neutral'}]"
Cummins' filtration unit valued at $1.8 billion in strong market debut,https://www.reuters.com/markets/deals/cummins-filtration-unit-valued-18-billion-strong-market-debut-2023-05-26/,20230526T160300,['Reuters'],"May 26 ( Reuters ) - Atmus Filtration Technologies Inc ( ATMU.N ) , the filtration solutions business of U.S. diesel engine maker Cummins Inc ( CMI.N ) , fetched a valuation of $1.8 billion in a strong market debut on Friday.",https://cloudfront-us-east-2.images.arcpublishing.com/reuters/SQE5HPDH5NNGLHVR33LTLXPMMU.jpg,Reuters,Markets,www.reuters.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'IPO', 'relevance_score': '0.838487'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.188724,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.185306', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RIVN', 'relevance_score': '0.185306', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMI', 'relevance_score': '0.185306', 'ticker_sentiment_score': '0.208773', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.185306', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Want Passive Income Forever? Buy These 2 Magnificent Stocks Now,https://www.fool.com/investing/2023/05/26/want-passive-income-forever-buy-these-magnificent/,20230526T135300,['Prosper Junior Bakiny'],You can take these companies' dividends straight to the bank.,https://media.ycharts.com/charts/0cc1b516041ad4b186b8f465000a8a15.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}]",0.185698,Somewhat-Bullish,"[{'ticker': 'AAPL', 'relevance_score': '0.499789', 'ticker_sentiment_score': '0.246654', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.314151', 'ticker_sentiment_score': '0.213914', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Solid Earnings Fuel Potential Bull Market in Medical Devices,https://www.zacks.com/stock/news/2100240/solid-earnings-fuel-potential-bull-market-in-medical-devices,20230526T135100,['Zacks Investment Research'],"CNBC's Jim Cramer predicts a booming bull market for medical devices, with positive earnings reports across the space. INMD, JNJ, ISRG and GEHC can emerge as potential winners.",https://staticx-tuner.zacks.com/images/articles/main/09/2677.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.890401'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.839681'}]",0.317122,Somewhat-Bullish,"[{'ticker': 'GEHC', 'relevance_score': '0.170475', 'ticker_sentiment_score': '0.15112', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ISRG', 'relevance_score': '0.384608', 'ticker_sentiment_score': '0.494259', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'INMD', 'relevance_score': '0.384608', 'ticker_sentiment_score': '0.291234', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.384608', 'ticker_sentiment_score': '0.31924', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
A Challenger to J&J's Top Blockbuster Is on the Way. Here's What You Need to Know.,https://www.fool.com/investing/2023/05/26/a-challenger-to-jjs-top-blockbuster-is-on-the-way/,20230526T093000,['Adria Cimino'],Biotech-giant Amgen aims to launch a rival.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F733741%2Fgettyimages-1056449108.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.989041'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.095581,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.055492', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.165409', 'ticker_sentiment_score': '0.019369', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.110717', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Cummins braving debt ceiling jitters with $275M engine filter unit IPO,https://www.foxbusiness.com/markets/cummins-braving-debt-ceiling-jitters-275m-engine-filter-unit-ipo,20230526T063023,[],"Diesel engine maker Cummins is going to buck the recent initial public offering draught and bring its engine filtration unit to market on Friday. Cummings priced the IPO of its unit to raise about $275 million on Thursday, defying volatile markets which are being shaken by uncertainty over a deal ...",https://static.foxbusiness.com/foxbusiness.com/content/uploads/2023/05/Atmus-A.png,Fox Business News,n/a,www.foxbusiness.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.682689'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}]",-0.084819,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.146025', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.146025', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
"Hair Products Market to grow at a CAGR of 4.12% between 2022 and 2027, Growing demand for natural and organic hair products expected to be a primary trend -Technavio",https://www.prnewswire.com/news-releases/hair-products-market-to-grow-at-a-cagr-of-4-12-between-2022-and-2027--growing-demand-for-natural-and-organic-hair-products-expected-to-be-a-primary-trend--technavio-301834376.html,20230526T051500,['Technavio'],Hair Products Market to grow at a CAGR of 4.12% between 2022 ... PR ...,https://mma.prnewswire.com/media/2085257/Technavio_Logo_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.19203,Somewhat-Bullish,"[{'ticker': 'KAOCF', 'relevance_score': '0.055492', 'ticker_sentiment_score': '0.096014', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSDOF', 'relevance_score': '0.055492', 'ticker_sentiment_score': '0.096014', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'REVRQ', 'relevance_score': '0.055492', 'ticker_sentiment_score': '0.096014', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.055492', 'ticker_sentiment_score': '0.096014', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.219312', 'ticker_sentiment_score': '0.101014', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UL', 'relevance_score': '0.055492', 'ticker_sentiment_score': '0.096014', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HENKY', 'relevance_score': '0.055492', 'ticker_sentiment_score': '0.096014', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'III', 'relevance_score': '0.027763', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CL', 'relevance_score': '0.055492', 'ticker_sentiment_score': '0.096014', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRLCF', 'relevance_score': '0.055492', 'ticker_sentiment_score': '0.096014', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COTY', 'relevance_score': '0.055492', 'ticker_sentiment_score': '0.096014', 'ticker_sentiment_label': 'Neutral'}]"
"Value Stocks Hit 15-Month Low Against Growth As AI Fuels Tech's Vengeance Over 2022's Rate-Hike-Induced Market Fall - iShares Core S&P U.S. Growth ETF  ( NASDAQ:IUSG ) , iShares Core S&P U.S. Value ETF  ( NASDAQ:IUSV ) ",https://www.benzinga.com/news/large-cap/23/05/32583715/value-stocks-hit-15-month-low-against-growth-as-ai-fuels-techs-vengeance-over-2022s-rate-hike-indu,20230525T211809,['Piero Cingari'],"Value stocks fell to a seven-month low in relation to growth stocks, already lagging by more than 20% year to date on the heels of an AI-related rally propelling equities in the technology sector.",https://cdn.benzinga.com/files/images/story/2023/05/25/shutterstock_1720647151.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.980716'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}]",0.130789,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.178459', 'ticker_sentiment_score': '0.184661', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GOOG', 'relevance_score': '0.178459', 'ticker_sentiment_score': '0.184661', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.178459', 'ticker_sentiment_score': '-0.065671', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.178459', 'ticker_sentiment_score': '0.184661', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.178459', 'ticker_sentiment_score': '0.184661', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BAC', 'relevance_score': '0.178459', 'ticker_sentiment_score': '-0.075643', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVX', 'relevance_score': '0.178459', 'ticker_sentiment_score': '-0.075643', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.178459', 'ticker_sentiment_score': '-0.075643', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.178459', 'ticker_sentiment_score': '-0.075643', 'ticker_sentiment_label': 'Neutral'}]"
Alkermes Files Definitive Proxy Statement and Issues Letter to Shareholders Detailing Business Execution That Has Driven Strong Performance and Delivered Shareholder Value,https://www.prnewswire.com/news-releases/alkermes-files-definitive-proxy-statement-and-issues-letter-to-shareholders-detailing-business-execution-that-has-driven-strong-performance-and-delivered-shareholder-value-301835124.html,20230525T201500,['Alkermes plc'],Alkermes Files Definitive Proxy Statement and Issues Letter to ... PR ...,https://mma.prnewswire.com/media/616416/Alkermes_plc_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.77141'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.304093,Somewhat-Bullish,"[{'ticker': 'RARE', 'relevance_score': '0.008968', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SRPT', 'relevance_score': '0.008968', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.008968', 'ticker_sentiment_score': '0.137825', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.008968', 'ticker_sentiment_score': '0.110344', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NBIX', 'relevance_score': '0.008968', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALNY', 'relevance_score': '0.008968', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IONS', 'relevance_score': '0.008968', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SAGE', 'relevance_score': '0.008968', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.008968', 'ticker_sentiment_score': '0.136033', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALKS', 'relevance_score': '0.463562', 'ticker_sentiment_score': '0.421704', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'UTHR', 'relevance_score': '0.008968', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PTCT', 'relevance_score': '0.008968', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IRWD', 'relevance_score': '0.008968', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JAZZ', 'relevance_score': '0.008968', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HZNP', 'relevance_score': '0.008968', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EBS', 'relevance_score': '0.008968', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INCY', 'relevance_score': '0.008968', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EXEL', 'relevance_score': '0.008968', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ACAD', 'relevance_score': '0.008968', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BPMC', 'relevance_score': '0.008968', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Alkermes Files Definitive Proxy Statement and Issues Letter to Shareholders Detailing Business Execution That Has Driven Strong Performance and Delivered Shareholder Value - Alkermes  ( NASDAQ:ALKS ) ,https://www.benzinga.com/pressreleases/23/05/n32584139/alkermes-files-definitive-proxy-statement-and-issues-letter-to-shareholders-detailing-business-exe,20230525T201500,['PRNewswire'],"Company Has Outperformed Peers and Relevant Indices Since Unveiling its December 2020 Value Enhancement Plan 70% of Board's Independent Directors Have Been Appointed Over the Last Four Years, Including Four Directors Designated or Supported by Shareholders",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.858979'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.301909,Somewhat-Bullish,"[{'ticker': 'RARE', 'relevance_score': '0.008935', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SRPT', 'relevance_score': '0.008935', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.008935', 'ticker_sentiment_score': '0.137791', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.008935', 'ticker_sentiment_score': '0.110316', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NBIX', 'relevance_score': '0.008935', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALNY', 'relevance_score': '0.008935', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IONS', 'relevance_score': '0.008935', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SAGE', 'relevance_score': '0.008935', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.008935', 'ticker_sentiment_score': '0.135999', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALKS', 'relevance_score': '0.46204', 'ticker_sentiment_score': '0.436007', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'UTHR', 'relevance_score': '0.008935', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PTCT', 'relevance_score': '0.008935', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IRWD', 'relevance_score': '0.008935', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JAZZ', 'relevance_score': '0.008935', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HZNP', 'relevance_score': '0.008935', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EBS', 'relevance_score': '0.008935', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INCY', 'relevance_score': '0.008935', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EXEL', 'relevance_score': '0.008935', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ACAD', 'relevance_score': '0.008935', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BPMC', 'relevance_score': '0.008935', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Worried About a Recession? Stash Your Cash in These 2 ETFs.,https://www.fool.com/investing/2023/05/25/worried-about-a-recession-stash-your-cash-in-these/,20230525T124500,['David Jagielski'],"Rather than holding your cash, consider investing it in these stable ETFs.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F733395%2Fa-digital-render-of-a-self-driving-car-stopped-at-a-cross-walk-surrounded-by-people.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.99986'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.106613,Neutral,"[{'ticker': 'COST', 'relevance_score': '0.067347', 'ticker_sentiment_score': '0.220938', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AZN', 'relevance_score': '0.067347', 'ticker_sentiment_score': '0.033053', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.067347', 'ticker_sentiment_score': '0.033053', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.067347', 'ticker_sentiment_score': '0.220938', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PEP', 'relevance_score': '0.067347', 'ticker_sentiment_score': '0.220938', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.067347', 'ticker_sentiment_score': '0.033053', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.067347', 'ticker_sentiment_score': '0.033053', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.067347', 'ticker_sentiment_score': '0.220938', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Agios Appoints Catherine Owen to Board of Directors,https://www.globenewswire.com/news-release/2023/05/25/2675968/31990/en/Agios-Appoints-Catherine-Owen-to-Board-of-Directors.html,20230525T110000,"['Inc.', 'Agios Pharmaceuticals']",- John Maraganore Completes Tenure on Agios Board After Nearly a Dozen Years of Service ...,https://ml.globenewswire.com/Resource/Download/c7d64dad-71c8-47cc-a58d-c93a49ce8f01,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.310843'}]",0.16342,Somewhat-Bullish,"[{'ticker': 'AGIO', 'relevance_score': '0.057698', 'ticker_sentiment_score': '0.117976', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.057698', 'ticker_sentiment_score': '-0.038041', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.028868', 'ticker_sentiment_score': '0.141476', 'ticker_sentiment_label': 'Neutral'}]"
Agios Appoints Catherine Owen to Board of Directors - Agios Pharmaceuticals  ( NASDAQ:AGIO ) ,https://www.benzinga.com/pressreleases/23/05/g32569894/agios-appoints-catherine-owen-to-board-of-directors,20230525T110000,['Globe Newswire'],"- John Maraganore Completes Tenure on Agios Board After Nearly a Dozen Years of Service - - Kaye Foster to Be Appointed Lead Independent Director - CAMBRIDGE, Mass., May 25, 2023 ( GLOBE NEWSWIRE ) -- Agios Pharmaceuticals, Inc.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.495866'}]",0.158598,Somewhat-Bullish,"[{'ticker': 'AGIO', 'relevance_score': '0.055881', 'ticker_sentiment_score': '0.115893', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.055881', 'ticker_sentiment_score': '-0.038016', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.027958', 'ticker_sentiment_score': '0.138966', 'ticker_sentiment_label': 'Neutral'}]"
Adverum Biotechnologies Announces New Executive Leadership Roles,https://www.globenewswire.com/news-release/2023/05/25/2675941/32452/en/Adverum-Biotechnologies-Announces-New-Executive-Leadership-Roles.html,20230525T103000,"['Inc.', 'Adverum Biotechnologies']","- Richard Beckman, M.D., chief medical officer, transitions to senior medical advisor ...",https://ml.globenewswire.com/Resource/Download/aaad6041-1171-4391-8d0f-65f10a3830cd,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.310843'}]",0.125208,Neutral,"[{'ticker': 'ADVM', 'relevance_score': '0.212814', 'ticker_sentiment_score': '0.150702', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GILD', 'relevance_score': '0.02692', 'ticker_sentiment_score': '0.043135', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.02692', 'ticker_sentiment_score': '0.043135', 'ticker_sentiment_label': 'Neutral'}]"
Adverum Biotechnologies Announces New Executive Leadership Roles - Adverum Biotechnologies  ( NASDAQ:ADVM ) ,https://www.benzinga.com/pressreleases/23/05/g32569208/adverum-biotechnologies-announces-new-executive-leadership-roles,20230525T103000,['Globe Newswire'],"- Richard Beckman, M.D., chief medical officer, transitions to senior medical advisor - - Star Seyedkazemi, Pharm.D., chief development officer, expands her responsibilities to lead Adverum's clinical development, medical affairs and pharmacovigilance teams -",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.495866'}]",0.124735,Neutral,"[{'ticker': 'ADVM', 'relevance_score': '0.177709', 'ticker_sentiment_score': '0.130266', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.025596', 'ticker_sentiment_score': '0.04281', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.025596', 'ticker_sentiment_score': '0.04281', 'ticker_sentiment_label': 'Neutral'}]"
Is Vanguard High Dividend Yield ETF  ( VYM )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2099432/is-vanguard-high-dividend-yield-etf-vym-a-strong-etf-right-now,20230525T102008,['Zacks Investment Research'],Smart Beta ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default214.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999999'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.267405,Somewhat-Bullish,"[{'ticker': 'JPM', 'relevance_score': '0.116348', 'ticker_sentiment_score': '0.06132', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.116348', 'ticker_sentiment_score': '0.06132', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.116348', 'ticker_sentiment_score': '0.06132', 'ticker_sentiment_label': 'Neutral'}]"
"Boyu, Hillhouse, others vie for HK-based medical device firm Quasar -sources",https://www.reuters.com/markets/deals/boyu-hillhouse-others-vie-hk-based-medical-device-firm-quasar-sources-2023-05-25/,20230525T035603,"['Kane Wu', 'Yantoultra Ngui']","Boyu, Hillhouse, others vie for HK-based medical device firm Quasar ... ...",https://cloudfront-us-east-2.images.arcpublishing.com/reuters/4QXBW6RP45FBRHDZQXLNRGX5UY.jpg,Reuters,Markets,www.reuters.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.086558,Neutral,"[{'ticker': 'GS', 'relevance_score': '0.111488', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.111488', 'ticker_sentiment_score': '0.068056', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.111488', 'ticker_sentiment_score': '0.068056', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson  ( JNJ )  Stock Moves -0.1%: What You Should Know,https://www.zacks.com/stock/news/2099322/johnson-johnson-jnj-stock-moves--01-what-you-should-know,20230524T214508,['Zacks Investment Research'],"Johnson & Johnson (JNJ) closed the most recent trading day at $156.66, moving -0.1% from the previous trading session.",https://staticx-tuner.zacks.com/images/default_article_images/default142.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.976913'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.162739,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.658245', 'ticker_sentiment_score': '0.242794', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Boston Scientific  ( BSX )  Gains From Acquisitions, New Launches",https://www.zacks.com/stock/news/2099237/boston-scientific-bsx-gains-from-acquisitions-new-launches,20230524T163800,['Zacks Investment Research'],Boston Scientific (BSX) remains excited about 2023 performance and expects to continue to outpace its peers within the EMEA market.,https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.838487'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.976913'}]",0.244213,Somewhat-Bullish,"[{'ticker': 'HESG', 'relevance_score': '0.056143', 'ticker_sentiment_score': '0.130013', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZBH', 'relevance_score': '0.221819', 'ticker_sentiment_score': '0.119883', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EW', 'relevance_score': '0.056143', 'ticker_sentiment_score': '0.061901', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HOLX', 'relevance_score': '0.221819', 'ticker_sentiment_score': '0.113893', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNN', 'relevance_score': '0.056143', 'ticker_sentiment_score': '0.061901', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSSMY', 'relevance_score': '0.056143', 'ticker_sentiment_score': '0.061901', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BSX', 'relevance_score': '0.426824', 'ticker_sentiment_score': '0.303608', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.056143', 'ticker_sentiment_score': '0.061901', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEN', 'relevance_score': '0.221819', 'ticker_sentiment_score': '0.17906', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MDT', 'relevance_score': '0.056143', 'ticker_sentiment_score': '0.061901', 'ticker_sentiment_label': 'Neutral'}]"
Check Out What Whales Are Doing With JNJ - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/05/32554353/check-out-what-whales-are-doing-with-jnj,20230524T150247,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.187404,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.723441', 'ticker_sentiment_score': '0.353392', 'ticker_sentiment_label': 'Bullish'}]"
Hemostasis Diagnostics Market to Grow Significantly by 2029- Brandessence Market Research,https://www.prnewswire.com/news-releases/hemostasis-diagnostics-market-to-grow-significantly-by-2029--brandessence-market-research-301833482.html,20230524T142000,['Brandessence Market Research and Consulting Private Limited'],Hemostasis Diagnostics Market to Grow Significantly by 2029 ... PR ...,https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Earnings', 'relevance_score': '0.87644'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.228698,Somewhat-Bullish,"[{'ticker': 'NHNKF', 'relevance_score': '0.019474', 'ticker_sentiment_score': '0.085922', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABT', 'relevance_score': '0.019474', 'ticker_sentiment_score': '0.085922', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSMXF', 'relevance_score': '0.019474', 'ticker_sentiment_score': '0.085922', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.019474', 'ticker_sentiment_score': '0.103792', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TMO', 'relevance_score': '0.019474', 'ticker_sentiment_score': '0.085922', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GRFS', 'relevance_score': '0.019474', 'ticker_sentiment_score': '0.085922', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.019474', 'ticker_sentiment_score': '0.085922', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HAE', 'relevance_score': '0.019474', 'ticker_sentiment_score': '0.085922', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.019474', 'ticker_sentiment_score': '0.103792', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DHR', 'relevance_score': '0.019474', 'ticker_sentiment_score': '0.085922', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:UZS', 'relevance_score': '0.019474', 'ticker_sentiment_score': '0.143111', 'ticker_sentiment_label': 'Neutral'}]"
"Wall Street's Most Accurate Analysts Say Buy These 3 Health Care Stocks With Over 3% Dividend Yields - CVS Health  ( NYSE:CVS ) , AbbVie  ( NYSE:ABBV ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/05/32550121/wall-streets-most-accurate-analysts-say-buy-these-3-health-care-stocks-with-over-3-divid,20230524T123538,['Lisa Levin'],"During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.",https://cdn.benzinga.com/files/images/story/2023/05/24/image47.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.071733,Neutral,"[{'ticker': 'CVS', 'relevance_score': '0.09402', 'ticker_sentiment_score': '-0.045597', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.09402', 'ticker_sentiment_score': '0.085727', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.09402', 'ticker_sentiment_score': '-0.146768', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GMAB', 'relevance_score': '0.09402', 'ticker_sentiment_score': '0.085727', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.09402', 'ticker_sentiment_score': '-0.087733', 'ticker_sentiment_label': 'Neutral'}]"
"New Data Out Of Cleveland Clinic Shows BioSig PURE EP May Be Used For More Precise Approach For $6 Billion Annual Atrial Fibrillation Market - Abbott Laboratories  ( NYSE:ABT ) , AtriCure  ( NASDAQ:ATRC ) ",https://www.benzinga.com/general/biotech/23/05/32548741/new-data-out-of-cleveland-clinic-shows-biosig-pure-ep-may-be-used-for-more-precise-approach-for-6,20230524T120052,['Rachael Green'],"Cleveland Clinic researchers presented data from three new studies involving BioSig Technologies' BSGM proprietary PURE EP Platform at the annual Heart Rhythm 2023 meeting in New Orleans, LA last week.",https://cdn.benzinga.com/files/images/story/2023/05/24/screenshot_2023-05-24_at_5.24.40_pm.png?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}]",0.210663,Somewhat-Bullish,"[{'ticker': 'BSGM', 'relevance_score': '0.101154', 'ticker_sentiment_score': '0.213755', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ATRC', 'relevance_score': '0.101154', 'ticker_sentiment_score': '0.103909', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.101154', 'ticker_sentiment_score': '0.103909', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.101154', 'ticker_sentiment_score': '0.103909', 'ticker_sentiment_label': 'Neutral'}]"
"The daily business briefing: May 24, 2023",https://theweek.com/briefing/business-briefing/1023762/the-daily-business-briefing-may-24-2023,20230524T111632,['Harold Maass'],Kevin McCarthy and President Biden have yet to reach a deal on raising the debt limit Jabin Botsford/The Washington Post via Getty Images House Speaker Kevin McCarthy ( R ) left the Capitol late Tuesday without a deal to raise the debt ceiling and avert an unprecedented default.,"https://mediacloud.theweek.com/image/upload/f_auto,t_primary-image-mobile@1/v1684926679/GettyImages-1257681961.jpg",The Week News,n/a,theweek.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}]",-0.035921,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.059341', 'ticker_sentiment_score': '-0.08316', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NFLX', 'relevance_score': '0.176717', 'ticker_sentiment_score': '0.125631', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.059341', 'ticker_sentiment_score': '-0.070006', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GETY', 'relevance_score': '0.059341', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVGO', 'relevance_score': '0.118354', 'ticker_sentiment_score': '0.02832', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.059341', 'ticker_sentiment_score': '-0.08316', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AEO', 'relevance_score': '0.059341', 'ticker_sentiment_score': '-0.070006', 'ticker_sentiment_label': 'Neutral'}]"
"10 things you need to know today: May 24, 2023",https://theweek.com/briefing/daily-briefing/1023761/10-things-you-need-to-know-today-may-24-2023,20230524T105718,['Harold Maass'],A judge scheduled Trump's trial on criminal charges for March 2024 A Manhattan judge on Tuesday scheduled a March 2024 trial for former President Donald Trump on criminal charges of falsifying business records to hide hush money payments to cover up alleged extramarital affairs during his 2016 ...,"https://mediacloud.theweek.com/image/private/s--fUPV03G0--/f_auto,t_primary-image-mobile@1/v1608561665/GettyImages-901868142.jpg",The Week News,n/a,theweek.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}]",-0.151848,Somewhat-Bearish,"[{'ticker': 'MSFT', 'relevance_score': '0.031322', 'ticker_sentiment_score': '-0.065359', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NYT', 'relevance_score': '0.031322', 'ticker_sentiment_score': '0.039794', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.031322', 'ticker_sentiment_score': '-0.065359', 'ticker_sentiment_label': 'Neutral'}]"
Medtronic Stock: Bull vs. Bear,https://www.fool.com/investing/2023/05/24/medtronic-stock-bull-vs-bear/,20230524T095300,['Keith Speights and Adria Cimino'],This medical device giant has its positives and negatives.,https://media.ycharts.com/charts/070de00f93285d012a947e7389e3bdcf.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.891286'}]",0.404679,Bullish,"[{'ticker': 'MDT', 'relevance_score': '0.827318', 'ticker_sentiment_score': '0.663241', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.063933', 'ticker_sentiment_score': '0.007162', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.063933', 'ticker_sentiment_score': '-0.154186', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
Better Buy: Medtronic vs. Johnson & Johnson,https://www.fool.com/investing/2023/05/24/better-buy-medtronic-vs-johnson-johnson/,20230524T093000,['Adria Cimino'],Both companies are medical device leaders.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F733558%2Finvestor-68.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.997874'}]",0.333403,Somewhat-Bullish,"[{'ticker': 'MDT', 'relevance_score': '0.54572', 'ticker_sentiment_score': '0.59588', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.16171', 'ticker_sentiment_score': '0.236908', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Beijing moves to limit collateral damage from Micron sales ban,https://www.scmp.com/tech/big-tech/article/3221571/tech-war-beijing-moves-limit-collateral-damage-micron-sales-ban-muted-reaction-consumers,20230524T000021,"['Ann Cao', 'Che Pan']","China's foreign ministry, the commerce ministry and tabloid Global Times have all described the Micron ban as an individual case, and not a signal that other US firms may be in jeopardy.",,South China Morning Post,Business,www.scmp.com,"[{'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",-0.106552,Neutral,"[{'ticker': 'BABA', 'relevance_score': '0.059636', 'ticker_sentiment_score': '-0.060178', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.059636', 'ticker_sentiment_score': '0.1', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:AMD', 'relevance_score': '0.11894', 'ticker_sentiment_score': '0.109421', 'ticker_sentiment_label': 'Neutral'}]"
Microsoft bonds are seen as safer than Treasury bills due this summer as the default X-date nears,https://markets.businessinsider.com/news/bonds/microsoft-jnj-corporate-bonds-safe-haven-treasury-debt-default-ceiling-2023-5,20230523T195800,['Filip De Mott'],Microsoft Bonds Are Seen As Safer Than Treasurys As Default X ... - Markets Insider ...,https://i.insider.com/646d042aa739dc0018091030?width=1200&format=jpeg,Business Insider,GoogleRSS,markets.businessinsider.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.021813,Neutral,"[{'ticker': 'MCO', 'relevance_score': '0.205807', 'ticker_sentiment_score': '0.200412', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.485711', 'ticker_sentiment_score': '0.390831', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'AWON', 'relevance_score': '0.103778', 'ticker_sentiment_score': '0.006636', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.205807', 'ticker_sentiment_score': '0.200412', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara,https://www.reuters.com/business/healthcare-pharmaceuticals/amgen-settles-jj-patent-lawsuit-over-drug-similar-blockbuster-stelara-2023-05-23/,20230523T153500,['Blake Brittain'],Amgen settles patent lawsuit over biosimilar of J&J's big-selling ... ...,https://s3.amazonaws.com/arc-authors/reuters/e80269c0-8a61-4e5d-afa1-d2c4740ed247.png,Reuters,Business,www.reuters.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.188663,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.18967', 'ticker_sentiment_score': '-0.078613', 'ticker_sentiment_label': 'Neutral'}]"
Buying These 2 Stocks Is a Good Way to Hedge Against a Market Crash,https://www.fool.com/investing/2023/05/23/buying-these-2-stocks-is-a-good-way-to-hedge-again/,20230523T140700,['Jim Halley'],Both companies have produced consistent revenue growth and predictable profitability.,https://media.ycharts.com/charts/1180e17eb6cbd3825643dc05211482fd.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.999999'}]",0.177604,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.103331', 'ticker_sentiment_score': '0.0635', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DG', 'relevance_score': '0.254573', 'ticker_sentiment_score': '0.17587', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.350564', 'ticker_sentiment_score': '0.113499', 'ticker_sentiment_label': 'Neutral'}]"
"Star Equity Fund Launches Proxy Solicitation at Servotronics - Servotronics  ( AMEX:SVT ) , Star Equity Hldgs  ( NASDAQ:STRR ) ",https://www.benzinga.com/pressreleases/23/05/g32527808/star-equity-fund-launches-proxy-solicitation-at-servotronics,20230523T123023,['Globe Newswire'],Urges All Shareholders to Vote the WHITE Proxy Card Today to Elect Mark Pomeroy and Rick Coleman to SVT'S Board at Upcoming Annual Meeting,https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.310843'}]",0.173493,Somewhat-Bullish,"[{'ticker': 'HQI', 'relevance_score': '0.030563', 'ticker_sentiment_score': '0.120291', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STRR', 'relevance_score': '0.408317', 'ticker_sentiment_score': '0.277978', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.030563', 'ticker_sentiment_score': '0.067076', 'ticker_sentiment_label': 'Neutral'}]"
"Medical device companies are in an 'emerging bull market,' Jim Cramer says",https://www.cnbc.com/2023/05/22/medical-device-companies-are-in-an-emerging-bull-market-jim-cramer-says.html,20230522T231340,['Julie Coleman'],"CNBC's Jim Cramer touted the burgeoning bull market of medical devices, which is taking off post Covid.",https://image.cnbcfm.com/api/v1/image/107243731-1684454364693-gettyimages-1254161031-AFP_33EX9LE.jpeg?v=1684769394,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.891286'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.109019,Neutral,"[{'ticker': 'META', 'relevance_score': '0.073546', 'ticker_sentiment_score': '-0.090564', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.073546', 'ticker_sentiment_score': '0.164543', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'INMD', 'relevance_score': '0.218161', 'ticker_sentiment_score': '-0.075638', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.146469', 'ticker_sentiment_score': '0.389319', 'ticker_sentiment_label': 'Bullish'}]"
JNJ: Johnson & Johnson  ( JNJ )  and SNDL Inc.  ( SNDL )  -- Buy or Sell?,https://stocknews.com/news/jnj-sndl-johnson-johnson-jnj-and-sndl-inc-sndl-buy/,20230522T190830,[],"Although healthcare stocks could help hedge some market risks, not all stocks are worth owning. While Johnson & Johnson ( JNJ ) could be an ideal buy, fundamentally weak SNDL Inc. ( SNDL ) might be best avoided.",https://stocknews.com/wp-content/uploads/2022/06/shutterstock_1924266296-scaled.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Earnings', 'relevance_score': '0.993856'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}]",0.12863,Neutral,"[{'ticker': 'SNDL', 'relevance_score': '0.290952', 'ticker_sentiment_score': '0.220069', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.544495', 'ticker_sentiment_score': '0.225766', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
RUBICON BAKERS HIRE SEB SIETHOFF AS CEO,https://www.prnewswire.com/news-releases/rubicon-bakers-hire-seb-siethoff-as-ceo-301829852.html,20230522T160000,['Rubicon Bakers'],"RICHMOND, Calif., May 22, 2023 /PRNewswire/ -- Rubicon Bakers ( ""Rubicon"" or the ""Company"" ) is pleased to announce the hiring of Sebastian ""Seb"" Siethoff as Chief Executive Officer. Mr. Siethoff comes to Rubicon from Ball Corporation where he served as General Manager.",https://mma.prnewswire.com/media/2081464/Rubicon_Bakers_Logo_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}]",0.268268,Somewhat-Bullish,"[{'ticker': 'MDNDF', 'relevance_score': '0.084423', 'ticker_sentiment_score': '0.062411', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.084423', 'ticker_sentiment_score': '0.062411', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UL', 'relevance_score': '0.084423', 'ticker_sentiment_score': '0.062411', 'ticker_sentiment_label': 'Neutral'}]"
Sports Medicine Market to Grow Exponentially by 2029- Brandessence Market Research,https://www.prnewswire.com/news-releases/sports-medicine-market-to-grow-exponentially-by-2029--brandessence-market-research-301830920.html,20230522T144200,['Brandessence Market Research And Consulting Private Limited'],Sports Medicine Market to Grow Exponentially by 2029 ... PR ...,https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.251703,Somewhat-Bullish,"[{'ticker': 'OMRNF', 'relevance_score': '0.019978', 'ticker_sentiment_score': '0.084606', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZBH', 'relevance_score': '0.019978', 'ticker_sentiment_score': '0.107246', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNN', 'relevance_score': '0.019978', 'ticker_sentiment_score': '0.107246', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SYK', 'relevance_score': '0.019978', 'ticker_sentiment_score': '0.107246', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSSMY', 'relevance_score': '0.019978', 'ticker_sentiment_score': '0.107246', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BSX', 'relevance_score': '0.019978', 'ticker_sentiment_score': '0.084606', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.019978', 'ticker_sentiment_score': '0.107246', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.039944', 'ticker_sentiment_score': '0.088725', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CNMD', 'relevance_score': '0.019978', 'ticker_sentiment_score': '0.107246', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:UZS', 'relevance_score': '0.019978', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
"US-China Relations To Improve ""Very Shortly"", Examining The Micron ""Ban"", Full Truck & Kuaishou Beat",https://www.forbes.com/sites/brendanahern/2023/05/22/us-china-relations-to-improve-very-shortly-examining-the-micron-ban-full-truck--kuaishou-beat/,20230522T141625,['Brendan Ahern'],Asian equities had a strong start to the week as Hong Kong outperformed the region.,https://imageio.forbes.com/specials-images/imageserve/646b77c77ddb7fe48676b700/0x0.jpg?format=jpg&width=1200,Forbes,Money,www.forbes.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Earnings', 'relevance_score': '0.744043'}, {'topic': 'Technology', 'relevance_score': '0.5'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.229897,Somewhat-Bullish,"[{'ticker': 'BABA', 'relevance_score': '0.049322', 'ticker_sentiment_score': '0.351574', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'YMM', 'relevance_score': '0.098456', 'ticker_sentiment_score': '0.157784', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SZIHF', 'relevance_score': '0.098456', 'ticker_sentiment_score': '0.117531', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TCTZF', 'relevance_score': '0.147216', 'ticker_sentiment_score': '0.201651', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.049322', 'ticker_sentiment_score': '0.050443', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MPNGY', 'relevance_score': '0.098456', 'ticker_sentiment_score': '0.173445', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.049322', 'ticker_sentiment_score': '0.087', 'ticker_sentiment_label': 'Neutral'}]"
Should You Invest in the iShares U.S. Pharmaceuticals ETF  ( IHE ) ?,https://www.zacks.com/stock/news/2097784/should-you-invest-in-the-ishares-us-pharmaceuticals-etf-ihe,20230522T102006,['Zacks Investment Research'],Sector ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default10.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999999'}]",0.187164,Somewhat-Bullish,"[{'ticker': 'BLK', 'relevance_score': '0.06697', 'ticker_sentiment_score': '0.031043', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.13347', 'ticker_sentiment_score': '0.061665', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.13347', 'ticker_sentiment_score': '0.137166', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.13347', 'ticker_sentiment_score': '0.061665', 'ticker_sentiment_label': 'Neutral'}]"
"ACCENTURE, BIC TO LEAD AFRICA'S MOST INSPIRATIONAL WOMEN IN LEADERSHIP AT 2023 AFRICA BREAK THE CEILING TOUCH THE SKY SUMMIT.",https://www.prnewswire.com/news-releases/accenture-bic-to-lead-africas-most-inspirational-women-in-leadership-at-2023-africa-break-the-ceiling-touch-the-sky-summit-301830566.html,20230522T084500,['House of Rose Professional Pte. Ltd.'],"ACCENTURE, BIC TO LEAD AFRICA'S MOST INSPIRATIONAL ... PR ...",https://mma.prnewswire.com/media/1837174/4046836/House_of_Rose_Professional_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.212961,Somewhat-Bullish,"[{'ticker': 'VODAF', 'relevance_score': '0.08687', 'ticker_sentiment_score': '0.022644', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AGRPF', 'relevance_score': '0.08687', 'ticker_sentiment_score': '0.022644', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.08687', 'ticker_sentiment_score': '0.022644', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VTRS', 'relevance_score': '0.08687', 'ticker_sentiment_score': '0.022644', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BICEF', 'relevance_score': '0.256538', 'ticker_sentiment_score': '0.170687', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SBGSF', 'relevance_score': '0.08687', 'ticker_sentiment_score': '0.022644', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ACN', 'relevance_score': '0.256538', 'ticker_sentiment_score': '0.170687', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ROK', 'relevance_score': '0.08687', 'ticker_sentiment_score': '0.022644', 'ticker_sentiment_label': 'Neutral'}]"
"Got $1,000? 5 Buffett Stocks to Buy and Hold Forever",https://www.fool.com/investing/2023/05/21/got-1000-5-buffett-stocks-to-buy-and-hold-forever/,20230521T100400,['Neha Chamaria'],"Warren Buffett owns many stocks, but these five have solid growth potential.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F733098%2Fbuffett21-tmf.png&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.999966'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.875462'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.227104,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.03443', 'ticker_sentiment_score': '0.09313', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.03443', 'ticker_sentiment_score': '0.09313', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.03443', 'ticker_sentiment_score': '0.09313', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.170878', 'ticker_sentiment_score': '0.155947', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CVX', 'relevance_score': '0.237469', 'ticker_sentiment_score': '0.116762', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'V', 'relevance_score': '0.170878', 'ticker_sentiment_score': '0.157284', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BRK-A', 'relevance_score': '0.137083', 'ticker_sentiment_score': '0.128933', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.204359', 'ticker_sentiment_score': '0.123881', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KVUE', 'relevance_score': '0.03443', 'ticker_sentiment_score': '-0.039518', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.03443', 'ticker_sentiment_score': '0.09313', 'ticker_sentiment_label': 'Neutral'}]"
3 Relatively Safe Stocks to Buy if a Recession Is on the Way,https://www.fool.com/investing/2023/05/20/3-relatively-safe-stocks-to-buy-if-a-recession-is/,20230520T101400,"['Keith Speights', 'David Jagielski', 'and Prosper Junior Bakiny']","If the economy falters, these stocks should hold up better than most.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F733076%2Fbull-market-1.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.980922'}, {'topic': 'Earnings', 'relevance_score': '0.99676'}]",0.109648,Neutral,"[{'ticker': 'KVUE', 'relevance_score': '0.043499', 'ticker_sentiment_score': '-0.093027', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.337427', 'ticker_sentiment_score': '0.131217', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABT', 'relevance_score': '0.043499', 'ticker_sentiment_score': '-0.012978', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.214937', 'ticker_sentiment_score': '0.045511', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.214937', 'ticker_sentiment_score': '-0.11223', 'ticker_sentiment_label': 'Neutral'}]"
"Global Surgical Procedures Market to Generate 372,837 thousand units by 2030, Outlines a New Report by Next Move Strategy Consulting",https://www.benzinga.com/pressreleases/23/05/g32497992/global-surgical-procedures-market-to-generate-372-837-thousand-units-by-2030-outlines-a-new-report,20230520T040000,['Globe Newswire'],"New York, May 20, 2023 ( GLOBE NEWSWIRE ) -- According to a new research report by Next Move Strategy Consulting, the Surgical Procedures Market size was 2,94,237 thousand units in 2022, and is predicted to reach 3,72,837 thousand units by 2030, with a CAGR of 3.1% during the forecast period, ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.167795,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.036587', 'ticker_sentiment_score': '0.059758', 'ticker_sentiment_label': 'Neutral'}]"
"Echocardiography  ( ECG )  Devices Market size to grow by USD 4,102.12 million from 2022 and 2027; Allengers Medical Systems Ltd., Bionet Co. Ltd., identified as key vendors - Technavio",https://www.prnewswire.com/news-releases/echocardiography-ecg-devices-market-size-to-grow-by-usd-4-102-12-million-from-2022-and-2027-allengers-medical-systems-ltd-bionet-co-ltd-identified-as-key-vendors--technavio-301828858.html,20230520T004500,['Technavio'],Echocardiography ( ECG ) Devices Market size to grow by USD ... PR ...,https://mma.prnewswire.com/media/2080570/Technavio_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}]",0.176265,Somewhat-Bullish,"[{'ticker': 'NHNKF', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HLMAF', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IRTC', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAH', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OSIS', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GE', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Clinical Project Manager  ( CPM )  Beginner Training Course,https://www.prnewswire.com/news-releases/clinical-project-manager-cpm-beginner-training-course-301829578.html,20230520T000000,['Research and Markets'],"DUBLIN, May 19, 2023 /PRNewswire/ -- The ""Clinical Project Manager ( CPM ) Beginner"" training has been added to ResearchAndMarkets.com's offering. If you are looking to enter the field of clinical research, this CPD-accredited is for you.",https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.195609,Somewhat-Bullish,"[{'ticker': 'ABBV', 'relevance_score': '0.072655', 'ticker_sentiment_score': '0.033182', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.072655', 'ticker_sentiment_score': '0.033182', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.072655', 'ticker_sentiment_score': '0.033182', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.072655', 'ticker_sentiment_score': '0.158298', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SNY', 'relevance_score': '0.072655', 'ticker_sentiment_score': '0.158298', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Global Cellulite Treatment Global Market 2023-2030: Increasing Trend of Anti-Cellulite Massage Presents Opportunities,https://www.prnewswire.com/news-releases/global-cellulite-treatment-global-market-2023-2030-increasing-trend-of-anti-cellulite-massage-presents-opportunities-301829574.html,20230519T234500,['Research and Markets'],Global Cellulite Treatment Global Market 2023-2030: Increasing ... PR ...,https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.197505,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.077593', 'ticker_sentiment_score': '0.085064', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SIEN', 'relevance_score': '0.077593', 'ticker_sentiment_score': '0.085064', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.077593', 'ticker_sentiment_score': '0.085064', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BHC', 'relevance_score': '0.154455', 'ticker_sentiment_score': '0.018332', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ENDPQ', 'relevance_score': '0.077593', 'ticker_sentiment_score': '0.085064', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HCSG', 'relevance_score': '0.077593', 'ticker_sentiment_score': '0.258095', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CUTR', 'relevance_score': '0.077593', 'ticker_sentiment_score': '0.085064', 'ticker_sentiment_label': 'Neutral'}]"
"Autoimmune Drugs Market size to grow by USD 29,314.5 million between 2022 and 2027; AbbVie Inc., and AdvaCare Pharma among others, identified as key vendors - Technavio",https://www.prnewswire.com/news-releases/autoimmune-drugs-market-size-to-grow-by-usd-29-314-5-million-between-2022-and-2027-abbvie-inc-and-advacare-pharma-among-others-identified-as-key-vendors--technavio-301828870.html,20230519T231500,['Technavio'],"Autoimmune Drugs Market size to grow by USD 29,314.5 million ... PR ...",https://mma.prnewswire.com/media/2080550/Technavio_Logo_Logo_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}]",0.200974,Somewhat-Bullish,"[{'ticker': 'AZN', 'relevance_score': '0.075161', 'ticker_sentiment_score': '0.137715', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.075161', 'ticker_sentiment_score': '0.137715', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BOALF', 'relevance_score': '0.037622', 'ticker_sentiment_score': '0.140333', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HKMPF', 'relevance_score': '0.075161', 'ticker_sentiment_score': '0.137715', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.075161', 'ticker_sentiment_score': '0.137715', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAH', 'relevance_score': '0.075161', 'ticker_sentiment_score': '0.137715', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TEVA', 'relevance_score': '0.075161', 'ticker_sentiment_score': '0.137715', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'REGN', 'relevance_score': '0.075161', 'ticker_sentiment_score': '0.137715', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.075161', 'ticker_sentiment_score': '0.137715', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.075161', 'ticker_sentiment_score': '0.137715', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.075161', 'ticker_sentiment_score': '0.137715', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TAK', 'relevance_score': '0.075161', 'ticker_sentiment_score': '0.137715', 'ticker_sentiment_label': 'Neutral'}]"
What Are Penny Stocks & Should You Buy Them In 2023?,https://pennystocks.com/featured/2023/05/19/what-are-penny-stocks-should-you-buy-them-2023/,20230519T193222,['J. Samuel'],"In this article, we're going to go over some basics. We'll discuss the definition of penny stocks, the pros & cons, plus some extra details you should know before jumping into the market. A penny stock represents the stock of a company that trades for less than $5 per share.",,PennyStocks.com,n/a,pennystocks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}]",0.163856,Somewhat-Bullish,"[{'ticker': 'AAPL', 'relevance_score': '0.052169', 'ticker_sentiment_score': '0.085992', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.052169', 'ticker_sentiment_score': '0.181814', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.052169', 'ticker_sentiment_score': '0.120545', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AWON', 'relevance_score': '0.026098', 'ticker_sentiment_score': '0.080859', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVAX', 'relevance_score': '0.078184', 'ticker_sentiment_score': '0.122774', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SWN', 'relevance_score': '0.052169', 'ticker_sentiment_score': '-0.055666', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABEV', 'relevance_score': '0.052169', 'ticker_sentiment_score': '-0.055666', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.052169', 'ticker_sentiment_score': '0.120545', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.052169', 'ticker_sentiment_score': '0.181814', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GME', 'relevance_score': '0.078184', 'ticker_sentiment_score': '-0.043527', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.052169', 'ticker_sentiment_score': '0.120545', 'ticker_sentiment_label': 'Neutral'}]"
Most stocks end up losing you money. What's an investor to do?,https://www.marketwatch.com/story/most-stocks-end-up-losing-you-money-whats-an-investor-to-do-996e8326,20230519T150100,['Brett Arends'],Read this before trying to pick stocks.,https://images.mktw.net/im-785122/horizontal,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.99737'}]",0.243169,Somewhat-Bullish,"[{'ticker': 'GOOG', 'relevance_score': '0.102231', 'ticker_sentiment_score': '0.219254', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.051221', 'ticker_sentiment_score': '0.210496', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.20279', 'ticker_sentiment_score': '0.315899', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CVX', 'relevance_score': '0.102231', 'ticker_sentiment_score': '0.21384', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BRK-A', 'relevance_score': '0.051221', 'ticker_sentiment_score': '0.198473', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.102231', 'ticker_sentiment_score': '0.21384', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABNB', 'relevance_score': '0.102231', 'ticker_sentiment_score': '0.104806', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DASH', 'relevance_score': '0.102231', 'ticker_sentiment_score': '0.104806', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.152821', 'ticker_sentiment_score': '0.262174', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PG', 'relevance_score': '0.102231', 'ticker_sentiment_score': '0.21384', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UBER', 'relevance_score': '0.102231', 'ticker_sentiment_score': '0.104806', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.152821', 'ticker_sentiment_score': '0.262174', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WMT', 'relevance_score': '0.102231', 'ticker_sentiment_score': '0.21384', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.051221', 'ticker_sentiment_score': '-0.374884', 'ticker_sentiment_label': 'Bearish'}]"
"STERIS  ( STE )  Continues to Face Dull Dental Sales, Margin Woes",https://www.zacks.com/stock/news/2097434/steris-ste-continues-to-face-dull-dental-sales-margin-woes,20230519T144800,['Zacks Investment Research'],"STERIS (STE) competes for pharmaceutical, research and industrial customers against several large companies that have robust product portfolios and global reach.",https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.650727'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.961735'}]",0.093708,Neutral,"[{'ticker': 'KMB', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.078811', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MMSI', 'relevance_score': '0.143415', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STE', 'relevance_score': '0.530253', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.078811', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DVA', 'relevance_score': '0.282234', 'ticker_sentiment_score': '-0.06744', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADUS', 'relevance_score': '0.282234', 'ticker_sentiment_score': '0.170588', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ECL', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.078811', 'ticker_sentiment_label': 'Neutral'}]"
2 Healthcare Stocks You Can Buy and Hold for the Next Decade,https://www.fool.com/investing/2023/05/19/2-healthcare-stocks-you-can-hold-for-next-decade/,20230519T142300,['Jim Halley'],These two solid companies should be buoyed by recent tailwinds.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F732639%2Fbuffett17-tmf.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}]",0.260394,Somewhat-Bullish,"[{'ticker': 'VRTX', 'relevance_score': '0.089965', 'ticker_sentiment_score': '0.220609', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MDT', 'relevance_score': '0.307511', 'ticker_sentiment_score': '0.231593', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SWAV', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.013906', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.013906', 'ticker_sentiment_label': 'Neutral'}]"
"Kenvue Just IPO'd, but Is the Stock a Buy?",https://www.fool.com/investing/2023/05/19/kenvue-just-ipod-but-is-the-stock-a-buy/,20230519T092400,['Alex Carchidi'],"The Johnson & Johnson spinoff is worth considering, but it's not a must-buy.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F732639%2Fbuffett17-tmf.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.451494'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}, {'topic': 'Earnings', 'relevance_score': '0.614606'}]",0.159235,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.414559', 'ticker_sentiment_score': '0.087843', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.144275', 'ticker_sentiment_score': '0.091031', 'ticker_sentiment_label': 'Neutral'}]"
"Tesla, Apple, Microsoft Stakes Slashed By New York State Retirement Fund In Q1: Here's What It Bought - Microsoft  ( NASDAQ:MSFT ) , Apple  ( NASDAQ:AAPL ) , Tesla  ( NASDAQ:TSLA ) , Johnson & Johnson  ( NYSE:JNJ ) , Charles Schwab  ( NYSE:SCHW ) , Texas Instruments  ( NASDAQ:TXN ) , Amazon.com  ( NASDAQ:AMZN ) , Taiwan Semiconductor  ( NYSE:TSM ) ",https://www.benzinga.com/markets/equities/23/05/32480849/tesla-apple-microsoft-stakes-slashed-by-new-york-state-retirement-fund-in-q1-heres-what-it-bough,20230519T073144,['Bhavik Nair'],"The New York State Common Retirement Fund, a public pension plan for the employees of the New York State government, cut down on its holdings of mega-cap technology stocks in the first quarter, according to its latest 13F filing with the Securities and Exchange Commission.",https://cdn.benzinga.com/files/images/story/2023/Tesla_stock_2.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}]",0.266393,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.535653', 'ticker_sentiment_score': '0.291638', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.535653', 'ticker_sentiment_score': '0.459497', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.416844', 'ticker_sentiment_score': '0.32399', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.285526', 'ticker_sentiment_score': '0.151986', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SCHW', 'relevance_score': '0.285526', 'ticker_sentiment_score': '0.151986', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TXN', 'relevance_score': '0.285526', 'ticker_sentiment_score': '0.435169', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'AMZN', 'relevance_score': '0.285526', 'ticker_sentiment_score': '0.189634', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
RSV Vaccine: FDA Advisors Recommend Pfizer Shot To Protect Infants From Infection-Here's What To Know,https://www.forbes.com/sites/roberthart/2023/05/18/rsv-vaccine-fda-advisors-recommend-pfizer-shot-to-protect-infants-from-infection-heres-what-to-know/,20230518T234650,['Robert Hart'],The vaccine is given to pregnant people to protect infants from RSV in their first months of life.,"https://imageio.forbes.com/specials-images/imageserve/63f4d468626131bccfd51cbb/0x0.jpg?format=jpg&crop=2473,1389,x127,y0,safe&width=1200",Forbes,Business,www.forbes.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.087094,Neutral,"[{'ticker': 'TRMNF', 'relevance_score': '0.042122', 'ticker_sentiment_score': '-0.507649', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'MRNA', 'relevance_score': '0.042122', 'ticker_sentiment_score': '0.074325', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.042122', 'ticker_sentiment_score': '0.082841', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.125898', 'ticker_sentiment_score': '0.061808', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.042122', 'ticker_sentiment_score': '0.074325', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.042122', 'ticker_sentiment_score': '0.082841', 'ticker_sentiment_label': 'Neutral'}]"
UM Crowned Campaign's Media Agency Global Network of the Year,https://www.prnewswire.com/news-releases/um-crowned-campaigns-media-agency-global-network-of-the-year-301828905.html,20230518T172800,['UM'],"Campaign's 2022 Global Agency of the Year Awards Celebrate the Very Best All-round Performers on the Globe NEW YORK, May 18, 2023 /PRNewswire/ -- UM, a global media agency network of IPG Mediabrands, was awarded ""Media Agency Global Network of the Year"" in Campaign's 2022 Global Agency of the ...",https://mma.prnewswire.com/media/941707/UM__Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}]",0.54247,Bullish,"[{'ticker': 'SNEJF', 'relevance_score': '0.095138', 'ticker_sentiment_score': '0.198052', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MAT', 'relevance_score': '0.095138', 'ticker_sentiment_score': '0.198052', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SPOT', 'relevance_score': '0.095138', 'ticker_sentiment_score': '0.198052', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GPRO', 'relevance_score': '0.095138', 'ticker_sentiment_score': '0.198052', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.095138', 'ticker_sentiment_score': '0.198052', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'XOM', 'relevance_score': '0.095138', 'ticker_sentiment_score': '0.198052', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AXP', 'relevance_score': '0.095138', 'ticker_sentiment_score': '0.198052', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ACN', 'relevance_score': '0.095138', 'ticker_sentiment_score': '0.198052', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Johnson & Johnson  ( JNJ )  Down 2.2% Since Last Earnings Report: Can It Rebound?,https://www.zacks.com/stock/news/2096971/johnson-johnson-jnj-down-22-since-last-earnings-report-can-it-rebound,20230518T153010,['Zacks Investment Research'],Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,https://staticx-tuner.zacks.com/images/default_article_images/default181.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999917'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}]",0.140819,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.096866', 'ticker_sentiment_score': '0.071051', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.024273', 'ticker_sentiment_score': '0.116592', 'ticker_sentiment_label': 'Neutral'}]"
RSV Vaccine: Here's What To Know As FDA Advisors Consider Approving Pfizer's Shot,https://www.forbes.com/sites/roberthart/2023/05/18/rsv-vaccine-heres-what-to-know-as-fda-advisors-consider-approving-pfizers-shot/,20230518T123107,['Robert Hart'],"FDA analysts have flagged concerns over the risk of preterm birth for the shot, which is given to pregnant people to protect infants from RSV in their first months of life.","https://imageio.forbes.com/specials-images/imageserve/63f4d468626131bccfd51cbb/0x0.jpg?format=jpg&crop=2473,1389,x127,y0,safe&width=1200",Forbes,Business,www.forbes.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.099037,Neutral,"[{'ticker': 'TRMNF', 'relevance_score': '0.041538', 'ticker_sentiment_score': '-0.507462', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'MRNA', 'relevance_score': '0.041538', 'ticker_sentiment_score': '0.074247', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.041538', 'ticker_sentiment_score': '0.082698', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.124164', 'ticker_sentiment_score': '0.012019', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.041538', 'ticker_sentiment_score': '0.074247', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.041538', 'ticker_sentiment_score': '0.082698', 'ticker_sentiment_label': 'Neutral'}]"
3 Goldman Sachs Mutual Funds for Excellent Returns,https://www.zacks.com/stock/news/2096715/3-goldman-sachs-mutual-funds-for-excellent-returns,20230518T112300,['Zacks Investment Research'],"Below, we share with you three top-ranked Goldman Sachs mutual funds. Each has earned a Zacks Mutual Fund Rank #1.",https://staticx-tuner.zacks.com/images/default_article_images/default29.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.99793'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.365204,Bullish,"[{'ticker': 'GS', 'relevance_score': '0.874135', 'ticker_sentiment_score': '0.546944', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.081276', 'ticker_sentiment_score': '0.152256', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Is 3M Company Stock a Buy?,https://www.fool.com/investing/2023/05/18/is-3m-company-stock-a-buy/,20230518T103500,['Justin Pope'],Uncertainty around litigation is weighing on the stock.,https://media.ycharts.com/charts/3a809a25fc3c4498d2e6b68e0589e96d.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}]",-0.085167,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.056674', 'ticker_sentiment_score': '0.027005', 'ticker_sentiment_label': 'Neutral'}]"
Should Invesco S&P 500 Low Volatility ETF  ( SPLV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2096645/should-invesco-sp-500-low-volatility-etf-splv-be-on-your-investing-radar,20230518T102007,['Zacks Investment Research'],Style Box ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default246.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.060002,Neutral,"[{'ticker': 'PEP', 'relevance_score': '0.133841', 'ticker_sentiment_score': '0.071297', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.199584', 'ticker_sentiment_score': '0.016198', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.067158', 'ticker_sentiment_score': '0.060109', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.133841', 'ticker_sentiment_score': '0.071297', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCD', 'relevance_score': '0.133841', 'ticker_sentiment_score': '0.071297', 'ticker_sentiment_label': 'Neutral'}]"
"Got $2,500? 2 Top Stocks That You Can Buy and Hold for a Lifetime",https://www.fool.com/investing/2023/05/18/got-2500-2-top-stocks-that-you-can-buy-and-hold-fo/,20230518T095200,['Keith Speights'],"Buy these stocks, then...do nothing.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F732462%2Fstock-chart-quote-bear-bull-trading-invest-short-options-getty.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.972756'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.336785,Somewhat-Bullish,"[{'ticker': 'AAPL', 'relevance_score': '0.720958', 'ticker_sentiment_score': '0.533368', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'MDT', 'relevance_score': '0.061631', 'ticker_sentiment_score': '0.149452', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.300946', 'ticker_sentiment_score': '0.439977', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'BRK-A', 'relevance_score': '0.061631', 'ticker_sentiment_score': '0.1811', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.061631', 'ticker_sentiment_score': '0.149452', 'ticker_sentiment_label': 'Neutral'}]"
"Virtualware rewards its employees with more than 52,000 shares during its first month as a listed company on the Paris Stock Exchange",https://www.globenewswire.com/news-release/2023/05/17/2671266/0/en/Virtualware-rewards-its-employees-with-more-than-52-000-shares-during-its-first-month-as-a-listed-company-on-the-Paris-Stock-Exchange.html,20230517T151300,['Virtualware'],"PARIS and BILBAO, Spain, May 17, 2023 ( GLOBE NEWSWIRE ) -- Virtual reality company Virtualware ( EPA:MLVIR ) has distributed in its first month of trading a total of 52,602 shares among most of its employees, with a total value of more than 315,612 euros.",,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.486418,Bullish,"[{'ticker': 'HTHIF', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.132715', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IBDSF', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.132715', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AOMFF', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.132715', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.132715', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.115232', 'ticker_sentiment_score': '0.132715', 'ticker_sentiment_label': 'Neutral'}]"
2 Dividend Stocks to Double Up On Right Now,https://www.fool.com/investing/2023/05/17/2-dividend-stocks-to-double-up-on-right-now/,20230517T123500,['Matthew DiLallo'],These dividend stocks look attractive right now.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F732461%2Fpercentage-interest-rate-growth-rate-mortgage-savings.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '0.989041'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.5'}]",0.281789,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.208017', 'ticker_sentiment_score': '0.179029', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PLD', 'relevance_score': '0.307603', 'ticker_sentiment_score': '0.228626', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.355588', 'ticker_sentiment_score': '0.344567', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Johnson & Johnson Sets Aside $400M To End US State Consumer Protection Claims - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/government/23/05/32440362/johnson-johnson-sets-aside-400m-to-end-us-state-consumer-protection-claims,20230517T122039,['Vandana Singh'],"As a part of the $8.9 billion effort to settle claims related to talc products, Johnson & Johnson JNJ has earmarked $400 million to end claims alleging it violated state unfair business practices and consumer protection laws by misleading consumers about the safety of its talc products.",https://cdn.benzinga.com/files/images/story/2023/05/17/jnj.png?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.416062,Bearish,"[{'ticker': 'JNJ', 'relevance_score': '0.465196', 'ticker_sentiment_score': '-0.096279', 'ticker_sentiment_label': 'Neutral'}]"
Which Pharmaceuticals Stock Is A Better Pick: Johnson & Johnson Or Eliquis' Maker?,https://www.forbes.com/sites/greatspeculations/2023/05/17/which-pharmaceuticals-stock-is-a-better-pick-johnson--johnson-or-eliquis-maker/,20230517T120000,['Trefis Team'],"There is more to the comparison, and in the sections below, we discuss why we believe BMY stock will offer higher returns than JNJ stock in the next three years.",https://imageio.forbes.com/specials-images/imageserve/630ecf48f8b543e8c0ab966d/0x0.jpg?format=jpg&width=1200,Forbes,Markets,www.forbes.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}, {'topic': 'Earnings', 'relevance_score': '1.0'}]",0.214267,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.034332', 'ticker_sentiment_score': '0.087059', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMED', 'relevance_score': '0.034332', 'ticker_sentiment_score': '0.136733', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.333107', 'ticker_sentiment_score': '0.244088', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.424207', 'ticker_sentiment_score': '0.250228', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Should You Invest in the iShares U.S. Healthcare ETF  ( IYH ) ?,https://www.zacks.com/stock/news/2096105/should-you-invest-in-the-ishares-us-healthcare-etf-iyh,20230517T102005,['Zacks Investment Research'],Sector ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default74.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}]",0.258188,Somewhat-Bullish,"[{'ticker': 'BLK', 'relevance_score': '0.065685', 'ticker_sentiment_score': '0.08812', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.130926', 'ticker_sentiment_score': '0.069334', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.130926', 'ticker_sentiment_score': '0.069334', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.130926', 'ticker_sentiment_score': '0.069334', 'ticker_sentiment_label': 'Neutral'}]"
3 High-Yield Dividend Stocks You Probably Didn't Know Warren Buffett Owns,https://www.fool.com/investing/2023/05/17/high-yield-dividend-stocks-warren-buffett-owns/,20230517T095000,['Keith Speights'],Buffett has a few cards up his sleeve with these stocks.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F732461%2Fpercentage-interest-rate-growth-rate-mortgage-savings.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.623304'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.201257,Somewhat-Bullish,"[{'ticker': 'VZ', 'relevance_score': '0.377142', 'ticker_sentiment_score': '0.197867', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ARCC', 'relevance_score': '0.433877', 'ticker_sentiment_score': '0.303312', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BRK-A', 'relevance_score': '0.065327', 'ticker_sentiment_score': '0.100729', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.065327', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VTRS', 'relevance_score': '0.433877', 'ticker_sentiment_score': '0.244478', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"AstraZeneca's Tagrisso, chemo combination shows promise in lung cancer trial",https://www.reuters.com/business/healthcare-pharmaceuticals/astrazenecas-tagrisso-chemo-combination-shows-promise-lung-cancer-trial-2023-05-17/,20230517T092600,['Reuters'],"AstraZeneca's Tagrisso, chemo combination shows promise in lung ... ...",https://cloudfront-us-east-2.images.arcpublishing.com/reuters/OTFPALQGWRMCDBLC4LNF6R6QIU.jpg,Reuters,Business,www.reuters.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",-0.022221,Neutral,"[{'ticker': 'BCS', 'relevance_score': '0.213048', 'ticker_sentiment_score': '-0.328832', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.213048', 'ticker_sentiment_score': '-0.328832', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
"3 No-Brainer Stocks to Buy With $1,000 Right Now",https://www.fool.com/investing/2023/05/17/3-no-brainer-stocks-to-buy-with-1000-right-now/,20230517T092100,['Sean Williams'],You don't need a mountain of cash to build wealth on Wall Street.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F732391%2Fperson-holding-cash-bills-money-hundred-dollar-fifty-dividend-income-invest-retire-spend-getty.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999967'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.995921'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.118522,Neutral,"[{'ticker': 'GOOG', 'relevance_score': '0.276909', 'ticker_sentiment_score': '0.294031', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SPGI', 'relevance_score': '0.031405', 'ticker_sentiment_score': '0.08632', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVGO', 'relevance_score': '0.276909', 'ticker_sentiment_score': '0.102115', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.156055', 'ticker_sentiment_score': '0.153663', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
FTC Seeks to Block Amgen's Acquisition of Horizon Therapeutics: What's Next for Both Stocks?,https://www.fool.com/investing/2023/05/17/ftc-seeks-to-block-amgens-acquisition-of-horizon-t/,20230517T091300,['Keith Speights'],Don't bank on the FTC winning in its attempt to stop Amgen's buyout of Horizon just yet.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F732461%2Fpercentage-interest-rate-growth-rate-mortgage-savings.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.007304,Neutral,"[{'ticker': 'AMGN', 'relevance_score': '0.753867', 'ticker_sentiment_score': '0.035968', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HZNP', 'relevance_score': '0.18343', 'ticker_sentiment_score': '-0.071609', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.061631', 'ticker_sentiment_score': '0.006099', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.061631', 'ticker_sentiment_score': '0.006099', 'ticker_sentiment_label': 'Neutral'}]"
"Got $5,000? These 3 High-Yielding Dividend Stocks Are Trading Near Their 52-Week Lows",https://www.fool.com/investing/2023/05/17/got-5000-high-yield-dividend-stocks-near-lows/,20230517T091000,['David Jagielski'],These stocks provide good value and can be excellent sources of recurring income.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F732461%2Fpercentage-interest-rate-growth-rate-mortgage-savings.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.986413'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.241187,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.056943', 'ticker_sentiment_score': '0.104009', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PAYX', 'relevance_score': '0.331765', 'ticker_sentiment_score': '0.333773', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KDP', 'relevance_score': '0.224903', 'ticker_sentiment_score': '0.143747', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.224903', 'ticker_sentiment_score': '0.176886', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Is Novavax Finally Turning Things Around? - Novavax  ( NASDAQ:NVAX ) ,https://www.benzinga.com/news/earnings/23/05/32422604/is-novavax-finally-turning-things-around,20230516T204722,['MarketBeat'],"Vaccine developer Novavax Inc. NVAX stock shot up 28% following its Q1 2023 earnings report. The company specializes in vaccines for infectious diseases, including COVID-19, influenza, respiratory syncytial and Ebola. Its shares ran up to $331.68 on Feb. 9, 2021, on its COVID-19 vaccine, ...",https://cdn.benzinga.com/files/images/story/2023/05/16/mufid-majnun-cm1au42fnrg-unsplash.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.983783'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.087659,Neutral,"[{'ticker': 'NVAX', 'relevance_score': '0.707988', 'ticker_sentiment_score': '0.140901', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.147516', 'ticker_sentiment_score': '0.051038', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.147516', 'ticker_sentiment_score': '0.051038', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.098659', 'ticker_sentiment_score': '0.088878', 'ticker_sentiment_label': 'Neutral'}]"
FTC Suing To Stop Amgen's $27.8 Billion Purchase Of Horizon Therapeutics,https://www.forbes.com/sites/mollybohannon/2023/05/16/ftc-suing-to-stop-amgens-278-billion-purchase-of-horizon-therapeutics/,20230516T162141,['Molly Bohannon'],The FTC is attempting to stop the sale out of fears it will give the company too much power over rare disease treatments.,"https://imageio.forbes.com/specials-images/imageserve/6463ad3eb90c53927a65a233/0x0.jpg?format=jpg&crop=2521,1417,x0,y1,safe&width=1200",Forbes,Business,www.forbes.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.002469,Neutral,"[{'ticker': 'AMGN', 'relevance_score': '0.642977', 'ticker_sentiment_score': '0.003752', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HZNP', 'relevance_score': '0.104683', 'ticker_sentiment_score': '-0.181631', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.104683', 'ticker_sentiment_score': '0.07514', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.104683', 'ticker_sentiment_score': '0.07514', 'ticker_sentiment_label': 'Neutral'}]"
UnitedHealth Group is an AI Stock That Isn't Beating Expectations - UnitedHealth Group  ( NYSE:UNH ) ,https://www.benzinga.com/news/earnings/23/05/32420786/unitedhealth-group-is-an-ai-stock-that-isnt-beating-expectations,20230516T142648,['MarketBeat'],"UnitedHealth Group Inc. UNH is down 7.2% in 2023. The health maintenance organization ( HMO ) sector in general is lagging in the market. So, investors may simply be taking a pause on a stock that's climbed 100% over the last five years.",https://cdn.benzinga.com/files/images/story/2023/05/16/markus-spiske-jgokejvw-km-unsplash.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.99977'}, {'topic': 'Earnings', 'relevance_score': '0.976671'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.1013,Neutral,"[{'ticker': 'GOOG', 'relevance_score': '0.058047', 'ticker_sentiment_score': '0.108016', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.115787', 'ticker_sentiment_score': '0.122244', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.115787', 'ticker_sentiment_score': '0.122244', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.576851', 'ticker_sentiment_score': '0.101711', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.172919', 'ticker_sentiment_score': '-0.077724', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLTR', 'relevance_score': '0.115787', 'ticker_sentiment_score': '0.122244', 'ticker_sentiment_label': 'Neutral'}]"
Kenvue Has Gone Public: Should You Buy the Stock?,https://www.fool.com/investing/2023/05/16/kenvue-has-gone-public-should-you-buy-the-stock/,20230516T133857,['David Jagielski'],Its business could be resistant to the effects of inflation.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F731372%2Fkenvues-sales-broken-down-by-segment-and-geography.png&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.658903'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.169721,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.67165', 'ticker_sentiment_score': '0.190571', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.348103', 'ticker_sentiment_score': '0.049813', 'ticker_sentiment_label': 'Neutral'}]"
Which Is the Better Forever Stock: Johnson & Johnson or UnitedHealth Group?,https://www.fool.com/investing/2023/05/16/which-is-the-better-forever-stock-johnson-johnson/,20230516T131000,['Jim Halley'],Both stocks have built-in economic diversity and are solid long-term investments.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F732070%2Fbuffett-getty.jpeg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '0.459462'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.289873,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.096091', 'ticker_sentiment_score': '0.217703', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UNH', 'relevance_score': '0.453905', 'ticker_sentiment_score': '0.254505', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.453905', 'ticker_sentiment_score': '0.301486', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Is Trending Stock Johnson & Johnson  ( JNJ )  a Buy Now?,https://www.zacks.com/stock/news/2095715/is-trending-stock-johnson-johnson-jnj-a-buy-now,20230516T130011,['Zacks Investment Research'],"Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",https://staticx-tuner.zacks.com/images/default_article_images/default168.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}]",0.230847,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.479385', 'ticker_sentiment_score': '0.142699', 'ticker_sentiment_label': 'Neutral'}]"
Should You Invest in the Health Care Select Sector SPDR ETF  ( XLV ) ?,https://www.zacks.com/stock/news/2095596/should-you-invest-in-the-health-care-select-sector-spdr-etf-xlv,20230516T102007,['Zacks Investment Research'],Sector ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default318.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}]",0.259659,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.125789', 'ticker_sentiment_score': '0.062237', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPGI', 'relevance_score': '0.063091', 'ticker_sentiment_score': '0.127323', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STT', 'relevance_score': '0.063091', 'ticker_sentiment_score': '0.089036', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.125789', 'ticker_sentiment_score': '0.062237', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.125789', 'ticker_sentiment_score': '0.062237', 'ticker_sentiment_label': 'Neutral'}]"
Aspergillosis Treatment Market is to reach USD 3569.72 Mn by 2029 at a growth rate of 5.4 percent over the forecast period,https://www.benzinga.com/pressreleases/23/05/g32416515/aspergillosis-treatment-market-is-to-reach-usd-3569-72-mn-by-2029-at-a-growth-rate-of-5-4-percent-,20230516T101655,['Globe Newswire'],"Pune, May 16, 2023 ( GLOBE NEWSWIRE ) -- Maximize Market Research, a global Healthcare market research firm has published a competitive intelligence and market research report on the ""Aspergillosis Treatment Market"". The Aspergillosis Treatment Market size was valued at USD 2470.30 Mn in 2022.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.999355'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.294185,Somewhat-Bullish,"[{'ticker': 'BAYZF', 'relevance_score': '0.031159', 'ticker_sentiment_score': '0.133497', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.031159', 'ticker_sentiment_score': '0.133497', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALPMF', 'relevance_score': '0.031159', 'ticker_sentiment_score': '0.133497', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SKXJF', 'relevance_score': '0.031159', 'ticker_sentiment_score': '0.133497', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVS', 'relevance_score': '0.031159', 'ticker_sentiment_score': '0.133497', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.031159', 'ticker_sentiment_score': '0.133497', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSKYF', 'relevance_score': '0.031159', 'ticker_sentiment_score': '0.133497', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.031159', 'ticker_sentiment_score': '0.133497', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.031159', 'ticker_sentiment_score': '0.133497', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.031159', 'ticker_sentiment_score': '0.133497', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.031159', 'ticker_sentiment_score': '0.133497', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TEVA', 'relevance_score': '0.031159', 'ticker_sentiment_score': '0.133497', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.031159', 'ticker_sentiment_score': '0.133497', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TAK', 'relevance_score': '0.031159', 'ticker_sentiment_score': '0.133497', 'ticker_sentiment_label': 'Neutral'}]"
Major Shareholder Announcement - AIM international Mutual Funds,https://www.globenewswire.com/news-release/2023/05/16/2669724/0/en/Major-Shareholder-Announcement-AIM-international-Mutual-Funds.html,20230516T093200,['Chemometec A/S'],ANNOUNCEMENT NO. ...,https://ml-eu.globenewswire.com/Resource/Download/dda6d08e-1d43-433e-bc7b-b1e84b4963be,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.130012,Neutral,"[{'ticker': 'IVZ', 'relevance_score': '0.541149', 'ticker_sentiment_score': '0.265851', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AZN', 'relevance_score': '0.288893', 'ticker_sentiment_score': '0.08505', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.288893', 'ticker_sentiment_score': '0.08505', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.288893', 'ticker_sentiment_score': '0.08505', 'ticker_sentiment_label': 'Neutral'}]"
ONWARD Reports Q1 Business Update and Year-To-Date Highlights,https://www.globenewswire.com/news-release/2023/05/16/2669545/0/en/ONWARD-Reports-Q1-Business-Update-and-Year-To-Date-Highlights.html,20230516T053000,['ONWARD Medical'],"EINDHOVEN, the Netherlands, May 16, 2023 ( GLOBE NEWSWIRE ) -- ONWARD Medical N.V. ( Euronext: ONWD ) , the medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal cord injury ( SCI ) , today provided a first quarter 2023 ...",https://ml.globenewswire.com/Resource/Download/95ed2186-48e9-4dce-a2e0-1533a50b7f90,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.242941,Somewhat-Bullish,"[{'ticker': 'NVRO', 'relevance_score': '0.026591', 'ticker_sentiment_score': '0.115531', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.026591', 'ticker_sentiment_score': '0.115531', 'ticker_sentiment_label': 'Neutral'}]"
People used to fight over getting a COVID-19 vaccine. Now millions of doses are getting tossed in the trash because no one's using them.,https://www.businessinsider.com/johnson-and-johnson-vaccine-thrown-out-us-2023-5,20230515T210200,['Grace Eliza Goodwin'],Johnson & Johnson Vaccine Doses Getting Thrown Out in the - Business Insider ...,,Business Insider,GoogleRSS,www.businessinsider.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.189482,Somewhat-Bearish,"[{'ticker': 'WBD', 'relevance_score': '0.116348', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.230235', 'ticker_sentiment_score': '-0.191105', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
"3 Recession-Proof Stocks With Nice Dividends - Kimberly-Clark  ( NYSE:KMB ) , Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/news/23/05/32378094/3-recession-proof-stocks-with-nice-dividends,20230515T134119,['MarketBeat'],Prices and interest rates are higher. American households are strapped for cash. But is the economy really headed into a recession? The Federal Reserve Bank of New York's latest U.S. Recession Probabilities model has the odds of the country entering a negative growth period at 68%.,https://cdn.benzinga.com/files/images/story/2023/05/15/alexander-grey-8lnbxtxfgzw-unsplash.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",0.200385,Somewhat-Bullish,"[{'ticker': 'KMB', 'relevance_score': '0.141448', 'ticker_sentiment_score': '0.221946', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PEP', 'relevance_score': '0.094576', 'ticker_sentiment_score': '0.097372', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.094576', 'ticker_sentiment_score': '0.092854', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.094576', 'ticker_sentiment_score': '0.107016', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.047371', 'ticker_sentiment_score': '0.09079', 'ticker_sentiment_label': 'Neutral'}]"
Accumulus Synergy Announces the Appointment of New Leadership Team Members,https://www.benzinga.com/pressreleases/23/05/g32393385/accumulus-synergy-announces-the-appointment-of-new-leadership-team-members,20230515T132200,['Globe Newswire'],"BURLINGAME, Calif., May 15, 2023 ( GLOBE NEWSWIRE ) -- Accumulus Synergy ( ""Accumulus"" ) , a nonprofit trade association working to address the global need for digital transformation within the life sciences - health authority ecosystem, today announced the appointment of two new executive ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.413277,Bullish,"[{'ticker': 'AZN', 'relevance_score': '0.070517', 'ticker_sentiment_score': '0.292523', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.070517', 'ticker_sentiment_score': '0.292523', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BMY', 'relevance_score': '0.070517', 'ticker_sentiment_score': '0.292523', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.070517', 'ticker_sentiment_score': '0.292523', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SNY', 'relevance_score': '0.070517', 'ticker_sentiment_score': '0.292523', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Ray Dalio's Bridgewater fund dumped GameStop and AMC last quarter - while Jim Simons' RenTech bet on Tesla and Bed Bath & Beyond,https://markets.businessinsider.com/news/stocks/dalio-bridgewater-simons-rentech-gamestop-amc-tesla-bbby-meme-stocks-2023-5,20230515T120002,['Theron Mohamed'],"Dalio's Bridgewater Sells GameStop, AMC. RenTech Buys Tesla ... - Markets Insider ...",https://i.insider.com/61e97ceb7c6a20001842b993?width=1200&format=jpeg,Business Insider,GoogleRSS,markets.businessinsider.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.175264,Somewhat-Bullish,"[{'ticker': 'TSLA', 'relevance_score': '0.280615', 'ticker_sentiment_score': '0.273619', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KO', 'relevance_score': '0.07157', 'ticker_sentiment_score': '0.146997', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'APE', 'relevance_score': '0.142565', 'ticker_sentiment_score': '0.238498', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.07157', 'ticker_sentiment_score': '0.191443', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.07157', 'ticker_sentiment_score': '0.146997', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.07157', 'ticker_sentiment_score': '0.146997', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.07157', 'ticker_sentiment_score': '0.146997', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABNB', 'relevance_score': '0.07157', 'ticker_sentiment_score': '0.191443', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BBBYQ', 'relevance_score': '0.142565', 'ticker_sentiment_score': '0.238498', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GME', 'relevance_score': '0.280615', 'ticker_sentiment_score': '0.335433', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Major shareholder announcement - Invesco Ltd.,https://www.globenewswire.com/news-release/2023/05/15/2668634/0/en/Major-shareholder-announcement-Invesco-Ltd.html,20230515T112000,['Chemometec A/S'],ANNOUNCEMENT NO. ...,https://ml-eu.globenewswire.com/Resource/Download/dda6d08e-1d43-433e-bc7b-b1e84b4963be,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.134692,Neutral,"[{'ticker': 'IVZ', 'relevance_score': '0.570165', 'ticker_sentiment_score': '0.302224', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AZN', 'relevance_score': '0.306963', 'ticker_sentiment_score': '0.089308', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.306963', 'ticker_sentiment_score': '0.089308', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.306963', 'ticker_sentiment_score': '0.089308', 'ticker_sentiment_label': 'Neutral'}]"
3 PIMCO Mutual Funds to Buy for Excellent Returns,https://www.zacks.com/stock/news/2095120/3-pimco-mutual-funds-to-buy-for-excellent-returns,20230515T110500,['Zacks Investment Research'],"Below, we share with you three top-ranked PIMCO mutual funds. Each has earned a Zacks Mutual Fund Rank #1.",https://staticx-tuner.zacks.com/images/articles/main/a8/346.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.980922'}]",0.217196,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.083541', 'ticker_sentiment_score': '0.054034', 'ticker_sentiment_label': 'Neutral'}]"
Global Home Health Hub Market to Garner High Returns by 2029 - Brandessence Market Research,https://www.prnewswire.com/news-releases/global-home-health-hub-market-to-garner-high-returns-by-2029---brandessence-market-research-301824468.html,20230515T104800,['Brandessence Market Research and Consulting Private Limited'],Global Home Health Hub Market to Garner High Returns by 2029 ... PR ...,https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.259061,Somewhat-Bullish,"[{'ticker': 'CSCO', 'relevance_score': '0.019879', 'ticker_sentiment_score': '0.184268', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'QCOM', 'relevance_score': '0.019879', 'ticker_sentiment_score': '0.184268', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HCSG', 'relevance_score': '0.079392', 'ticker_sentiment_score': '0.119309', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HON', 'relevance_score': '0.019879', 'ticker_sentiment_score': '0.184268', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.019879', 'ticker_sentiment_score': '0.108575', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.019879', 'ticker_sentiment_score': '0.108575', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:UZS', 'relevance_score': '0.019879', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Size of Microalgae Market to Grow at 4.5% CAGR and Reach $4996.8 Million by 2027: Brandessence Market Research,https://www.prnewswire.com/news-releases/size-of-microalgae-market-to-grow-at-4-5-cagr-and-reach-4996-8-million-by-2027-brandessence-market-research-301824453.html,20230515T103500,['Brandessence Market Research And Consulting Private Limited'],Size of Microalgae Market to Grow at 4.5% CAGR and Reach ... PR ...,https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Mergers & Acquisitions', 'relevance_score': '0.108179'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.283045,Somewhat-Bullish,"[{'ticker': 'DICCF', 'relevance_score': '0.022243', 'ticker_sentiment_score': '0.005588', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CYAN', 'relevance_score': '0.022243', 'ticker_sentiment_score': '0.005588', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.022243', 'ticker_sentiment_score': '0.110124', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.022243', 'ticker_sentiment_score': '0.110124', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:UZS', 'relevance_score': '0.022243', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Digital Lending Market: How Digital Platforms are Democratizing Access to Finance | Brandessence Market Research,https://www.prnewswire.com/news-releases/digital-lending-market-how-digital-platforms-are-democratizing-access-to-finance--brandessence-market-research-301824432.html,20230515T101400,['Brandessence Market Research And Consulting Private Limited'],Digital Lending Market: How Digital Platforms are Democratizing ... PR ...,https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.998356'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.108179'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.268727,Somewhat-Bullish,"[{'ticker': 'BCS', 'relevance_score': '0.039679', 'ticker_sentiment_score': '0.075377', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FISV', 'relevance_score': '0.019846', 'ticker_sentiment_score': '0.127521', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.019846', 'ticker_sentiment_score': '0.114533', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.019846', 'ticker_sentiment_score': '0.114533', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:UZS', 'relevance_score': '0.019846', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Some rural communities use opioid settlement funds to pay off debt instead of investing in addiction programs,https://www.cnn.com/2023/05/15/health/opioid-crisis-settlement-funds-kff-health-news-partner/index.html,20230515T101300,['Aneri Pattani'],"Over the past two years, rural Greene County in northeastern Tennessee has collected more than $2.7 million from regional and national settlements with opioid manufacturers and distributors. But instead of helping people harmed by addiction, county officials are finding other ways to spend it.","https://media.cnn.com/api/v1/images/stellar/prod/230512140321-03-opioid-crisis-settlement-funds-kff-health-news-partner.jpg?c=16x9&q=h_720,w_1280,c_fill",CNN,Markets,www.cnn.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}]",-0.028739,Neutral,"[{'ticker': 'WBD', 'relevance_score': '0.023349', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVS', 'relevance_score': '0.023349', 'ticker_sentiment_score': '-0.107571', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAH', 'relevance_score': '0.023349', 'ticker_sentiment_score': '-0.107571', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.023349', 'ticker_sentiment_score': '-0.107571', 'ticker_sentiment_label': 'Neutral'}]"
Global Acute Repetitive Seizures Market to Showcase Promising Growth says Brandessence Market Research,https://www.prnewswire.com/news-releases/global-acute-repetitive-seizures-market-to-showcase-promising-growth-says-brandessence-market-research-301824427.html,20230515T100600,['Brandessence Market Research And Consulting Private Limited'],Global Acute Repetitive Seizures Market to Showcase Promising ... PR ...,https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.14369,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.018146', 'ticker_sentiment_score': '0.10739', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OVID', 'relevance_score': '0.018146', 'ticker_sentiment_score': '-0.104162', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UCBJF', 'relevance_score': '0.018146', 'ticker_sentiment_score': '0.044502', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNS', 'relevance_score': '0.018146', 'ticker_sentiment_score': '-0.010245', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.036282', 'ticker_sentiment_score': '0.109896', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.018146', 'ticker_sentiment_score': '0.044502', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TAK', 'relevance_score': '0.036282', 'ticker_sentiment_score': '-0.114262', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:UZS', 'relevance_score': '0.018146', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Report Forecasts Promising Future for Alzheimer's Disease Market with New Therapeutic Approaches | Brandessence Market Research,https://www.prnewswire.com/news-releases/report-forecasts-promising-future-for-alzheimers-disease-market-with-new-therapeutic-approaches--brandessence-market-research-301824407.html,20230515T093200,['Brandessence Market Research and Consulting Private Limited'],Report Forecasts Promising Future for Alzheimer's Disease Market ... PR ...,https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.172476,Somewhat-Bullish,"[{'ticker': 'ACIU', 'relevance_score': '0.017394', 'ticker_sentiment_score': '-0.017349', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PHYOF', 'relevance_score': '0.017394', 'ticker_sentiment_score': '0.117319', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.03478', 'ticker_sentiment_score': '0.017283', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALEC', 'relevance_score': '0.017394', 'ticker_sentiment_score': '-0.017349', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVXL', 'relevance_score': '0.017394', 'ticker_sentiment_score': '-0.017349', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.03478', 'ticker_sentiment_score': '0.124339', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TMO', 'relevance_score': '0.017394', 'ticker_sentiment_score': '0.117319', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVS', 'relevance_score': '0.017394', 'ticker_sentiment_score': '0.117319', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.017394', 'ticker_sentiment_score': '-0.017349', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SEMHF', 'relevance_score': '0.017394', 'ticker_sentiment_score': '0.117319', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.017394', 'ticker_sentiment_score': '0.112745', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.069495', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:UZS', 'relevance_score': '0.017394', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
2 No-Brainer Healthcare Stocks to Buy Right Now,https://www.fool.com/investing/2023/05/13/2-no-brainer-healthcare-stocks-to-buy-right-now/,20230513T125500,['Josh Kohn-Lindquist'],Boring businesses can make for beautiful lifelong holdings -- these two stocks show us why.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F732236%2Fmarket-2.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.996718'}]",0.270279,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.085476', 'ticker_sentiment_score': '0.077959', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MTD', 'relevance_score': '0.127908', 'ticker_sentiment_score': '0.082574', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RFGPF', 'relevance_score': '0.0428', 'ticker_sentiment_score': '0.196201', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.21156', 'ticker_sentiment_score': '0.151679', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Amazon sponsored 'small business week' in San Francisco and hosted a panel on how to start selling goods on its website,https://africa.businessinsider.com/retail/amazon-sponsored-small-business-week-in-san-francisco-and-hosted-a-panel-on-how-to/rrtqlqk,20230513T093629,[],Amazon sponsored 'small business week' in San Francisco and ... - Business Insider Africa ...,https://ocdn.eu/pulscms-transforms/1/ZQAktkuTURBXy82ZWI3YjJjYS1kMDRlLTQ0YmMtYjMwYy0zZmY1MTc1M2YzYzkuanBlZ5GTBc0DFs0Brg,Business Insider,GoogleRSS,africa.businessinsider.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.062533,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.105604', 'ticker_sentiment_score': '0.114543', 'ticker_sentiment_label': 'Neutral'}]"
"Where to Invest $10,000 in a Bear Market",https://www.fool.com/investing/2023/05/13/where-to-invest-10000-in-a-bear-market/,20230513T093000,['Adria Cimino'],Cautious and aggressive investors both might find opportunities in a bear market.,https://media.ycharts.com/charts/c541105859b2d9fde8f03c33cfeed0f5.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.998356'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}]",0.070768,Neutral,"[{'ticker': 'VRTX', 'relevance_score': '0.111747', 'ticker_sentiment_score': '0.20793', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KMB', 'relevance_score': '0.056011', 'ticker_sentiment_score': '-0.163937', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'KO', 'relevance_score': '0.166935', 'ticker_sentiment_score': '0.105808', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCK', 'relevance_score': '0.111747', 'ticker_sentiment_score': '0.20793', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMZN', 'relevance_score': '0.221313', 'ticker_sentiment_score': '-0.110964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.111747', 'ticker_sentiment_score': '0.20793', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Amazon sponsored 'small business week' in San Francisco and hosted a panel on how to start selling goods on its website,https://www.businessinsider.com/amazon-sponsored-san-franciscos-small-business-week-2023-5,20230512T173538,['Alex Bitter'],Amazon Sponsored San Francisco's Small Business Week. Really. - Business Insider ...,,Business Insider,GoogleRSS,www.businessinsider.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.026529,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.07887', 'ticker_sentiment_score': '0.107615', 'ticker_sentiment_label': 'Neutral'}]"
Promising Phase 1 Results: Protagonist Therapeutics and Janssen Biotech Unlock New Potential in Colitis and Inflammation Treatment - Protagonist Therapeutics  ( NASDAQ:PTGX ) ,https://www.benzinga.com/general/biotech/23/05/32367591/promising-phase-1-results-protagonist-therapeutics-and-janssen-biotech-unlock-new-potential-in-co,20230512T171430,['Vandana Singh'],"Protagonist Therapeutics PTGX reported data from its collaboration with Janssen Biotech Inc, a unit of Johnson & Johnson JNJ, on Phase 1 and preclinical studies of JNJ-2113 ( formerly PN-235 ) .",https://cdn.benzinga.com/files/images/story/2023/05/12/ptgx.png?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.15789,Somewhat-Bearish,"[{'ticker': 'PTGX', 'relevance_score': '0.462395', 'ticker_sentiment_score': '0.149947', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.89979', 'ticker_sentiment_score': '-0.39755', 'ticker_sentiment_label': 'Bearish'}]"
Eli Lilly on track to close with a higher market cap than J&J for first time since 1997,https://www.marketwatch.com/story/eli-lilly-on-track-to-close-with-a-higher-market-cap-than-j-j-for-first-time-since-1997-a718df7f,20230512T165500,['Ciara Linnane'],Eli Lilly's stock has benefited from positive data in trials of an obesity drug and a treatment for Alzheimer's disease.,https://images.mktw.net/im-780959?width=700&height=372,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",-0.115501,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.469457', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.165598', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
How Apple Pleased Investors,https://www.fool.com/investing/2023/05/12/how-apple-pleased-investors/,20230512T164300,['Chris Hill'],We've got a lot of ground to cover as company earnings reports continue to flood in.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F732236%2Fmarket-2.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.838487'}, {'topic': 'IPO', 'relevance_score': '0.682689'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.360215'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",0.145614,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.006097', 'ticker_sentiment_score': '0.004756', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.054829', 'ticker_sentiment_score': '0.087005', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OXM', 'relevance_score': '0.030477', 'ticker_sentiment_score': '0.012361', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PARA', 'relevance_score': '0.006097', 'ticker_sentiment_score': '0.004756', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.012193', 'ticker_sentiment_score': '0.082379', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.018289', 'ticker_sentiment_score': '0.024733', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.012193', 'ticker_sentiment_score': '-0.033856', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.006097', 'ticker_sentiment_score': '0.062337', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FHN', 'relevance_score': '0.006097', 'ticker_sentiment_score': '0.06254', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.006097', 'ticker_sentiment_score': '0.044567', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SHOP', 'relevance_score': '0.030477', 'ticker_sentiment_score': '0.030834', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MELI', 'relevance_score': '0.042658', 'ticker_sentiment_score': '0.130832', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.018289', 'ticker_sentiment_score': '-0.020183', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FRC', 'relevance_score': '0.006097', 'ticker_sentiment_score': '0.040661', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ATVI', 'relevance_score': '0.006097', 'ticker_sentiment_score': '0.019608', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KVUE', 'relevance_score': '0.030477', 'ticker_sentiment_score': '0.092092', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WBD', 'relevance_score': '0.018289', 'ticker_sentiment_score': '0.046668', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TEAM', 'relevance_score': '0.030477', 'ticker_sentiment_score': '-0.019334', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BKNG', 'relevance_score': '0.042658', 'ticker_sentiment_score': '0.066199', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBER', 'relevance_score': '0.054829', 'ticker_sentiment_score': '0.063197', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.018289', 'ticker_sentiment_score': '0.049478', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MAR', 'relevance_score': '0.048745', 'ticker_sentiment_score': '0.083892', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.012193', 'ticker_sentiment_score': '0.101753', 'ticker_sentiment_label': 'Neutral'}]"
"UM Announces New U.S. Leadership Across Growth, Strategy, Planning, Intelligence, Client Services and Operations",https://www.prnewswire.com/news-releases/um-announces-new-us-leadership-across-growth-strategy-planning-intelligence-client-services-and-operations-301823355.html,20230512T141100,['UM'],"UM Announces New U.S. Leadership Across Growth, Strategy ... PR ...",https://mma.prnewswire.com/media/941707/UM__Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}]",0.485518,Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.030998', 'ticker_sentiment_score': '0.229234', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SNEJF', 'relevance_score': '0.030998', 'ticker_sentiment_score': '0.1789', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MAT', 'relevance_score': '0.030998', 'ticker_sentiment_score': '0.1789', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ROKU', 'relevance_score': '0.030998', 'ticker_sentiment_score': '0.202478', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SPOT', 'relevance_score': '0.030998', 'ticker_sentiment_score': '0.1789', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GPRO', 'relevance_score': '0.030998', 'ticker_sentiment_score': '0.1789', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.061949', 'ticker_sentiment_score': '0.225224', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'XOM', 'relevance_score': '0.030998', 'ticker_sentiment_score': '0.1789', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AXP', 'relevance_score': '0.061949', 'ticker_sentiment_score': '0.225224', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ACN', 'relevance_score': '0.030998', 'ticker_sentiment_score': '0.1789', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"STERIS  ( STE )  Q4 Earnings Beat Estimates, Gross Margin Falls",https://www.zacks.com/stock/news/2094734/steris-ste-q4-earnings-beat-estimates-gross-margin-falls,20230512T134700,['Zacks Investment Research'],"Heading into fiscal 2024, STERIS (STE) expects many of its fiscal 2023 challenges to abate, including procedure volumes and supply chain constraints.",https://staticx-tuner.zacks.com/images/articles/main/94/1507.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.091675,Neutral,"[{'ticker': 'EW', 'relevance_score': '0.187463', 'ticker_sentiment_score': '0.00452', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.187463', 'ticker_sentiment_score': '0.005948', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STE', 'relevance_score': '0.40638', 'ticker_sentiment_score': '0.110426', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.187463', 'ticker_sentiment_score': '0.060027', 'ticker_sentiment_label': 'Neutral'}]"
"BeiGene Goes For Global Growth With Sales And R&D Push - BeiGene  ( NASDAQ:BGNE ) , Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/23/05/32364362/beigene-goes-for-global-growth-with-sales-and-r-d-push,20230512T132314,['The Bamboo Works'],BeiGene's revenue in the first quarter grew 56% while global sales of its core cancer drug doubled The company's sales costs are rising even faster than its R&D spending It ranks as China's market leader for innovative cancer drugs and is rapidly raising its global profile. But BeiGene Ltd.,https://cdn.benzinga.com/files/beigene.jpeg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.992549'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}]",0.085511,Neutral,"[{'ticker': 'BGNE', 'relevance_score': '0.383995', 'ticker_sentiment_score': '0.047842', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVBXF', 'relevance_score': '0.036365', 'ticker_sentiment_score': '0.104543', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.072655', 'ticker_sentiment_score': '0.107355', 'ticker_sentiment_label': 'Neutral'}]"
Haemonetics  ( HAE )  Q4 Earnings and Revenues Top Estimates,https://www.zacks.com/stock/news/2094599/haemonetics-hae-q4-earnings-and-revenues-top-estimates,20230512T123200,['Zacks Investment Research'],"Amid a challenging economic environment, Haemonetics (HAE) delivers impressive fiscal fourth-quarter organic revenues, led by the stellar performance across the Plasma and Hospital business.",https://staticx-tuner.zacks.com/images/articles/main/eb/4111.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.77141'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.148115,Neutral,"[{'ticker': 'EW', 'relevance_score': '0.157483', 'ticker_sentiment_score': '-0.025429', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HAE', 'relevance_score': '0.41518', 'ticker_sentiment_score': '0.335595', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ISRG', 'relevance_score': '0.157483', 'ticker_sentiment_score': '0.005269', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.157483', 'ticker_sentiment_score': '0.05317', 'ticker_sentiment_label': 'Neutral'}]"
Should Vanguard High Dividend Yield ETF  ( VYM )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2094527/should-vanguard-high-dividend-yield-etf-vym-be-on-your-investing-radar,20230512T102009,['Zacks Investment Research'],Style Box ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default264.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.22073,Somewhat-Bullish,"[{'ticker': 'JPM', 'relevance_score': '0.124809', 'ticker_sentiment_score': '0.068938', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.124809', 'ticker_sentiment_score': '0.068938', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.124809', 'ticker_sentiment_score': '0.068938', 'ticker_sentiment_label': 'Neutral'}]"
3 Things About Intuitive Surgical That Smart Investors Know,https://www.fool.com/investing/2023/05/12/things-about-intuitive-surgical-smart-investors/,20230512T095000,['Sushree Mohanty'],Intuitive's business model makes it stand out in the medical device industry.,https://media.ycharts.com/charts/6bc482b675f8befef407e3d7d2237236.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.955357'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.261717,Somewhat-Bullish,"[{'ticker': 'MDT', 'relevance_score': '0.060236', 'ticker_sentiment_score': '0.173506', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ISRG', 'relevance_score': '0.179343', 'ticker_sentiment_score': '0.08143', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.060236', 'ticker_sentiment_score': '0.173506', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"TSLA, IONQ, NNOX, PTON, HEPA: Top 5 Trending Stocks - PacWest Banc  ( NASDAQ:PACW ) , Alphabet  ( NASDAQ:GOOG ) , Alphabet  ( NASDAQ:GOOGL ) , Tesla  ( NASDAQ:TSLA ) , Peloton Interactive  ( NASDAQ:PTON ) , Johnson & Johnson  ( NYSE:JNJ ) , IonQ  ( NYSE:IONQ ) , Nano X Imaging  ( NASDAQ:NNOX ) , Walt Disney  ( NYSE:DIS ) , Hepion Pharmaceuticals  ( NASDAQ:HEPA ) ",https://www.benzinga.com/markets/equities/23/05/32356575/tesla-ionq-nano-x-peloton-hepion-why-these-five-stocks-are-drawing-investors-attention-today,20230512T012242,['Bhavik Nair'],"U.S. markets ended mixed on Thursday with the S&P 500 and the Dow Jones recording losses dragged by Walt Disney Co DIS and PacWest Bancorp PACW and the Nasdaq registering gains led by Alphabet Inc GOOG GOOGL. In another development, President Joe Biden and House Speaker Kevin McCarthy have ...",https://cdn.benzinga.com/files/images/story/2023/Ambuja_Cement_and_ACC_shares_are_up_today_2.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}]",-0.060442,Neutral,"[{'ticker': 'PACW', 'relevance_score': '0.256989', 'ticker_sentiment_score': '-0.257097', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'GOOG', 'relevance_score': '0.256989', 'ticker_sentiment_score': '-0.257097', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TSLA', 'relevance_score': '0.256989', 'ticker_sentiment_score': '0.145121', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PTON', 'relevance_score': '0.256989', 'ticker_sentiment_score': '-0.102317', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.377142', 'ticker_sentiment_score': '0.443115', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'IONQ', 'relevance_score': '0.256989', 'ticker_sentiment_score': '-0.131525', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NNOX', 'relevance_score': '0.256989', 'ticker_sentiment_score': '0.338761', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HEPA', 'relevance_score': '0.256989', 'ticker_sentiment_score': '-0.118158', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:NANO', 'relevance_score': '0.256989', 'ticker_sentiment_score': '0.338761', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"With debt crisis looming, look to these names and sectors, Jim Cramer says",https://www.cnbc.com/2023/05/11/jim-cramer-with-debt-crisis-looming-look-to-these-names-and-sectors.html,20230511T235748,['Rohan Goswami'],"""Be careful and use the parameters I've laid out,"" CNBC's Jim Cramer said.",https://image.cnbcfm.com/api/v1/image/107240075-1683844728MM-Block-A-SHORT-051123.jpg?v=1683846087&w=750&h=422&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.451494'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.114047,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.235823', 'ticker_sentiment_score': '0.388042', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'MDLZ', 'relevance_score': '0.119235', 'ticker_sentiment_score': '0.090229', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.119235', 'ticker_sentiment_score': '-0.103366', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.235823', 'ticker_sentiment_score': '0.388042', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.235823', 'ticker_sentiment_score': '0.16645', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PG', 'relevance_score': '0.235823', 'ticker_sentiment_score': '0.16645', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KVUE', 'relevance_score': '0.119235', 'ticker_sentiment_score': '-0.10007', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.119235', 'ticker_sentiment_score': '0.090229', 'ticker_sentiment_label': 'Neutral'}]"
The Surprising Reason Nanox Stock Jumped Again Today,https://www.fool.com/investing/2023/05/11/surprising-reason-nanox-nnox-stock-jumped-today/,20230511T202700,['Jon Quast'],This $400 billion dollar company just increased its investment in Nanox by 62%.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F731491%2Folder-man-at-laptop-raising-his-arms-as-if-frustrated.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.324968,Somewhat-Bullish,"[{'ticker': 'NNOX', 'relevance_score': '0.235823', 'ticker_sentiment_score': '0.079191', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.546745', 'ticker_sentiment_score': '0.573021', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'CRYPTO:NANO', 'relevance_score': '0.119235', 'ticker_sentiment_score': '0.050421', 'ticker_sentiment_label': 'Neutral'}]"
RealTruck adds talent and expertise in key executive positions,https://www.prnewswire.com/news-releases/realtruck-adds-talent-and-expertise-in-key-executive-positions-301822580.html,20230511T180000,['RealTruck'],Manufacturer and online retailer continues to grow leadership team under CEO Lindahl's tenure,https://mma.prnewswire.com/media/1769656/realtruck_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}]",0.135499,Neutral,"[{'ticker': 'WHR', 'relevance_score': '0.213048', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BWFG', 'relevance_score': '0.071784', 'ticker_sentiment_score': '-0.057489', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IRBT', 'relevance_score': '0.142989', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LEA', 'relevance_score': '0.071784', 'ticker_sentiment_score': '0.067361', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.071784', 'ticker_sentiment_score': '0.067361', 'ticker_sentiment_label': 'Neutral'}]"
3 Healthcare Stocks to Buy and Hold for the Next 10 Years,https://www.fool.com/investing/2023/05/11/3-stocks-to-buy-and-hold-for-the-next-10-years/,20230511T180000,['Adria Cimino'],These stocks may help your portfolio thrive over time.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F731926%2Ffeatured-daily-upside-image.png&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.983783'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.302147,Somewhat-Bullish,"[{'ticker': 'MRNA', 'relevance_score': '0.398939', 'ticker_sentiment_score': '0.171645', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VRTX', 'relevance_score': '0.104002', 'ticker_sentiment_score': '0.107509', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.104002', 'ticker_sentiment_score': '0.235613', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Alcon  ( ALC )  Q1 Earnings Surpass Estimates, 23' EPS View Up",https://www.zacks.com/stock/news/2094384/alcon-alc-q1-earnings-surpass-estimates-23-eps-view-up,20230511T164000,['Zacks Investment Research'],Alcon (ALC) Q1 revenues were driven by strong consumables and equipment sales.,https://staticx-tuner.zacks.com/images/articles/main/41/899.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Earnings', 'relevance_score': '0.999939'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.1155,Neutral,"[{'ticker': 'ALC', 'relevance_score': '0.262052', 'ticker_sentiment_score': '0.238023', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'EW', 'relevance_score': '0.176502', 'ticker_sentiment_score': '-0.002923', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.176502', 'ticker_sentiment_score': '0.005698', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.176502', 'ticker_sentiment_score': '0.058966', 'ticker_sentiment_label': 'Neutral'}]"
Here's Why You Should Retain Walgreens Boots  ( WBA )  For Now,https://www.zacks.com/stock/news/2094383/heres-why-you-should-retain-walgreens-boots-wba-for-now,20230511T163700,['Zacks Investment Research'],Investors are optimistic about Walgreens Boots (WBA) on consistent partnership growth and a strong focus on strategic execution.,https://staticx-tuner.zacks.com/images/articles/main/5e/1108.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.997874'}]",0.196114,Somewhat-Bullish,"[{'ticker': 'EW', 'relevance_score': '0.199447', 'ticker_sentiment_score': '-0.003201', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PRTA', 'relevance_score': '0.100518', 'ticker_sentiment_score': '0.182645', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ISRG', 'relevance_score': '0.199447', 'ticker_sentiment_score': '0.006239', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.199447', 'ticker_sentiment_score': '0.064556', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WBA', 'relevance_score': '0.100518', 'ticker_sentiment_score': '0.192701', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Charles River  ( CRL )  Q1 Earnings Top Estimates, View Narrowed",https://www.zacks.com/stock/news/2094318/charles-river-crl-q1-earnings-top-estimates-view-narrowed,20230511T154200,['Zacks Investment Research'],"Charles River (CRL) registers robust growth in small research models, research model services and the Cell Solutions business.",https://staticx-tuner.zacks.com/images/articles/main/0c/2749.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.310843'}, {'topic': 'Earnings', 'relevance_score': '1.0'}]",0.18929,Somewhat-Bullish,"[{'ticker': 'EW', 'relevance_score': '0.17813', 'ticker_sentiment_score': '0.004354', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRL', 'relevance_score': '0.17813', 'ticker_sentiment_score': '0.075098', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.17813', 'ticker_sentiment_score': '0.00573', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.17813', 'ticker_sentiment_score': '0.057831', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.044885', 'ticker_sentiment_score': '0.157911', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"NuVasive  ( NUVA )  Q1 Earnings Beat Estimates, Margins Fall",https://www.zacks.com/stock/news/2094294/nuvasive-nuva-q1-earnings-beat-estimates-margins-fall,20230511T152600,['Zacks Investment Research'],NuVasive's (NUVA) strong sales across the U.S. Spinal Hardware and U.S. Surgical Support businesses instill optimism.,https://staticx-tuner.zacks.com/images/articles/main/a0/644.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.495866'}, {'topic': 'Earnings', 'relevance_score': '0.999816'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.125217,Neutral,"[{'ticker': 'EW', 'relevance_score': '0.185662', 'ticker_sentiment_score': '0.004488', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GMED', 'relevance_score': '0.09347', 'ticker_sentiment_score': '0.117104', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.185662', 'ticker_sentiment_score': '0.005906', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NUVA', 'relevance_score': '0.402761', 'ticker_sentiment_score': '0.102956', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.185662', 'ticker_sentiment_score': '0.0596', 'ticker_sentiment_label': 'Neutral'}]"
Saucony and Galen College of Nursing Launch the First-Ever NIL Student Nurse Initiative in Recognition of National Student Nurse Day - Wolverine World Wide  ( NYSE:WWW ) ,https://www.benzinga.com/pressreleases/23/05/n32344138/saucony-and-galen-college-of-nursing-launch-the-first-ever-nil-student-nurse-initiative-in-recogni,20230511T150000,['PRNewswire'],"Partnership Aims to Recognize, Support and Celebrate Critical Next Generation of Nurses",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",0.373898,Bullish,"[{'ticker': 'MDNDF', 'relevance_score': '0.03786', 'ticker_sentiment_score': '0.157825', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WWW', 'relevance_score': '0.075635', 'ticker_sentiment_score': '0.240356', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.03786', 'ticker_sentiment_score': '0.157825', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
2 Warren Buffett Stocks to Buy Hand Over Fist in May,https://www.fool.com/investing/2023/05/11/2-warren-buffett-stocks-to-buy-hand-over-fist-in-m/,20230511T134500,['George Budwell'],These two Berkshire Hathaway holdings are solid picks in May.,https://media.ycharts.com/charts/9836dcec46531cac46b9283d1f26da16.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.349563,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.068306', 'ticker_sentiment_score': '0.065167', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.202932', 'ticker_sentiment_score': '0.271815', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MTAC', 'relevance_score': '0.068306', 'ticker_sentiment_score': '0.065167', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.068306', 'ticker_sentiment_score': '0.232221', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.136113', 'ticker_sentiment_score': '0.259305', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Syneos Health  ( SYNH )  Tops Q1 Earnings, Announces Merger Plan",https://www.zacks.com/stock/news/2094120/syneos-health-synh-tops-q1-earnings-announces-merger-plan,20230511T131900,['Zacks Investment Research'],Syneos Health's (SYNH) first-quarter 2023 earnings and revenues beat estimates. The company enters into a definitive merger agreement to be acquired by a private investment consortium.,https://staticx-tuner.zacks.com/images/articles/main/2a/3899.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.992549'}, {'topic': 'Earnings', 'relevance_score': '0.999954'}, {'topic': 'Technology', 'relevance_score': '0.5'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.157316,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.09402', 'ticker_sentiment_score': '0.219727', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'EW', 'relevance_score': '0.186738', 'ticker_sentiment_score': '-0.02864', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.186738', 'ticker_sentiment_score': '0.00593', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.186738', 'ticker_sentiment_score': '0.059855', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SYNH', 'relevance_score': '0.624289', 'ticker_sentiment_score': '0.309907', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Baldwin & Obenauf Named to Inc's Best Workplaces of 2023,https://www.prnewswire.com/news-releases/baldwin--obenauf-named-to-incs-best-workplaces-of-2023-301821701.html,20230511T125400,['BNO'],"SOMERVILLE, N.J., May 11, 2023 /PRNewswire/ -- Creative agency Baldwin & Obenauf, Inc. ( BNO ) today announced that the company has been named to Inc's annual Best Workplaces list. With over 40 years in business, BNO also earned special recognition in the Enduring Impact category.",https://mma.prnewswire.com/media/2074598/BNO_best_workplaces_.mp4?p=medium,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.561407,Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.058615', 'ticker_sentiment_score': '0.213015', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Cancer Immunotherapy Market to reach USD 261.7 Bn in 2031, expanding at a CAGR of 13.6%: TMR Report",https://www.benzinga.com/pressreleases/23/05/g32335317/cancer-immunotherapy-market-to-reach-usd-261-7-bn-in-2031-expanding-at-a-cagr-of-13-6-tmr-report,20230511T103000,['Globe Newswire'],"Wilmington, Delaware, United States, May 11, 2023 ( GLOBE NEWSWIRE ) -- The global cancer immunotherapy market is projected to flourish at a CAGR of 13.6% from 2022 to 2031. As per the report published by TMR, the global cancer immunotherapy market is expected to exceed a value of US$ 261.7 ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.066605,Neutral,"[{'ticker': 'BGNE', 'relevance_score': '0.043186', 'ticker_sentiment_score': '-0.02581', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.043186', 'ticker_sentiment_score': '0.089004', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TAK', 'relevance_score': '0.043186', 'ticker_sentiment_score': '0.0969', 'ticker_sentiment_label': 'Neutral'}]"
Should You Invest in the Vanguard Health Care ETF  ( VHT ) ?,https://www.zacks.com/stock/news/2093950/should-you-invest-in-the-vanguard-health-care-etf-vht,20230511T102006,['Zacks Investment Research'],Sector ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default181.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999998'}]",0.212478,Somewhat-Bullish,"[{'ticker': 'SPGI', 'relevance_score': '0.068698', 'ticker_sentiment_score': '0.125928', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.072135', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.072135', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.072135', 'ticker_sentiment_label': 'Neutral'}]"
Levy Konigsberg Partner Jerome Block Discusses J&J Talc Powder Claims on CNN's The Whole Story with Anderson Cooper,https://www.benzinga.com/pressreleases/23/05/n32324617/levy-konigsberg-partner-jerome-block-discusses-j-j-talc-powder-claims-on-cnns-the-whole-story-with,20230510T185400,['PRNewswire'],"NEW YORK, May 10, 2023 /PRNewswire/ -- Levy Konigsberg Partner Jerome Block was recently featured in a CNN investigation that premiered on Sunday, May 7th on The Whole Story with Anderson Cooper.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.232502,Somewhat-Bearish,"[{'ticker': 'WBD', 'relevance_score': '0.282234', 'ticker_sentiment_score': '-0.240943', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.072', 'ticker_sentiment_score': '-0.108488', 'ticker_sentiment_label': 'Neutral'}]"
"SmileDirectClub  ( SDC )  Q1 Earnings Miss, Gross Margin Up",https://www.zacks.com/stock/news/2093682/smiledirectclub-sdc-q1-earnings-miss-gross-margin-up,20230510T154200,['Zacks Investment Research'],SmileDirectClub (SDC) Q1 revenues are affected by persistent macroeconomic headwinds.,https://staticx-tuner.zacks.com/images/articles/main/41/899.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}, {'topic': 'Earnings', 'relevance_score': '0.990786'}]",-0.040299,Neutral,"[{'ticker': 'EW', 'relevance_score': '0.21686', 'ticker_sentiment_score': '-0.001706', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SDC', 'relevance_score': '0.508593', 'ticker_sentiment_score': '-0.012984', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.21686', 'ticker_sentiment_score': '0.006656', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.21686', 'ticker_sentiment_score': '0.067141', 'ticker_sentiment_label': 'Neutral'}]"
Genmab Announces Financial Results for the First Quarter of 2023,https://www.globenewswire.com/news-release/2023/05/10/2665762/0/en/Genmab-Announces-Financial-Results-for-the-First-Quarter-of-2023.html,20230510T150100,['Genmab A/S'],"May 10, 2023 Copenhagen, Denmark. Interim Report for the First Quarter Ended March ...",https://ml-eu.globenewswire.com/Resource/Download/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.310843'}, {'topic': 'Earnings', 'relevance_score': '0.214378'}, {'topic': 'Economy - Macro', 'relevance_score': '0.310843'}]",0.136132,Neutral,"[{'ticker': 'GMAB', 'relevance_score': '0.392537', 'ticker_sentiment_score': '0.149726', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HZNP', 'relevance_score': '0.040969', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.040969', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVS', 'relevance_score': '0.040969', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.122477', 'ticker_sentiment_score': '0.080958', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SGEN', 'relevance_score': '0.040969', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BNTX', 'relevance_score': '0.08183', 'ticker_sentiment_score': '0.084823', 'ticker_sentiment_label': 'Neutral'}]"
"Emergent  ( EBS )  Q1 Earnings Miss Estimates, Revenues Beat",https://www.zacks.com/stock/news/2093582/emergent-ebs-q1-earnings-miss-estimates-revenues-beat,20230510T144700,['Zacks Investment Research'],Emergent (EBS) reports wider-than-expected first-quarter loss. The company updates its 2023 guidance for selected categories.,https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.890401'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",-0.073717,Neutral,"[{'ticker': 'OCUP', 'relevance_score': '0.150906', 'ticker_sentiment_score': '0.09337', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.150906', 'ticker_sentiment_score': '-0.225664', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'EBS', 'relevance_score': '0.342939', 'ticker_sentiment_score': '-0.126116', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.100941', 'ticker_sentiment_score': '-0.045831', 'ticker_sentiment_label': 'Neutral'}]"
"Exact Sciences  ( EXAS )  Q1 Earnings Top, Sales View Raised",https://www.zacks.com/stock/news/2093375/exact-sciences-exas-q1-earnings-top-sales-view-raised,20230510T133700,['Zacks Investment Research'],The upside in Exact Sciences' (EXAS) screening revenues is primarily coming from broad-based momentum in Cologuard adoption.,https://staticx-tuner.zacks.com/images/articles/main/27/21481.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.998311'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.310843'}]",-0.016797,Neutral,"[{'ticker': 'EW', 'relevance_score': '0.199447', 'ticker_sentiment_score': '-0.028525', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AWON', 'relevance_score': '0.050359', 'ticker_sentiment_score': '0.061474', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EXAS', 'relevance_score': '0.386626', 'ticker_sentiment_score': '0.049177', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.199447', 'ticker_sentiment_score': '0.006234', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.199447', 'ticker_sentiment_score': '0.0629', 'ticker_sentiment_label': 'Neutral'}]"
Breast Reconstruction Market is Expected to Reach $647 million | MarketsandMarkets.,https://www.benzinga.com/pressreleases/23/05/g32316473/breast-reconstruction-market-is-expected-to-reach-647-million-marketsandmarkets,20230510T133000,['Globe Newswire'],"Chicago, May 10, 2023 ( GLOBE NEWSWIRE ) -- The breast reconstruction industry is expected to witness significant advancements and growth in the near future. With the increasing focus on breast cancer awareness and improved patient outcomes, breast reconstruction procedures are becoming more ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.251985,Somewhat-Bullish,"[{'ticker': 'IART', 'relevance_score': '0.036146', 'ticker_sentiment_score': '0.063795', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SIEN', 'relevance_score': '0.072217', 'ticker_sentiment_score': '0.086533', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.036146', 'ticker_sentiment_score': '0.063795', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ESTA', 'relevance_score': '0.036146', 'ticker_sentiment_score': '0.063795', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HCSG', 'relevance_score': '0.036146', 'ticker_sentiment_score': '-0.052971', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.072217', 'ticker_sentiment_score': '0.103677', 'ticker_sentiment_label': 'Neutral'}]"
Ireland wants to put its soaring corporate tax receipts into a new sovereign wealth fund,https://www.cnbc.com/2023/05/10/ireland-wants-to-put-soaring-corporate-taxes-into-a-new-sovereign-wealth-fund-.html,20230510T070119,['Jenni Reid'],"Multinationals in Ireland have paid record amounts of corporate tax in recent years, and the country estimates its budget surplus could hit 6.3% of GDP.",https://image.cnbcfm.com/api/v1/image/107224046-mcgrath.JPG?v=1681328069&w=750&h=422&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.078808,Neutral,"[{'ticker': 'PFE', 'relevance_score': '0.06515', 'ticker_sentiment_score': '0.082087', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.06515', 'ticker_sentiment_score': '0.082087', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:EUR', 'relevance_score': '0.06515', 'ticker_sentiment_score': '0.049231', 'ticker_sentiment_label': 'Neutral'}]"
Addex Announces ADX71149 Phase 2 Epilepsy Clinical Study's Independent Interim Review Committee Recommends Continuing Study,https://www.globenewswire.com/news-release/2023/05/10/2665174/0/en/Addex-Announces-ADX71149-Phase-2-Epilepsy-Clinical-Study-s-Independent-Interim-Review-Committee-Recommends-Continuing-Study.html,20230510T050000,['Addex Therapeutics'],Ad Hoc Announcement Pursuant to Art. 53 LR ...,https://ml-eu.globenewswire.com/Resource/Download/e6c12443-4244-46f9-909c-5ab241bbea41,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}]",0.161974,Somewhat-Bullish,"[{'ticker': 'IZQVF', 'relevance_score': '0.072326', 'ticker_sentiment_score': '0.030443', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADXN', 'relevance_score': '0.28346', 'ticker_sentiment_score': '0.073824', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.072326', 'ticker_sentiment_score': '0.062359', 'ticker_sentiment_label': 'Neutral'}]"
Covid vaccine maker Novavax plans to cut 25% jobs to slash expenses,https://www.business-standard.com/companies/news/covid-vaccine-maker-novavax-plans-to-cut-25-jobs-to-slash-expenses-123050901043_1.html,20230509T155017,['Business Standard'],"Novavax is cutting about a quarter of its workforce as the COVID-19 vaccine maker seeks to slash expenses while dealing with uncertain future revenue. The company said on Tuesday that it expects to trim next year's costs for research and development as well as selling, general and administrative ...","https://bsmedia.business-standard.com/_media/bs/img/article/2021-10/18/full/1634497147-8543.jpg?im=FeatureCrop,width=826,height=465",Business Standard,Companies,www.business-standard.com,"[{'topic': 'Earnings', 'relevance_score': '0.905476'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}]",-0.055477,Neutral,"[{'ticker': 'NVAX', 'relevance_score': '0.500753', 'ticker_sentiment_score': '0.022359', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.107495', 'ticker_sentiment_score': '0.103186', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.107495', 'ticker_sentiment_score': '0.103186', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.107495', 'ticker_sentiment_score': '0.103186', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/05/32294792/johnson-johnson-unusual-options-activity,20230509T153122,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 13 strange trades. If we consider the specifics of each trade, it is accurate to state that 38% of the investors opened trades with ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.143538,Neutral,"[{'ticker': 'MS', 'relevance_score': '0.214937', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.827318', 'ticker_sentiment_score': '0.100692', 'ticker_sentiment_label': 'Neutral'}]"
Pharma ETFs Gain Post Q1 Earnings,https://www.zacks.com/stock/news/2092464/pharma-etfs-gain-post-q1-earnings,20230509T151500,['Zacks Investment Research'],"Many industry bigwigs reported solid results, with some beating on earnings or revenues or both. As such, pharma ETFs have been in the green over the past month.",https://staticx-tuner.zacks.com/images/articles/main/66/1019.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.128662,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.156461', 'ticker_sentiment_score': '0.043614', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.156461', 'ticker_sentiment_score': '0.091412', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.117678', 'ticker_sentiment_score': '0.037251', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.156461', 'ticker_sentiment_score': '0.043614', 'ticker_sentiment_label': 'Neutral'}]"
"Henry Schein  ( HSIC )  Q1 Earnings Miss, Operating Margin Dips",https://www.zacks.com/stock/news/2092454/henry-schein-hsic-q1-earnings-miss-operating-margin-dips,20230509T150300,['Zacks Investment Research'],Henry Schein's (HSIC) first-quarter results largely reflect lower contributions from the sales of PPE products and COVID-19 test kits.,https://staticx-tuner.zacks.com/images/articles/main/79/961.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.744043'}, {'topic': 'Earnings', 'relevance_score': '0.99986'}]",0.085303,Neutral,"[{'ticker': 'CURN', 'relevance_score': '0.153961', 'ticker_sentiment_score': '-0.070538', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EW', 'relevance_score': '0.153961', 'ticker_sentiment_score': '-0.025063', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HSIC', 'relevance_score': '0.439786', 'ticker_sentiment_score': '0.095284', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.153961', 'ticker_sentiment_score': '0.005194', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.153961', 'ticker_sentiment_score': '0.052409', 'ticker_sentiment_label': 'Neutral'}]"
"Omnicell's  ( OMCL )  New Acquisitions Aid Growth, Cost Woes Stay",https://www.zacks.com/stock/news/2092444/omnicells-omcl-new-acquisitions-aid-growth-cost-woes-stay,20230509T145100,['Zacks Investment Research'],"Omnicell (OMCL) remains well-positioned to meet pharmacy and hospital needs, backed by the recent acquisitions and expansion of its advanced services solutions.",https://www.zacks.com/images/articles/main/e7/288.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.16346,Somewhat-Bullish,"[{'ticker': 'EW', 'relevance_score': '0.194632', 'ticker_sentiment_score': '-0.003142', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OMCL', 'relevance_score': '0.333685', 'ticker_sentiment_score': '0.274882', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ISRG', 'relevance_score': '0.194632', 'ticker_sentiment_score': '0.006124', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.194632', 'ticker_sentiment_score': '0.063365', 'ticker_sentiment_label': 'Neutral'}]"
Bruker's  ( BRKR )  New Buyout to Advance Digital Transformation,https://www.zacks.com/stock/news/2092451/brukers-brkr-new-buyout-to-advance-digital-transformation,20230509T140200,['Zacks Investment Research'],Bruker's (BRKR) IDS division expands its unique vendor-agnostic software solutions portfolio by integrating ZONTAL with the Mestrelab Research and Arxspan scientific software solutions.,https://staticx-tuner.zacks.com/images/articles/main/e7/288.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}, {'topic': 'Earnings', 'relevance_score': '0.967321'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.30606,Somewhat-Bullish,"[{'ticker': 'BRKR', 'relevance_score': '0.442853', 'ticker_sentiment_score': '0.438979', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'DTST', 'relevance_score': '0.046816', 'ticker_sentiment_score': '0.156491', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'EW', 'relevance_score': '0.185662', 'ticker_sentiment_score': '-0.003032', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.185662', 'ticker_sentiment_score': '0.005911', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.185662', 'ticker_sentiment_score': '0.061169', 'ticker_sentiment_label': 'Neutral'}]"
Here's Why You Should Retain Abbott  ( ABT )  Stock For Now,https://www.zacks.com/stock/news/2092431/heres-why-you-should-retain-abbott-abt-stock-for-now,20230509T133700,['Zacks Investment Research'],Investors are optimistic about Abbott (ABT) on continued growth in the core Diagnostics arm.,https://staticx-tuner.zacks.com/images/articles/main/db/2802.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.99915'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.495866'}]",0.242685,Somewhat-Bullish,"[{'ticker': 'EW', 'relevance_score': '0.195419', 'ticker_sentiment_score': '-0.003151', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABT', 'relevance_score': '0.098456', 'ticker_sentiment_score': '0.155885', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ISRG', 'relevance_score': '0.195419', 'ticker_sentiment_score': '-0.041668', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.195419', 'ticker_sentiment_score': '0.063559', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:EUR', 'relevance_score': '0.049322', 'ticker_sentiment_score': '0.055924', 'ticker_sentiment_label': 'Neutral'}]"
"COVID-19 vaccine maker Novavax to chop workforce, expenses",https://apnews.com/article/novavax-covid-vaccine-b78ec71aa83eb7b4496b35a307787e09,20230509T133333,[],"Novavax is cutting about a quarter of its workforce as the COVID-19 vaccine maker seeks to slash expenses while dealing with uncertain future revenue. The company said Tuesday that it expects to trim next year's costs for research and development as well as selling, general and administrative ...",https://storage.googleapis.com/afs-prod/media/419406f111624b4bb370f5acd92ce765/2525.jpeg,Associated Press,Markets,apnews.com,"[{'topic': 'Earnings', 'relevance_score': '0.905476'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}]",-0.072318,Neutral,"[{'ticker': 'NVAX', 'relevance_score': '0.441698', 'ticker_sentiment_score': '-0.032631', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.116348', 'ticker_sentiment_score': '0.1062', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.116348', 'ticker_sentiment_score': '0.1062', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.116348', 'ticker_sentiment_score': '0.1062', 'ticker_sentiment_label': 'Neutral'}]"
The Honest Company Announces Appointment of Kate Barton as Chief Growth Officer,https://www.globenewswire.com/news-release/2023/05/09/2664194/0/en/The-Honest-Company-Announces-Appointment-of-Kate-Barton-as-Chief-Growth-Officer.html,20230509T104500,"['The Honest Company', 'Inc.']","LOS ANGELES, May 09, 2023 ( GLOBE NEWSWIRE ) -- The Honest Company, a digitally-native consumer products company dedicated to creating clean- and sustainably-designed products spanning baby care, beauty, personal care, wellness and household care, announced today that experienced innovator, ...",https://ml.globenewswire.com/Resource/Download/a4486d9f-8676-4819-84ca-6f1dab430399,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}]",0.622906,Bullish,"[{'ticker': 'GIS', 'relevance_score': '0.052685', 'ticker_sentiment_score': '0.238762', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HNST', 'relevance_score': '0.491255', 'ticker_sentiment_score': '0.781039', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.052685', 'ticker_sentiment_score': '0.238762', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
The Honest Company Announces Appointment of Kate Barton as Chief Growth Officer - Honest Co  ( NASDAQ:HNST ) ,https://www.benzinga.com/pressreleases/23/05/g32282711/the-honest-company-announces-appointment-of-kate-barton-as-chief-growth-officer,20230509T104500,['Globe Newswire'],"LOS ANGELES, May 09, 2023 ( GLOBE NEWSWIRE ) -- The Honest Company, a digitally-native consumer products company dedicated to creating clean- and sustainably-designed products spanning baby care, beauty, personal care, wellness and household care, announced today that experienced innovator, ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}]",0.616737,Bullish,"[{'ticker': 'GIS', 'relevance_score': '0.051551', 'ticker_sentiment_score': '0.238611', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HNST', 'relevance_score': '0.482078', 'ticker_sentiment_score': '0.77626', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.051551', 'ticker_sentiment_score': '0.238611', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
3 Obvious Truths About Growth Stocks That Investors Often Forget,https://www.fool.com/investing/2023/05/09/3-obvious-truths-about-growth-stocks-that-investor/,20230509T102900,['Alex Carchidi'],It's easy to get caught up in hype and miss what actually makes stocks go up.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729516%2Fconcerned-investor-with-two-people-in-background.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.999365'}]",0.039377,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.128822', 'ticker_sentiment_score': '-0.167293', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
Should iShares Russell Top 200 Value ETF  ( IWX )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2092039/should-ishares-russell-top-200-value-etf-iwx-be-on-your-investing-radar,20230509T102007,['Zacks Investment Research'],Style Box ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default353.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.24601,Somewhat-Bullish,"[{'ticker': 'BLK', 'relevance_score': '0.061003', 'ticker_sentiment_score': '0.114012', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.061003', 'ticker_sentiment_score': '-0.019034', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.12165', 'ticker_sentiment_score': '-0.022157', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.12165', 'ticker_sentiment_score': '-0.022157', 'ticker_sentiment_label': 'Neutral'}]"
Unlock the Profit Potential in AI Healthcare Innovation with This Leading Biotech Stock,https://moneymorning.com/investing/unlock-the-profit-potential-in-ai-healthcare-innovation-with-this-leading-biotech-stock/,20230508T210012,"['nblack', 'Shah Gilani', 'Chris Johnson', 'Nick Black']","Before we dive into today's top tech stock for cryptocurrency investors, let me introduce myself... ...I'm Alex Kagin, Director of Technology Investing Research at Money Map Press.",https://moneymorning.com/wp-content/blogs.dir/1/files/2022/06/crypto-syndication.jpg,Money Morning,RSS,moneymorning.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.961735'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.5'}, {'topic': 'Blockchain', 'relevance_score': '0.451494'}]",0.106601,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.076602', 'ticker_sentiment_score': '-0.130624', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LNTH', 'relevance_score': '0.227007', 'ticker_sentiment_score': '0.163685', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.076602', 'ticker_sentiment_score': '-0.130624', 'ticker_sentiment_label': 'Neutral'}]"
"Mineral Sunscreen Market Revenue to Reach USD 1.6 Bn by 2031, growing at a CAGR of 5.4%: Reveals TMR Study",https://www.benzinga.com/pressreleases/23/05/g32268955/mineral-sunscreen-market-revenue-to-reach-usd-1-6-bn-by-2031-growing-at-a-cagr-of-5-4-reveals-tmr-,20230508T163000,['Globe Newswire'],"Wilmington, Delaware, United States, May 08, 2023 ( GLOBE NEWSWIRE ) -- The global mineral sunscreen market was valued at USD 960.0 Mn in 2021 and is anticipated to reach USD 1.6 Bn by 2031, expanding at a CAGR of 5.4% between 2022 and 2031.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}]",0.233135,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.045918', 'ticker_sentiment_score': '0.198223', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Q3 2022/23 - Solid operating result in a challenging market,https://www.globenewswire.com/news-release/2023/05/08/2663630/0/en/Q3-2022-23-Solid-operating-result-in-a-challenging-market.html,20230508T155000,['Chemometec A/S'],ANNOUNCEMENT NO. ...,https://ml-eu.globenewswire.com/Resource/Download/dda6d08e-1d43-433e-bc7b-b1e84b4963be,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '1.0'}]",0.016461,Neutral,"[{'ticker': 'MDT', 'relevance_score': '0.024622', 'ticker_sentiment_score': '0.068384', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.024622', 'ticker_sentiment_score': '0.036512', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.024622', 'ticker_sentiment_score': '0.036512', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.024622', 'ticker_sentiment_score': '0.036512', 'ticker_sentiment_label': 'Neutral'}]"
"Teleflex  ( TFX )  Q1 Earnings Top Estimates, 2023 Sales View Up",https://www.zacks.com/stock/news/2091676/teleflex-tfx-q1-earnings-top-estimates-2023-sales-view-up,20230508T145000,['Zacks Investment Research'],"Teleflex (TFX) registers growth across the majority of its businesses, including double-digit increases in interventional and surgical revenues in Q1.",https://staticx-tuner.zacks.com/images/articles/main/e7/288.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.167929,Somewhat-Bullish,"[{'ticker': 'EW', 'relevance_score': '0.178459', 'ticker_sentiment_score': '-0.001471', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.178459', 'ticker_sentiment_score': '0.005738', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.178459', 'ticker_sentiment_score': '0.057908', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TFX', 'relevance_score': '0.348103', 'ticker_sentiment_score': '0.30883', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Does Johnson & Johnson's Kenvue Spinoff Make Sense?,https://www.fool.com/investing/2023/05/08/does-johnson-johnsons-kenvue-spinoff-make-sense/,20230508T134500,"['CFP', 'Matthew Frankel', 'Asit Sharma', 'Ricky Mulvey', 'and Deidre Woollard']",We also look at Darden Restaurants' acquisition and Yum! Brands' quarter.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F730896%2Fbuy-sell-stock-market-rolling-dice-getty.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'IPO', 'relevance_score': '0.451494'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.998287'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.451494'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.141373,Neutral,"[{'ticker': 'BAC', 'relevance_score': '0.040061', 'ticker_sentiment_score': '0.049138', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVX', 'relevance_score': '0.020037', 'ticker_sentiment_score': '-0.002729', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALLY', 'relevance_score': '0.010019', 'ticker_sentiment_score': '0.015201', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.040061', 'ticker_sentiment_score': '0.118434', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'YUM', 'relevance_score': '0.040061', 'ticker_sentiment_score': '0.038358', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OXY', 'relevance_score': '0.020037', 'ticker_sentiment_score': '0.008155', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RUTH', 'relevance_score': '0.06006', 'ticker_sentiment_score': '0.06305', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.020037', 'ticker_sentiment_score': '0.102687', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ATVI', 'relevance_score': '0.030051', 'ticker_sentiment_score': '0.078134', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KVUE', 'relevance_score': '0.040061', 'ticker_sentiment_score': '0.08112', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DRI', 'relevance_score': '0.030051', 'ticker_sentiment_score': '0.048562', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'YUMC', 'relevance_score': '0.010019', 'ticker_sentiment_score': '0.068048', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RDFN', 'relevance_score': '0.010019', 'ticker_sentiment_score': '-0.00254', 'ticker_sentiment_label': 'Neutral'}]"
Short Sellers Won't Bet Against 8 Rock-Solid Buffett-Like Stocks,https://www.investors.com/etfs-and-funds/sectors/sp500-even-short-sellers-wont-bet-against-buffett-like-stocks/,20230508T120000,"[""Investor's Business Daily"", 'MATT KRANTZ']",Short sellers aren't afraid of many stocks in the S&P 500. But one stock they won't touch is Warren Buffett's Berkshire Hathaway.,https://www.investors.com/wp-content/uploads/2019/05/stock-Buffet-Warren-01-shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.998356'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",-0.002449,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.135729', 'ticker_sentiment_score': '0.189944', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GOOG', 'relevance_score': '0.068112', 'ticker_sentiment_score': '0.090065', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPGI', 'relevance_score': '0.068112', 'ticker_sentiment_score': '0.011061', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.267559', 'ticker_sentiment_score': '0.133562', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.135729', 'ticker_sentiment_score': '0.189944', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WMT', 'relevance_score': '0.267559', 'ticker_sentiment_score': '-0.036546', 'ticker_sentiment_label': 'Neutral'}]"
These 2 Top Stocks Just Declared Dividend Raises,https://www.fool.com/investing/2023/05/08/these-2-top-stocks-just-declared-dividend-raises/,20230508T091500,['Eric Volkman'],"These companies manage to keep growing and generating excess profits, which is admirable given their age and size.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F730922%2Fsenior-man-counting-cash-money-bills-social-security-retire-invest-inflation-cola-getty.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Earnings', 'relevance_score': '0.928769'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.250985,Somewhat-Bullish,"[{'ticker': 'KVUE', 'relevance_score': '0.26224', 'ticker_sentiment_score': '0.13471', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.159218', 'ticker_sentiment_score': '0.196165', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MA', 'relevance_score': '0.05339', 'ticker_sentiment_score': '0.081015', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.407844', 'ticker_sentiment_score': '0.168145', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
3 Things About Eli Lilly That Smart Investors Know,https://www.fool.com/investing/2023/05/08/3-things-about-eli-lilly-that-smart-investors-know/,20230508T090500,['Alex Carchidi'],"There are quite a few details to keep track of with this company, and they all matter.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F730975%2Fa-digital-rendering-of-a-computer-chip-being-plugged-into-a-circuit-board.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.149688,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.369685', 'ticker_sentiment_score': '0.252615', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.063933', 'ticker_sentiment_score': '0.134318', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.063933', 'ticker_sentiment_score': '0.134318', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.063933', 'ticker_sentiment_score': '0.134318', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.063933', 'ticker_sentiment_score': '0.134318', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.063933', 'ticker_sentiment_score': '-0.029181', 'ticker_sentiment_label': 'Neutral'}]"
"The Global Skin Care Product Market Expected to Grow by $180 Billion by 2026, According to Brandessence Market Research",https://www.prnewswire.com/news-releases/the-global-skin-care-product-market-expected-to-grow-by-180-billion-by-2026-according-to-brandessence-market-research-301818025.html,20230508T083000,['Brandessence Market Research and Consulting Private Limited'],The Global Skin Care Product Market Expected to Grow by $180 ... PR ...,https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.433845,Bullish,"[{'ticker': 'BDRFF', 'relevance_score': '0.025087', 'ticker_sentiment_score': '0.08803', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KAOCF', 'relevance_score': '0.025087', 'ticker_sentiment_score': '0.08803', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSDOF', 'relevance_score': '0.025087', 'ticker_sentiment_score': '0.08803', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.025087', 'ticker_sentiment_score': '0.08803', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.050148', 'ticker_sentiment_score': '0.207689', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UL', 'relevance_score': '0.025087', 'ticker_sentiment_score': '0.08803', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CL', 'relevance_score': '0.025087', 'ticker_sentiment_score': '0.08803', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRLCF', 'relevance_score': '0.050148', 'ticker_sentiment_score': '0.131324', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:UZS', 'relevance_score': '0.025087', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
"Exelixis, facing challenge from Farallon, says Willsey to exit board",https://www.reuters.com/business/healthcare-pharmaceuticals/exelixis-facing-challenge-farallon-says-willsey-exit-board-2023-05-07/,20230507T234300,['Svea Herbst-Bayliss'],"BOSTON, May 7 ( Reuters ) - Biotechnology company Exelixis ( EXEL.O ) said on Sunday that Lance Willsey was leaving its board and that it would not contest the election of a dissident director candidate amid a proxy battle with investor Farallon Capital Management.",https://www.reuters.com/pf/resources/images/reuters/reuters-default.webp?d=139,Reuters,Business,www.reuters.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.042771,Neutral,"[{'ticker': 'EXEL', 'relevance_score': '0.636698', 'ticker_sentiment_score': '-0.086867', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.144275', 'ticker_sentiment_score': '0.019118', 'ticker_sentiment_label': 'Neutral'}]"
This Incredible Growth Stock Has All the Hallmarks of a Prototypical Warren Buffett Stock,https://www.fool.com/investing/2023/05/06/this-incredible-growth-stock-has-all-the-hallmarks/,20230506T170000,['George Budwell'],"Vertex Pharmaceuticals faces limited competition in its core area of expertise, has a top-shelf CEO, and is building out a profoundly valuable pipeline of next-generation assets.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F731188%2Fcastle-moat.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.230762,Somewhat-Bullish,"[{'ticker': 'VRTX', 'relevance_score': '0.089965', 'ticker_sentiment_score': '0.171585', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABBV', 'relevance_score': '0.089965', 'ticker_sentiment_score': '0.009879', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.009005', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.320356', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.089965', 'ticker_sentiment_score': '0.063792', 'ticker_sentiment_label': 'Neutral'}]"
"Looking for Steady, Passive Income? Buy AbbVie Stock",https://www.fool.com/investing/2023/05/06/looking-for-steady-passive-income-buy-abbvie-stock/,20230506T130000,['Kody Kester'],The drugmaker looks poised to rebound from its Humira loss of exclusivity.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F730634%2Fa-doctor-and-patient-talk-to-each-other-during-an-appointment.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.858979'}]",0.209978,Somewhat-Bullish,"[{'ticker': 'ABBV', 'relevance_score': '0.355588', 'ticker_sentiment_score': '0.32216', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABT', 'relevance_score': '0.073546', 'ticker_sentiment_score': '0.210197', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.073546', 'ticker_sentiment_score': '0.077916', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.073546', 'ticker_sentiment_score': '-0.034528', 'ticker_sentiment_label': 'Neutral'}]"
3 Great Income Stocks That Retirees Should Love,https://www.fool.com/investing/2023/05/06/3-great-income-stocks-that-retirees-should-love/,20230506T101400,"['Keith Speights', 'David Jagielski', 'and Prosper Junior Bakiny']","If you're looking for additional retirement income, these three stocks should be right up your alley.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F730735%2Fshiba-inu.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.999897'}, {'topic': 'Earnings', 'relevance_score': '0.905476'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.283497,Somewhat-Bullish,"[{'ticker': 'ABBV', 'relevance_score': '0.288408', 'ticker_sentiment_score': '0.269959', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABT', 'relevance_score': '0.042122', 'ticker_sentiment_score': '0.139137', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.288408', 'ticker_sentiment_score': '0.299809', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.365464', 'ticker_sentiment_score': '0.348602', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Empowering Innovation to the Global Market with Acro Certify,https://www.prnewswire.com/news-releases/empowering-innovation-to-the-global-market-with-acro-certify-301817589.html,20230506T021800,['ACROBiosystems Inc.'],"NEWARK, Del., May 5, 2023 /PRNewswire/ -- For many companies, entering the global market is a daunting challenge. These obstacles can come in various forms. Sometimes the problem is finding the right target customer base or establishing an appropriate quality management system and shipping ...",,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.323391,Somewhat-Bullish,"[{'ticker': 'PFE', 'relevance_score': '0.052918', 'ticker_sentiment_score': '0.126637', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.052918', 'ticker_sentiment_score': '0.126637', 'ticker_sentiment_label': 'Neutral'}]"
Uber and Pfizer Update Their Investors About How Things Are Going,https://www.fool.com/investing/2023/05/05/uber-and-pfizer-update-their-investors/,20230505T222619,"['Chris Hill', 'Robert Brokamp', 'and Alison Southwick', 'CFP(R)', 'Bill Mann']","We also chat about whether there is a ""new normal"" for start-ups and venture capital.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F730305%2Fbuffett13-tmf.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'IPO', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.839681'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.25'}]",0.116632,Neutral,"[{'ticker': 'NYT', 'relevance_score': '0.011306', 'ticker_sentiment_score': '-0.043658', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.022611', 'ticker_sentiment_score': '0.111164', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBER', 'relevance_score': '0.223145', 'ticker_sentiment_score': '0.10671', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.135031', 'ticker_sentiment_score': '0.05636', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WE', 'relevance_score': '0.011306', 'ticker_sentiment_score': '-0.096375', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.011306', 'ticker_sentiment_score': '0.007', 'ticker_sentiment_label': 'Neutral'}]"
S&P 500 Finishes Strong Following Wild Week Of Bank Stock Volatility - JPMorgan Chase  ( NYSE:JPM ) ,https://www.benzinga.com/news/23/05/32246312/s-p-500-finishes-strong-following-wild-week-of-bank-stock-volatility,20230505T195937,['Wayne Duggan'],"The Fed's tenth consecutive interest rate hike, the buyout of First Republic's assets by JPMorgan Chase & Co JPM and a hot April jobs report gave investors plenty to digest this week. On Wednesday, the Federal Open Market Committee raised its fed funds target range by 0.25% to between 5% and ...",https://cdn.benzinga.com/files/images/story/2023/05/05/shutterstock_176534375.jpg?width=1200&height=800&fit=crop,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Earnings', 'relevance_score': '0.614606'}]",-0.069657,Neutral,"[{'ticker': 'PACW', 'relevance_score': '0.183198', 'ticker_sentiment_score': '-0.263228', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'PYPL', 'relevance_score': '0.183198', 'ticker_sentiment_score': '-0.160812', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'OXY', 'relevance_score': '0.183198', 'ticker_sentiment_score': '-0.160812', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'PARA', 'relevance_score': '0.183198', 'ticker_sentiment_score': '0.130085', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.271777', 'ticker_sentiment_score': '-0.176432', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.183198', 'ticker_sentiment_score': '0.125991', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBNY', 'relevance_score': '0.092213', 'ticker_sentiment_score': '-0.188861', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'BFC', 'relevance_score': '0.092213', 'ticker_sentiment_score': '-0.188861', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
"Acelyrin Raises $540M In IPO, Stock Gains Over 20% In Trading Debut - Acelyrin  ( NASDAQ:SLRN ) ",https://www.benzinga.com/general/biotech/23/05/32244803/acelyrin-raises-540m-in-ipo-stock-gains-over-20-in-trading-debut,20230505T175206,['Vandana Singh'],"Acelyrin Inc SLRN, a late-stage clinical biopharma company, started trading today and opened at $23/share compared to IPO pricing of $18/share. Acelyrin has raised $540 million in an upsized initial public offering, and it sold 30 million shares at $18 apiece, exceeding the projections it set ...",https://cdn.benzinga.com/files/images/story/2023/05/05/aapharma_6.png?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.451494'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",0.197051,Somewhat-Bullish,"[{'ticker': 'RIVN', 'relevance_score': '0.306963', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.306963', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
"Globus Medical  ( GMED )  Q1 Earnings Beat, Operating Margin Dips",https://www.zacks.com/stock/news/2091102/globus-medical-gmed-q1-earnings-beat-operating-margin-dips,20230505T172300,['Zacks Investment Research'],The significant year-over-year surge in Globus Medical's (GMED) Enabling Technologies sales is driven by ongoing demand for the company's robotics and imaging system technologies.,https://staticx-tuner.zacks.com/images/articles/main/0c/2749.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Earnings', 'relevance_score': '0.999993'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.251328,Somewhat-Bullish,"[{'ticker': 'EW', 'relevance_score': '0.174903', 'ticker_sentiment_score': '0.004298', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GMED', 'relevance_score': '0.341503', 'ticker_sentiment_score': '0.30126', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ISRG', 'relevance_score': '0.174903', 'ticker_sentiment_score': '0.005656', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NUVA', 'relevance_score': '0.04406', 'ticker_sentiment_score': '0.271768', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.174903', 'ticker_sentiment_score': '0.057083', 'ticker_sentiment_label': 'Neutral'}]"
"Insulet  ( PODD )  Q1 Earnings Beat Estimates, Sales View Up",https://www.zacks.com/stock/news/2091100/insulet-podd-q1-earnings-beat-estimates-sales-view-up,20230505T172100,['Zacks Investment Research'],"Omnipod 5 continues to be a driving force of Insulet's (PODD) strong U.S. growth, representing almost 95% of U.S. new customer starts in the first quarter.",https://staticx-tuner.zacks.com/images/articles/main/94/1507.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.310843'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.073556,Neutral,"[{'ticker': 'EW', 'relevance_score': '0.196212', 'ticker_sentiment_score': '0.004681', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PODD', 'relevance_score': '0.423843', 'ticker_sentiment_score': '0.357646', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'ISRG', 'relevance_score': '0.196212', 'ticker_sentiment_score': '0.006155', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.196212', 'ticker_sentiment_score': '0.060554', 'ticker_sentiment_label': 'Neutral'}]"
Biopharma firm Acelyrin valued at $2.1 billion in strong market debut,https://www.reuters.com/markets/deals/biopharma-firm-acelyrin-valued-21-billion-strong-market-debut-2023-05-05/,20230505T161045,['Reuters'],"May 5 ( Reuters ) - Shares of Acelyrin Inc ( SLRN.O ) rose 28% in their Nasdaq debut on Friday, giving the biopharma company a market capitalization of $2.1 billion. The Los Angeles-based company, which had priced its shares at $18 apiece, raised $540 million by selling 30 million shares in ...",https://www.reuters.com/pf/resources/images/reuters/reuters-default.webp?d=139,Reuters,Markets,www.reuters.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'IPO', 'relevance_score': '0.576289'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.117724,Neutral,"[{'ticker': 'RIVN', 'relevance_score': '0.227007', 'ticker_sentiment_score': '0.190789', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MS', 'relevance_score': '0.227007', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.227007', 'ticker_sentiment_score': '0.190789', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
The $25.3 Billion Market That Sent This Top 1% Stock Into A Breakout,https://www.investors.com/news/technology/ptgx-stock-briefly-breaks-out-as-it-eyes-a-big-market/,20230505T155800,"[""Investor's Business Daily"", 'ALLISON GATLIN']",PTGX Stock Briefly Breaks Out As It Eyes A $25.3 Billion Market Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2018/10/Stock-DrugSpill-02-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.980922'}]",0.110075,Neutral,"[{'ticker': 'PTGX', 'relevance_score': '0.48268', 'ticker_sentiment_score': '0.396169', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.48268', 'ticker_sentiment_score': '-0.086401', 'ticker_sentiment_label': 'Neutral'}]"
ETFs to Bet on the Successful Debut of Kenvue,https://www.zacks.com/stock/news/2090987/etfs-to-bet-on-the-successful-debut-of-kenvue,20230505T152000,['Zacks Investment Research'],"Kenvue is the world's largest pure-play consumer health company by revenue, and makes well-known products, including Tylenol, Neutrogena, Listerine, Johnson???s', Band-Aid, Aveeno, Zyrtec and Nicorette.",https://staticx-tuner.zacks.com/images/default_article_images/default13.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}, {'topic': 'IPO', 'relevance_score': '0.99489'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.264427,Somewhat-Bullish,"[{'ticker': 'IVZ', 'relevance_score': '0.193078', 'ticker_sentiment_score': '0.223535', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'RIVN', 'relevance_score': '0.04872', 'ticker_sentiment_score': '0.05156', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.193078', 'ticker_sentiment_score': '0.10231', 'ticker_sentiment_label': 'Neutral'}]"
Epilepsy Drugs Market Is Expected to Reach $9.8 Billion by 2032: Allied Market Research,https://www.benzinga.com/pressreleases/23/05/g32241720/epilepsy-drugs-market-is-expected-to-reach-9-8-billion-by-2032-allied-market-research,20230505T151617,['Globe Newswire'],"Portland, OR, May 05, 2023 ( GLOBE NEWSWIRE ) -- According to the report published by Allied Market Research, the global epilepsy drugs market generated $7 billion in 2022, and is estimated to reach $9.8 billion by 2032, witnessing a CAGR of 3.5% from 2023 to 2032.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.231592,Somewhat-Bullish,"[{'ticker': 'ABT', 'relevance_score': '0.036756', 'ticker_sentiment_score': '0.063953', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DNPUF', 'relevance_score': '0.036756', 'ticker_sentiment_score': '0.063953', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSUMF', 'relevance_score': '0.036756', 'ticker_sentiment_score': '0.063953', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.036756', 'ticker_sentiment_score': '0.063953', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VTRS', 'relevance_score': '0.036756', 'ticker_sentiment_score': '0.063953', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVS', 'relevance_score': '0.036756', 'ticker_sentiment_score': '0.063953', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BHC', 'relevance_score': '0.036756', 'ticker_sentiment_score': '0.063953', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UCBJF', 'relevance_score': '0.036756', 'ticker_sentiment_score': '0.063953', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.036756', 'ticker_sentiment_score': '0.063953', 'ticker_sentiment_label': 'Neutral'}]"
ABNB Stock In Holding Pattern Ahead Of Q1 Results; Warren Buffett Favorite Occidental Petroleum Set To Report,https://www.investors.com/research/earnings-preview/abnb-stock-holding-pattern-q1-results-warren-buffett-favorite-occidental-petroleum-oxy-earnings/,20230505T144300,"[""Investor's Business Daily"", 'KEN SHREVE']",ABNB Stock In Holding Pattern Ahead Of Q1 Results. Warren Buffett ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2023/05/EARNwatch050823.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.107738,Neutral,"[{'ticker': 'OXY', 'relevance_score': '0.098121', 'ticker_sentiment_score': '0.046385', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BSX', 'relevance_score': '0.065506', 'ticker_sentiment_score': '0.043037', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.032781', 'ticker_sentiment_score': '0.103066', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.065506', 'ticker_sentiment_score': '0.043037', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXON', 'relevance_score': '0.098121', 'ticker_sentiment_score': '-0.001078', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEN', 'relevance_score': '0.065506', 'ticker_sentiment_score': '0.043037', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABNB', 'relevance_score': '0.288515', 'ticker_sentiment_score': '0.070957', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SWAV', 'relevance_score': '0.098121', 'ticker_sentiment_score': '-0.014859', 'ticker_sentiment_label': 'Neutral'}]"
"Kenvue CEO looks to brand, product innovation to drive growth after IPO",https://www.cnbc.com/2023/05/05/jj-spinoff-kenvue-ceo-looks-to-innovation-after-ipo.html,20230505T133745,['Annika Kim Constantino'],"Kenvue CEO Thibaut Mongon said the spinoff's portfolio of brands, which includes Band-Aid, Tylenol and Neutrogena, has ""ample opportunity"" to grow.",https://image.cnbcfm.com/api/v1/image/107235862-16832241112023-05-04t170844z_1909065194_rc2qr0adtejx_rtrmadp_0_kenvue-ipo.jpeg?v=1683280801,CNBC,Business,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.918141'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.451494'}]",0.208097,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.044304', 'ticker_sentiment_score': '0.038076', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson  ( JNJ )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2090794/johnson-johnson-jnj-is-attracting-investor-attention-here-is-what-you-should-know,20230505T130013,['Zacks Investment Research'],"Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",https://staticx-tuner.zacks.com/images/default_article_images/default227.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.239754,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.473208', 'ticker_sentiment_score': '0.176729', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Bruker  ( BRKR )  Tops Q1 Earnings Estimates, Raises '23 Outlook",https://www.zacks.com/stock/news/2090714/bruker-brkr-tops-q1-earnings-estimates-raises-23-outlook,20230505T115900,['Zacks Investment Research'],"Bruker (BRKR) delivers a year-over-year revenue increase across all its segments in the first quarter, led by the strong demand for differentiated, high-performance scientific instruments and life-science solutions.",https://staticx-tuner.zacks.com/images/articles/main/c0/2563.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Earnings', 'relevance_score': '1.0'}]",0.149943,Neutral,"[{'ticker': 'BRKR', 'relevance_score': '0.45283', 'ticker_sentiment_score': '0.289671', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'EW', 'relevance_score': '0.159043', 'ticker_sentiment_score': '-0.025592', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.159043', 'ticker_sentiment_score': '0.005302', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.159043', 'ticker_sentiment_score': '0.05351', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:NANO', 'relevance_score': '0.079921', 'ticker_sentiment_score': '0.139658', 'ticker_sentiment_label': 'Neutral'}]"
"Bio-Rad  ( BIO )  Q1 Earnings Beat Estimates, Operating Margin Down",https://www.zacks.com/stock/news/2090697/bio-rad-bio-q1-earnings-beat-estimates-operating-margin-down,20230505T113500,['Zacks Investment Research'],Bio-Rad's (BIO) first-quarter results reflect core strength across the Life Science and Clinical Diagnostics segments amid ongoing supply-chain constraints.,https://staticx-tuner.zacks.com/images/articles/main/c7/282.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}, {'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.016706,Neutral,"[{'ticker': 'BIO', 'relevance_score': '0.207216', 'ticker_sentiment_score': '0.029101', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EW', 'relevance_score': '0.166455', 'ticker_sentiment_score': '-0.026384', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.166455', 'ticker_sentiment_score': '0.005465', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.166455', 'ticker_sentiment_score': '0.055156', 'ticker_sentiment_label': 'Neutral'}]"
J&J's Kenvue rallies out of the gate,https://www.axios.com/2023/05/04/kenvue-ipo,20230504T222553,"['https://www.axios.com/authors/danprimack', 'Dan Primack']","There was a giant IPO today. We haven't been able to write that since November 2021, when Rivian went public.",https://images.axios.com/MIc0y-HExsTdExaK-PP-btqWVZg=/0x0:1920x1080/1366x768/2023/05/04/1683239135055.jpg,Axios,Markets,www.axios.com,"[{'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.769861'}]",-0.054191,Neutral,"[{'ticker': 'PFE', 'relevance_score': '0.139265', 'ticker_sentiment_score': '-0.06272', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.139265', 'ticker_sentiment_score': '0.072279', 'ticker_sentiment_label': 'Neutral'}]"
US Stocks End Lower As Regional Banks Dive Again,https://www.barrons.com/news/us-stocks-end-lower-as-regional-banks-dive-again-24dbec8f,20230504T201620,['AFP - Agence France Presse'],"Wall Street stocks dropped Thursday following another brutal sell-off in regional banking shares, in the wake of four bank failures since early March. The broad-based S&P 500 shed 0.7 percent to 4,061.22, while the tech-rich Nasdaq Composite Index lost 0.5 percent at 11,966.40.",,Barrons,n/a,www.barrons.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",-0.277902,Somewhat-Bearish,"[{'ticker': 'PACW', 'relevance_score': '0.16171', 'ticker_sentiment_score': '-0.156478', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'FHN', 'relevance_score': '0.16171', 'ticker_sentiment_score': '-0.156478', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'PARA', 'relevance_score': '0.16171', 'ticker_sentiment_score': '-0.156478', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.16171', 'ticker_sentiment_score': '-0.156478', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
Stock Market Today: Stocks Slide as Regional Bank Rout Worsens,https://www.kiplinger.com/investing/stocks/stock-market-today-stocks-slide-as-regional-bank-rout-worsens,20230504T201532,['Karee Venema'],Panic selling in regional bank stocks resulted in losses for the major indexes Thursday.,https://cdn.mos.cms.futurecdn.net/VgHpYQDLqZch8vXdd9juwk-415-80.jpg,Kiplinger,n/a,www.kiplinger.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'IPO', 'relevance_score': '0.576289'}, {'topic': 'Financial Markets', 'relevance_score': '0.967645'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",-0.13223,Neutral,"[{'ticker': 'PACW', 'relevance_score': '0.192183', 'ticker_sentiment_score': '-0.174944', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TD', 'relevance_score': '0.128822', 'ticker_sentiment_score': '-0.167353', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'AAPL', 'relevance_score': '0.128822', 'ticker_sentiment_score': '-0.157975', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'PARA', 'relevance_score': '0.128822', 'ticker_sentiment_score': '-0.110538', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.192183', 'ticker_sentiment_score': '0.061366', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.128822', 'ticker_sentiment_score': '-0.110538', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FHN', 'relevance_score': '0.128822', 'ticker_sentiment_score': '-0.167353', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
"Kenvue IPO: Profitable Company, Expensive Stock",https://www.forbes.com/sites/greatspeculations/2023/05/04/kenvue-ipo-profitable-company-expensive-stock/,20230504T190254,['David Trainer'],"At its expected valuation, KVUE looks fully valued and does not provide investors with much upside potential.",https://imageio.forbes.com/specials-images/imageserve/6453d8a94c6f501eff227174/0x0.jpg?format=jpg&width=1200,Forbes,Money,www.forbes.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.576289'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.999997'}]",0.142116,Neutral,"[{'ticker': 'KMB', 'relevance_score': '0.092213', 'ticker_sentiment_score': '0.057175', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.242587', 'ticker_sentiment_score': '-0.019315', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.030799', 'ticker_sentiment_score': '0.110795', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UL', 'relevance_score': '0.030799', 'ticker_sentiment_score': '0.110795', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CL', 'relevance_score': '0.061552', 'ticker_sentiment_score': '0.055002', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRLCF', 'relevance_score': '0.030799', 'ticker_sentiment_score': '0.110795', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CLX', 'relevance_score': '0.030799', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.061552', 'ticker_sentiment_score': '0.118024', 'ticker_sentiment_label': 'Neutral'}]"
"Kenvue stock cheered in Wall Street debut, as Tylenol and Band-Aid brand parent is valued at $48 billion",https://www.marketwatch.com/story/kenvue-stock-opens-16-above-ipo-valuing-the-company-at-47-7-billion-ff0c65cb,20230504T180100,['Tomi Kilgore'],"Kenvue's stock was cheered in its Wall Street debut Thursday, as the J&J spinoff saw its stock open 16.0% above where the initial public offering was priced.",https://images.mktw.net/im-775991/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.928139'}, {'topic': 'Financial Markets', 'relevance_score': '0.905476'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}]",0.277469,Somewhat-Bullish,"[{'ticker': 'DSSMY', 'relevance_score': '0.131643', 'ticker_sentiment_score': '0.133209', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.259727', 'ticker_sentiment_score': '0.222733', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Amedisys  ( AMED )  Q1 Earnings Beat Estimates, Margins Dip",https://www.zacks.com/stock/news/2090275/amedisys-amed-q1-earnings-beat-estimates-margins-dip,20230504T164700,['Zacks Investment Research'],Amedisys (AMED) sees a year-over-year decline in the Hospice segment's revenues.,https://staticx-tuner.zacks.com/images/articles/main/a0/644.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999894'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}]",0.131403,Neutral,"[{'ticker': 'EW', 'relevance_score': '0.195419', 'ticker_sentiment_score': '0.004664', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMED', 'relevance_score': '0.379291', 'ticker_sentiment_score': '0.121617', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.195419', 'ticker_sentiment_score': '0.036889', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.195419', 'ticker_sentiment_score': '0.061929', 'ticker_sentiment_label': 'Neutral'}]"
"Tandem Diabetes  ( TNDM )  Q1 Earnings Miss, Gross Margin Dips",https://www.zacks.com/stock/news/2090267/tandem-diabetes-tndm-q1-earnings-miss-gross-margin-dips,20230504T164300,['Zacks Investment Research'],"According to Tandem Diabetes (TNDM), Q1 revenues are in line with the high end of its expectations.",https://staticx-tuner.zacks.com/images/articles/main/0c/2749.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999997'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}]",0.016694,Neutral,"[{'ticker': 'EW', 'relevance_score': '0.213517', 'ticker_sentiment_score': '0.004996', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TNDM', 'relevance_score': '0.213517', 'ticker_sentiment_score': '-0.008692', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.213517', 'ticker_sentiment_score': '0.039514', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.213517', 'ticker_sentiment_score': '0.066323', 'ticker_sentiment_label': 'Neutral'}]"
"Club meeting recap: Equities slide, J&J consumer IPO, Costco sales",https://www.cnbc.com/2023/05/04/club-meeting-recap-equities-slide-jj-consumer-ipo-costco-sales.html,20230504T160307,['Paulina Likos'],"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",https://image.cnbcfm.com/api/v1/image/107235604-16832110191683211013-29303246042-1080pnbcnews.jpg?v=1683212560&w=600&h=300&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'IPO', 'relevance_score': '0.769861'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.980716'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}]",0.07472,Neutral,"[{'ticker': 'PACW', 'relevance_score': '0.138464', 'ticker_sentiment_score': '0.039276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RIVN', 'relevance_score': '0.138464', 'ticker_sentiment_score': '0.039276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.138464', 'ticker_sentiment_score': '0.039276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.399204', 'ticker_sentiment_score': '0.086', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.138464', 'ticker_sentiment_score': '0.039276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.206392', 'ticker_sentiment_score': '0.051684', 'ticker_sentiment_label': 'Neutral'}]"
FATE Incurs Narrower-Than-Expected Q1 Loss on Lower Expenses,https://www.zacks.com/stock/news/2090210/fate-incurs-narrower-than-expected-q1-loss-on-lower-expenses,20230504T155900,['Zacks Investment Research'],FATE reports lower-than-expected loss on higher collaboration revenues and lower operating expenses in first-quarter 2023.,https://staticx-tuner.zacks.com/images/articles/main/37/2337.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.744043'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.004764,Neutral,"[{'ticker': 'LGND', 'relevance_score': '0.256179', 'ticker_sentiment_score': '0.053399', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FATE', 'relevance_score': '0.3527', 'ticker_sentiment_score': '-0.063595', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPRO', 'relevance_score': '0.206245', 'ticker_sentiment_score': '0.009736', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.104002', 'ticker_sentiment_score': '0.036407', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OPHLF', 'relevance_score': '0.104002', 'ticker_sentiment_score': '0.063277', 'ticker_sentiment_label': 'Neutral'}]"
A stock portfolio created by ChatGPT is outperforming the top UK investment funds,https://markets.businessinsider.com/news/stocks/chatgpt-ai-stock-portfolio-outperforming-investment-uk-funds-finder-outlook-2023-5,20230504T153100,['Phil Rosen'],ChatGPT Built a Stock Portfolio That's Outperforming Top UK Funds - Markets Insider ...,https://i.insider.com/6453c025dcb78700180cdb61?width=1200&format=jpeg,Business Insider,GoogleRSS,markets.businessinsider.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.891286'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.147298,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.17715', 'ticker_sentiment_score': '0.174299', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NFLX', 'relevance_score': '0.089129', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.089129', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HD', 'relevance_score': '0.089129', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.17715', 'ticker_sentiment_score': '0.174299', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.089129', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
"Sports Medicine Market Size, Share, Revenue, Trends And Drivers For 2023-2032 As Per The Business Research Company's Sports Medicine Global Market Report 2023",https://www.benzinga.com/pressreleases/23/05/g32217713/sports-medicine-market-size-share-revenue-trends-and-drivers-for-2023-2032-as-per-the-business-res,20230504T153000,['Globe Newswire'],"LONDON, May 04, 2023 ( GLOBE NEWSWIRE ) -- The Business Research Company's research on the sports medicine market identifies the sports medicine market share to grow at a compound annual growth rate ( CAGR ) of more than 7% from $7 billion in 2022 to $7.6 billion in 2023.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.191645,Somewhat-Bullish,"[{'ticker': 'ZBH', 'relevance_score': '0.129866', 'ticker_sentiment_score': '0.093812', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNN', 'relevance_score': '0.129866', 'ticker_sentiment_score': '0.093812', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SYK', 'relevance_score': '0.06515', 'ticker_sentiment_score': '-0.002006', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CNMD', 'relevance_score': '0.06515', 'ticker_sentiment_score': '-0.002006', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSSMY', 'relevance_score': '0.129866', 'ticker_sentiment_score': '0.093812', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.06515', 'ticker_sentiment_score': '-0.002006', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson Spins Off Kenvue in Biggest IPO Haul Since 2021,https://www.kiplinger.com/investing/johnson-and-johnson-spins-off-kenvue-in-biggest-ipo-haul-since-2021,20230504T152508,['Dan Burrows'],"Johnson & Johnson ( JNJ ( opens in new tab ) ) spun off its Kenvue ( KVUE ( opens in new tab ) ) consumer brands division on Thursday, raising the most cash from an initial public offering ( IPO ) in more than a year.",https://cdn.mos.cms.futurecdn.net/GNUV5Mf2itvqe8uC5xwLp5-415-80.jpg,Kiplinger,n/a,www.kiplinger.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.682689'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.310843'}]",0.259171,Somewhat-Bullish,"[{'ticker': 'SPGI', 'relevance_score': '0.071357', 'ticker_sentiment_score': '0.237002', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.755649', 'ticker_sentiment_score': '0.278952', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Phibro  ( PAHC )  Q3 Earnings Miss Estimates, Gross Margin Up",https://www.zacks.com/stock/news/2090216/phibro-pahc-q3-earnings-miss-estimates-gross-margin-up,20230504T151200,['Zacks Investment Research'],Higher domestic demand and higher average selling prices for dairy products and growth in the companion animal product drive Phibro's (PAHC) Q3 revenues.,https://staticx-tuner.zacks.com/images/articles/main/41/899.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999998'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}]",-0.0144,Neutral,"[{'ticker': 'PAHC', 'relevance_score': '0.182506', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EW', 'relevance_score': '0.182506', 'ticker_sentiment_score': '-0.001495', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.182506', 'ticker_sentiment_score': '0.005832', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.182506', 'ticker_sentiment_score': '0.058855', 'ticker_sentiment_label': 'Neutral'}]"
"Envista  ( NVST )  Q1 Earnings Miss Estimates, Margins Down",https://www.zacks.com/stock/news/2090207/envista-nvst-q1-earnings-miss-estimates-margins-down,20230504T145500,['Zacks Investment Research'],Weakness in China and Russia and lower demand for large capital equipment hurts Envista's (NVST) Q1 revenues.,https://staticx-tuner.zacks.com/images/articles/main/41/899.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999759'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}]",-0.028878,Neutral,"[{'ticker': 'EW', 'relevance_score': '0.199447', 'ticker_sentiment_score': '-0.001598', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.199447', 'ticker_sentiment_score': '0.006234', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVST', 'relevance_score': '0.386626', 'ticker_sentiment_score': '-0.247617', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.199447', 'ticker_sentiment_score': '0.0629', 'ticker_sentiment_label': 'Neutral'}]"
Should Investors Buy This Hot Growth Stock?,https://www.fool.com/investing/2023/05/04/should-investors-buy-this-hot-growth-stock/,20230504T141500,['Kody Kester'],This pharmaceutical giant has proved to be a tremendous wealth creator for its shareholders in recent years.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F730473%2Fa-doctor-consults-with-their-patient.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.99994'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.918141'}]",0.2182,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.308504', 'ticker_sentiment_score': '0.175385', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.063258', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
J&J Consumer-Health IPO Kenvue to Raise $3.8 Billion,https://www.barrons.com/articles/jnj-stock-ipo-kenvue-5cc1207d,20230504T141500,['Josh Nathan-Kazis'],J&J Consumer-Health IPO Stock Kenvue to Raise $3.8 Billion ...,https://images.barrons.com/im-775612?width=639&height=426,Barrons,n/a,www.barrons.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.769861'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.119012,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.193465', 'ticker_sentiment_score': '-0.04057', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HLN', 'relevance_score': '0.28664', 'ticker_sentiment_score': '0.006288', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.28664', 'ticker_sentiment_score': '-0.018759', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.608634', 'ticker_sentiment_score': '0.222028', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PG', 'relevance_score': '0.193465', 'ticker_sentiment_score': '0.00459', 'ticker_sentiment_label': 'Neutral'}]"
Want to Get Richer? 2 Best Stocks to Buy Now and Hold Forever,https://www.fool.com/investing/2023/05/04/want-to-get-richer-2-best-stocks-to-buy-and-hold/,20230504T135300,['Sushree Mohanty'],These two high-growth stocks have the potential to deliver solid long-term returns.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F730363%2Fbuffett22-tmf.png&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.99393'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}]",0.328509,Somewhat-Bullish,"[{'ticker': 'TDOC', 'relevance_score': '0.107736', 'ticker_sentiment_score': '-0.172627', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'MDT', 'relevance_score': '0.053992', 'ticker_sentiment_score': '0.104986', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.107736', 'ticker_sentiment_score': '0.083147', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.053992', 'ticker_sentiment_score': '0.104986', 'ticker_sentiment_label': 'Neutral'}]"
5 Mid-Cap Stocks With Large Yields,https://www.barrons.com/articles/federated-hermes-hanover-hf-sinclair-dividend-stocks-yields-89ffeafc,20230504T124000,['Lawrence C. Strauss'],"Federated Herms, Hanover Insurance, and 3 Other Mid-Cap Stocks With Large Yields ...",https://images.barrons.com/im-775267?width=619&height=413,Barrons,n/a,www.barrons.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.323493,Somewhat-Bullish,"[{'ticker': 'THG', 'relevance_score': '0.195287', 'ticker_sentiment_score': '0.352669', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'KO', 'relevance_score': '0.130926', 'ticker_sentiment_score': '0.296984', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UNM', 'relevance_score': '0.319725', 'ticker_sentiment_score': '0.249386', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WFC', 'relevance_score': '0.065685', 'ticker_sentiment_score': '0.154002', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DINO', 'relevance_score': '0.195287', 'ticker_sentiment_score': '0.116858', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FHI', 'relevance_score': '0.258351', 'ticker_sentiment_score': '0.472935', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.130926', 'ticker_sentiment_score': '0.296984', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Qiagen  ( QGEN )  Q1 Earnings Top Estimates, Operating Margin Down",https://www.zacks.com/stock/news/2089830/qiagen-qgen-q1-earnings-top-estimates-operating-margin-down,20230504T122700,['Zacks Investment Research'],"Amid an uncertain macroeconomic environment, Qiagen's (QGEN) first-quarter results reflect an impressive organic top line, led by strength in non-COVID-19 product groups.",https://staticx-tuner.zacks.com/images/articles/main/08/595.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.037873,Neutral,"[{'ticker': 'EW', 'relevance_score': '0.145364', 'ticker_sentiment_score': '-0.024195', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QGEN', 'relevance_score': '0.417419', 'ticker_sentiment_score': '0.117102', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.145364', 'ticker_sentiment_score': '0.005016', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.145364', 'ticker_sentiment_score': '0.050607', 'ticker_sentiment_label': 'Neutral'}]"
"Myriad Genetics  ( MYGN )  Lags Q1 Earnings, Updates '23 View",https://www.zacks.com/stock/news/2089774/myriad-genetics-mygn-lags-q1-earnings-updates-23-view,20230504T120000,['Zacks Investment Research'],"Myriad Genetics (MYGN) delivers a year-over-year increase in first-quarter revenues, reflecting a positive volume improvement across the portfolio.",https://staticx-tuner.zacks.com/images/articles/main/8e/391.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.99737'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}]",-0.023941,Neutral,"[{'ticker': 'EW', 'relevance_score': '0.177802', 'ticker_sentiment_score': '-0.027632', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.177802', 'ticker_sentiment_score': '0.005722', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.177802', 'ticker_sentiment_score': '0.057755', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MYGN', 'relevance_score': '0.425746', 'ticker_sentiment_score': '0.129613', 'ticker_sentiment_label': 'Neutral'}]"
"Psychedelic Drug Industry Analysis: Forecast Market Size, Major Players And Their Strategies, And Key Segments - By The Business Research Company",https://www.prnewswire.com/news-releases/psychedelic-drug-industry-analysis-forecast-market-size-major-players-and-their-strategies-and-key-segments--by-the-business-research-company-301814512.html,20230504T093000,['The Business Reseach Company'],"Psychedelic Drug Industry Analysis: Forecast Market Size, Major ... PR ...",https://mma.prnewswire.com/media/1751581/tbrc_logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.0,Neutral,"[{'ticker': 'CMPS', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.018172', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.018172', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JAZZ', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.018172', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.018172', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HKMPF', 'relevance_score': '0.143415', 'ticker_sentiment_score': '-0.158649', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'ABBV', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.018172', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.018172', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SEEL', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.018172', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TAK', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.018172', 'ticker_sentiment_label': 'Neutral'}]"
"J&J, cancer victims ordered to start settlement talks in bankruptcy",https://www.business-standard.com/companies/news/j-j-cancer-victims-ordered-to-start-settlement-talks-in-bankruptcy-123050400455_1.html,20230504T074403,['Business Standard'],A federal judge ordered a new round of settlement talks between Johnson & Johnson and lawyers who spurned the company's offer to pay $8.9 billion to end tens of thousands of cancer claims ...,"https://bsmedia.business-standard.com/_media/bs/img/article/2023-05/04/full/1683185574-7857.jpg?im=FeatureCrop,width=826,height=465",Business Standard,Companies,www.business-standard.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.329889,Somewhat-Bearish,"[{'ticker': 'JNJ', 'relevance_score': '0.108466', 'ticker_sentiment_score': '-0.071662', 'ticker_sentiment_label': 'Neutral'}]"
5 Mid-Cap Stocks With Large Yields,https://www.barrons.com/articles/mid-cap-dividend-stocks-yields-89ffeafc,20230504T070000,['Lawrence C. Strauss'],"When it comes to dividend stocks, large-cap names command a lot of attention. But the likes of Johnson & Johnson ( ticker: JNJ ) , AT&T ( T ) , and Coca-Cola ( KO ) aren't the only places to find nice yields. Mid-cap stocks are worth a look as well.",https://images.barrons.com/im-775267?width=639&height=426,Barrons,n/a,www.barrons.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.323493,Somewhat-Bullish,"[{'ticker': 'THG', 'relevance_score': '0.195287', 'ticker_sentiment_score': '0.352669', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'KO', 'relevance_score': '0.130926', 'ticker_sentiment_score': '0.296984', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UNM', 'relevance_score': '0.319725', 'ticker_sentiment_score': '0.249386', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WFC', 'relevance_score': '0.065685', 'ticker_sentiment_score': '0.154002', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DINO', 'relevance_score': '0.195287', 'ticker_sentiment_score': '0.116858', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FHI', 'relevance_score': '0.258351', 'ticker_sentiment_score': '0.472935', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.130926', 'ticker_sentiment_score': '0.296984', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Weight-Loss Drugs Will Be Blockbusters. Here's the Stock to Buy.,https://www.barrons.com/articles/weight-loss-drugs-buy-this-stock-c5d4418c,20230504T053000,['Josh Nathan-Kazis'],"In the year since Eli Lilly announced trial results showing that tirzepatide-best known by the brand name Mounjaro-helped patients drop more than 20% of their weight, the drug has become the most talked about, and most hyped, pharmaceutical in recent memory.",https://images.barrons.com/im-773655?width=940&height=627,Barrons,n/a,www.barrons.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.028228,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.507932', 'ticker_sentiment_score': '0.035198', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.353059', 'ticker_sentiment_score': '0.092107', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.353059', 'ticker_sentiment_score': '0.092107', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson and Kenvue Announce Pricing of Upsized Kenvue Inc. Initial Public Offering,https://investingnews.com/johnson-johnson-and-kenvue-announce-pricing-of-upsized-kenvue-inc-initial-public-offering/,20230503T235241,[],"Johnson & Johnson ( NYSE: JNJ ) and Kenvue Inc. ( ""Kenvue"" ) , a wholly owned subsidiary of Johnson & Johnson, today announced the pricing of Kenvue's upsized initial public offering ( ""IPO"" ) of 172,812,560 shares of Kenvue's common stock at a price to the public of $22.00 per share.",https://investingnews.com/media-library/eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJpbWFnZSI6Imh0dHBzOi8vYXNzZXRzLnJibC5tcy8yNTg1ODg1NS9vcmlnaW4ucG5nIiwiZXhwaXJlc19hdCI6MTcwODY4MTIxOX0.Phin9ClvosnPNpkGRdBWHz_VFepTco5fqEYZcXCsZIQ/image.png?width=210,Investing News Network,n/a,investingnews.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.983605'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.283119,Somewhat-Bullish,"[{'ticker': 'BR', 'relevance_score': '0.044141', 'ticker_sentiment_score': '0.130844', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.044141', 'ticker_sentiment_score': '0.12985', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.088147', 'ticker_sentiment_score': '0.137497', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ICNB', 'relevance_score': '0.044141', 'ticker_sentiment_score': '0.196636', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.381625', 'ticker_sentiment_score': '0.279357', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Johnson & Johnson's Kenvue IPO to command valuation of more than $40 billion in biggest public debut since 2021,https://www.marketwatch.com/story/johnson-johnsons-kenvue-ipo-to-command-valuation-of-more-than-40-billion-in-biggest-public-debut-since-2021-7974a202,20230503T233800,['Jeremy C. Owens'],A unit of Johnson & Johnson is headed for the biggest initial public offering in more than a year after its shares priced near the top of the range.,https://images.mktw.net/im-775408/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}]",0.241773,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.916507', 'ticker_sentiment_score': '0.415128', 'ticker_sentiment_label': 'Bullish'}]"
THE PALEY CENTER FOR MEDIA ANNOUNCES NEW MEMBERS TO ITS ESTEEMED BOARD OF TRUSTEES AND LOS ANGELES BOARD OF GOVERNORS,https://www.benzinga.com/pressreleases/23/05/n32202093/the-paley-center-for-media-announces-new-members-to-its-esteemed-board-of-trustees-and-los-angeles,20230503T221900,['PRNewswire'],"Sean ""Diddy"" Combs, Robert Kyncl, Ryan Roslansky, and Joseph C. Tsai Join the Paley Center's Board of Trustees",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.281464,Somewhat-Bullish,"[{'ticker': 'BABA', 'relevance_score': '0.028764', 'ticker_sentiment_score': '-0.108563', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NFLX', 'relevance_score': '0.028764', 'ticker_sentiment_score': '0.100327', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MAT', 'relevance_score': '0.028764', 'ticker_sentiment_score': '0.03749', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.05749', 'ticker_sentiment_score': '0.064011', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.143074', 'ticker_sentiment_score': '0.033012', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VZ', 'relevance_score': '0.028764', 'ticker_sentiment_score': '0.03749', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PARA', 'relevance_score': '0.028764', 'ticker_sentiment_score': '0.03749', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.028764', 'ticker_sentiment_score': '0.100327', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LBTYA', 'relevance_score': '0.028764', 'ticker_sentiment_score': '0.03749', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SIRI', 'relevance_score': '0.028764', 'ticker_sentiment_score': '0.03749', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOX', 'relevance_score': '0.05749', 'ticker_sentiment_score': '0.034011', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ATUS', 'relevance_score': '0.028764', 'ticker_sentiment_score': '0.03749', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DIS', 'relevance_score': '0.028764', 'ticker_sentiment_score': '0.03749', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FCN', 'relevance_score': '0.028764', 'ticker_sentiment_score': '0.100327', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.028764', 'ticker_sentiment_score': '0.03749', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNEJF', 'relevance_score': '0.05749', 'ticker_sentiment_score': '0.064011', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMG', 'relevance_score': '0.028764', 'ticker_sentiment_score': '-0.108563', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.028764', 'ticker_sentiment_score': '0.03749', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WBD', 'relevance_score': '0.028764', 'ticker_sentiment_score': '0.100327', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RBLX', 'relevance_score': '0.028764', 'ticker_sentiment_score': '0.03749', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HAS', 'relevance_score': '0.028764', 'ticker_sentiment_score': '0.03749', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EA', 'relevance_score': '0.028764', 'ticker_sentiment_score': '0.03749', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMCX', 'relevance_score': '0.028764', 'ticker_sentiment_score': '0.100327', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TTWO', 'relevance_score': '0.028764', 'ticker_sentiment_score': '0.03749', 'ticker_sentiment_label': 'Neutral'}]"
J&J Prices Consumer Unit IPO at $22 a Share,https://www.wsj.com/articles/j-j-prices-consumer-unit-ipo-at-22-a-share-1950af12,20230503T215500,['Corrie Driebusch and Laura Cooper'],The listing of the Tylenol maker would be by far the biggest initial public offering so far this year.,https://images.wsj.net/im-775381?width=700&height=448,Wall Street Journal,Markets,www.wsj.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.158519'}]",0.22397,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.504646', 'ticker_sentiment_score': '0.290171', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
J&J's Kenvue prices IPO within range to raise $3.7 bln - source,https://www.reuters.com/markets/us/jjs-kenvue-prices-ipo-within-range-raise-37-bln-source-2023-05-03/,20230503T210700,['Echo Wang'],"NEW YORK, May 3 ( Reuters ) - Johnson & Johnson ( JNJ.N ) on Wednesday priced the initial public offering ( IPO ) of its consumer-health business at the upper end of its target range to raise $3.66 billion, people familiar with the matter said,",https://cloudfront-us-east-2.images.arcpublishing.com/reuters/H4AO6XWSHZM75I42PR7T6GM5Y4.jpg,Reuters,Markets,www.reuters.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.451494'}]",0.162359,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.306963', 'ticker_sentiment_score': '0.065349', 'ticker_sentiment_label': 'Neutral'}]"
"CVS Health  ( CVS )  Q1 Earnings Surpass Estimates, EPS View Cut",https://www.zacks.com/stock/news/2089344/cvs-health-cvs-q1-earnings-surpass-estimates-eps-view-cut,20230503T182200,['Zacks Investment Research'],CVS Health's (CVS) robust sales growth across all three operating segments drives top-line results.,https://staticx-tuner.zacks.com/images/articles/main/5a/926.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}, {'topic': 'Earnings', 'relevance_score': '0.999994'}]",0.185773,Somewhat-Bullish,"[{'ticker': 'CVS', 'relevance_score': '0.372139', 'ticker_sentiment_score': '0.370992', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'EW', 'relevance_score': '0.170576', 'ticker_sentiment_score': '0.004223', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.170576', 'ticker_sentiment_score': '0.005557', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OSH', 'relevance_score': '0.085782', 'ticker_sentiment_score': '0.233275', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.170576', 'ticker_sentiment_score': '0.05609', 'ticker_sentiment_label': 'Neutral'}]"
Syniti to Showcase New Cloud-Native Data Migration Platform at SAP Sapphire Conferences,https://www.prnewswire.com/news-releases/syniti-to-showcase-new-cloud-native-data-migration-platform-at-sap-sapphire-conferences-301815018.html,20230503T180600,['Syniti'],Syniti to Showcase New Cloud-Native Data Migration Platform at ... PR ...,,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.352382,Bullish,"[{'ticker': 'NOC', 'relevance_score': '0.095899', 'ticker_sentiment_score': '0.05499', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SAP', 'relevance_score': '0.867939', 'ticker_sentiment_score': '0.498429', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'BTI', 'relevance_score': '0.048036', 'ticker_sentiment_score': '0.096957', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.048036', 'ticker_sentiment_score': '0.051582', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:ECC', 'relevance_score': '0.048036', 'ticker_sentiment_score': '0.096957', 'ticker_sentiment_label': 'Neutral'}]"
Iron Pillar leads supply chain tech firm Pando's $30 mn Series B Funding,https://www.business-standard.com/companies/news/iron-pillar-leads-supply-chain-tech-firm-pando-s-30-mn-series-b-funding-123050301094_1.html,20230503T175006,['Business Standard'],"With the global logistics SaaS tech market estimated to grow to $25 billion by 2025, Pando said it is well-positioned to benefit from the broader tailwinds ...","https://bsmedia.business-standard.com/_media/bs/img/article/2023-05/03/full/1683125784-8676.jpg?im=FeatureCrop,width=826,height=465",Business Standard,Companies,www.business-standard.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}]",0.285299,Somewhat-Bullish,"[{'ticker': 'NSRGF', 'relevance_score': '0.091162', 'ticker_sentiment_score': '0.204527', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.091162', 'ticker_sentiment_score': '0.204527', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Powell Takes the Stage: Another Rate Increase Widely Expected as Investors Eye Banks, Debt Ceiling - First Republic Bank  ( NYSE:FRC ) ",https://www.benzinga.com/markets/penny-stocks/23/05/32189679/powell-takes-the-stage-another-rate-increase-widely-expected-as-investors-eye-banks-debt-cei,20230503T145046,['Alex Coffey'],"( Wednesday market open ) For the second straight meeting, the Federal Open Market Committee ( FOMC ) arrives at an interest rate decision today just as the market gets jittery over small banks.",https://cdn.benzinga.com/files/images/story/2023/05/03/shutterstock_2284599845.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.9973'}, {'topic': 'IPO', 'relevance_score': '0.9545'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.999986'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.310843'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",-0.071962,Neutral,"[{'ticker': 'JCI', 'relevance_score': '0.03878', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.03878', 'ticker_sentiment_score': '0.029175', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.13513', 'ticker_sentiment_score': '-0.003636', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.03878', 'ticker_sentiment_score': '0.050431', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PCG', 'relevance_score': '0.03878', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FRC', 'relevance_score': '0.03878', 'ticker_sentiment_score': '-0.302478', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'MS', 'relevance_score': '0.058141', 'ticker_sentiment_score': '-0.023049', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.03878', 'ticker_sentiment_score': '0.097216', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SFTBF', 'relevance_score': '0.03878', 'ticker_sentiment_score': '0.029175', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.03878', 'ticker_sentiment_score': '-0.001', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CME', 'relevance_score': '0.03878', 'ticker_sentiment_score': '-0.110237', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSN', 'relevance_score': '0.03878', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
DENTSPLY SIRONA  ( XRAY )  Q1 Earnings & Revenues Beat Estimates,https://www.zacks.com/stock/news/2089149/dentsply-sirona-xray-q1-earnings-revenues-beat-estimates,20230503T144900,['Zacks Investment Research'],"DENTSPLY SIRONA's (XRAY) Q1 earnings and revenues decline year over year, driven by the unfavorable foreign currency movement and soft demand across all geographical segments.",https://staticx-tuner.zacks.com/images/articles/main/f5/266.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999986'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}]",0.071398,Neutral,"[{'ticker': 'EW', 'relevance_score': '0.194632', 'ticker_sentiment_score': '0.09186', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XRAY', 'relevance_score': '0.377855', 'ticker_sentiment_score': '0.049108', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.194632', 'ticker_sentiment_score': '0.067342', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.194632', 'ticker_sentiment_score': '0.098356', 'ticker_sentiment_label': 'Neutral'}]"
2 Stocks to Buy With $200 That Can Survive Any Recession,https://www.fool.com/investing/2023/05/03/2-stocks-to-buy-that-can-survive-any-recession/,20230503T140000,['Prosper Junior Bakiny'],These businesses have an excellent track record of surviving difficult economic times.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F730363%2Fbuffett22-tmf.png&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}, {'topic': 'Earnings', 'relevance_score': '0.839681'}]",0.111748,Neutral,"[{'ticker': 'AMZN', 'relevance_score': '0.359447', 'ticker_sentiment_score': '0.16876', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.273807', 'ticker_sentiment_score': '0.121883', 'ticker_sentiment_label': 'Neutral'}]"
"Penumbra  ( PEN )  Q1 Earnings Top Estimates, Sales Remain Robust",https://www.zacks.com/stock/news/2089135/penumbra-pen-q1-earnings-top-estimates-sales-remain-robust,20230503T132800,['Zacks Investment Research'],Penumbra's (PEN) sales during the first quarter reflect continued demand for its products. The 2023 outlook is encouraging as earnings improve despite macro challenges.,https://staticx-tuner.zacks.com/images/articles/main/55/4324.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999763'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}]",0.182446,Somewhat-Bullish,"[{'ticker': 'PEN', 'relevance_score': '0.53764', 'ticker_sentiment_score': '0.277843', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'EW', 'relevance_score': '0.210731', 'ticker_sentiment_score': '0.09601', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.210731', 'ticker_sentiment_score': '0.071586', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.210731', 'ticker_sentiment_score': '0.10455', 'ticker_sentiment_label': 'Neutral'}]"
How Long Could It Take for Johnson & Johnson's Dividend Yield to Get to 5%?,https://www.fool.com/investing/2023/05/03/how-long-could-it-take-for-johnson-johnsons-divide/,20230503T130900,['David Jagielski'],"Over time, your dividend payments from the stock are likely to rise significantly.",https://media.ycharts.com/charts/6db0b404f12b38b81d7a387b38275032.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}]",0.311428,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.497126', 'ticker_sentiment_score': '0.387217', 'ticker_sentiment_label': 'Bullish'}]"
J&J's consumer health business Kenvue is going public this week. Here's what to know,https://www.cnbc.com/2023/05/03/jj-kenvue-ipo-what-to-know.html,20230503T123840,['Annika Kim Constantino'],J&J's consumer health spinoff Kenvue is expected to set an initial public offering price Wednesday night and trade Thursday on the New York Stock Exchange.,https://image.cnbcfm.com/api/v1/image/105340568-1532013104570rtx6bp3f.jpg?v=1683117520&w=1920&h=1080,CNBC,Business,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'IPO', 'relevance_score': '0.972193'}, {'topic': 'Financial Markets', 'relevance_score': '0.938793'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.839681'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.083348,Neutral,"[{'ticker': 'RIVN', 'relevance_score': '0.036756', 'ticker_sentiment_score': '0.186354', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PEP', 'relevance_score': '0.036756', 'ticker_sentiment_score': '-0.073612', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.036756', 'ticker_sentiment_score': '0.148798', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.036756', 'ticker_sentiment_score': '0.148798', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.036756', 'ticker_sentiment_score': '0.148798', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.109956', 'ticker_sentiment_score': '0.018271', 'ticker_sentiment_label': 'Neutral'}]"
Only 2 Companies Are AAA Rated As U.S. Risks Being A Deadbeat,https://www.investors.com/etfs-and-funds/sectors/sp500-companies-cling-to-aaa-rating-as-u-s-risks-being-a-deadbeat/,20230503T120000,"['MATT KRANTZ', ""Investor's Business Daily""]",Lawmakers are playing chicken with the debt ceiling - and the U.S.' creditworthiness. Luckily there are still two U.S. S&P 500 companies left with perfect AAA credit ratings - a key asset with interest rates on the rise.,https://www.investors.com/wp-content/uploads/2023/05/Stock-GoldAAAcredit-01-shut.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}]",0.064524,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.239895', 'ticker_sentiment_score': '0.173845', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.181137', 'ticker_sentiment_score': '0.181451', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'XOM', 'relevance_score': '0.121343', 'ticker_sentiment_score': '0.159645', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SPGI', 'relevance_score': '0.121343', 'ticker_sentiment_score': '0.140368', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DISH', 'relevance_score': '0.121343', 'ticker_sentiment_score': '-0.159774', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LPLA', 'relevance_score': '0.060848', 'ticker_sentiment_score': '-0.018387', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADP', 'relevance_score': '0.121343', 'ticker_sentiment_score': '0.159645', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GE', 'relevance_score': '0.121343', 'ticker_sentiment_score': '0.159645', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.121343', 'ticker_sentiment_score': '0.159645', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Omnicell  ( OMCL )  Q1 Earnings Top Estimates, Margins Down",https://www.zacks.com/stock/news/2088752/omnicell-omcl-q1-earnings-top-estimates-margins-down,20230503T112200,['Zacks Investment Research'],"Despite a year-over-year decrease, Omnicell's (OMCL) first-quarter revenues and earnings exceed the top end of the previously announced outlook amid an uncertain macroeconomic environment.",https://staticx-tuner.zacks.com/images/articles/main/b2/19786.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.087158,Neutral,"[{'ticker': 'EW', 'relevance_score': '0.162255', 'ticker_sentiment_score': '-0.025933', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OMCL', 'relevance_score': '0.42666', 'ticker_sentiment_score': '0.365137', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'ISRG', 'relevance_score': '0.162255', 'ticker_sentiment_score': '0.005372', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.162255', 'ticker_sentiment_score': '0.054218', 'ticker_sentiment_label': 'Neutral'}]"
"Key Marijuana Executive Changes You Should Know About: New Appointments And Promotions - Humble & Fume  ( OTC:HUMBF ) , Green Thumb Industries  ( OTC:GTBIF ) ",https://www.benzinga.com/markets/cannabis/23/05/32164073/key-marijuana-executive-changes-you-should-know-about-new-appointments-and-promotions,20230502T221501,['Jelena Martinovic'],Cannabis operator Humble & Fume Inc. HMBL HUMBF has appointed Chris Candelario as the president of US distribution. Candelario is a veteran of nearly twenty years in the distribution industry.,https://cdn.benzinga.com/files/images/story/2023/05/02/mediensturmer-awf7mjwwjjo-unsplash.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}]",0.338086,Somewhat-Bullish,"[{'ticker': 'HD', 'relevance_score': '0.06211', 'ticker_sentiment_score': '0.326672', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MAYNF', 'relevance_score': '0.06211', 'ticker_sentiment_score': '0.326672', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.06211', 'ticker_sentiment_score': '0.326672', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Stanley Black & Decker Appoints Chris Nelson Chief Operating Officer and Executive Vice President and President of Tools & Outdoor,https://www.prnewswire.com/news-releases/stanley-black--decker-appoints-chris-nelson-chief-operating-officer-and-executive-vice-president-and-president-of-tools--outdoor-301813814.html,20230502T203600,['Stanley Black & Decker'],Stanley Black & Decker Appoints Chris Nelson Chief Operating ... PR ...,https://mma.prnewswire.com/media/199180/stanley_black_and_decker_logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}]",0.363148,Bullish,"[{'ticker': 'TOSBF', 'relevance_score': '0.063091', 'ticker_sentiment_score': '0.24743', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ICNB', 'relevance_score': '0.063091', 'ticker_sentiment_score': '0.09118', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SWK', 'relevance_score': '0.571381', 'ticker_sentiment_score': '0.491589', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'SWKH', 'relevance_score': '0.125789', 'ticker_sentiment_score': '0.067129', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.063091', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
"Zimmer Biomet  ( ZBH )  Q1 Earnings Beat Estimates, View Raised",https://www.zacks.com/stock/news/2088455/zimmer-biomet-zbh-q1-earnings-beat-estimates-view-raised,20230502T180300,['Zacks Investment Research'],Each of Zimmer Biomet's (ZBH) geographic segments and product divisions records strong year-over-year sales growth at CER.,https://staticx-tuner.zacks.com/images/articles/main/4f/17576.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}, {'topic': 'Earnings', 'relevance_score': '0.999992'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.166489,Somewhat-Bullish,"[{'ticker': 'ZBH', 'relevance_score': '0.409503', 'ticker_sentiment_score': '0.42524', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'EW', 'relevance_score': '0.212115', 'ticker_sentiment_score': '0.004973', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.212115', 'ticker_sentiment_score': '0.039293', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.212115', 'ticker_sentiment_score': '0.02799', 'ticker_sentiment_label': 'Neutral'}]"
Sylvia Banderas Coffinet Named CEO of Latino Media Network,https://www.benzinga.com/pressreleases/23/05/n32168573/sylvia-banderas-coffinet-named-ceo-of-latino-media-network,20230502T175400,['PRNewswire'],"Sylvia joins founders Stephanie Valencia and Jessica Morales Rocketto in scaling one of the largest, Latina owned multi-platform audio & media companies serving the Latino market in the US",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Earnings', 'relevance_score': '0.161647'}]",0.247902,Somewhat-Bullish,"[{'ticker': 'ULTA', 'relevance_score': '0.057767', 'ticker_sentiment_score': '0.075962', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRLCF', 'relevance_score': '0.057767', 'ticker_sentiment_score': '0.075962', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'M', 'relevance_score': '0.057767', 'ticker_sentiment_score': '0.075962', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.057767', 'ticker_sentiment_score': '0.075962', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.057767', 'ticker_sentiment_score': '0.075962', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.057767', 'ticker_sentiment_score': '0.075962', 'ticker_sentiment_label': 'Neutral'}]"
"Biotech/Drug Stocks' Q1 Earnings Due May 3: UTHR, PCRX & More",https://www.zacks.com/stock/news/2088427/biotechdrug-stocks-q1-earnings-due-may-3-uthr-pcrx-more,20230502T173200,['Zacks Investment Research'],"Let us take a look at what's in store for biotech/drug stocks UTHR, PCRX, CORT, AMRN and IONS, which are scheduled to report on May 3.",https://staticx-tuner.zacks.com/images/default_article_images/default6.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.077073,Neutral,"[{'ticker': 'CORT', 'relevance_score': '0.222022', 'ticker_sentiment_score': '0.053562', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMRN', 'relevance_score': '0.306963', 'ticker_sentiment_score': '-0.075464', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.04497', 'ticker_sentiment_score': '-0.053922', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IONS', 'relevance_score': '0.222022', 'ticker_sentiment_score': '0.053562', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.04497', 'ticker_sentiment_score': '-0.053922', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PCRX', 'relevance_score': '0.222022', 'ticker_sentiment_score': '0.053562', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UTHR', 'relevance_score': '0.264897', 'ticker_sentiment_score': '0.140167', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.04497', 'ticker_sentiment_score': '-0.053922', 'ticker_sentiment_label': 'Neutral'}]"
"Hologic's  ( HOLX )  Q2 Earnings Beat Estimates, 2023 View Up",https://www.zacks.com/stock/news/2088415/hologics-holx-q2-earnings-beat-estimates-2023-view-up,20230502T162700,['Zacks Investment Research'],The year-over-year growth in Breast Health and GYN Surgical Businesses contributed to Hologic's (HOLX) Q2 revenues.,https://staticx-tuner.zacks.com/images/articles/main/41/899.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.021542,Neutral,"[{'ticker': 'EW', 'relevance_score': '0.150357', 'ticker_sentiment_score': '-0.023401', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HOLX', 'relevance_score': '0.295421', 'ticker_sentiment_score': '0.303319', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ISRG', 'relevance_score': '0.150357', 'ticker_sentiment_score': '0.005119', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.150357', 'ticker_sentiment_score': '0.051644', 'ticker_sentiment_label': 'Neutral'}]"
2 Biotech IPOs Are Thursday. Why the Window Is Still Shut.,https://www.barrons.com/articles/kenvue-acelyrin-stocks-ipos-3f9805ab,20230502T162400,['Josh Nathan-Kazis'],"Kenvue, Acelyrin Go Public on Thursday. Don't Expect a Flood of Biotech ...",https://images.barrons.com/im-774017?width=639&height=426,Barrons,n/a,www.barrons.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.682689'}, {'topic': 'Financial Markets', 'relevance_score': '0.94762'}]",0.158147,Somewhat-Bullish,"[{'ticker': 'RXDX', 'relevance_score': '0.108466', 'ticker_sentiment_score': '0.11446', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GPCR', 'relevance_score': '0.108466', 'ticker_sentiment_score': '-0.134215', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.108466', 'ticker_sentiment_score': '0.077237', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson Ignites CAR-T Ambitions With Licensing Pact With Cellular Biomedicine - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/23/05/32165424/johnson-johnson-ignites-car-t-ambitions-with-licensing-pact-with-cellular-biomedicine,20230502T161429,['Vandana Singh'],"Johnson & Johnson's JNJ pharma unit Janssen entered into a worldwide collaboration and license agreement with Cellular Biomedicine Group Inc to develop, manufacture and commercialize next-generation chimeric antigen receptor ( CAR ) T-cell therapies for B-cell malignancies.",https://cdn.benzinga.com/files/images/story/2023/05/02/jnj.png?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.139258,Neutral,"[{'ticker': 'GILD', 'relevance_score': '0.303175', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.56415', 'ticker_sentiment_score': '0.057639', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LEGN', 'relevance_score': '0.303175', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
"IDEXX  ( IDXX )  Q1 Earnings Beat Estimates, Margins Increase",https://www.zacks.com/stock/news/2088405/idexx-idxx-q1-earnings-beat-estimates-margins-increase,20230502T160200,['Zacks Investment Research'],Continued solid demand for veterinary services and record global premium instrument placements drive IDEXX's (IDXX) Q1 revenues.,https://staticx-tuner.zacks.com/images/articles/main/41/899.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999994'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}]",0.11575,Neutral,"[{'ticker': 'IDXX', 'relevance_score': '0.185662', 'ticker_sentiment_score': '0.089104', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EW', 'relevance_score': '0.185662', 'ticker_sentiment_score': '-0.001514', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.185662', 'ticker_sentiment_score': '0.005906', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.185662', 'ticker_sentiment_score': '0.0596', 'ticker_sentiment_label': 'Neutral'}]"
Looking At Johnson & Johnson's Recent Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/05/32164112/looking-at-johnson-johnsons-recent-unusual-options-activity,20230502T151609,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.14329,Neutral,"[{'ticker': 'MS', 'relevance_score': '0.194242', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.823771', 'ticker_sentiment_score': '0.167301', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
NCLAT sets aside CCI's six-year-old penalty on ITC for not furnishing info on Savlon deal | The Financial Express,https://www.financialexpress.com/industry/nclat-sets-aside-ccis-six-year-old-penalty-on-itc-for-not-furnishing-info-on-savlon-deal/3071960/,20230502T150857,[],NCLAT sets aside CCI's six-year-old penalty on ITC for not ... The Financial Express ...,https://www.financialexpress.com/wp-content/uploads/2023/05/ITC-reuters-pic.jpg,The Financial Express,n/a,www.financialexpress.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.028913,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.098659', 'ticker_sentiment_score': '0.020617', 'ticker_sentiment_label': 'Neutral'}]"
NCLAT sets aside CCI penalty on ITC for not furnishing info on Savlon deal,https://www.business-standard.com/companies/news/nclat-sets-aside-cci-penalty-on-itc-for-not-furnishing-info-on-savlon-deal-123050201083_1.html,20230502T144837,['Business Standard'],The National Company Law Appellate Tribunal (NCLAT) has set aside the penalty imposed on multi-conglomerate ITC by fair trade regulator CCI for not notifying for the acquisition of brands 'Savlon' and 'Shower to Shower' in 2017.,"https://bsmedia.business-standard.com/_media/bs/img/article/2019-01/22/full/1548172477-3927.jpg?im=FeatureCrop,width=826,height=465",Business Standard,Companies,www.business-standard.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.028913,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.098659', 'ticker_sentiment_score': '0.152828', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
2 Incredibly Cheap Dividend Stocks to Buy in May,https://www.fool.com/investing/2023/05/02/2-incredibly-cheap-dividend-stocks-to-buy-in-may/,20230502T134500,['George Budwell'],These two dividend-paying pharma stocks both screen as significantly undervalued right now.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F730203%2Fpaper-certificate-shares-invest-stock-split-market-reverse-getty.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.996023'}, {'topic': 'Earnings', 'relevance_score': '0.995921'}]",0.378169,Bullish,"[{'ticker': 'ICNB', 'relevance_score': '0.050148', 'ticker_sentiment_score': '0.111698', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.149656', 'ticker_sentiment_score': '0.232116', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.100099', 'ticker_sentiment_score': '0.177057', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Better Growth Stock: Johnson & Johnson vs. Intuitive Surgical,https://www.fool.com/investing/2023/05/02/better-growth-stock-johnson-johnson-vs-intuitive-s/,20230502T112000,['Sushree Mohanty'],"Both are great companies, but one might be a slightly better option.",https://media.ycharts.com/charts/5a5eec70f5d76af05987d7a1d8397aa3.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.980716'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.336437,Somewhat-Bullish,"[{'ticker': 'ISRG', 'relevance_score': '0.221616', 'ticker_sentiment_score': '0.436559', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.13409', 'ticker_sentiment_score': '0.01854', 'ticker_sentiment_label': 'Neutral'}]"
Biden will end Covid vaccine mandates for federal workers and international travelers on May 11,https://www.cnbc.com/2023/05/01/covid-biden-will-end-vaccine-mandates-for-federal-workers-travelers.html,20230502T003901,['Spencer Kimball'],"The Biden administration will end Covid vaccine mandates for federal employees, contractors and air travelers on May 11.",https://image.cnbcfm.com/api/v1/image/106800835-1606137435956-laxx.jpg?v=1682983112&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.158519'}]",-0.168398,Somewhat-Bearish,"[{'ticker': 'ILMN', 'relevance_score': '0.082677', 'ticker_sentiment_score': '-0.265959', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'BIIB', 'relevance_score': '0.082677', 'ticker_sentiment_score': '0.285622', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.082677', 'ticker_sentiment_score': '0.148346', 'ticker_sentiment_label': 'Neutral'}]"
Politan nominates two director candidates at Masimo -filing,https://www.reuters.com/business/sustainable-business/politan-nominates-two-director-candidates-masimo-filing-2023-05-01/,20230501T211100,['Svea Herbst-Bayliss'],Politan nominates two director candidates at ...,https://www.reuters.com/pf/resources/images/reuters/reuters-default.webp?d=138,Reuters,Business,www.reuters.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",-0.078695,Neutral,"[{'ticker': 'CNC', 'relevance_score': '0.092927', 'ticker_sentiment_score': '0.10436', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MASI', 'relevance_score': '0.800874', 'ticker_sentiment_score': '-0.064712', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.092927', 'ticker_sentiment_score': '0.024951', 'ticker_sentiment_label': 'Neutral'}]"
Daescu Dominates In Doubles At The Association Of Pickleball Professionals Sacramento Open,https://www.forbes.com/sites/toddboss/2023/05/01/daescu-dominates-in-doubles-at-the-association-of-pickleball-professionals-sacramento-open/,20230501T142945,['Todd Boss'],"Andrei Daescu too both Men's and Mixed doubles gold in Sacramento, his second straight Double Double on the APP tour. Meanwhile, Yates Johnson wins his first ever gold medal in any competition and the Jardim & Todd doubles freight train continues on.",https://imageio.forbes.com/specials-images/imageserve/644fc73048d3b73d940d1575/0x0.jpg?format=jpg&width=1200,Forbes,Business,www.forbes.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.273149,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.032825', 'ticker_sentiment_score': '0.161623', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"After Jumping 49% in 1 Month, Is It Too Late to Buy Legend Biotech?",https://moneymorning.com/investing/after-jumping-49-in-1-month-is-it-too-late-to-buy-legend-biotech/,20230501T132500,"['Garrett Baldwin', 'Nick Black', 'Shah Gilani', 'fool.com', 'Fool.com']","With its shares up by 49% in one month and 80% in one year, shareholders of Legend Biotech ( NASDAQ: LEGN ) are bound to be feeling pretty smart right about now.",https://moneymorning.com/wp-content/blogs.dir/1/files/2023/04/motley-fool-mark.png,Money Morning,GoogleRSS,moneymorning.com,"[{'topic': 'Earnings', 'relevance_score': '0.161647'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.245732,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.081001', 'ticker_sentiment_score': '0.131379', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LEGN', 'relevance_score': '0.388879', 'ticker_sentiment_score': '0.403866', 'ticker_sentiment_label': 'Bullish'}]"
"After Jumping 49% in 1 Month, Is It Too Late to Buy Legend Biotech?",https://www.fool.com/investing/2023/05/01/after-jumping-49-in-1-month-is-it-too-late-to-buy/,20230501T132500,['Alex Carchidi'],"Legend's cell therapy seems like it's a winner, but it might be priced in already.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729712%2Fwoman-30s-laptop-gettyimages-1418471348.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.161647'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}]",0.212413,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.049732', 'ticker_sentiment_score': '0.127668', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LEGN', 'relevance_score': '0.244846', 'ticker_sentiment_score': '0.290524', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments,https://www.cnbc.com/2023/05/01/states-medicare-alzheimers-treatments.html,20230501T130001,['Spencer Kimball'],"Attorneys general from 23 states, Washington D.C., and two U.S. territories called on Medicare to cover Alzheimer's treatments without restrictions.",https://image.cnbcfm.com/api/v1/image/107090864-1658245265138-NUP_198367_01033_copy.jpg?v=1682945506,CNBC,Business,www.cnbc.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.158519'}]",0.048171,Neutral,"[{'ticker': 'ILMN', 'relevance_score': '0.041181', 'ticker_sentiment_score': '-0.255497', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'BIIB', 'relevance_score': '0.041181', 'ticker_sentiment_score': '0.274564', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.041181', 'ticker_sentiment_score': '0.141776', 'ticker_sentiment_label': 'Neutral'}]"
Biopharma firm Acelyrin seeks $1.5 bln valuation in US IPO,https://www.reuters.com/markets/deals/biopharma-firm-acelyrin-seeks-15-bln-valuation-us-ipo-2023-05-01/,20230501T122500,['Reuters'],Biopharma firm Acelyrin seeks $1.5 bln valuation in US ...,https://www.reuters.com/pf/resources/images/reuters/reuters-default.webp?d=138,Reuters,Markets,www.reuters.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.576289'}, {'topic': 'Financial Markets', 'relevance_score': '0.77141'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.081892,Neutral,"[{'ticker': 'MS', 'relevance_score': '0.158519', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.158519', 'ticker_sentiment_score': '0.097032', 'ticker_sentiment_label': 'Neutral'}]"
JPMorgan Chase Returns to a Familiar Role: Bank Rescuer,https://www.nytimes.com/2023/05/01/business/dealbook/jpmorgan-first-republic-rescue.html,20230501T113300,[],The lending giant's shares jumped on the news that it is buying First Republic. But investors are watching to see if the deal ends the regional banking crisis.,https://static01.nyt.com/images/2023/05/01/multimedia/01db-firstrepublic-gfcb/01db-firstrepublic-gfcb-articleLarge.jpg?quality=75&auto=webp&disable=upscale,New York Times,Dealbook,www.nytimes.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.986714'}, {'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.026598,Neutral,"[{'ticker': 'BABA', 'relevance_score': '0.02083', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.02083', 'ticker_sentiment_score': '0.116155', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.062434', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PNC', 'relevance_score': '0.041646', 'ticker_sentiment_score': '0.052442', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.205982', 'ticker_sentiment_score': '0.021673', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.02083', 'ticker_sentiment_score': '-0.277159', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.02083', 'ticker_sentiment_score': '0.109665', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.02083', 'ticker_sentiment_score': '0.114298', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOX', 'relevance_score': '0.02083', 'ticker_sentiment_score': '-0.229812', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'MSFT', 'relevance_score': '0.041646', 'ticker_sentiment_score': '0.141782', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.02083', 'ticker_sentiment_score': '0.101599', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SFTBF', 'relevance_score': '0.02083', 'ticker_sentiment_score': '-0.014383', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MANU', 'relevance_score': '0.02083', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBER', 'relevance_score': '0.02083', 'ticker_sentiment_score': '0.101599', 'ticker_sentiment_label': 'Neutral'}]"
"If I Could Buy Only 1 Warren Buffett Stock in May, This Would Be It",https://www.fool.com/investing/2023/05/01/if-i-could-buy-only-1-warren-buffett-stock-in-may/,20230501T095400,['Keith Speights'],Buffett would probably agree with this choice.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729969%2Fstock-market-crash-plunge-dollar-newspaper-invest-dow-sp-500-getty.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.995077'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}]",0.177776,Somewhat-Bullish,"[{'ticker': 'AAPL', 'relevance_score': '0.348919', 'ticker_sentiment_score': '0.327142', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BAC', 'relevance_score': '0.236972', 'ticker_sentiment_score': '0.154635', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KO', 'relevance_score': '0.236972', 'ticker_sentiment_score': '0.103605', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCK', 'relevance_score': '0.1789', 'ticker_sentiment_score': '0.178306', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BRK-A', 'relevance_score': '0.1789', 'ticker_sentiment_score': '0.241046', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.236972', 'ticker_sentiment_score': '0.104581', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KR', 'relevance_score': '0.1789', 'ticker_sentiment_score': '0.154256', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PG', 'relevance_score': '0.1789', 'ticker_sentiment_score': '0.154256', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMZN', 'relevance_score': '0.348919', 'ticker_sentiment_score': '0.182536', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"If I Could Buy Only 1 Warren Buffett Stock in May, This Would Be It",https://moneymorning.com/investing/if-i-could-buy-only-1-warren-buffett-stock-in-may-this-would-be-it/,20230501T095400,"['fool.com', 'Fool.com']","It's a new month and a new opportunity to invest. When it comes to investing ideas, I can't think of a better fount of wisdom than Warren Buffett. His Berkshire Hathaway ( NYSE: BRK.A ) ( NYSE: BRK.B ) portfolio features plenty of great stocks.",https://moneymorning.com/wp-content/blogs.dir/1/files/2023/04/motley-fool-mark.png,Money Morning,RSS,moneymorning.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.955357'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}]",0.186732,Somewhat-Bullish,"[{'ticker': 'AAPL', 'relevance_score': '0.376005', 'ticker_sentiment_score': '0.54673', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'BAC', 'relevance_score': '0.231332', 'ticker_sentiment_score': '-0.077988', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.155451', 'ticker_sentiment_score': '-0.013884', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCK', 'relevance_score': '0.155451', 'ticker_sentiment_score': '-0.098445', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.155451', 'ticker_sentiment_score': '0.271286', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.155451', 'ticker_sentiment_score': '-0.098445', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KR', 'relevance_score': '0.155451', 'ticker_sentiment_score': '-0.013884', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.155451', 'ticker_sentiment_score': '-0.013884', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.305058', 'ticker_sentiment_score': '0.1029', 'ticker_sentiment_label': 'Neutral'}]"
Healthium Medtech appoints Prashant Krishnan as Global Business Head for Advanced Wound Care and Surgery | The Financial Express,https://www.financialexpress.com/healthcare/healthtech/healthium-medtech-appoints-prashant-krishnan-as-global-business-head-for-advanced-wound-care-and-surgery/3070089/,20230501T092500,[],Healthium Medtech appoints Prashant Krishnan as Global Business ... The Financial Express ...,https://www.financialexpress.com/wp-content/uploads/2023/05/Prashant-Krishnan.jpeg,The Financial Express,n/a,www.financialexpress.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.406278,Bullish,"[{'ticker': 'MDT', 'relevance_score': '0.149192', 'ticker_sentiment_score': '0.108758', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.074926', 'ticker_sentiment_score': '0.100958', 'ticker_sentiment_label': 'Neutral'}]"
SoftBank Group's chip maker Arm registers for blockbuster US IPO,https://www.business-standard.com/world-news/softbank-group-s-chip-maker-arm-registers-for-blockbuster-us-ipo-123043000988_1.html,20230430T181550,['Business Standard'],"The IPO registration shows that SoftBank is pressing ahead with the blockbuster offering despite adverse market conditions, after saying in March that it planned to list Arm in the US stock market.","https://bsmedia.business-standard.com/_media/bs/img/article/2023-04/23/full/1682272348-7726.jpg?im=FeatureCrop,width=826,height=465",Business Standard,GoogleRSS,www.business-standard.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'IPO', 'relevance_score': '0.890401'}, {'topic': 'Financial Markets', 'relevance_score': '0.839681'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.05467,Neutral,"[{'ticker': 'NVDA', 'relevance_score': '0.09989', 'ticker_sentiment_score': '-0.124429', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.09989', 'ticker_sentiment_score': '0.013179', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.09989', 'ticker_sentiment_score': '0.013179', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.09989', 'ticker_sentiment_score': '0.08811', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SFTBF', 'relevance_score': '0.469744', 'ticker_sentiment_score': '0.015391', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.09989', 'ticker_sentiment_score': '0.013179', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MFG', 'relevance_score': '0.09989', 'ticker_sentiment_score': '0.013179', 'ticker_sentiment_label': 'Neutral'}]"
"Sales, spins and splits - what are the differences and why do they matter for investors like us?",https://www.cnbc.com/2023/04/30/sales-spin-offs-and-splits-the-differences-and-why-they-matter-for-investors.html,20230430T143752,['Kevin Stankiewicz'],"While each transaction needs to be evaluated on its own merits, the Club has come to recognize that sometimes, less is more.",https://image.cnbcfm.com/api/v1/image/106974802-1636726530213-gettyimages-1269284025-cajohnson04.jpeg?v=1682865472&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.324426,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.913524', 'ticker_sentiment_score': '0.537717', 'ticker_sentiment_label': 'Bullish'}]"
"Alzheimer's patients may wait years to get treated with new drugs, putting them at risk of more severe disease",https://www.cnbc.com/2023/04/30/alzheimers-treatment-patients-may-wait-years-for-new-drugs.html,20230430T130001,['Spencer Kimball'],Patients could face wait times ranging from 18 months to four years or more to get diagnosed and then treated for Alzheimer's disease.,https://image.cnbcfm.com/api/v1/image/107231937-16825975612023-03-29t000000z_583469951_rc2w30aoohoj_rtrmadp_0_usa-health.jpeg?v=1682853517,CNBC,Top News,www.cnbc.com,"[{'topic': 'Earnings', 'relevance_score': '0.818451'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}]",0.052423,Neutral,"[{'ticker': 'CVS', 'relevance_score': '0.014541', 'ticker_sentiment_score': '0.04246', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DGX', 'relevance_score': '0.029078', 'ticker_sentiment_score': '-0.012914', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.029078', 'ticker_sentiment_score': '-0.008616', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.014541', 'ticker_sentiment_score': '-0.37311', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'ESALF', 'relevance_score': '0.08708', 'ticker_sentiment_score': '0.074793', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.029078', 'ticker_sentiment_score': '0.083295', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QTRX', 'relevance_score': '0.014541', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
"2 Simple Ways to Make $40,000 in Passive Income",https://moneymorning.com/investing/2-simple-ways-to-make-40000-in-passive-income/,20230430T095200,"['Fool.com', 'fool.com']","Most people work hard for their money. That's admirable. But it's also smart to let your money work hard for you. Some avenues for putting your money to work can be super complicated. There are less complex approaches, though. Here are two simple ways to make $40,000 in passive income.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729175%2Fyoung-woman-smiling-hands-behind-head.jpg&w=700,Money Morning,RSS,moneymorning.com,"[{'topic': 'Real Estate & Construction', 'relevance_score': '0.5'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.989041'}]",0.384486,Bullish,"[{'ticker': 'OHI', 'relevance_score': '0.356865', 'ticker_sentiment_score': '0.270393', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.183198', 'ticker_sentiment_score': '0.311202', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"2 Simple Ways to Make $40,000 in Passive Income",https://www.fool.com/investing/2023/04/30/simple-ways-to-make-passive-income/,20230430T095200,['Keith Speights'],Make your money work for you with these two investment options.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729175%2Fyoung-woman-smiling-hands-behind-head.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.99999'}]",0.311736,Somewhat-Bullish,"[{'ticker': 'OHI', 'relevance_score': '0.263231', 'ticker_sentiment_score': '0.214933', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.13347', 'ticker_sentiment_score': '0.257971', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Exclusive: SoftBank's Arm registers for blockbuster US IPO,https://www.reuters.com/markets/deals/softbanks-arm-registers-blockbuster-us-ipo-sources-2023-04-29/,20230429T150800,"['Anirban Sen', 'Echo Wang']",Exclusive: SoftBank's Arm registers for blockbuster US ...,https://cloudfront-us-east-2.images.arcpublishing.com/reuters/F5575Y2M2BKEHAW4SPWW4KVS6A.jpg,Reuters,Markets,www.reuters.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'IPO', 'relevance_score': '0.838487'}, {'topic': 'Financial Markets', 'relevance_score': '0.839681'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.084964,Neutral,"[{'ticker': 'NVDA', 'relevance_score': '0.09402', 'ticker_sentiment_score': '-0.122526', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.09402', 'ticker_sentiment_score': '0.161545', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JPM', 'relevance_score': '0.09402', 'ticker_sentiment_score': '0.161545', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.09402', 'ticker_sentiment_score': '0.077332', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SFTBF', 'relevance_score': '0.363388', 'ticker_sentiment_score': '-0.002587', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.09402', 'ticker_sentiment_score': '0.161545', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MFG', 'relevance_score': '0.09402', 'ticker_sentiment_score': '0.161545', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Initial public offerings scheduled to debut next week,https://apnews.com/article/ipos-business-f3e7cbb42bfc422886d2510a5ebd2b89,20230429T024817,[],"NEW YORK ( AP ) - The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings. CaliberCos - Scottsdale, Ariz., 1.2 million shares, priced at $5, managed by Scottsdale, Ariz.",https://storage.googleapis.com/afs-prod/media/afs:Medium:751921853724/700.png,Associated Press,Business,apnews.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.272617,Somewhat-Bullish,"[{'ticker': 'GS', 'relevance_score': '0.355588', 'ticker_sentiment_score': '0.20397', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JPM', 'relevance_score': '0.355588', 'ticker_sentiment_score': '0.20397', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.355588', 'ticker_sentiment_score': '0.20397', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Initial public offerings scheduled to debut next week,https://apnews.com/article/ipos-business-dcde52c917c74fcd9451bc9344e1ef91,20230429T024817,[],"NEW YORK ( AP ) - The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings. CaliberCos - Scottsdale, Ariz., 1.2 million shares, priced at $5, managed by Scottsdale, Ariz.",https://storage.googleapis.com/afs-prod/media/afs:Medium:751921853724/700.png,Associated Press,Markets,apnews.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.272617,Somewhat-Bullish,"[{'ticker': 'GS', 'relevance_score': '0.355588', 'ticker_sentiment_score': '0.20397', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JPM', 'relevance_score': '0.355588', 'ticker_sentiment_score': '0.20397', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.355588', 'ticker_sentiment_score': '0.20397', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Merit Medical  ( MMSI )  Tops Q1 Earnings Estimates, Ups FY23 View",https://www.zacks.com/stock/news/2087122/merit-medical-mmsi-tops-q1-earnings-estimates-ups-fy23-view,20230428T172700,['Zacks Investment Research'],Merit Medical (MMSI) benefits from revenue growth in both segments and all product categories within its Cardiovascular unit in the first quarter.,https://staticx-tuner.zacks.com/images/articles/main/d9/554.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}, {'topic': 'Earnings', 'relevance_score': '0.999955'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.224795,Somewhat-Bullish,"[{'ticker': 'EW', 'relevance_score': '0.143629', 'ticker_sentiment_score': '-0.024041', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MMSI', 'relevance_score': '0.143629', 'ticker_sentiment_score': '0.064144', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.143629', 'ticker_sentiment_score': '0.00498', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.143629', 'ticker_sentiment_score': '0.02131', 'ticker_sentiment_label': 'Neutral'}]"
"Integer Holdings  ( ITGR )  Q1 Earnings, Revenues Beat Estimates",https://www.zacks.com/stock/news/2087031/integer-holdings-itgr-q1-earnings-revenues-beat-estimates,20230428T160100,['Zacks Investment Research'],"Integer Holdings' (ITGR) first-quarter results reflect robust Medical and Non-Medical sales, besides strength in all the product lines.",https://staticx-tuner.zacks.com/images/articles/main/79/359.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.999896'}]",0.139027,Neutral,"[{'ticker': 'EW', 'relevance_score': '0.144275', 'ticker_sentiment_score': '-0.022826', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ITGR', 'relevance_score': '0.475461', 'ticker_sentiment_score': '0.226256', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ISRG', 'relevance_score': '0.144275', 'ticker_sentiment_score': '0.004995', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.144275', 'ticker_sentiment_score': '0.022642', 'ticker_sentiment_label': 'Neutral'}]"
2 Dow 30 Stocks To Watch Before May 2023,https://stockmarket.com/featured/2-dow-30-stocks-to-watch-before-may-2023-2023-04-28,20230428T152651,['Brett David'],"The Dow Jones Industrial Average ( DJIA ) , often referred to as ""the Dow,"" is a widely followed stock market index. In addition, Dow Jones tracks the performance of 30 blue-chip companies listed on the New York Stock Exchange and NASDAQ. The index serves as a barometer for the health of the U.S. ...",https://u3j7m9h7.rocketcdn.me/wp-content/uploads/2023/04/MMM-stock.jpg,StockMarket.com,n/a,stockmarket.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999987'}, {'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.210541,Somewhat-Bullish,"[{'ticker': 'AAPL', 'relevance_score': '0.154455', 'ticker_sentiment_score': '0.191474', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.154455', 'ticker_sentiment_score': '0.191474', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MMM', 'relevance_score': '0.229872', 'ticker_sentiment_score': '0.168743', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GBHL', 'relevance_score': '0.077593', 'ticker_sentiment_score': '0.071872', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DIS', 'relevance_score': '0.373751', 'ticker_sentiment_score': '0.27239', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.154455', 'ticker_sentiment_score': '0.191474', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
ResMed  ( RMD )  Q3 Earnings and Revenues Surpass Estimates,https://www.zacks.com/stock/news/2086818/resmed-rmd-q3-earnings-and-revenues-surpass-estimates,20230428T131600,['Zacks Investment Research'],"ResMed (RMD) reports a solid third-quarter top line, led by strong device sales growth through steady production and delivery of its cloud-connected flow generator devices to meet high market demand.",https://staticx-tuner.zacks.com/images/articles/main/2a/3899.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.310843'}, {'topic': 'Earnings', 'relevance_score': '0.999986'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.108179'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.133968,Neutral,"[{'ticker': 'RMD', 'relevance_score': '0.369685', 'ticker_sentiment_score': '0.174758', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'EW', 'relevance_score': '0.169378', 'ticker_sentiment_score': '-0.02672', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.169378', 'ticker_sentiment_score': '0.005529', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.169378', 'ticker_sentiment_score': '0.05441', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:EUR', 'relevance_score': '0.042647', 'ticker_sentiment_score': '-0.128404', 'ticker_sentiment_label': 'Neutral'}]"
Is It Too Late to Buy Johnson & Johnson's Stock?,https://moneymorning.com/investing/is-it-too-late-to-buy-johnson-johnsons-stock/,20230428T123000,"['Fool.com', 'fool.com']","Johnson & Johnson ( NYSE: JNJ ) ( J&J ) is a renowned name in the healthcare and consumer goods industries. Band-Aids, Listerine, Neutrogena, and Tylenol are among its most well-known brands. The company has been around for over a century and has a strong global presence.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729333%2Fperson-lying-down-on-dollar-notes.jpeg&w=700,Money Morning,RSS,moneymorning.com,"[{'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.283575,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.152983', 'ticker_sentiment_score': '0.199503', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Is It Too Late to Buy Johnson & Johnson's Stock?,https://www.fool.com/investing/2023/04/28/is-it-too-late-to-buy-johnson-johnsons-stock/,20230428T123000,['Sushree Mohanty'],This healthcare juggernaut's recent quarterly results prove just how strong its business is.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729333%2Fperson-lying-down-on-dollar-notes.jpeg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}, {'topic': 'Earnings', 'relevance_score': '0.938793'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.290392,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.149346', 'ticker_sentiment_score': '0.257961', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Government Drug Price Curbs Could Sound A Death Knell For Industry,https://www.investors.com/news/technology/biotech-stocks-brace-for-the-worst-as-government-drug-price-negotiations-loom/,20230428T120000,"[""Investor's Business Daily"", 'ALLISON GATLIN']",Biotech Stocks Brace For The Worst As Government Drug Price ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2022/09/Stock-humira-01-shutt.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.839681'}, {'topic': 'Earnings', 'relevance_score': '0.684621'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.024097,Neutral,"[{'ticker': 'NVO', 'relevance_score': '0.040668', 'ticker_sentiment_score': '-0.11222', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.027118', 'ticker_sentiment_score': '0.044929', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.027118', 'ticker_sentiment_score': '-0.055277', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.027118', 'ticker_sentiment_score': '-0.076847', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.08123', 'ticker_sentiment_score': '-0.011317', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.027118', 'ticker_sentiment_score': '0.044929', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BNTX', 'relevance_score': '0.027118', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSSMY', 'relevance_score': '0.013561', 'ticker_sentiment_score': '0.077066', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HZNP', 'relevance_score': '0.027118', 'ticker_sentiment_score': '-0.076847', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CLVT', 'relevance_score': '0.027118', 'ticker_sentiment_score': '0.05187', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.067727', 'ticker_sentiment_score': '-0.061364', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCO', 'relevance_score': '0.027118', 'ticker_sentiment_score': '0.0266', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.027118', 'ticker_sentiment_score': '0.052088', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SGEN', 'relevance_score': '0.040668', 'ticker_sentiment_score': '-0.064288', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.067727', 'ticker_sentiment_score': '0.005039', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'REGN', 'relevance_score': '0.027118', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.054205', 'ticker_sentiment_score': '-0.077946', 'ticker_sentiment_label': 'Neutral'}]"
Pharmaceutical Company Sets Gold Standard for New Drugs,https://www.investorideas.com/news/2023/biotech/04271Pharmaceutical-Drug-Standard.asp,20230427T192004,[],"April 27, 2023 ( Investorideas.com Newswire ) Algernon Pharmaceuticals Inc. has received a U.S. patent for a ground-breaking new Non-Alcoholic Steatohepatitis ( NASH ) drug under investigation, and is developing another for refractory chronic cough ( RCC ) .",https://www.streetwisereports.com/images/pexels-chokniti-khongchum-2280571.jpg,Investor Ideas,n/a,www.investorideas.com,"[{'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.955357'}]",0.133713,Neutral,"[{'ticker': 'MRNA', 'relevance_score': '0.026098', 'ticker_sentiment_score': '0.077548', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.026098', 'ticker_sentiment_score': '0.077548', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSSMY', 'relevance_score': '0.052169', 'ticker_sentiment_score': '0.020987', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.026098', 'ticker_sentiment_score': '0.077548', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.052169', 'ticker_sentiment_score': '0.125845', 'ticker_sentiment_label': 'Neutral'}]"
The Fed Forecasts a Recession: 2 Top Warren Buffett Stocks to Buy Now,https://moneymorning.com/investing/the-fed-forecasts-a-recession-2-top-warren-buffett-stocks-to-buy-now/,20230427T180000,"['Fool.com', 'fool.com']",The Fed Forecasts a Recession: 2 Top Warren Buffett Stocks to Buy ... Money Morning ...,https://moneymorning.com/wp-content/blogs.dir/1/files/2023/04/motley-fool-mark.png,Money Morning,GoogleRSS,moneymorning.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.891286'}]",0.147157,Neutral,"[{'ticker': 'KO', 'relevance_score': '0.391311', 'ticker_sentiment_score': '0.436742', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.162255', 'ticker_sentiment_score': '-0.080192', 'ticker_sentiment_label': 'Neutral'}]"
The Fed Forecasts a Recession: 2 Top Warren Buffett Stocks to Buy Now,https://www.fool.com/investing/2023/04/27/fed-forecasts-a-recession-2-top-buffett-stocks/,20230427T180000,['Adria Cimino'],These two stocks will bring you passive income and growth over time.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729228%2Frolled-up-cash-money-invest-save-three-hundred-dollars-getty.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.891286'}]",0.179836,Somewhat-Bullish,"[{'ticker': 'KO', 'relevance_score': '0.392948', 'ticker_sentiment_score': '0.406709', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.136113', 'ticker_sentiment_score': '-0.072159', 'ticker_sentiment_label': 'Neutral'}]"
"AbbVie  ( ABBV )  Q1 Earnings Beat, Skyrizi Sales Underperform",https://www.zacks.com/stock/news/2086355/abbvie-abbv-q1-earnings-beat-skyrizi-sales-underperform,20230427T163300,['Zacks Investment Research'],"AbbVie's (ABBV) first-quarter 2023 earnings and sales beat estimates. However, share price dives as some key drugs miss sales estimates.",https://staticx-tuner.zacks.com/images/articles/main/36/1919.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.972476'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.085916,Neutral,"[{'ticker': 'ABBV', 'relevance_score': '0.290361', 'ticker_sentiment_score': '0.181809', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMGN', 'relevance_score': '0.16849', 'ticker_sentiment_score': '0.078911', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.042421', 'ticker_sentiment_score': '0.055312', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.042421', 'ticker_sentiment_score': '0.055312', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.084722', 'ticker_sentiment_score': '0.13344', 'ticker_sentiment_label': 'Neutral'}]"
Accuray  ( ARAY )  Q3 Earnings and Revenues Surpass Estimates,https://www.zacks.com/stock/news/2086215/accuray-aray-q3-earnings-and-revenues-surpass-estimates,20230427T154200,['Zacks Investment Research'],Accuray (ARAY) reports a solid fiscal third-quarter top line on the back of robust segmental performances.,https://staticx-tuner.zacks.com/images/articles/main/4b/23030.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}, {'topic': 'Earnings', 'relevance_score': '0.998311'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.007232,Neutral,"[{'ticker': 'EW', 'relevance_score': '0.18856', 'ticker_sentiment_score': '-0.027337', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.18856', 'ticker_sentiment_score': '0.005974', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ARAY', 'relevance_score': '0.449106', 'ticker_sentiment_score': '0.368385', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.18856', 'ticker_sentiment_score': '0.060288', 'ticker_sentiment_label': 'Neutral'}]"
DOJ sues Tennessee for discriminating against transgender youth with new law,https://www.cnbc.com/2023/04/27/transgender-biden-doj-sues-tennessee-for-discrimination.html,20230427T152907,['Spencer Kimball'],The Biden administration asked a judge to declare that a Tennessee law targeting gender-affirming care for transgender kids violates the U.S. Constitution.,https://image.cnbcfm.com/api/v1/image/107232052-1682604891941-gettyimages-1250361629-AFP_33CG8F3.jpeg?v=1682609347&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.0147,Neutral,"[{'ticker': 'MRNA', 'relevance_score': '0.061315', 'ticker_sentiment_score': '-0.391706', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.122269', 'ticker_sentiment_score': '-0.010718', 'ticker_sentiment_label': 'Neutral'}]"
Nevro  ( NVRO )  Q1 Earnings and Revenues Surpass Estimates,https://www.zacks.com/stock/news/2086189/nevro-nvro-q1-earnings-and-revenues-surpass-estimates,20230427T145700,['Zacks Investment Research'],"Nevro's (NVRO) worldwide revenues improve on a year-over-year basis in Q1, partly owing to robust domestic performance.",https://staticx-tuner.zacks.com/images/articles/main/d9/554.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Earnings', 'relevance_score': '0.9996'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.067539,Neutral,"[{'ticker': 'NVRO', 'relevance_score': '0.500902', 'ticker_sentiment_score': '0.082006', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EW', 'relevance_score': '0.164749', 'ticker_sentiment_score': '-0.001391', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.164749', 'ticker_sentiment_score': '0.005426', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.164749', 'ticker_sentiment_score': '0.052012', 'ticker_sentiment_label': 'Neutral'}]"
Abortion pill mifepristone is banned or restricted in some states despite Supreme Court ruling,https://www.cnbc.com/2023/04/27/supreme-court-abortion-pill-mifepristone-still-limited-in-some-states.html,20230427T145559,['Spencer Kimball'],Mifepristone will remain largely unavailable in 13 states that have banned abortion despite the Supreme Court's decision last week to uphold FDA rules.,https://image.cnbcfm.com/api/v1/image/107227742-1681909867939-gettyimages-1481957802-_m010697_jzyejhcz.jpeg?v=1682607359&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.099035,Neutral,"[{'ticker': 'MRNA', 'relevance_score': '0.071784', 'ticker_sentiment_score': '-0.400269', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.142989', 'ticker_sentiment_score': '-0.011665', 'ticker_sentiment_label': 'Neutral'}]"
The Shake-Up at NBCUniversal and Johnson & Johnson's Spinoff Plans,https://moneymorning.com/investing/the-shake-up-at-nbcuniversal-and-johnson-johnsons-spinoff-plans/,20230427T144329,"['Fool.com', 'fool.com']"," Ripple effects for Peacock in the wake of NBCUniversal CEO Jeff Shell resigning.  Disney, and the fate of NBCUniversal's minority stake in Hulu.  Johnson & Johnson aiming to raise $3.5 billion in the IPO spinoff of its consumer healthcare division.",https://moneymorning.com/wp-content/blogs.dir/1/files/2023/04/motley-fool-mark.png,Money Morning,RSS,moneymorning.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.744043'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.019231,Neutral,"[{'ticker': 'CCZ', 'relevance_score': '0.17715', 'ticker_sentiment_score': '0.095575', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.089129', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
The Shake-Up at NBCUniversal and Johnson & Johnson's Spinoff Plans,https://www.fool.com/investing/2023/04/27/the-shake-up-at-nbcuniversal-and-johnson-johnsons/,20230427T144329,['Chris Hill'],"Plus, ""Doomberg"" talks about Tesla.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F726327%2Ffinance-stock-chart-tsla-nvda-mrna.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'IPO', 'relevance_score': '0.769861'}, {'topic': 'Financial Markets', 'relevance_score': '0.999966'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.929393'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.099971,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.018583', 'ticker_sentiment_score': '0.051949', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CCZ', 'relevance_score': '0.055707', 'ticker_sentiment_score': '0.046997', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.009292', 'ticker_sentiment_score': '0.061026', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.027871', 'ticker_sentiment_score': '0.058155', 'ticker_sentiment_label': 'Neutral'}]"
"Surmodics  ( SRDX )  Q2 Earnings Top Estimates, FY23 View Revised",https://www.zacks.com/stock/news/2086168/surmodics-srdx-q2-earnings-top-estimates-fy23-view-revised,20230427T142900,['Zacks Investment Research'],Surmodics (SRDX) reports a solid fiscal second-quarter top line on the back of robust Medical Device revenues.,https://staticx-tuner.zacks.com/images/articles/main/79/359.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999998'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}]",0.060072,Neutral,"[{'ticker': 'EW', 'relevance_score': '0.141517', 'ticker_sentiment_score': '-0.001263', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.141517', 'ticker_sentiment_score': '0.00494', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SRDX', 'relevance_score': '0.55143', 'ticker_sentiment_score': '0.222102', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.141517', 'ticker_sentiment_score': '0.049828', 'ticker_sentiment_label': 'Neutral'}]"
Feminine Hygiene Products Market Size Worth USD 31.51 Billion by 2027 - Emergen Research,https://markets.businessinsider.com/news/stocks/feminine-hygiene-products-market-size-worth-usd-31-51-billion-by-2027---emergen-research-1032267941,20230427T142606,[],"Discover the latest trends and insights into the feminine hygiene products market. Learn about the drivers, restraints, growth factors, and government statistics that are shaping this rapidly expanding industry.",https://markets.businessinsider.com/Images/FacebookIcon.jpg,Business Insider,RSS,markets.businessinsider.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",0.157276,Somewhat-Bullish,"[{'ticker': 'HEGIF', 'relevance_score': '0.035189', 'ticker_sentiment_score': '-0.072185', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KMB', 'relevance_score': '0.035189', 'ticker_sentiment_score': '-0.072185', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KAOCF', 'relevance_score': '0.035189', 'ticker_sentiment_score': '-0.072185', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.035189', 'ticker_sentiment_score': '-0.072185', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.035189', 'ticker_sentiment_score': '-0.072185', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EPC', 'relevance_score': '0.035189', 'ticker_sentiment_score': '-0.072185', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ONXXF', 'relevance_score': '0.174587', 'ticker_sentiment_score': '0.148883', 'ticker_sentiment_label': 'Neutral'}]"
"CURE Media Group announces Abbey Kaler, MS, APRN, FNP-C, CMSRN, as winner of 2023 Extraordinary Healer Award",https://www.benzinga.com/pressreleases/23/04/g32047083/cure-media-group-announces-abbey-kaler-ms-aprn-fnp-c-cmsrn-as-winner-of-2023-extraordinary-healer-,20230427T134015,['Globe Newswire'],Kaler was recognized for her remarkable contributions in oncology care,https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.435029,Bullish,"[{'ticker': 'HESG', 'relevance_score': '0.044469', 'ticker_sentiment_score': '-0.029809', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HLCO', 'relevance_score': '0.044469', 'ticker_sentiment_score': '0.345299', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'INCY', 'relevance_score': '0.262052', 'ticker_sentiment_score': '0.362553', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.132855', 'ticker_sentiment_score': '0.255242', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Chemed  ( CHE )  Lags Q1 Earnings Estimates, Reaffirms Guidance",https://www.zacks.com/stock/news/2085874/chemed-che-lags-q1-earnings-estimates-reaffirms-guidance,20230427T133300,['Zacks Investment Research'],Strength in the VITAS and Roto-Rooter branches contributes to Chemed's (CHE) first-quarter top line.,https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}]",0.15055,Somewhat-Bullish,"[{'ticker': 'CHE', 'relevance_score': '0.440133', 'ticker_sentiment_score': '0.14208', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EW', 'relevance_score': '0.167904', 'ticker_sentiment_score': '-0.026567', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.167904', 'ticker_sentiment_score': '0.005496', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.167904', 'ticker_sentiment_score': '0.054084', 'ticker_sentiment_label': 'Neutral'}]"
Eli Lilly says obesity drug tirzepatide resulted in weight loss of up to 34 pounds,https://www.cnbc.com/2023/04/27/eli-lilly-weight-loss-drug-tirzepatide-data-released.html,20230427T131523,"['Annika Kim Constantino', 'Spencer Kimball']",Eli Lilly plans to complete its application for FDA approval of tirzepatide in the coming weeks and expects regulatory action as early as later this year.,https://image.cnbcfm.com/api/v1/image/107217409-16801283632023-03-29t220746z_600745745_rc2w30aq63my_rtrmadp_0_usa-health.jpeg?v=1682601323&w=1920&h=1080,CNBC,Business,www.cnbc.com,"[{'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.165659,Somewhat-Bearish,"[{'ticker': 'MRNA', 'relevance_score': '0.063763', 'ticker_sentiment_score': '-0.393476', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.127119', 'ticker_sentiment_score': '-0.010928', 'ticker_sentiment_label': 'Neutral'}]"
Eli Lilly misses on earnings but raises full-year guidance,https://www.cnbc.com/2023/04/27/eli-lilly-lly-q1-earnings-2023.html,20230427T120703,['Spencer Kimball'],"The company reported adjusted earnings of $1.62, which missed analyst expectations of $1.73 for the quarter.",https://image.cnbcfm.com/api/v1/image/107220862-1680697969216-gettyimages-1244662753-porzycki-pharmace221110_npMth.jpeg?v=1682597223&w=1920&h=1080,CNBC,Earnings,www.cnbc.com,"[{'topic': 'Earnings', 'relevance_score': '0.999998'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.012118,Neutral,"[{'ticker': 'MRNA', 'relevance_score': '0.084423', 'ticker_sentiment_score': '-0.413728', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.167904', 'ticker_sentiment_score': '-0.012942', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.084423', 'ticker_sentiment_score': '-0.007235', 'ticker_sentiment_label': 'Neutral'}]"
"Fanatics moves one step closer to IPO, hiring Meta's head of investor relations",https://www.cnbc.com/2023/04/27/fanatics-moves-closer-to-ipo-with-hire-of-meta-investor-relations-head.html,20230427T113001,['Ian Thomas'],"Fanatics hires Meta IR head Deborah Crawford, who had also run investor relations at Netflix, as the sports platform company takes another step closer to IPO.",https://image.cnbcfm.com/api/v1/image/107193821-16763203481676320345-28183238635-1080pnbcnews.jpg?v=1676321424&w=750&h=422&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}, {'topic': 'Blockchain', 'relevance_score': '0.158519'}, {'topic': 'IPO', 'relevance_score': '0.983605'}, {'topic': 'Financial Markets', 'relevance_score': '0.905476'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.333333'}]",-0.009664,Neutral,"[{'ticker': 'BABA', 'relevance_score': '0.038906', 'ticker_sentiment_score': '0.111132', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BLK', 'relevance_score': '0.038906', 'ticker_sentiment_score': '0.111132', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DKNG', 'relevance_score': '0.038906', 'ticker_sentiment_score': '-0.142858', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NFLX', 'relevance_score': '0.038906', 'ticker_sentiment_score': '-0.104689', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MGM', 'relevance_score': '0.038906', 'ticker_sentiment_score': '-0.142858', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRPHF', 'relevance_score': '0.038906', 'ticker_sentiment_score': '-0.052922', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.038906', 'ticker_sentiment_score': '0.140884', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SFTBF', 'relevance_score': '0.038906', 'ticker_sentiment_score': '-0.040893', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CZR', 'relevance_score': '0.038906', 'ticker_sentiment_score': '-0.142858', 'ticker_sentiment_label': 'Neutral'}]"
Merck revenue falls after dramatic drop in sales of Covid antiviral treatment,https://www.cnbc.com/2023/04/27/merck-mrk-q1-earnings-report-2023.html,20230427T103320,['Annika Kim Constantino'],"Despite the drop in molnupiravir sales, Merck's revenue and adjusted earnings for Q1 2023 beat Wall Street's expectations.",https://image.cnbcfm.com/api/v1/image/106970625-1636025413080-gettyimages-1235705320-porzycki-merckcop211004_npVSU.jpeg?v=1682591600&w=1920&h=1080,CNBC,Earnings,www.cnbc.com,"[{'topic': 'Earnings', 'relevance_score': '0.999483'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.019229,Neutral,"[{'ticker': 'MRNA', 'relevance_score': '0.076358', 'ticker_sentiment_score': '0.095058', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RXDX', 'relevance_score': '0.076358', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.076358', 'ticker_sentiment_score': '0.095058', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.076358', 'ticker_sentiment_score': '0.095058', 'ticker_sentiment_label': 'Neutral'}]"
Russian oil sanctions appear to be working - crude still flows even as Moscow's pulling in less money. But there's more to it than that.,https://www.businessinsider.com/russia-oil-exports-sanctions-war-ukraine-markets-economy-flows-putin-2023-4,20230427T103000,['Phil Rosen'],Russian Oil Sanctions Appear to Be Working - but It's Complicated. - Business Insider ...,,Business Insider,GoogleRSS,www.businessinsider.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}, {'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",-0.050621,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.048919', 'ticker_sentiment_score': '0.227083', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SSNLF', 'relevance_score': '0.048919', 'ticker_sentiment_score': '0.157988', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BAC', 'relevance_score': '0.048919', 'ticker_sentiment_score': '0.227083', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.048919', 'ticker_sentiment_score': '0.055291', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.097655', 'ticker_sentiment_score': '0.00111', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.048919', 'ticker_sentiment_score': '0.157988', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FOREX:CNY', 'relevance_score': '0.097655', 'ticker_sentiment_score': '-0.066472', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.048919', 'ticker_sentiment_score': '-0.061809', 'ticker_sentiment_label': 'Neutral'}]"
2 High-Yielding Dividend Stocks That Just Boosted Their Payouts,https://moneymorning.com/investing/2-high-yielding-dividend-stocks-that-just-boosted-their-payouts/,20230427T093100,"['Fool.com', 'fool.com']","If earning dividend income is a priority for you, it's important to focus on quality stocks that offer above-average yields and that also regularly increase their payouts. That way, you can ensure you're collecting a good yield today and that it's likely to rise in the future, giving you an ...",https://g.foolcdn.com/image/?url=https%3A%2F%2Fmedia.ycharts.com%2Fcharts%2F542e7cca278257f8d5a6d0c70dd76c41.png&w=700,Money Morning,RSS,moneymorning.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.769861'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.5'}]",0.355086,Bullish,"[{'ticker': 'SO', 'relevance_score': '0.24289', 'ticker_sentiment_score': '0.299012', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.52949', 'ticker_sentiment_score': '0.446535', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NGS', 'relevance_score': '0.082111', 'ticker_sentiment_score': '0.214344', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
2 High-Yielding Dividend Stocks That Just Boosted Their Payouts,https://www.fool.com/investing/2023/04/27/high-yielding-dividend-stocks-boosted-payouts/,20230427T093100,['David Jagielski'],These are ideal stocks for long-term investors who crave dividends.,https://media.ycharts.com/charts/542e7cca278257f8d5a6d0c70dd76c41.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}, {'topic': 'Earnings', 'relevance_score': '0.769861'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.5'}]",0.318793,Somewhat-Bullish,"[{'ticker': 'SO', 'relevance_score': '0.452639', 'ticker_sentiment_score': '0.246378', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.508345', 'ticker_sentiment_score': '0.407442', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'NGS', 'relevance_score': '0.068502', 'ticker_sentiment_score': '0.209248', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
The Fed Expects a Recession: 2 Dow Stocks to Buy Hand Over Fist and 1 to Avoid Like the Plague,https://moneymorning.com/investing/the-fed-expects-a-recession-2-dow-stocks-to-buy-hand-over-fist-and-1-to-avoid-like-the-plague/,20230427T090600,"['fool.com', 'Fool.com']",The Fed Expects a Recession: 2 Dow Stocks to Buy Hand Over Fist ... Money Morning ...,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729284%2Fstock-market-ticker-symbol-digital-quote-board-nyse-sp-500-nasdaq-getty.jpg&w=700,Money Morning,GoogleRSS,moneymorning.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}]",0.090507,Neutral,"[{'ticker': 'HCSG', 'relevance_score': '0.07446', 'ticker_sentiment_score': '0.063103', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.42503', 'ticker_sentiment_score': '0.358379', 'ticker_sentiment_label': 'Bullish'}]"
The Fed Expects a Recession: 2 Dow Stocks to Buy Hand Over Fist and 1 to Avoid Like the Plague,https://www.fool.com/investing/2023/04/27/fed-recession-2-dow-stocks-to-buy-and-1-to-avoid/,20230427T090600,['Sean Williams'],"Two time-tested Dow stocks are perfectly positioned if the U.S. dips into a recession, while another Dow component has an abysmal track record during economic downturns.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729284%2Fstock-market-ticker-symbol-digital-quote-board-nyse-sp-500-nasdaq-getty.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.998356'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.029473,Neutral,"[{'ticker': 'VZ', 'relevance_score': '0.266504', 'ticker_sentiment_score': '0.147317', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HCSG', 'relevance_score': '0.030178', 'ticker_sentiment_score': '0.059635', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.377142', 'ticker_sentiment_score': '-0.132822', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.179565', 'ticker_sentiment_score': '0.192248', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says",https://www.cnbc.com/2023/04/26/medicare-will-cover-alzheimers-treatment-leqembi-after-fda-approves.html,20230426T174414,['Spencer Kimball'],"Medicare has severely restricted access to the medication Leqembi, which costs $26,500 per year, because the FDA approved it just on an expedited basis.",https://image.cnbcfm.com/api/v1/image/107231474-1682524280131-gettyimages-1232324799-SENATE_FINANCE_009_04152021JPG.jpeg?v=1682531054&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.08128,Neutral,"[{'ticker': 'MRNA', 'relevance_score': '0.048621', 'ticker_sentiment_score': '-0.385039', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'ESALF', 'relevance_score': '0.048621', 'ticker_sentiment_score': '0.112001', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.048621', 'ticker_sentiment_score': '0.112001', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.097062', 'ticker_sentiment_score': '-0.009783', 'ticker_sentiment_label': 'Neutral'}]"
Why Legend Biotech Stock Is Having Its Best Month Yet - Legend Biotech  ( NASDAQ:LEGN ) ,https://www.benzinga.com/general/biotech/23/04/32007247/why-legend-biotech-stock-is-having-its-best-month-yet,20230426T163745,['MarketBeat'],"Legend Biotech Corporation LEGN is among the many healthcare names vying for a breakthrough in cancer treatment. Last week, the New Jersey-based company had just that. On April 19th, a data leak revealed that Legend Biotech's Carvykti, a blood cancer therapy, performed extremely well in a recent ...",https://cdn.benzinga.com/files/images/story/2023/04/26/national-cancer-institute-xknubmnjbkg-unsplash.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.165482,Somewhat-Bullish,"[{'ticker': 'ALNY', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.097348', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRKR', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.097348', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LEGN', 'relevance_score': '0.265378', 'ticker_sentiment_score': '-0.030734', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.034999', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.045054', 'ticker_sentiment_score': '0.097348', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.089965', 'ticker_sentiment_score': '0.106771', 'ticker_sentiment_label': 'Neutral'}]"
"Market Pullback Ahead: 2 Stocks To Sell, 2 Soaring Dividends To Buy",https://www.forbes.com/sites/brettowens/2023/04/26/market-pullback-ahead-2-stocks-to-sell-2-soaring-dividends-to-buy/,20230426T144200,['Brett Owens'],"If you're caught holding the wrong dividend payers, you could be in for some serious losses.",https://imageio.forbes.com/specials-images/imageserve/6443f718f7de2a6fd0a821c1/0x0.jpg?format=jpg&width=1200,Forbes,Markets,www.forbes.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.928769'}]",0.065244,Neutral,"[{'ticker': 'MDLZ', 'relevance_score': '0.087503', 'ticker_sentiment_score': '-0.005204', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CF', 'relevance_score': '0.216473', 'ticker_sentiment_score': '0.090028', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.087503', 'ticker_sentiment_score': '0.155986', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KO', 'relevance_score': '0.087503', 'ticker_sentiment_score': '-0.005204', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CBRL', 'relevance_score': '0.216473', 'ticker_sentiment_score': '-0.102389', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.258351', 'ticker_sentiment_score': '0.200121', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KHC', 'relevance_score': '0.130926', 'ticker_sentiment_score': '-0.048496', 'ticker_sentiment_label': 'Neutral'}]"
"How a Janitor Built an $8 Million Fortune Without Touching Cryptos, Stock Options or Leverage",https://www.benzinga.com/news/23/04/32012718/how-a-janitor-built-an-8-million-fortune-without-touching-cryptos-stock-options-or-leverage,20230426T143843,['William Dahl'],Ronald Reid was the last person you would expect to be a millionaire. He used safety pins to hold his old coats together and cut his own firewood well into his 90s. He drove a second-hand Toyota Yaris and resisted new purchases.,https://cdn.benzinga.com/files/images/story/2023/04/26/sean-pollock-phyq704ffda-unsplash_1.jpg?width=1200&height=800&fit=crop,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'IPO', 'relevance_score': '0.451494'}, {'topic': 'Financial Markets', 'relevance_score': '0.961735'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.205234,Somewhat-Bullish,"[{'ticker': 'META', 'relevance_score': '0.194763', 'ticker_sentiment_score': '0.061147', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.065506', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.065506', 'ticker_sentiment_score': '0.010105', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.065506', 'ticker_sentiment_score': '0.010105', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.065506', 'ticker_sentiment_score': '0.010105', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ATVI', 'relevance_score': '0.065506', 'ticker_sentiment_score': '0.08988', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABNB', 'relevance_score': '0.065506', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
"Drug/Biotech Stocks' Q1 Earnings Due Apr 27: LLY, ABBV & More",https://www.zacks.com/stock/news/2084870/drugbiotech-stocks-q1-earnings-due-apr-27-lly-abbv-more,20230426T132800,['Zacks Investment Research'],Let's look at the five biotech/pharma companies slated to release quarterly results on Apr 27.,https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.193386,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.263942', 'ticker_sentiment_score': '0.031445', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.263942', 'ticker_sentiment_score': '0.127168', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.263942', 'ticker_sentiment_score': '0.095222', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.038407', 'ticker_sentiment_score': '0.106241', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.227361', 'ticker_sentiment_score': '0.046608', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.038407', 'ticker_sentiment_score': '0.106241', 'ticker_sentiment_label': 'Neutral'}]"
Boston Scientific lifts annual profit forecast on heart devices strength,https://www.reuters.com/business/healthcare-pharmaceuticals/boston-scientific-lifts-annual-profit-forecast-heart-devices-strength-2023-04-26/,20230426T122300,['Reuters'],"April 26 ( Reuters ) - Boston Scientific Corp ( BSX.N ) raised its full-year profit forecast on Wednesday, after strong sales in its cardiovascular devices unit helped the company beat first-quarter estimates.",https://www.reuters.com/pf/resources/images/reuters/reuters-default.webp?d=138,Reuters,Business,www.reuters.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.382192,Bullish,"[{'ticker': 'ABT', 'relevance_score': '0.12165', 'ticker_sentiment_score': '0.119638', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BSX', 'relevance_score': '0.555911', 'ticker_sentiment_score': '0.484933', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'SWAV', 'relevance_score': '0.12165', 'ticker_sentiment_score': '0.115053', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.12165', 'ticker_sentiment_score': '0.119638', 'ticker_sentiment_label': 'Neutral'}]"
"Johnson & Johnson, A. O. Smith And This Health Insurer On CNBC's 'Final Trades' - A.O. Smith  ( NYSE:AOS ) , Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/04/32004328/johnson-johnson-a-o-smith-and-this-health-insurer-on-cnbcs-final-trades,20230426T121227,['Priya Nigam'],"On CNBC's ""Halftime Report Final Trades,"" Joshua Brown of Ritholtz Wealth Management said A. O. Smith Corporation AOS is scheduled to release earnings this week and is about to approach a 52-week high. ""I like it long term,"" he added. Analysts expect A. O.",https://cdn.benzinga.com/files/images/story/2023/04/26/shutterstock_1908894220.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.795202'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.238647,Somewhat-Bullish,"[{'ticker': 'DSSMY', 'relevance_score': '0.550532', 'ticker_sentiment_score': '0.320835', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UNH', 'relevance_score': '0.686739', 'ticker_sentiment_score': '0.194308', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.550532', 'ticker_sentiment_score': '0.39694', 'ticker_sentiment_label': 'Bullish'}]"
Alkermes plc Reports First Quarter 2023 Financial Results,https://www.prnewswire.com/news-releases/alkermes-plc-reports-first-quarter-2023-financial-results-301807602.html,20230426T110000,['Alkermes plc'],- First Quarter Revenues of $287.6 Million Reflect Strong Performance of Proprietary Product Portfolio - - GAAP Loss per Share of $0.25 and Basic and Diluted Non-GAAP Earnings per Share of $0.01 - - Planned Separation of Oncology Business Expected to be Completed in Second Half of 2023 -,https://mma.prnewswire.com/media/616416/Alkermes_plc_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.858979'}]",0.114002,Neutral,"[{'ticker': 'ALKS', 'relevance_score': '0.372246', 'ticker_sentiment_score': '0.065574', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.01682', 'ticker_sentiment_score': '-0.020903', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.033632', 'ticker_sentiment_score': '0.040587', 'ticker_sentiment_label': 'Neutral'}]"
The Fed Thinks a Recession Is Likely: 5 Warren Buffett Stocks to Buy Now,https://www.fool.com/investing/2023/04/26/the-fed-thinks-a-recession-is-likely-5-warren-buff/,20230426T095000,['Keith Speights'],These stocks owned by Buffett's Berkshire Hathaway can be safe havens during economic downturns.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729185%2Fstack-of-one-hundred-dollar-bills-cash-money-invest-retire-getty.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}]",0.017064,Neutral,"[{'ticker': 'KO', 'relevance_score': '0.42503', 'ticker_sentiment_score': '0.250812', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MCK', 'relevance_score': '0.291471', 'ticker_sentiment_score': '0.111329', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.148273', 'ticker_sentiment_score': '0.027359', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.220809', 'ticker_sentiment_score': '0.12016', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KR', 'relevance_score': '0.220809', 'ticker_sentiment_score': '-0.058472', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.220809', 'ticker_sentiment_score': '0.118491', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HCSG', 'relevance_score': '0.07446', 'ticker_sentiment_score': '0.060399', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson to Participate in the Bernstein 39th Annual Strategic Decisions Conference,https://investingnews.com/johnson-johnson-to-participate-in-the-bernstein-39th-annual-strategic-decisions-conference/,20230425T205158,[],"Johnson & Johnson ( NYSE: JNJ ) will participate in the Bernstein 39 th Annual Strategic Decisions Conference on Wednesday, May 31 st , at the New York Hilton Midtown in New York. Joaquin Duato, Chairman of the Board and Chief Executive Officer will represent the Company in a session scheduled at ...",https://investingnews.com/media-library/eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJpbWFnZSI6Imh0dHBzOi8vYXNzZXRzLnJibC5tcy8yNTg1ODg1NS9vcmlnaW4ucG5nIiwiZXhwaXJlc19hdCI6MTcwODY4MTIxOX0.Phin9ClvosnPNpkGRdBWHz_VFepTco5fqEYZcXCsZIQ/image.png?width=210,Investing News Network,n/a,investingnews.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.239554,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.922387', 'ticker_sentiment_score': '0.384122', 'ticker_sentiment_label': 'Bullish'}]"
Dow Jones Falls Sharply As Google Earnings Loom; First Republic Craters,https://www.investors.com/market-trend/stock-market-today/dow-jones-falls-as-google-earnings-microsoft-earnings-loom-first-republic-stock-craters-amid-barrage-of-sell-signals/,20230425T192200,"['MICHAEL LARKIN', ""Investor's Business Daily""]",Dow Jones Falls Sharply As Google Earnings Loom. First Republic ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2023/01/Stock-microsoftgoogle-01-ibdgraphicsadobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",-0.004888,Neutral,"[{'ticker': 'GOOG', 'relevance_score': '0.085022', 'ticker_sentiment_score': '-0.138979', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LSCC', 'relevance_score': '0.085022', 'ticker_sentiment_score': '-0.220457', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'MDNDF', 'relevance_score': '0.127231', 'ticker_sentiment_score': '-0.162718', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'FISV', 'relevance_score': '0.127231', 'ticker_sentiment_score': '0.081927', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.085022', 'ticker_sentiment_score': '0.065005', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RMBS', 'relevance_score': '0.085022', 'ticker_sentiment_score': '-0.08464', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DOW', 'relevance_score': '0.085022', 'ticker_sentiment_score': '0.065005', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WDAY', 'relevance_score': '0.085022', 'ticker_sentiment_score': '-0.220457', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'MSFT', 'relevance_score': '0.169081', 'ticker_sentiment_score': '-0.154837', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TSLA', 'relevance_score': '0.042571', 'ticker_sentiment_score': '0.115508', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNPS', 'relevance_score': '0.085022', 'ticker_sentiment_score': '-0.220457', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CDNS', 'relevance_score': '0.085022', 'ticker_sentiment_score': '-0.220457', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'ZS', 'relevance_score': '0.085022', 'ticker_sentiment_score': '-0.098468', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PANW', 'relevance_score': '0.085022', 'ticker_sentiment_score': '0.129966', 'ticker_sentiment_label': 'Neutral'}]"
Looking At Johnson & Johnson's Recent Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/04/31996287/looking-at-johnson-johnsons-recent-unusual-options-activity,20230425T181541,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.165874,Somewhat-Bullish,"[{'ticker': 'MS', 'relevance_score': '0.191929', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.818461', 'ticker_sentiment_score': '0.291217', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Medtronic Is Partnering With Nvidia to Create Potentially Game-Changing Tech. Is the Stock a Buy?,https://www.fool.com/investing/2023/04/25/medtronic-partnering-with-nvidia-is-it-a-buy/,20230425T181400,['Adria Cimino'],Medtronic may be among the companies to dominate the AI healthcare market.,https://media.ycharts.com/charts/636b5179418af5636458d2b4925a3819.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.818451'}]",0.317699,Somewhat-Bullish,"[{'ticker': 'GLDAF', 'relevance_score': '0.045743', 'ticker_sentiment_score': '0.050754', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.22574', 'ticker_sentiment_score': '0.257926', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TRMNF', 'relevance_score': '0.045743', 'ticker_sentiment_score': '0.121802', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.724228', 'ticker_sentiment_score': '0.454072', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.045743', 'ticker_sentiment_score': '0.050754', 'ticker_sentiment_label': 'Neutral'}]"
"Calm Before The Storm? Markets Await Tech Earnings, PCE, And FOMC - Morgan Stanley  ( NYSE:MS ) , Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/federal-reserve/23/04/31995497/calm-before-the-storm-markets-await-tech-earnings-pce-and-fomc,20230425T173907,['Giles Coghlan'],Market activity has been muted lately. investors are seemingly cautious ahead of the next FOMC meeting.,"data:image/png;base64,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?optimize=medium&dpr=2&auto=webp&width=1920",Benzinga,Markets,www.benzinga.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.838487'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999922'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.938238'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.007238,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.038407', 'ticker_sentiment_score': '0.016711', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.114865', 'ticker_sentiment_score': '-0.029441', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.076724', 'ticker_sentiment_score': '-0.019183', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.114865', 'ticker_sentiment_score': '-0.029441', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.076724', 'ticker_sentiment_score': '-0.019183', 'ticker_sentiment_label': 'Neutral'}]"
"A Rotation Into Defensive Stocks? Market Strength Seen In Consumer Defensive And Healthcare On Tuesday - Centene  ( NYSE:CNC ) , AbbVie  ( NYSE:ABBV ) ",https://www.benzinga.com/general/health-care/23/04/31995117/a-rotation-into-defensive-stocks-market-strength-seen-in-consumer-defensive-and-healthcare-on,20230425T172337,['Ryan Glosier'],"The U.S. stock market is seeing some modest selling on Tuesday morning after a series of largely uneventful sessions last week. Two hours into the trading day, the S&P 500 was down around 0.75% and the Nasdaq had pared 0.90%.",https://cdn.benzinga.com/files/images/story/2023/04/25/screenshot_2023-04-25_at_10.51.40_pm.png?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.928139'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.248484,Somewhat-Bullish,"[{'ticker': 'GIS', 'relevance_score': '0.141171', 'ticker_sentiment_score': '0.185585', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KMB', 'relevance_score': '0.141171', 'ticker_sentiment_score': '0.209855', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SMGBF', 'relevance_score': '0.047278', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.141171', 'ticker_sentiment_score': '0.074575', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.233108', 'ticker_sentiment_score': '0.271429', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CNC', 'relevance_score': '0.141171', 'ticker_sentiment_score': '0.169954', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PEP', 'relevance_score': '0.141171', 'ticker_sentiment_score': '0.105321', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.141171', 'ticker_sentiment_score': '0.234773', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PM', 'relevance_score': '0.141171', 'ticker_sentiment_score': '0.071111', 'ticker_sentiment_label': 'Neutral'}]"
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease,https://www.cnbc.com/2023/04/25/fda-grants-accelerated-approval-biogen-als-drug.html,20230425T172041,['Annika Kim Constantino'],The FDA's approval requires Biogen to further study its ALS drug tofersen to further verify its clinical benefits.,https://image.cnbcfm.com/api/v1/image/106893719-1623152809766-gettyimages-1233323372-ALZHEIMERS_BIOGEN.jpeg?v=1682443241&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.026502,Neutral,"[{'ticker': 'MRNA', 'relevance_score': '0.055492', 'ticker_sentiment_score': '-0.388108', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'BIIB', 'relevance_score': '0.110717', 'ticker_sentiment_score': '0.177693', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.110717', 'ticker_sentiment_score': '-0.010255', 'ticker_sentiment_label': 'Neutral'}]"
J&J's $40 Billion Spinoff Has One Rival. Who Will Rule Consumer Health.,https://www.barrons.com/articles/johnson-and-johnson-kenvue-ipo-8800eb5f,20230425T171000,['Josh Nathan-Kazis'],J&J's Spinoff Kenvue Valued at $40 Billion. What's Ahead for Consumer Health. ...,https://images.barrons.com/im-769814/social,Barrons,n/a,www.barrons.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.310843'}]",0.142583,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.958038', 'ticker_sentiment_score': '0.255508', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Mpox outbreak was wake-up call for smallpox preparation, vaccine maker Bavarian Nordic says",https://www.cnbc.com/2023/04/25/mpox-shows-smallpox-risk-vaccine-maker-bavarian-nordic-says.html,20230425T162546,['Spencer Kimball'],"Bavarian Nordic plans to sharply scale up production of its Jynneos vaccine to prepare for a smallpox emergency, CEO Paul Chaplin said.",https://image.cnbcfm.com/api/v1/image/107101503-gettyimages-1242408097-AFP_32GA6XP.jpeg?v=1682439946&w=1920&h=1080,CNBC,Business,www.cnbc.com,"[{'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.170479,Somewhat-Bearish,"[{'ticker': 'MRNA', 'relevance_score': '0.023909', 'ticker_sentiment_score': '-0.379647', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.047797', 'ticker_sentiment_score': '-0.008994', 'ticker_sentiment_label': 'Neutral'}]"
Are Investors Undervaluing Johnson & Johnson's Stock?,https://www.fool.com/investing/2023/04/25/are-investors-undervaluing-johnson-johnson-stock/,20230425T153008,['David Jagielski'],The stock isn't as expensive as it may look at first glance.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F728810%2Finvestor-31.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}, {'topic': 'Earnings', 'relevance_score': '0.838487'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.134159,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.52612', 'ticker_sentiment_score': '0.103413', 'ticker_sentiment_label': 'Neutral'}]"
This Supercharged Dividend King Stock Might Soon Run Out of Steam,https://www.fool.com/investing/2023/04/25/this-supercharged-dividend-king-stock-may-soon-run/,20230425T134500,['George Budwell'],"Emerging competitive threats in immunology, oncology, and medical aesthetics, along with a highly leveraged balance sheet, might dampen the drugmaker's growth trajectory post-2025.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729290%2Fnegative-growth-trend.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.77141'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.122113,Neutral,"[{'ticker': 'ABT', 'relevance_score': '0.076358', 'ticker_sentiment_score': '0.13366', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.038223', 'ticker_sentiment_score': '0.056664', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.038223', 'ticker_sentiment_score': '0.001966', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.434763', 'ticker_sentiment_score': '0.12606', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.038223', 'ticker_sentiment_score': '0.001966', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RXDX', 'relevance_score': '0.076358', 'ticker_sentiment_score': '0.023564', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.038223', 'ticker_sentiment_score': '0.056664', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.038223', 'ticker_sentiment_score': '0.056664', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TAK', 'relevance_score': '0.038223', 'ticker_sentiment_score': '0.056664', 'ticker_sentiment_label': 'Neutral'}]"
Open Book Extracts Announces Allen Olson as VP of Supply Chain,https://www.prnewswire.com/news-releases/open-book-extracts-announces-allen-olson-as-vp-of-supply-chain-301806759.html,20230425T120000,['Open Book Extracts'],Olson will focus on driving operational excellence to deliver quality products and services,,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}]",0.518787,Bullish,"[{'ticker': 'HD', 'relevance_score': '0.067347', 'ticker_sentiment_score': '0.240094', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MAYNF', 'relevance_score': '0.067347', 'ticker_sentiment_score': '0.240094', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.067347', 'ticker_sentiment_score': '0.240094', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
The banking crisis may have set the stage for an IPO comeback | Business,https://www.cnn.com/2023/04/25/investing/premarket-stocks-trading/index.html,20230425T115000,['Nicole Goodkind'],The banking crisis may have set the stage for an IPO comeback ...,"https://media.cnn.com/api/v1/images/stellar/prod/230424202127-premarket-stocks-trading-042023.jpg?c=16x9&q=w_800,c_fill",CNN,Markets,www.cnn.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'IPO', 'relevance_score': '0.9545'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.769861'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.076834,Neutral,"[{'ticker': 'WBD', 'relevance_score': '0.035821', 'ticker_sentiment_score': '0.048365', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBNY', 'relevance_score': '0.107175', 'ticker_sentiment_score': '-0.055264', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FRC', 'relevance_score': '0.035821', 'ticker_sentiment_score': '-0.224585', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.07157', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Want Consistently Growing Passive Income? Buy Johnson & Johnson Stock,https://www.fool.com/investing/2023/04/25/want-consistently-growing-passive-income-buy-johns/,20230425T105000,['Kody Kester'],The healthcare juggernaut recently extended its illustrious dividend growth streak.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729022%2Fhealthcare-professionals-talking-to-each-other.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.905476'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.77141'}]",0.260736,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.064449', 'ticker_sentiment_score': '0.047025', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.064449', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.128478', 'ticker_sentiment_score': '0.195915', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.064449', 'ticker_sentiment_score': '0.15322', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Idorsia announces financial results for the first quarter 2023 - QUVIVIQ now the leading branded insomnia medicine in the commercial market in the US,https://www.globenewswire.com/news-release/2023/04/25/2653493/0/en/Idorsia-announces-financial-results-for-the-first-quarter-2023-QUVIVIQ-now-the-leading-branded-insomnia-medicine-in-the-commercial-market-in-the-US.html,20230425T050000,['Idorsia Pharmaceuticals Ltd'],Ad hoc announcement pursuant to Art. 53 LR ...,https://ml-eu.globenewswire.com/Resource/Download/d7f9f469-b878-4c25-b27f-5b80480b35fc,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.155669,Somewhat-Bullish,"[{'ticker': 'IDRSF', 'relevance_score': '0.216307', 'ticker_sentiment_score': '0.170819', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.015644', 'ticker_sentiment_score': '0.029107', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NBIX', 'relevance_score': '0.031282', 'ticker_sentiment_score': '0.050154', 'ticker_sentiment_label': 'Neutral'}]"
Point-of-Care Diagnostics Market Worth USD 66.0 Bn by 2028: Says Transparency Market Research,https://www.benzinga.com/pressreleases/23/04/g31972595/point-of-care-diagnostics-market-worth-usd-66-0-bn-by-2028-says-transparency-market-research,20230424T213000,['Globe Newswire'],"Wilmington, Delaware, United States, April 25, 2023 ( GLOBE NEWSWIRE ) -- According to the recent study published by Transparency Market Research, the global point-of-care diagnostics market stood at USD 34.1 billion in 2020 and the global market is projected to reach USD 66.0 billion by 2028.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}]",0.247326,Somewhat-Bullish,"[{'ticker': 'BIO', 'relevance_score': '0.038101', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABT', 'relevance_score': '0.038101', 'ticker_sentiment_score': '-0.018606', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAH', 'relevance_score': '0.038101', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.038101', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TMO', 'relevance_score': '0.038101', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson Announces Launch of Kenvue Inc. IPO Roadshow - Investing News Network,https://investingnews.com/johnson-johnson-announces-launch-of-kenvue-inc-ipo-roadshow/,20230424T211837,[],Johnson & Johnson Announces Launch of Kenvue Inc. IPO Roadshow Investing News Network ...,,Investing News Network,n/a,investingnews.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.983605'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Finance', 'relevance_score': '0.5'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.268487,Somewhat-Bullish,"[{'ticker': 'BR', 'relevance_score': '0.037387', 'ticker_sentiment_score': '0.077474', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CURN', 'relevance_score': '0.037387', 'ticker_sentiment_score': '0.083955', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.037387', 'ticker_sentiment_score': '0.12745', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.074692', 'ticker_sentiment_score': '0.100172', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.393884', 'ticker_sentiment_score': '0.327889', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
J&J aims for up to $43 bln valuation for consumer health unit Kenvue,https://www.reuters.com/markets/deals/jj-aims-up-43-bln-valuation-consumer-health-unit-kenvue-2023-04-24/,20230424T205200,['Reuters'],J&J aims for up to $43 bln valuation for consumer health unit ...,https://cloudfront-us-east-2.images.arcpublishing.com/reuters/HGLTI5FDOVO2JN2O7HEZNT7ILM.jpg,Reuters,Markets,www.reuters.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '0.650727'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.089141,Neutral,"[{'ticker': 'GS', 'relevance_score': '0.214937', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.214937', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson to price shares of consumer spinoff Kenvue at $20 to $23 in IPO,https://www.cnbc.com/2023/04/24/johnson-johnson-to-price-shares-of-consumer-spinoff-kenvue-at-20-to-23-in-ipo.html,20230424T204156,['Annika Kim Constantino'],J&J said it launched a roadshow for Kenvue's IPO of more than 151 million shares of common stock.,https://image.cnbcfm.com/api/v1/image/107228068-1681927113210-gettyimages-1250758498-US-NEWS-FLA-DISNEY-DISTRICT-EDITORIAL-OS.jpeg?v=1682364091,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.576289'}, {'topic': 'Financial Markets', 'relevance_score': '0.650727'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.262987,Somewhat-Bullish,"[{'ticker': 'BAC', 'relevance_score': '0.285526', 'ticker_sentiment_score': '0.270211', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.285526', 'ticker_sentiment_score': '0.270211', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.285526', 'ticker_sentiment_score': '0.145711', 'ticker_sentiment_label': 'Neutral'}]"
Investors Discuss News From Bank of America and Johnson & Johnson,https://www.fool.com/investing/2023/04/24/investors-discuss-news-from-bank-of-america-and-jo/,20230424T201355,['Chris Hill'],"And we answer listener questions about retirement accounts, buying stock in your employer, and more.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729072%2Fstock-certificate-investment-retire-heirloom-donate-capital-gains-tax-getty.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.857896'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.133625,Neutral,"[{'ticker': 'LIN', 'relevance_score': '0.00959', 'ticker_sentiment_score': '0.063457', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JCI', 'relevance_score': '0.00959', 'ticker_sentiment_score': '0.063457', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.019178', 'ticker_sentiment_score': '0.016023', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.00959', 'ticker_sentiment_score': '0.043737', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.076602', 'ticker_sentiment_score': '0.052171', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.019178', 'ticker_sentiment_score': '0.060997', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.00959', 'ticker_sentiment_score': '0.043737', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.067051', 'ticker_sentiment_score': '0.067508', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.028764', 'ticker_sentiment_score': '0.048426', 'ticker_sentiment_label': 'Neutral'}]"
"Wall Street Headlines, International Investing, and Stocks to Watch",https://www.fool.com/investing/2023/04/24/wall-street-headlines-international-investing-and/,20230424T194911,"['Jason Moser', 'Bill Mann', 'and Dan Boyd', 'Andy Cross', 'Chris Hill']","The ""Motley Fool Money"" crew kicks things off with a look at what's going on with Netflix.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F728889%2Fjoe-biden-wh-photo-east-room-deliver-remarks-adam-schultz.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.108179'}]",0.14175,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.051901', 'ticker_sentiment_score': '0.017974', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NRHI', 'relevance_score': '0.006492', 'ticker_sentiment_score': '0.083605', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.090694', 'ticker_sentiment_score': '0.023225', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.006492', 'ticker_sentiment_score': '0.04496', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.006492', 'ticker_sentiment_score': '-0.167535', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TWNK', 'relevance_score': '0.012984', 'ticker_sentiment_score': '0.031977', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AWON', 'relevance_score': '0.006492', 'ticker_sentiment_score': '0.054387', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSCO', 'relevance_score': '0.058377', 'ticker_sentiment_score': '0.051015', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GIS', 'relevance_score': '0.012984', 'ticker_sentiment_score': '0.031977', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.077782', 'ticker_sentiment_score': '0.057029', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.019474', 'ticker_sentiment_score': '0.015029', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.025964', 'ticker_sentiment_score': '0.072754', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.019474', 'ticker_sentiment_score': '0.127153', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.025964', 'ticker_sentiment_score': '-0.00555', 'ticker_sentiment_label': 'Neutral'}]"
"Wall Street optimistic on Disney and AMD, while J&J prepares for consumer brand IPO. Here's our take on these Club stocks in the news",https://www.cnbc.com/2023/04/24/wall-street-optimistic-on-disney-amd-jj-prepares-for-consumer-brand-ipo.html,20230424T192131,"['Kevin Stankiewicz', 'Paulina Likos']","Club holdings Disney (DIS), Johnson & Johnson (JNJ) and Advanced Micro Devices (AMD) are in the headlines. Here's our take on the news.",https://image.cnbcfm.com/api/v1/image/107228068-1681927113210-gettyimages-1250758498-US-NEWS-FLA-DISNEY-DISTRICT-EDITORIAL-OS.jpeg?v=1682364091&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",0.27652,Somewhat-Bullish,"[{'ticker': 'AMD', 'relevance_score': '0.947069', 'ticker_sentiment_score': '0.466161', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.947069', 'ticker_sentiment_score': '0.466161', 'ticker_sentiment_label': 'Bullish'}]"
J&J consumer-health IPO process to kick off key test for moribund new-issue market,https://www.foxbusiness.com/markets/jj-consumer-health-ipo-process-kick-off-key-test-moribund-new-issue-market,20230424T183345,[],"Johnson & Johnson is poised to begin a roadshow to pitch shares of its consumer-healthcare business, the producer of household names such as Tylenol, in a test for an IPO market that has been in the doldrums for the past year.",https://static.foxbusiness.com/foxbusiness.com/content/uploads/2021/11/GettyImages-1164570932.jpg,Fox Business News,n/a,www.foxbusiness.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'IPO', 'relevance_score': '0.890401'}, {'topic': 'Financial Markets', 'relevance_score': '0.986714'}, {'topic': 'Earnings', 'relevance_score': '0.77141'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.090391,Neutral,"[{'ticker': 'BAYZF', 'relevance_score': '0.050044', 'ticker_sentiment_score': '0.071387', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.050044', 'ticker_sentiment_score': '0.166218', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MBLY', 'relevance_score': '0.050044', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.050044', 'ticker_sentiment_score': '0.027987', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.050044', 'ticker_sentiment_score': '0.071387', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HLN', 'relevance_score': '0.050044', 'ticker_sentiment_score': '0.071387', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.050044', 'ticker_sentiment_score': '0.166218', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GSK', 'relevance_score': '0.050044', 'ticker_sentiment_score': '0.071387', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.050044', 'ticker_sentiment_score': '0.071387', 'ticker_sentiment_label': 'Neutral'}]"
"Top Stories Monday, Apr. 24: Elon Musk Plans Next Starship Launch Within Two Months, NBCUniversal CEO Resigns Amid 'Inappropriate Relationship, Micron Tech Caught Between US-China Tensions - Alibaba Group Holding  ( NYSE:BABA ) , Amphastar Pharma  ( NASDAQ:AMPH ) ",https://www.benzinga.com/general/biotech/23/04/31956134/elon-musk-plans-next-starship-launch-within-two-months-nbcuniversal-ceo-resigns-amid-inappropriat,20230424T143406,['Vandana Singh'],"SpaceX CEO Elon Musk on Saturday said that Starship could be ready to launch again in 1 to 2 months. Starship can be ready to launch again in 1 to 2 months post-repairs of damage at the Starbase launch site, said Elon Musk in a Twitter reply on Saturday.",https://cdn.benzinga.com/files/images/story/2023/04/24/elon_musk_fernandi_putra_and_vitaliy_karimov_on_shutterstock_and_courtesy_photo_on_wikimedia_commons.jpg?width=1200&height=800&fit=crop,Benzinga,Mergers,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.360215'}]",0.150797,Somewhat-Bullish,"[{'ticker': 'BABA', 'relevance_score': '0.080865', 'ticker_sentiment_score': '0.053399', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.121037', 'ticker_sentiment_score': '0.169479', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.080865', 'ticker_sentiment_score': '0.096718', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBS', 'relevance_score': '0.080865', 'ticker_sentiment_score': '-0.005373', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MU', 'relevance_score': '0.080865', 'ticker_sentiment_score': '-0.088549', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.080865', 'ticker_sentiment_score': '-0.005373', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TCTZF', 'relevance_score': '0.040484', 'ticker_sentiment_score': '0.051014', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSNLF', 'relevance_score': '0.080865', 'ticker_sentiment_score': '0.104339', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PDD', 'relevance_score': '0.121037', 'ticker_sentiment_score': '-0.006265', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSTK', 'relevance_score': '0.040484', 'ticker_sentiment_score': '0.148446', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RYLPF', 'relevance_score': '0.040484', 'ticker_sentiment_score': '0.130636', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SFTBF', 'relevance_score': '0.080865', 'ticker_sentiment_score': '0.194047', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LLY', 'relevance_score': '0.121037', 'ticker_sentiment_score': '0.099385', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMPH', 'relevance_score': '0.080865', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CCZ', 'relevance_score': '0.080865', 'ticker_sentiment_score': '0.058628', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.160901', 'ticker_sentiment_score': '0.1299', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:EUR', 'relevance_score': '0.040484', 'ticker_sentiment_score': '0.321485', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
AbbVie  ( ABBV )  to Report Q1 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2083516/abbvie-abbv-to-report-q1-earnings-whats-in-the-cards,20230424T142900,['Zacks Investment Research'],AbbVie's (ABBV) Q1 performance will likely reflect declining sales of Humira following the loss of exclusivity. Sales of Rinvoq and Skyrizi are expected to partially offset this fall.,https://staticx-tuner.zacks.com/images/articles/main/d5/8276.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.9973'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.152361,Somewhat-Bullish,"[{'ticker': 'NVO', 'relevance_score': '0.229149', 'ticker_sentiment_score': '-0.003495', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.337811', 'ticker_sentiment_score': '0.178678', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.172919', 'ticker_sentiment_score': '0.04057', 'ticker_sentiment_label': 'Neutral'}]"
Jim Cramer's top 10 things to watch in the stock market Monday,https://www.cnbc.com/2023/04/24/jim-cramers-top-10-things-to-watch-in-the-stock-market-monday.html,20230424T132001,['Jim Cramer'],"The Dow, the S&P 500 and the Nasdaq are set for a mixed open Monday ahead of big earnings and inflation week.",https://image.cnbcfm.com/api/v1/image/107228097-1681928179212-gettyimages-1251954268-porzycki-streamin230418_npiag.jpeg?v=1682342401&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'IPO', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.839681'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.875462'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.067818,Neutral,"[{'ticker': 'SSNLF', 'relevance_score': '0.060388', 'ticker_sentiment_score': '-0.125634', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TJX', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.003629', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.179788', 'ticker_sentiment_score': '0.317033', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WFC', 'relevance_score': '0.060388', 'ticker_sentiment_score': '0.036164', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.179788', 'ticker_sentiment_score': '0.010144', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.2542', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMD', 'relevance_score': '0.120431', 'ticker_sentiment_score': '-0.147988', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BBBY', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.003629', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.179788', 'ticker_sentiment_score': '0.0293', 'ticker_sentiment_label': 'Neutral'}]"
ZyVersa Therapeutics Adds Dr. Douglas Golenbock to Its Inflammatory Disease Scientific Advisory Board to Support Advancement of Inflammasome ASC Inhibitor IC 100,https://www.globenewswire.com/news-release/2023/04/24/2652790/0/en/ZyVersa-Therapeutics-Adds-Dr-Douglas-Golenbock-to-Its-Inflammatory-Disease-Scientific-Advisory-Board-to-Support-Advancement-of-Inflammasome-ASC-Inhibitor-IC-100.html,20230424T130700,['ZyVersa Therapeutics'],"WESTON, Fla., April 24, 2023 ( GLOBE NEWSWIRE ) -- ZyVersa Therapeutics, Inc. ( Nasdaq: ZVSA. ""ZyVersa"" ) , a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of patients with renal and inflammatory diseases who have unmet medical needs, announces ...",https://ml.globenewswire.com/Resource/Download/9ca5d520-abbc-4128-a65d-fc012acd814d,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.310843'}]",0.019206,Neutral,"[{'ticker': 'ZVSA', 'relevance_score': '0.106423', 'ticker_sentiment_score': '0.025709', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CHRS', 'relevance_score': '0.05333', 'ticker_sentiment_score': '0.016994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.05333', 'ticker_sentiment_score': '0.016994', 'ticker_sentiment_label': 'Neutral'}]"
ZyVersa Therapeutics Adds Dr. Douglas Golenbock to Its Inflammatory Disease Scientific Advisory Board to Support Advancement of Inflammasome ASC Inhibitor IC 100 - ZyVersa Therapeutics  ( NASDAQ:ZVSA ) ,https://www.benzinga.com/pressreleases/23/04/g31956019/zyversa-therapeutics-adds-dr-douglas-golenbock-to-its-inflammatory-disease-scientific-advisory-boa,20230424T130700,['Globe Newswire'],"Dr. Golenbock is The Neil and Margery Blacklow Chair in Infectious Diseases and Immunology and Professor and Chief, Division of Infectious Diseases and Immunology at the UMass Chan Medical School",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.495866'}]",0.023987,Neutral,"[{'ticker': 'ZVSA', 'relevance_score': '0.102558', 'ticker_sentiment_score': '0.025358', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CHRS', 'relevance_score': '0.051386', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.051386', 'ticker_sentiment_score': '-0.079995', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson  ( JNJ )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2083298/johnson-johnson-jnj-is-a-trending-stock-facts-to-know-before-betting-on-it,20230424T130011,['Zacks Investment Research'],"Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",https://staticx-tuner.zacks.com/images/default_article_images/default263.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.246438,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.474958', 'ticker_sentiment_score': '0.177124', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Medical Aesthetics and Technology Leader Cynosure Appoints Nadav Tomer as its Chief Executive Officer,https://www.prnewswire.com/news-releases/medical-aesthetics-and-technology-leader-cynosure-appoints-nadav-tomer-as-its-chief-executive-officer-301805470.html,20230424T130000,"['Cynosure', 'Inc.']",Medical Aesthetics and Technology Leader Cynosure Appoints ... PR ...,https://mma.prnewswire.com/media/2061416/Cynosure_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.440438,Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.053749', 'ticker_sentiment_score': '0.149933', 'ticker_sentiment_label': 'Neutral'}]"
Medical Aesthetics and Technology Leader Cynosure Appoints Nadav Tomer as its Chief Executive Officer,https://www.prnewswire.com/in/news-releases/medical-aesthetics-and-technology-leader-cynosure-appoints-nadav-tomer-as-its-chief-executive-officer-301805484.html,20230424T130000,"['Cynosure', 'Inc.']",Medical Aesthetics and Technology Leader Cynosure Appoints ... PR ...,https://mma.prnewswire.com/media/2061416/Cynosure_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.440438,Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.053749', 'ticker_sentiment_score': '0.149933', 'ticker_sentiment_label': 'Neutral'}]"
Medical Aesthetics and Technology Leader Cynosure Appoints Nadav Tomer as its Chief Executive Officer,https://www.newswire.ca/news-releases/medical-aesthetics-and-technology-leader-cynosure-appoints-nadav-tomer-as-its-chief-executive-officer-831449751.html,20230424T130000,"['Inc.', 'Cynosure']",Medical Aesthetics and Technology Leader Cynosure Appoints ... Canada ...,https://mma.prnewswire.com/media/2061416/Cynosure_Logo.jpg?p=facebook,Canada Newswire,n/a,www.newswire.ca,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.440438,Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.053749', 'ticker_sentiment_score': '0.149933', 'ticker_sentiment_label': 'Neutral'}]"
"4 Pharma, Biotech Stocks Poised to Beat Q1 Earnings Estimates",https://www.zacks.com/stock/news/2083259/4-pharma-biotech-stocks-poised-to-beat-q1-earnings-estimates,20230424T123800,['Zacks Investment Research'],"We look at a few pharma/biotech companies, SNY, AMGN, REGN, ACAD, which are poised to beat on earnings in the first quarter.",https://staticx-tuner.zacks.com/images/default_article_images/default175.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.178822,Somewhat-Bullish,"[{'ticker': 'ACAD', 'relevance_score': '0.222022', 'ticker_sentiment_score': '-0.046605', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'REGN', 'relevance_score': '0.306963', 'ticker_sentiment_score': '0.190761', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMGN', 'relevance_score': '0.348103', 'ticker_sentiment_score': '0.075985', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.134339', 'ticker_sentiment_score': '-0.001252', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.222022', 'ticker_sentiment_score': '0.025583', 'ticker_sentiment_label': 'Neutral'}]"
Why First Republic Has Not Done a Deal,https://www.nytimes.com/2023/04/24/business/dealbook/first-republic.html,20230424T123514,[],"Big banks gave the regional lender a $30 billion lifeline following the collapse of Silicon Valley Bank, but it has yet to raise more cash, sell assets - or itself.",https://static01.nyt.com/images/2023/04/24/multimedia/24db-firstrepublic-tpbc/24db-firstrepublic-tpbc-articleLarge.jpg?quality=75&auto=webp&disable=upscale,New York Times,Dealbook,www.nytimes.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.795202'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.0,Neutral,"[{'ticker': 'BUD', 'relevance_score': '0.043069', 'ticker_sentiment_score': '-0.183183', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'MSFT', 'relevance_score': '0.021542', 'ticker_sentiment_score': '0.048945', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.021542', 'ticker_sentiment_score': '0.048945', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.021542', 'ticker_sentiment_score': '0.039164', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.021542', 'ticker_sentiment_score': '0.19068', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ATVI', 'relevance_score': '0.021542', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BBBY', 'relevance_score': '0.064564', 'ticker_sentiment_score': '-0.100029', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCO', 'relevance_score': '0.021542', 'ticker_sentiment_score': '-0.112224', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CCZ', 'relevance_score': '0.107399', 'ticker_sentiment_score': '-0.042664', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EA', 'relevance_score': '0.021542', 'ticker_sentiment_score': '-0.026063', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COIN', 'relevance_score': '0.021542', 'ticker_sentiment_score': '-0.019709', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NSRGF', 'relevance_score': '0.021542', 'ticker_sentiment_score': '0.048945', 'ticker_sentiment_label': 'Neutral'}]"
"Mixed Macro, Fed Debate, Earnings in Full Swing, S&P, Busy Week Ahead",https://realmoney.thestreet.com/investing/mixed-macro-fed-debate-earnings-in-full-swing-s-p-busy-week-ahead-16121922,20230424T122240,['Stephen Guilfoyle'],"Mixed Macro, Fed Debate, Earnings in Full Swing, S&P, Busy Week ... ...",https://s.thestreet.com/files/tsc/v2008/photos/contrib/uploads/be781097-e294-11ed-9ab0-a5674aede514.png,The Street,GoogleRSS,realmoney.thestreet.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Blockchain', 'relevance_score': '0.158519'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.890401'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '0.955357'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.999974'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.062085,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.039128', 'ticker_sentiment_score': '-0.005964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.039128', 'ticker_sentiment_score': '0.051653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVX', 'relevance_score': '0.039128', 'ticker_sentiment_score': '0.051653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.039128', 'ticker_sentiment_score': '0.051653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.01957', 'ticker_sentiment_score': '0.047022', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.039128', 'ticker_sentiment_score': '-0.005964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.039128', 'ticker_sentiment_score': '-0.005964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.039128', 'ticker_sentiment_score': '0.051653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.039128', 'ticker_sentiment_score': '0.051653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.039128', 'ticker_sentiment_score': '-0.005964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.039128', 'ticker_sentiment_score': '-0.005964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MA', 'relevance_score': '0.01957', 'ticker_sentiment_score': '0.047022', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'V', 'relevance_score': '0.039128', 'ticker_sentiment_score': '0.051653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.039128', 'ticker_sentiment_score': '-0.005964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.039128', 'ticker_sentiment_score': '0.051653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.039128', 'ticker_sentiment_score': '0.051653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPGI', 'relevance_score': '0.01957', 'ticker_sentiment_score': '-0.032983', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.039128', 'ticker_sentiment_score': '0.051653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.01957', 'ticker_sentiment_score': '0.077017', 'ticker_sentiment_label': 'Neutral'}]"
"Johnson & Johnson Unleashes Kenvue: Tylenol to Neutrogena, $40B Revenue Unit Spinoff Preps for IPO Blitz - Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/news/large-cap/23/04/31953000/johnson-johnson-unleashes-kenvue-tylenol-to-neutrogena-40b-revenue-unit-spinoff-preps-for-ipo-blit,20230424T121952,['Vandana Singh'],"Johnson & Johnson JNJ is reportedly readying an investor roadshow to pitch shares of its consumer-healthcare spinoff business, dubbed Kenvue, as early as Monday.",https://cdn.benzinga.com/files/images/story/2023/04/24/tylenol.png?width=1200&height=800&fit=crop,Benzinga,Mergers,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'IPO', 'relevance_score': '0.576289'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.310843'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.071422,Neutral,"[{'ticker': 'BAYZF', 'relevance_score': '0.138464', 'ticker_sentiment_score': '0.070146', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.272788', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.399204', 'ticker_sentiment_score': '0.272594', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PG', 'relevance_score': '0.272788', 'ticker_sentiment_score': '0.114812', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HLN', 'relevance_score': '0.272788', 'ticker_sentiment_score': '0.114812', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GSK', 'relevance_score': '0.272788', 'ticker_sentiment_score': '0.114812', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.272788', 'ticker_sentiment_score': '0.114812', 'ticker_sentiment_label': 'Neutral'}]"
Is ALPS O'Shares U.S. Quality Dividend ETF  ( OUSA )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2083181/is-alps-oshares-us-quality-dividend-etf-ousa-a-strong-etf-right-now,20230424T102010,['Zacks Investment Research'],Smart Beta ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default182.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999892'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.290604,Somewhat-Bullish,"[{'ticker': 'HD', 'relevance_score': '0.117774', 'ticker_sentiment_score': '0.060494', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.117774', 'ticker_sentiment_score': '0.060494', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.117774', 'ticker_sentiment_score': '0.060494', 'ticker_sentiment_label': 'Neutral'}]"
Should Invesco Dividend Achievers ETF  ( PFM )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2083186/should-invesco-dividend-achievers-etf-pfm-be-on-your-investing-radar,20230424T102007,['Zacks Investment Research'],Style Box ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default145.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.233743,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.123526', 'ticker_sentiment_score': '0.068619', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.184363', 'ticker_sentiment_score': '0.155457', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UNH', 'relevance_score': '0.123526', 'ticker_sentiment_score': '0.068619', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.123526', 'ticker_sentiment_score': '0.068619', 'ticker_sentiment_label': 'Neutral'}]"
News Exclusive | J&J Consumer-Health IPO Process to Kick Off Key Test for Moribund New-Issue Market,https://www.wsj.com/articles/j-j-consumer-health-ipo-process-to-kick-off-key-test-for-moribund-new-issue-market-3c978f38,20230423T214300,['Corrie Driebusch and Peter Loftus'],Kenvue plans to start meeting with prospective investors as early as Monday.,https://images.wsj.net/im-768546?width=700&height=466,Wall Street Journal,Markets,www.wsj.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.310843'}]",0.053915,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.421485', 'ticker_sentiment_score': '0.080352', 'ticker_sentiment_label': 'Neutral'}]"
Cancer Immunotherapy Market Size Worth USD 388.25 Billion in 2030 - Emergen Research,https://markets.businessinsider.com/news/stocks/cancer-immunotherapy-market-size-worth-usd-388-25-billion-in-2030-%E2%80%93-emergen-research-1032251605,20230423T132200,[],"The global Cancer Immunotherapy Market size was USD 119.39 Billion in 2021 and is expected to register a revenue CAGR of 14.0% during the forecast period, according to latest analysis by Emergen Research Cancer immunotherapy, also known as immuno-oncology, is a fast expanding specialty in cancer ...",https://markets.businessinsider.com/Images/FacebookIcon.jpg,Business Insider,RSS,markets.businessinsider.com,"[{'topic': 'Earnings', 'relevance_score': '0.929393'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}]",-0.174698,Somewhat-Bearish,"[{'ticker': 'AZN', 'relevance_score': '0.034282', 'ticker_sentiment_score': '-0.109525', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAYZF', 'relevance_score': '0.034282', 'ticker_sentiment_score': '-0.109525', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.034282', 'ticker_sentiment_score': '-0.109525', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVS', 'relevance_score': '0.034282', 'ticker_sentiment_score': '-0.109525', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.034282', 'ticker_sentiment_score': '-0.109525', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.034282', 'ticker_sentiment_score': '-0.109525', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.034282', 'ticker_sentiment_score': '-0.109525', 'ticker_sentiment_label': 'Neutral'}]"
"If You're a Dividend Investor, You'll Love This News From Johnson & Johnson",https://www.fool.com/investing/2023/04/22/if-youre-dividend-investor-youll-love-j-and-j-news/,20230422T180000,['Adria Cimino'],The company offers you growing recurrent income -- just for holding its shares.,https://media.ycharts.com/charts/ec84d8a48407b3df095cce3e49b15a38.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.980922'}, {'topic': 'Earnings', 'relevance_score': '0.795202'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.30636,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.202932', 'ticker_sentiment_score': '0.177638', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
3 Top Dividend Kings to Buy for the Long Haul,https://www.fool.com/investing/2023/04/22/3-top-dividend-kings-to-buy-for-the-long-haul/,20230422T112000,['Jim Halley'],These healthcare stocks all have above-average dividends.,https://media.ycharts.com/charts/49c54d53837a407641998e540002b196.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.200073,Somewhat-Bullish,"[{'ticker': 'EMBC', 'relevance_score': '0.151159', 'ticker_sentiment_score': '0.007802', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.2396', 'ticker_sentiment_score': '0.17618', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABT', 'relevance_score': '0.030408', 'ticker_sentiment_score': '0.158953', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.151159', 'ticker_sentiment_score': '0.107797', 'ticker_sentiment_label': 'Neutral'}]"
J&J to Lift Dividend for 61st Year. These 6 Others Are Raising Payouts Too.,https://www.barrons.com/articles/stocks-raising-dividends-j-j-costco-60f5d6ad,20230422T080000,['Lawrence C. Strauss'],J&J to Lift Dividend for 61st Year Plus 6 More Firms Raising ...,https://images.barrons.com/im-767680/social,Barrons,n/a,www.barrons.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}]",0.38899,Bullish,"[{'ticker': 'SO', 'relevance_score': '0.751437', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COST', 'relevance_score': '0.751437', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.999463', 'ticker_sentiment_score': '0.636157', 'ticker_sentiment_label': 'Bullish'}]"
HVAC equipment market size in Europe to grow by USD 9.49 billion between 2022 and 2027; Increasing use of renewable energy sources for HVAC systems to be key trend - Technavio,https://www.prnewswire.com/news-releases/hvac-equipment-market-size-in-europe-to-grow-by-usd-9-49-billion-between-2022-and-2027-increasing-use-of-renewable-energy-sources-for-hvac-systems-to-be-key-trend---technavio-301803193.html,20230422T023000,['Technavio'],HVAC equipment market size in Europe to grow by USD 9.49 billion ... PR ...,https://mma.prnewswire.com/media/2059374/Technavio_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}]",0.301502,Somewhat-Bullish,"[{'ticker': 'SSNLF', 'relevance_score': '0.029327', 'ticker_sentiment_score': '-0.044058', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CARR', 'relevance_score': '0.058615', 'ticker_sentiment_score': '0.166026', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HON', 'relevance_score': '0.029327', 'ticker_sentiment_score': '-0.044058', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.029327', 'ticker_sentiment_score': '-0.044058', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PCRFF', 'relevance_score': '0.029327', 'ticker_sentiment_score': '-0.044058', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IR', 'relevance_score': '0.029327', 'ticker_sentiment_score': '-0.044058', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSBHF', 'relevance_score': '0.029327', 'ticker_sentiment_score': '-0.044058', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RRX', 'relevance_score': '0.029327', 'ticker_sentiment_score': '-0.044058', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MIELF', 'relevance_score': '0.029327', 'ticker_sentiment_score': '-0.044058', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DKILF', 'relevance_score': '0.058615', 'ticker_sentiment_score': '0.166026', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HSHCY', 'relevance_score': '0.058615', 'ticker_sentiment_score': '0.166026', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Supreme Court says abortion pill mifepristone will remain broadly available during legal battle,https://www.cnbc.com/2023/04/21/supreme-court-says-abortion-pill-mifepristone-will-remain-broadly-available-during-legal-battle.html,20230421T224106,['Spencer Kimball'],Mifepristone has become the central flashpoint in the legal battle over abortion since the Supreme Court last summer overturned Roe v. Wade.,https://image.cnbcfm.com/api/v1/image/107227734-1681909011194-gettyimages-1251851910-AFP_33DA34J.jpeg?v=1682116866&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.079909,Neutral,"[{'ticker': 'MRNA', 'relevance_score': '0.078099', 'ticker_sentiment_score': '-0.406604', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.155451', 'ticker_sentiment_score': '-0.012288', 'ticker_sentiment_label': 'Neutral'}]"
"3 Very Low-Risk Ways to Invest $1,000 Right Now",https://www.fool.com/investing/2023/04/21/3-very-low-risk-ways-to-invest-1000-right-now/,20230421T194500,['Matt DiLallo'],These companies have durable businesses and elite financial profiles.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729084%2Fa-black-tesla-car-driving-on-an-open-road-in-the-snow.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.99793'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.5'}]",0.273892,Somewhat-Bullish,"[{'ticker': 'CPT', 'relevance_score': '0.219312', 'ticker_sentiment_score': '0.41169', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.323785', 'ticker_sentiment_score': '0.271095', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Why This Top 5% Biotech Just Hit A Profit-Taking Zone,https://www.investors.com/news/technology/legn-stock-hits-profit-taking-zone-after-reportedly-confirming-cancer-test/,20230421T181400,"['ALLISON GATLIN', ""Investor's Business Daily""]",LEGN Stock Hits Profit-Taking Zone After Reportedly Confirming ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2019/11/Stock-Drugs-74-shutt.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.977154'}]",-0.08037,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.182506', 'ticker_sentiment_score': '-0.378465', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'LEGN', 'relevance_score': '0.83383', 'ticker_sentiment_score': '0.265643', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVAX', 'relevance_score': '0.182506', 'ticker_sentiment_score': '-0.331384', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
Johnson & Johnson Stock: Should You Buy Before This Big Transition?,https://www.fool.com/investing/2023/04/21/j-and-j-stock-should-you-buy-before-transition/,20230421T180000,['Adria Cimino'],J&J may have reached a major turning point.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729088%2Fteslas-first-quarter-2023-performance.png&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.967645'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.359822,Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.222953', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Eli Lilly, Novo Nordisk and Sanofi CEOs to testify before Senate on lowering insulin prices",https://www.cnbc.com/2023/04/21/insulin-eli-lilly-sanofi-novo-nordisk-testify-to-senate-on-prices.html,20230421T165255,['Spencer Kimball'],"Eli Lilly, Novo Nordisk and Sanofi control 90% of the insulin market in the U.S, where a quarter of all health care spending is on people with diabetes.",https://image.cnbcfm.com/api/v1/image/107208373-1678805156449-gettyimages-1473508246-029a2481_35hair2l.jpeg?v=1682095975&w=1920&h=1080,CNBC,Business,www.cnbc.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.650727'}]",0.033433,Neutral,"[{'ticker': 'CVS', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.124832', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.060388', 'ticker_sentiment_score': '-0.391075', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'NVO', 'relevance_score': '0.179788', 'ticker_sentiment_score': '0.073802', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.120431', 'ticker_sentiment_score': '-0.010641', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.179788', 'ticker_sentiment_score': '0.073802', 'ticker_sentiment_label': 'Neutral'}]"
Plaintiffs' Attorneys Representing Talc-Cancer Victims Form Ad Hoc Committee to Support J&J Settlement,https://investingnews.com/plaintiffs-attorneys-representing-talc-cancer-victims-form-ad-hoc-committee-to-support-jj-settlement/,20230421T164847,[],"Leadership committee seeks to bring resolution to decade-long legal battle Lawyers representing approximately 55,000 plaintiffs in the litigation against Johnson & Johnson ( NYSE: JNJ ) over its cancer-causing talcum powder products have formed an Ad Hoc Committee to support an $8.9 billion deal ...",https://investingnews.com/media-library/eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJpbWFnZSI6Imh0dHBzOi8vYXNzZXRzLnJibC5tcy8yNTg1ODg1NS9vcmlnaW4ucG5nIiwiZXhwaXJlc19hdCI6MTcwODY4MTIxOX0.Phin9ClvosnPNpkGRdBWHz_VFepTco5fqEYZcXCsZIQ/image.png?width=210,Investing News Network,n/a,investingnews.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.170886,Somewhat-Bearish,"[{'ticker': 'JNJ', 'relevance_score': '0.172097', 'ticker_sentiment_score': '-0.005874', 'ticker_sentiment_label': 'Neutral'}]"
Alyssa Milano - Even Elmo - React To Elon Musk's Twitter Changes: 'We Are Officially Blue Check Mark Free',https://www.benzinga.com/general/entertainment/23/04/31937599/alyssa-milano-even-elmo-react-to-elon-musks-twitter-changes-we-are-officially-blue-check-ma,20230421T155216,['Chris Katje'],"Since taking over social media platform Twitter, new owner and CEO Elon Musk has put forth many changes. Among the biggest changes is the Twitter Blue subscription program, charging users to have their accounts verified. A change to the verification process happened on Thursday and many ...",https://cdn.benzinga.com/files/images/story/2023/04/21/1_0.png?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.026536,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.050148', 'ticker_sentiment_score': '-0.134235', 'ticker_sentiment_label': 'Neutral'}]"
Plaintiffs' Attorneys Representing Talc-Cancer Victims Form Ad Hoc Committee to Support J&J Settlement,https://www.prnewswire.com/news-releases/plaintiffs-attorneys-representing-talc-cancer-victims-form-ad-hoc-committee-to-support-jj-settlement-301804295.html,20230421T155100,['Nachawati Law Group'],Plaintiffs' Attorneys Representing Talc-Cancer Victims Form Ad Hoc ... PR ...,,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.17087,Somewhat-Bearish,"[{'ticker': 'JNJ', 'relevance_score': '0.177802', 'ticker_sentiment_score': '-0.005967', 'ticker_sentiment_label': 'Neutral'}]"
Market Rally Drifts Lower; Tesla Dives On Margins: Weekly Review,https://www.investors.com/news/stock-market-rally-drifts-lower-tesla-dives-on-margins-isrg-dhi-lvs-are-winners/,20230421T151600,"['IBD STAFF', ""Investor's Business Daily""]",Market Rally Drifts Lower. Tesla Dives On Margins: Weekly Review Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2021/01/Stock-Tesla-modelY-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '0.99977'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",-0.09001,Neutral,"[{'ticker': 'XPEV', 'relevance_score': '0.062271', 'ticker_sentiment_score': '-0.003015', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WAL', 'relevance_score': '0.041538', 'ticker_sentiment_score': '0.008941', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.062271', 'ticker_sentiment_score': '-0.0486', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LVS', 'relevance_score': '0.124164', 'ticker_sentiment_score': '-0.02055', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SLB', 'relevance_score': '0.062271', 'ticker_sentiment_score': '0.051316', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BK', 'relevance_score': '0.041538', 'ticker_sentiment_score': '0.008941', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STT', 'relevance_score': '0.062271', 'ticker_sentiment_score': '0.009061', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABT', 'relevance_score': '0.041538', 'ticker_sentiment_score': '-0.047931', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.185306', 'ticker_sentiment_score': '-0.079295', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNP', 'relevance_score': '0.062271', 'ticker_sentiment_score': '-0.087197', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRCX', 'relevance_score': '0.103598', 'ticker_sentiment_score': '-0.112153', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPGI', 'relevance_score': '0.020776', 'ticker_sentiment_score': '-0.013591', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DXCM', 'relevance_score': '0.041538', 'ticker_sentiment_score': '-0.060168', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NFLX', 'relevance_score': '0.062271', 'ticker_sentiment_score': '-0.087018', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IBKR', 'relevance_score': '0.062271', 'ticker_sentiment_score': '0.003046', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.041538', 'ticker_sentiment_score': '0.008941', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.041538', 'ticker_sentiment_score': '0.008941', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HCA', 'relevance_score': '0.041538', 'ticker_sentiment_score': '0.08633', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BKR', 'relevance_score': '0.062271', 'ticker_sentiment_score': '0.051316', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.041538', 'ticker_sentiment_score': '0.008941', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AN', 'relevance_score': '0.020776', 'ticker_sentiment_score': '-0.109884', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCB', 'relevance_score': '0.041538', 'ticker_sentiment_score': '0.008941', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSM', 'relevance_score': '0.082963', 'ticker_sentiment_score': '-0.105451', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.041538', 'ticker_sentiment_score': '0.050024', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NIO', 'relevance_score': '0.062271', 'ticker_sentiment_score': '-0.003015', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALB', 'relevance_score': '0.062271', 'ticker_sentiment_score': '-0.179135', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'PG', 'relevance_score': '0.062271', 'ticker_sentiment_score': '-0.056259', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.041538', 'ticker_sentiment_score': '-0.056996', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RIO', 'relevance_score': '0.041538', 'ticker_sentiment_score': '-0.175689', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'SCHW', 'relevance_score': '0.062271', 'ticker_sentiment_score': '0.003046', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FCX', 'relevance_score': '0.041538', 'ticker_sentiment_score': '-0.024978', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.062271', 'ticker_sentiment_score': '-0.043466', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.144646', 'ticker_sentiment_score': '0.007934', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LI', 'relevance_score': '0.062271', 'ticker_sentiment_score': '-0.003015', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KEY', 'relevance_score': '0.041538', 'ticker_sentiment_score': '0.008941', 'ticker_sentiment_label': 'Neutral'}]"
"Dow Jones Edges Lower, But Procter & Gamble Jumps On Blowout Results; Why Shockwave Is Soaring Today",https://www.investors.com/dow-jones-edges-higher-soaring-pg-stock-tesla-unfazed-cathie-woods-bullish-call/,20230421T145000,"['KEN SHREVE', ""Investor's Business Daily""]","Dow Jones Mixed, Helped By Soaring Procter & Gamble Stock ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2018/05/Stock-dow-04-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.142857'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.142857'}, {'topic': 'Technology', 'relevance_score': '0.142857'}, {'topic': 'Finance', 'relevance_score': '0.142857'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.142857'}, {'topic': 'Financial Markets', 'relevance_score': '0.999995'}, {'topic': 'Manufacturing', 'relevance_score': '0.142857'}, {'topic': 'Earnings', 'relevance_score': '0.983783'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.142857'}]",0.188852,Somewhat-Bullish,"[{'ticker': 'INSP', 'relevance_score': '0.097062', 'ticker_sentiment_score': '0.269556', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MTH', 'relevance_score': '0.097062', 'ticker_sentiment_score': '0.3134', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GOOG', 'relevance_score': '0.048621', 'ticker_sentiment_score': '0.072199', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.145145', 'ticker_sentiment_score': '0.044272', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CROX', 'relevance_score': '0.097062', 'ticker_sentiment_score': '0.3134', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HCA', 'relevance_score': '0.145145', 'ticker_sentiment_score': '0.394748', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'HDB', 'relevance_score': '0.097062', 'ticker_sentiment_score': '0.140477', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.097062', 'ticker_sentiment_score': '0.081098', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SLB', 'relevance_score': '0.145145', 'ticker_sentiment_score': '-0.147606', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DVA', 'relevance_score': '0.097062', 'ticker_sentiment_score': '0.151111', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.097062', 'ticker_sentiment_score': '0.076869', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ITCI', 'relevance_score': '0.097062', 'ticker_sentiment_score': '0.269556', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.145145', 'ticker_sentiment_score': '0.13211', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOW', 'relevance_score': '0.048621', 'ticker_sentiment_score': '0.29423', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PG', 'relevance_score': '0.097062', 'ticker_sentiment_score': '0.119625', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEN', 'relevance_score': '0.097062', 'ticker_sentiment_score': '0.081098', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMPH', 'relevance_score': '0.097062', 'ticker_sentiment_score': '0.269556', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FCX', 'relevance_score': '0.097062', 'ticker_sentiment_score': '-0.280249', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'HD', 'relevance_score': '0.097062', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.145145', 'ticker_sentiment_score': '0.085735', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SWAV', 'relevance_score': '0.145145', 'ticker_sentiment_score': '0.095728', 'ticker_sentiment_label': 'Neutral'}]"
Intrathecal Pumps Market to Grow at CAGR of 5.50% through 2030 - Advancements in Pump Technology to Bolster Growth: The Brainy Insights,https://markets.businessinsider.com/news/stocks/intrathecal-pumps-market-to-grow-at-cagr-of-5-50-through-2030-%E2%80%93-advancements-in-pump-technology-to-bolster-growth-the-brainy-insights-1032249762,20230421T141600,[],"As per the report published by The Brainy Insights, the global intrathecal pumps market is expected to grow from USD 384.59 million in 2021 to USD 622.68 million by 2030, at a CAGR of 5.50% during the forecast period 2022-2030. With a market share of around 39.02% and USD 242.96 ",https://markets.businessinsider.com/Images/FacebookIcon.jpg,Business Insider,RSS,markets.businessinsider.com,"[{'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.199028,Somewhat-Bullish,"[{'ticker': 'BAX', 'relevance_score': '0.062597', 'ticker_sentiment_score': '0.211242', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DRRX', 'relevance_score': '0.062597', 'ticker_sentiment_score': '0.211242', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MDT', 'relevance_score': '0.062597', 'ticker_sentiment_score': '0.211242', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.062597', 'ticker_sentiment_score': '0.211242', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TFX', 'relevance_score': '0.062597', 'ticker_sentiment_score': '0.211242', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
UM and Roku Partner to Increase Equity For Minority-Owned Networks Ahead of TV Upfronts,https://www.prnewswire.com/news-releases/um-and-roku-partner-to-increase-equity-for-minority-owned-networks-ahead-of-tv-upfronts-301804143.html,20230421T140000,['UM'],UM and Roku Partner to Increase Equity For Minority-Owned ... PR ...,https://mma.prnewswire.com/media/941707/UM__Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.999186'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.285672,Somewhat-Bullish,"[{'ticker': 'SNEJF', 'relevance_score': '0.033703', 'ticker_sentiment_score': '0.181627', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MAT', 'relevance_score': '0.033703', 'ticker_sentiment_score': '0.181627', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ROKU', 'relevance_score': '0.709186', 'ticker_sentiment_score': '0.446683', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'SPOT', 'relevance_score': '0.033703', 'ticker_sentiment_score': '0.181627', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GPRO', 'relevance_score': '0.033703', 'ticker_sentiment_score': '0.181627', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.033703', 'ticker_sentiment_score': '0.181627', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AXP', 'relevance_score': '0.033703', 'ticker_sentiment_score': '0.181627', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ACN', 'relevance_score': '0.033703', 'ticker_sentiment_score': '0.181627', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Top Stories Friday, Apr. 23: Carlyle Seeks New Investors For McDonald's China Arm, US Judge Halts Several Johnson & Johnson's Talc-Related Lawsuits, How Much Alphabet Analysts, Managers And Engineers Get Paid - BYD  ( OTC:BYDDY ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/news/earnings/23/04/31934504/carlyle-seeks-new-investors-for-mcdonalds-china-arm-us-judge-halts-several-johnson-johnsons-talc-re,20230421T132148,['Vandana Singh'],"Private equity company Carlyle Group Inc CG reportedly intends to find new investors for its investment in McDonald's Corp's MCD Chinese operations. The buyout firm, which controls McDonald's China, together with Trustar Capital, has been discussing shifting its ownership to a new investment ...",https://cdn.benzinga.com/files/images/story/2023/04/21/mcdonalds_china.jpg?optimize=medium&dpr=2&auto=webp&width=3840,Benzinga,Mergers,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.955357'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",-0.042899,Neutral,"[{'ticker': 'ANFGF', 'relevance_score': '0.037622', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.112532', 'ticker_sentiment_score': '-0.081569', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.075161', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SAP', 'relevance_score': '0.112532', 'ticker_sentiment_score': '0.013442', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.075161', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'F', 'relevance_score': '0.075161', 'ticker_sentiment_score': '0.051438', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HCA', 'relevance_score': '0.075161', 'ticker_sentiment_score': '-0.091876', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.075161', 'ticker_sentiment_score': '-0.253451', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'BYDDY', 'relevance_score': '0.075161', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CLX', 'relevance_score': '0.112532', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSM', 'relevance_score': '0.075161', 'ticker_sentiment_score': '-0.174026', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'XM', 'relevance_score': '0.037622', 'ticker_sentiment_score': '-0.076767', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HYMLF', 'relevance_score': '0.037622', 'ticker_sentiment_score': '-0.149224', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.112532', 'ticker_sentiment_score': '0.046322', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HAS', 'relevance_score': '0.037622', 'ticker_sentiment_score': '0.159077', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
MeiraGTx Announces Upcoming Presentations at the Association for Research in Vision and Ophthalmology  ( ARVO )  2023 Annual Meeting,https://www.globenewswire.com/news-release/2023/04/21/2651924/0/en/MeiraGTx-Announces-Upcoming-Presentations-at-the-Association-for-Research-in-Vision-and-Ophthalmology-ARVO-2023-Annual-Meeting.html,20230421T123000,['MeiraGTx'],"LONDON and NEW YORK, April 21, 2023 ( GLOBE NEWSWIRE ) -- MeiraGTx Holdings plc ( Nasdaq: MGTX ) , a vertically integrated, clinical stage gene therapy company, today announced two abstract presentations at the Association for Research in Vision and Ophthalmology ( ARVO ) 2023 Annual Meeting.",https://ml.globenewswire.com/Resource/Download/6b45b8d0-975e-494b-8a46-b88360aa1791,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.188019,Somewhat-Bullish,"[{'ticker': 'MGTX', 'relevance_score': '0.375251', 'ticker_sentiment_score': '0.253958', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.043342', 'ticker_sentiment_score': '0.053631', 'ticker_sentiment_label': 'Neutral'}]"
US Judge Halts Several Lawsuits Related To Johnson & Johnson's Talc Products Caused Cancer - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/23/04/31931708/us-judge-halts-several-lawsuits-related-to-johnson-johnsons-talc-products-caused-cancer,20230421T112801,['Vandana Singh'],"A federal bankruptcy judge Michael Kaplan temporarily held around 38,000 lawsuits alleging Johnson & Johnson's JNJ baby powder and other talc products caused cancer as a part of J&J's second attempt to settle thousands of talc cases in bankruptcy proceedings.",https://cdn.benzinga.com/files/images/story/2023/04/21/johnsons-5671315_1920.jpg?optimize=medium&dpr=2&auto=webp&width=3840,Benzinga,General,www.benzinga.com,"[{'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.269848,Somewhat-Bearish,"[{'ticker': 'JNJ', 'relevance_score': '0.392948', 'ticker_sentiment_score': '-0.439723', 'ticker_sentiment_label': 'Bearish'}]"
Senate legislation would cap insulin at $35 per month for people with private insurance,https://www.cnbc.com/2023/04/21/senate-bill-proposes-insulin-price-cap-diabetes.html,20230421T090001,['Spencer Kimball'],"More than 2 million patients with diabetes who take insulin are privately insured, according to the Health and Human Services Department.",https://image.cnbcfm.com/api/v1/image/107208364-1678804584372-gettyimages-1473505918-029a2172_pm2titbi.jpeg?v=1682067601&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.047861,Neutral,"[{'ticker': 'MRNA', 'relevance_score': '0.063258', 'ticker_sentiment_score': '-0.393099', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'NVO', 'relevance_score': '0.063258', 'ticker_sentiment_score': '-0.081354', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.126119', 'ticker_sentiment_score': '-0.010884', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.063258', 'ticker_sentiment_score': '-0.081354', 'ticker_sentiment_label': 'Neutral'}]"
Why Shares of Protagonist Therapeutics Rose This Week,https://www.fool.com/investing/2023/04/20/why-shares-of-protagonist-therapeutics-rose-this-w/,20230421T015113,['Jim Halley'],The company's lead pipeline candidate is making news.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F728644%2Fautonomous-driving.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.026617,Neutral,"[{'ticker': 'PTGX', 'relevance_score': '0.236972', 'ticker_sentiment_score': '0.245872', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SPGI', 'relevance_score': '0.11983', 'ticker_sentiment_score': '0.158797', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.348919', 'ticker_sentiment_score': '0.154657', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Genmab Announces Initial Resolution of Its Second Arbitration Under License Agreement with Janssen,https://www.globenewswire.com/news-release/2023/04/20/2651670/0/en/Genmab-Announces-Initial-Resolution-of-Its-Second-Arbitration-Under-License-Agreement-with-Janssen.html,20230420T234500,['Genmab A/S'],Company Announcement ...,https://ml-eu.globenewswire.com/Resource/Download/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}]",0.112608,Neutral,"[{'ticker': 'GMAB', 'relevance_score': '0.673107', 'ticker_sentiment_score': '0.197313', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.052112', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
"Pearpop Launches Fake Products to Show it Can Drive ""Real Results"" for Anything - Omnicom Group  ( NYSE:OMC ) ",https://www.benzinga.com/pressreleases/23/04/n31920638/pearpop-launches-fake-products-to-show-it-can-drive-real-results-for-anything,20230420T171000,['PRNewswire'],"DDB Chicago launches new campaign for Creator Economy startup Pearpop to show it can make any brand famous, even ones that don't exist.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}]",0.275251,Somewhat-Bullish,"[{'ticker': 'NFLX', 'relevance_score': '0.051003', 'ticker_sentiment_score': '0.093427', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.051003', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BYND', 'relevance_score': '0.051003', 'ticker_sentiment_score': '0.093427', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.051003', 'ticker_sentiment_score': '0.128378', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OMC', 'relevance_score': '0.101797', 'ticker_sentiment_score': '0.138014', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.051003', 'ticker_sentiment_score': '0.128378', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UL', 'relevance_score': '0.051003', 'ticker_sentiment_score': '0.128378', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABNB', 'relevance_score': '0.051003', 'ticker_sentiment_score': '0.131814', 'ticker_sentiment_label': 'Neutral'}]"
Why Shares of Geron Are Up 30% This Week,https://www.fool.com/investing/2023/04/20/why-shares-of-geron-are-up-30-this-week/,20230420T161800,['Jim Halley'],The company's CEO was scheduled to speak at a virtual conference on Thursday.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F728816%2Fwarren-buffett-buys-dividend-stocks.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.028833,Neutral,"[{'ticker': 'GERN', 'relevance_score': '0.518708', 'ticker_sentiment_score': '0.068927', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.112008', 'ticker_sentiment_score': '0.012354', 'ticker_sentiment_label': 'Neutral'}]"
"Surging S&P 500 Breaks Above 4150 Threshold With Unprecedented Momentum, Driven By Strong Earnings And Economic Recovery",https://www.benzinga.com/23/04/31919329/surging-s-p-500-breaks-above-4150-threshold-with-unprecedented-momentum-driven-by-strong-earnings-an,20230420T160734,['Zaheer Anwari'],"The S&P 500 has seen a 1.72% rise over the past week, with a promising start to the earnings season and potential for greater market returns. Major companies like Netflix, Nokia, American Express, and Johnson & Johnson have released earnings, with J&J beating expectations at $2.68 per share ...",https://cdn.benzinga.com/files/tyler-prahm-lmv3gjsagbo-unsplash.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.838487'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.195793,Somewhat-Bullish,"[{'ticker': 'NFLX', 'relevance_score': '0.18967', 'ticker_sentiment_score': '0.141357', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.18967', 'ticker_sentiment_score': '0.141357', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOK', 'relevance_score': '0.18967', 'ticker_sentiment_score': '0.141357', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.18967', 'ticker_sentiment_score': '0.141357', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson  ( JNJ )  Could Be a Great Choice,https://www.zacks.com/stock/news/2082304/johnson-johnson-jnj-could-be-a-great-choice,20230420T154504,['Zacks Investment Research'],"Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.",https://staticx-tuner.zacks.com/images/default_article_images/default178.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.904684'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.999365'}]",0.391631,Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.448316', 'ticker_sentiment_score': '0.456589', 'ticker_sentiment_label': 'Bullish'}]"
Business | Apr 22nd 2023 Edition,https://www.economist.com/the-world-this-week/2023/04/20/business,20230420T151114,[],"Elon Musk said he would launch a new artificial- intelligence platform called Truth as a rival to Chat and other generative- bots, somewhat contradicting his recent call for a moratorium on developing such technology.",https://www.economist.com/img/b/608/634/90/media-assets/image/20230422_WWC801.png,The Economist,BusinessGoogleRSS,www.economist.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.744043'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",-0.087129,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.049322', 'ticker_sentiment_score': '-0.019985', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.049322', 'ticker_sentiment_score': '-0.100742', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.049322', 'ticker_sentiment_score': '-0.018', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.049322', 'ticker_sentiment_score': '-0.018', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.049322', 'ticker_sentiment_score': '-0.018', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.049322', 'ticker_sentiment_score': '-0.018', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.049322', 'ticker_sentiment_score': '-0.018', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.049322', 'ticker_sentiment_score': '-0.190098', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'GS', 'relevance_score': '0.049322', 'ticker_sentiment_score': '-0.018', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOX', 'relevance_score': '0.049322', 'ticker_sentiment_score': '-0.065973', 'ticker_sentiment_label': 'Neutral'}]"
Home Medical Equipment Market in United States Is Expected to Reach $20.39 Billion by 2031: Allied Market Research,https://www.benzinga.com/pressreleases/23/04/g31917234/home-medical-equipment-market-in-united-states-is-expected-to-reach-20-39-billion-by-2031-allied-m,20230420T150140,['Globe Newswire'],"Portland, OR, April 20, 2023 ( GLOBE NEWSWIRE ) -- According to the report published by Allied Market Research, the U.S. home medical equipment market generated $12.38 billion in 2021, and is estimated to reach $20.39 billion by 2031, witnessing a CAGR of 5.1% from 2022 to 2031.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.538269'}]",0.303939,Somewhat-Bullish,"[{'ticker': 'SNN', 'relevance_score': '0.041039', 'ticker_sentiment_score': '-0.016685', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABT', 'relevance_score': '0.041039', 'ticker_sentiment_score': '-0.016685', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSSMY', 'relevance_score': '0.041039', 'ticker_sentiment_score': '-0.016685', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.041039', 'ticker_sentiment_score': '-0.016685', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RMD', 'relevance_score': '0.041039', 'ticker_sentiment_score': '-0.016685', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAX', 'relevance_score': '0.041039', 'ticker_sentiment_score': '-0.016685', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVCRQ', 'relevance_score': '0.041039', 'ticker_sentiment_score': '-0.016685', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.041039', 'ticker_sentiment_score': '-0.016685', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GE', 'relevance_score': '0.08197', 'ticker_sentiment_score': '-0.017498', 'ticker_sentiment_label': 'Neutral'}]"
MRK: 1 Pharma Stock You'll Regret Not Buying Earlier,https://stocknews.com/news/mrk-nvo-tak-jnj-rxdx-imgo-1-pharma-stock-youll-regret-not-buying-earlier/,20230420T144336,[],"The current macroeconomic climate is highly uncertain. The likelihood of a recession is high as the Fed will likely keep raising interest rates, and lending standards are expected to be tightened. Minutes from the Fed's March meeting show that the staff believes the economy could be in a mild ...",https://stocknews.com/wp-content/uploads/2022/03/shutterstock_517925923-scaled.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.209778,Somewhat-Bullish,"[{'ticker': 'C', 'relevance_score': '0.076479', 'ticker_sentiment_score': '0.121072', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RXDX', 'relevance_score': '0.1145', 'ticker_sentiment_score': '0.203008', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.076479', 'ticker_sentiment_score': '0.051938', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.076479', 'ticker_sentiment_score': '0.051938', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TAK', 'relevance_score': '0.076479', 'ticker_sentiment_score': '0.051938', 'ticker_sentiment_label': 'Neutral'}]"
WBA: Just In: WBA Named the Top Dividend Stock With Insider Buying. Is It a Buy?,https://stocknews.com/news/wba-jnj-bmy-cvs-opch-just-in-wba-named-the-top-dividend-stock-with-insider/,20230420T140035,[],WBA: Just In: WBA Named the Top Dividend Stock With Insider ... ...,https://stocknews.com/wp-content/uploads/2021/12/shutterstock_1271080456-1-scaled.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.459462'}, {'topic': 'Earnings', 'relevance_score': '0.999993'}]",0.208878,Somewhat-Bullish,"[{'ticker': 'CVS', 'relevance_score': '0.077593', 'ticker_sentiment_score': '0.03172', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OPCH', 'relevance_score': '0.077593', 'ticker_sentiment_score': '0.094295', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.077593', 'ticker_sentiment_score': '0.03172', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.077593', 'ticker_sentiment_score': '0.03172', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WBA', 'relevance_score': '0.56415', 'ticker_sentiment_score': '0.285592', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Novartis AG  ( NVS )  Hit a 52 Week High, Can the Run Continue?",https://www.zacks.com/stock/news/2081908/novartis-ag-nvs-hit-a-52-week-high-can-the-run-continue,20230420T131505,['Zacks Investment Research'],"Novartis (NVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",https://staticx-tuner.zacks.com/images/default_article_images/default292.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.99246'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.276615,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.433523', 'ticker_sentiment_score': '0.449924', 'ticker_sentiment_label': 'Bullish'}]"
3 of the Best Dividend Kings to Buy for the Rest of 2023,https://www.fool.com/investing/2023/04/20/3-of-the-best-dividend-kings-to-buy-for-the-rest-o/,20230420T121800,"['CPA', 'Mark Roussin']","All three of these stocks are trading at great valuations, providing for a nice entry point ...",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F728644%2Fautonomous-driving.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.24399,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.769861', 'ticker_sentiment_score': '0.450704', 'ticker_sentiment_label': 'Bullish'}]"
"Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names - CRISPR Therapeutics  ( NASDAQ:CRSP ) , Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/trading-ideas/23/04/31911510/where-is-the-current-bull-market-scan-of-stocks-gaining-over-20-over-the-past-week-almost-exclusive,20230420T120705,['Ryan Glosier'],"Where is the current bull market? All indications would be that it's in biotech! The broader market is not really moving. There have been plenty of attention-grabbing headlines, and earnings season is upon us, yet the S&P 500 has been largely stagnant in recent trading sessions.",https://cdn.benzinga.com/files/images/story/2023/04/20/screenshot_2023-04-20_at_5.35.53_pm.png?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.897321'}]",0.233922,Somewhat-Bullish,"[{'ticker': 'PCVX', 'relevance_score': '0.099476', 'ticker_sentiment_score': '0.030076', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LEGN', 'relevance_score': '0.132368', 'ticker_sentiment_score': '0.167275', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'RVMD', 'relevance_score': '0.132368', 'ticker_sentiment_score': '0.042337', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.066414', 'ticker_sentiment_score': '0.184069', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Altair Launches Future Says Podcast - Altair Engineering  ( NASDAQ:ALTR ) ,https://www.benzinga.com/pressreleases/23/04/n31909679/altair-launches-future-says-podcast,20230420T110000,['PRNewswire'],"Podcast features leading experts discussing the convergence of artificial intelligence, high-performance computing ( HPC ) , data analytics, and more",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.324249,Somewhat-Bullish,"[{'ticker': 'GOOG', 'relevance_score': '0.41627', 'ticker_sentiment_score': '0.330004', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SPOT', 'relevance_score': '0.108958', 'ticker_sentiment_score': '0.194311', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CAPMF', 'relevance_score': '0.108958', 'ticker_sentiment_score': '0.188421', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.108958', 'ticker_sentiment_score': '0.188421', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Altair Launches Future Says Podcast - Altair Engineering  ( NASDAQ:ALTR ) ,https://www.benzinga.com/pressreleases/23/04/n31909688/altair-launches-future-says-podcast,20230420T110000,['PRNewswire'],"Podcast features leading experts discussing the convergence of artificial intelligence, high-performance computing ( HPC ) , data analytics, and more",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.3306,Somewhat-Bullish,"[{'ticker': 'GOOG', 'relevance_score': '0.407844', 'ticker_sentiment_score': '0.325631', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SPOT', 'relevance_score': '0.106541', 'ticker_sentiment_score': '0.192773', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CAPMF', 'relevance_score': '0.106541', 'ticker_sentiment_score': '0.187009', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.106541', 'ticker_sentiment_score': '0.187009', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Supreme Court delays ruling on abortion pill mifepristone restrictions until at least Friday,https://www.cnbc.com/2023/04/19/supreme-court-rules-on-abortion-pill-mifepristone.html,20230419T191715,['Spencer Kimball'],Supreme Court Justice Samuel Alito on Wednesday issued an order allowing the abortion pill mifepristone to remain on the market without restrictions until at least Friday. Alito's decision punts a ruling by the high court on how the legal battle over mifepristone should proceed.,https://image.cnbcfm.com/api/v1/image/107227736-1681909011522-gettyimages-1251856300-AFP_33DA47B.jpeg?v=1681931835&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.147709,Neutral,"[{'ticker': 'MRNA', 'relevance_score': '0.045743', 'ticker_sentiment_score': '-0.384153', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'PFE', 'relevance_score': '0.045743', 'ticker_sentiment_score': '0.080802', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.091335', 'ticker_sentiment_score': '-0.009612', 'ticker_sentiment_label': 'Neutral'}]"
Abortion pill company GenBioPro asks U.S. court to keep generic mifepristone on market,https://www.cnbc.com/2023/04/19/abortion-pill-company-genbiopro-seeks-mifepristone-order.html,20230419T190608,['Spencer Kimball'],The Supreme Court is considering whether to maintain a court order that would severely restrict access to the abortion drug mifepristone.,https://image.cnbcfm.com/api/v1/image/107227741-16819096282023-04-12t200722z_312936920_rc29kz999u6z_rtrmadp_0_usa-abortion-pill.jpeg?v=1681931168&w=1920&h=1080,CNBC,Business,www.cnbc.com,"[{'topic': 'Earnings', 'relevance_score': '0.650727'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.014824,Neutral,"[{'ticker': 'MRNA', 'relevance_score': '0.083541', 'ticker_sentiment_score': '-0.412691', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.166169', 'ticker_sentiment_score': '-0.012849', 'ticker_sentiment_label': 'Neutral'}]"
"Abbott Labs shares pop as revenue, earnings defy steep drop in Covid test sales",https://www.cnbc.com/2023/04/19/abbott-labs-shares-pop-as-revenue-earnings-defy-drop-in-covid-sales.html,20230419T175722,['Annika Kim Constantino'],Abbott Laboratories said Covid-related headwinds may actually be easing.,https://image.cnbcfm.com/api/v1/image/107061165-1652480677071-gettyimages-1240647387-AFP_32A3382.jpeg?v=1681927042&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Earnings', 'relevance_score': '0.961735'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.148327,Neutral,"[{'ticker': 'ABT', 'relevance_score': '0.099476', 'ticker_sentiment_score': '0.089075', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.099476', 'ticker_sentiment_score': '0.067809', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.099476', 'ticker_sentiment_score': '0.067809', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.099476', 'ticker_sentiment_score': '0.236587', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Abbott Labs stock soars 8% as medical tests, procedures rebound from COVID lull",https://www.marketwatch.com/story/abbott-labs-stock-up-2-premarket-after-earnings-beat-despite-declining-covid-testing-sales-8cb12c61,20230419T164200,['Ciara Linnane'],Abbott's stock is the second biggest gainer on the S&P 500 index after company tops consensus estimates for the first quarter.,https://images.mktw.net/im-766478/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.967321'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.217718,Somewhat-Bullish,"[{'ticker': 'MRNA', 'relevance_score': '0.058188', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABT', 'relevance_score': '0.173333', 'ticker_sentiment_score': '0.139318', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.058188', 'ticker_sentiment_score': '-0.140995', 'ticker_sentiment_label': 'Neutral'}]"
Why Shares of Legend Biotech Jumped Wednesday,https://www.fool.com/investing/2023/04/19/why-shares-of-legend-biotech-jumped-wednesday/,20230419T164019,['Jim Halley'],A leaked abstract on a phase 3 trial for the company's multiple myeloma drug Carvykti gave the stock a jolt.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F728400%2Fbear-market-silhouette-newspaper-stock-market-quotes-invest-crash-plunge-correction-getty.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.038543,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.114682', 'ticker_sentiment_score': '-0.105055', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LEGN', 'relevance_score': '0.227007', 'ticker_sentiment_score': '-0.162491', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
ETFs to Buy on Solid Q1 JNJ Earnings Results,https://www.zacks.com/stock/news/2081411/etfs-to-buy-on-solid-q1-jnj-earnings-results,20230419T151000,['Zacks Investment Research'],Johnson & Johnson (JNJ) continued with its long streak of earnings beat. It topped the revenue estimate as well as lifted the full-year outlook.,https://staticx-tuner.zacks.com/images/articles/main/7d/1177.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.980509'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.999996'}]",0.191999,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.359447', 'ticker_sentiment_score': '0.204828', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Is Merck Stock a Screaming Buy After This $11 Billion Acquisition?,https://www.fool.com/investing/2023/04/19/is-merck-stock-a-screaming-buy-after-this-11-billi/,20230419T144500,['George Budwell'],Merck's move into immunology is a risky proposition.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F728755%2Fautoimmune.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.120481,Neutral,"[{'ticker': 'RXDX', 'relevance_score': '0.143415', 'ticker_sentiment_score': '0.148525', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.282234', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.03238', 'ticker_sentiment_label': 'Neutral'}]"
Here's Why You Should Buy Boston Scientific  ( BSX )  Stock,https://www.zacks.com/stock/news/2081423/heres-why-you-should-buy-boston-scientific-bsx-stock,20230419T142600,['Zacks Investment Research'],Investors are optimistic about Boston Scientific (BSX) owing to impressive growth in MedSurg market share.,https://staticx-tuner.zacks.com/images/articles/main/e7/288.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.986413'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.329063,Somewhat-Bullish,"[{'ticker': 'EW', 'relevance_score': '0.051003', 'ticker_sentiment_score': '0.090435', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HOLX', 'relevance_score': '0.201944', 'ticker_sentiment_score': '0.147911', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNN', 'relevance_score': '0.051003', 'ticker_sentiment_score': '0.090435', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AVNS', 'relevance_score': '0.152178', 'ticker_sentiment_score': '0.052279', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSSMY', 'relevance_score': '0.051003', 'ticker_sentiment_score': '0.090435', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BSX', 'relevance_score': '0.345674', 'ticker_sentiment_score': '0.446074', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'BDX', 'relevance_score': '0.152178', 'ticker_sentiment_score': '0.093308', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.051003', 'ticker_sentiment_score': '0.090435', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.051003', 'ticker_sentiment_score': '0.090435', 'ticker_sentiment_label': 'Neutral'}]"
How A Data Leak Pushed This Biotech To Break Out,https://www.investors.com/news/technology/legn-stock-breaks-out-on-an-unexpectedly-positive-data-leak/,20230419T142200,"[""Investor's Business Daily"", 'ALLISON GATLIN']",LEGN Stock Breaks Out On An Unexpectedly Positive Dats Leak ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2017/11/Stock-Drugs-09-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.996023'}]",0.002454,Neutral,"[{'ticker': 'TSVT', 'relevance_score': '0.166743', 'ticker_sentiment_score': '-0.193753', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LEGN', 'relevance_score': '0.538782', 'ticker_sentiment_score': '0.24684', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BMY', 'relevance_score': '0.166743', 'ticker_sentiment_score': '-0.193753', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.166743', 'ticker_sentiment_score': '-0.12204', 'ticker_sentiment_label': 'Neutral'}]"
"Stock Market News for Apr 19, 2023",https://www.zacks.com/stock/news/2081029/stock-market-news-for-apr-19-2023,20230419T133200,['Zacks Investment Research'],U.S. stocks finished little changed on Tuesday as investors digested a slew of corporate earnings reports from big banks and blue chip companies and also tried to gauge the future interest rate hike path.,https://staticx-tuner.zacks.com/images/articles/main/98/601.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Earnings', 'relevance_score': '0.986413'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.0,Neutral,"[{'ticker': 'GS', 'relevance_score': '0.132733', 'ticker_sentiment_score': '0.060752', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.132733', 'ticker_sentiment_score': '0.084662', 'ticker_sentiment_label': 'Neutral'}]"
Short Volatility Alert: Johnson & Johnson - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/23/04/31890878/short-volatility-alert-johnson-johnson,20230419T132605,['Christopher Sappo'],"On Tuesday, shares of Johnson & Johnson JNJ experienced volatile short activity. After the activity, the stock price went down -2.81% to $161.01. The overall sentiment for JNJ has been Bearish. The signal from the volatility alert is trending Bullish. Therefore, the recommendation is to Strong Buy.",https://cdn.benzinga.com/files/behnam-norouzi-rdxcfy5g5o4-unsplash_1_0.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.989041'}]",0.089021,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.350564', 'ticker_sentiment_score': '-0.211763', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
"US Stocks: Wall Street set to open lower as Treasury yields rise, Tesla slides | The Financial Express",https://www.financialexpress.com/market/us-stocks-wall-street-set-to-open-lower-as-treasury-yields-rise-tesla-slides/3054352/,20230419T131950,[],US Stocks: Wall Street set to open lower as Treasury yields rise ... The Financial Express ...,https://www.financialexpress.com/wp-content/uploads/2023/04/1-254.jpg,The Financial Express,n/a,www.financialexpress.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.955357'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.890401'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",-0.069943,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.070517', 'ticker_sentiment_score': '-0.251971', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'PACW', 'relevance_score': '0.070517', 'ticker_sentiment_score': '0.168033', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.140485', 'ticker_sentiment_score': '0.002608', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WAL', 'relevance_score': '0.070517', 'ticker_sentiment_score': '-0.190254', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CFG', 'relevance_score': '0.070517', 'ticker_sentiment_score': '-0.190254', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'FRC', 'relevance_score': '0.070517', 'ticker_sentiment_score': '0.168033', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MS', 'relevance_score': '0.070517', 'ticker_sentiment_score': '-0.086009', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.070517', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZIONL', 'relevance_score': '0.070517', 'ticker_sentiment_score': '0.168033', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.140485', 'ticker_sentiment_score': '-0.067447', 'ticker_sentiment_label': 'Neutral'}]"
Looking Into Johnson & Johnson's Recent Short Interest - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/short-sellers/23/04/31890504/looking-into-johnson-johnsons-recent-short-interest,20230419T131557,['Benzinga Insights'],"Johnson & Johnson's JNJ short percent of float has fallen 15.56% since its last report. The company recently reported that it has 11.72 million shares sold short, which is 0.38% of all regular shares that are available for trading.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.237013,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.221819', 'ticker_sentiment_score': '0.081322', 'ticker_sentiment_label': 'Neutral'}]"
"GS1 Connect 2023 Agenda Offers Supply Chain Visibility Best Practices From More Than 275 Companies Across Retail, Grocery, Foodservice and Healthcare",https://www.prnewswire.com/news-releases/gs1-connect-2023-agenda-offers-supply-chain-visibility-best-practices-from-more-than-275-companies-across-retail-grocery-foodservice-and-healthcare-301800955.html,20230419T131500,['GS1 US'],GS1 Connect 2023 Agenda Offers Supply Chain Visibility Best ... PR ...,,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Technology', 'relevance_score': '0.25'}]",0.310973,Somewhat-Bullish,"[{'ticker': 'NFLX', 'relevance_score': '0.060541', 'ticker_sentiment_score': '0.189109', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AVY', 'relevance_score': '0.060541', 'ticker_sentiment_score': '0.079', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.120733', 'ticker_sentiment_score': '0.047494', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.060541', 'ticker_sentiment_score': '0.047999', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.120733', 'ticker_sentiment_score': '0.047494', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPSC', 'relevance_score': '0.060541', 'ticker_sentiment_score': '0.079', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DKS', 'relevance_score': '0.060541', 'ticker_sentiment_score': '0.047999', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'M', 'relevance_score': '0.060541', 'ticker_sentiment_score': '0.047999', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCD', 'relevance_score': '0.060541', 'ticker_sentiment_score': '0.047999', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DDS', 'relevance_score': '0.060541', 'ticker_sentiment_score': '0.047999', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.120733', 'ticker_sentiment_score': '0.047494', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.120733', 'ticker_sentiment_score': '0.047494', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRLCF', 'relevance_score': '0.060541', 'ticker_sentiment_score': '0.047999', 'ticker_sentiment_label': 'Neutral'}]"
2 Top Dividend Stocks You Can Buy and Hold Forever,https://www.fool.com/investing/2023/04/19/2-top-dividend-stocks-you-can-buy-and-hold-forever/,20230419T123000,['Matthew DiLallo'],These companies arguably pay the safest dividends in the world.,https://media.ycharts.com/charts/f39cce145d272e57bd79564bde620f42.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.99793'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.295216,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.464844', 'ticker_sentiment_score': '0.306748', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.464844', 'ticker_sentiment_score': '0.484599', 'ticker_sentiment_label': 'Bullish'}]"
"SPY, QQQ: What Options Market Indicates During Earnings - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , Tesla  ( NASDAQ:TSLA ) , Bank of America  ( NYSE:BAC ) , Johnson & Johnson  ( NYSE:JNJ ) , Procter & Gamble  ( NYSE:PG ) , Goldman Sachs Gr  ( NYSE:GS ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/markets/equities/23/04/31888509/spy-qqq-as-earnings-season-gathers-pace-heres-what-options-market-indicates-about-these-etfs,20230419T122310,['Bhavik Nair'],U.S. markets closed flat on Tuesday following a mixed set of earnings announcements. The SPDR S&P 500 ETF Trust SPY closed 0.07% higher at 414.21 while the Invesco QQQ Trust Series 1 QQQ ended almost flat at 318.86.,https://cdn.benzinga.com/files/images/story/2023/Markets_Photo_by_ImageFlow_on_Shutterstock_2.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.614606'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.227514,Somewhat-Bullish,"[{'ticker': 'TSLA', 'relevance_score': '0.266828', 'ticker_sentiment_score': '0.1708', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BAC', 'relevance_score': '0.266828', 'ticker_sentiment_score': '0.1708', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.266828', 'ticker_sentiment_score': '0.1708', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'IVZ', 'relevance_score': '0.135347', 'ticker_sentiment_score': '0.105378', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.266828', 'ticker_sentiment_score': '0.1708', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PG', 'relevance_score': '0.266828', 'ticker_sentiment_score': '0.1708', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Internet of Things  ( IoT )  in Healthcare Market to be Worth $312.7 Billion by 2030 - Exclusive Report by Meticulous Research,https://www.benzinga.com/pressreleases/23/04/g31887285/internet-of-things-iot-in-healthcare-market-to-be-worth-312-7-billion-by-2030-exclusive-report-by-,20230419T114614,['Globe Newswire'],"Redding, California, April 19, 2023 ( GLOBE NEWSWIRE ) -- According to a new market research report titled, 'IoT in Healthcare Market by Component ( Monitoring Devices ( Glucose, Cardiac, Respiratory, Blood Pressure ) , Pacemaker, Ventilator, Infusion Pump}, Software ) , Application ( ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.268113,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.020722', 'ticker_sentiment_score': '0.037308', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OMRNF', 'relevance_score': '0.020722', 'ticker_sentiment_score': '0.037308', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IBM', 'relevance_score': '0.020722', 'ticker_sentiment_score': '0.037308', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BSX', 'relevance_score': '0.020722', 'ticker_sentiment_score': '0.037308', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.020722', 'ticker_sentiment_score': '0.037308', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RYLPF', 'relevance_score': '0.020722', 'ticker_sentiment_score': '0.037308', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.020722', 'ticker_sentiment_score': '0.037308', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GEHC', 'relevance_score': '0.020722', 'ticker_sentiment_score': '0.037308', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.020722', 'ticker_sentiment_score': '0.037308', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WLDS', 'relevance_score': '0.020722', 'ticker_sentiment_score': '0.141212', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HCSG', 'relevance_score': '0.103331', 'ticker_sentiment_score': '0.107905', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PHG', 'relevance_score': '0.020722', 'ticker_sentiment_score': '0.037308', 'ticker_sentiment_label': 'Neutral'}]"
The earnings recession is here. There could be worse to come | Business,https://www.cnn.com/2023/04/19/investing/premarket-stocks-trading/index.html,20230419T114200,['Nicole Goodkind'],The earnings recession is here. There could be worse to come ...,"https://media.cnn.com/api/v1/images/stellar/prod/230414163337-nyse-0414.jpg?c=16x9&q=w_800,c_fill",CNN,Markets,www.cnn.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}, {'topic': 'Earnings', 'relevance_score': '0.986413'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",-0.079484,Neutral,"[{'ticker': 'BLK', 'relevance_score': '0.031907', 'ticker_sentiment_score': '-0.232894', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'WBD', 'relevance_score': '0.063763', 'ticker_sentiment_score': '0.026045', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.095517', 'ticker_sentiment_score': '0.045057', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOX', 'relevance_score': '0.063763', 'ticker_sentiment_score': '-0.037099', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.063763', 'ticker_sentiment_score': '-0.082599', 'ticker_sentiment_label': 'Neutral'}]"
"Futures retreat as Treasury yields rise, Tesla slides",https://www.reuters.com/markets/us/futures-retreat-treasury-yields-rise-tesla-slides-2023-04-19/,20230419T101900,['Reuters'],"April 19 ( Reuters ) - U.S. stock index futures fell on Wednesday as Treasury yields rose on expectations the Federal Reserve could keep interest rates higher for longer, while a slide in Tesla and Netflix shares was set to weigh on the tech-heavy Nasdaq.",https://cloudfront-us-east-2.images.arcpublishing.com/reuters/MAY5Y2OJ3JLHDEAMVQERSMW5DQ.jpg,Reuters,Markets,www.reuters.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Financial Markets', 'relevance_score': '0.918141'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}]",-0.016696,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.169081', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PACW', 'relevance_score': '0.085022', 'ticker_sentiment_score': '0.139712', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.169081', 'ticker_sentiment_score': '0.051772', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WAL', 'relevance_score': '0.085022', 'ticker_sentiment_score': '-0.174861', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'FRC', 'relevance_score': '0.085022', 'ticker_sentiment_score': '0.139712', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.085022', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.085022', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BKR', 'relevance_score': '0.085022', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZIONL', 'relevance_score': '0.085022', 'ticker_sentiment_score': '0.139712', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.085022', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
"S&P 500 Settles Slightly Higher, Market Volatility Drops - Apple  ( NASDAQ:AAPL ) , Goldman Sachs Gr  ( NYSE:GS ) ",https://www.benzinga.com/news/earnings/23/04/31884744/s-p-500-settles-slightly-higher-market-volatility-drops,20230419T095438,['Lisa Levin'],"The S&P 500 closed slightly higher on Tuesday following the release of earnings results from major companies. Johnson & Johnson JNJ shares fell 2.8% on Tuesday after the company reported better-than-expected Q1 results, raised its 2023 guidance and increased its quarterly dividend.",https://cdn.benzinga.com/files/images/story/2023/04/19/image_4.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.06275,Neutral,"[{'ticker': 'NVDA', 'relevance_score': '0.338582', 'ticker_sentiment_score': '0.436999', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.338582', 'ticker_sentiment_score': '0.436999', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'GS', 'relevance_score': '0.338582', 'ticker_sentiment_score': '0.426399', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.338582', 'ticker_sentiment_score': '0.426399', 'ticker_sentiment_label': 'Bullish'}]"
2 Buffett Stocks With Above-Average Dividend Yields to Buy Now,https://www.fool.com/investing/2023/04/19/2-buffett-stocks-with-above-average-dividend-yield/,20230419T092700,['Cory Renauer'],"Not every stock in the Berkshire Hathaway portfolio will be a home run, but these have great chances to outperform.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F728463%2Ftmf-warren-buffett-4-tmf-may-2014.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.96136'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.220238,Somewhat-Bullish,"[{'ticker': 'ICNB', 'relevance_score': '0.054607', 'ticker_sentiment_score': '0.061821', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALLY', 'relevance_score': '0.162802', 'ticker_sentiment_score': '0.085099', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.054607', 'ticker_sentiment_score': '0.096798', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.054607', 'ticker_sentiment_score': '0.290984', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.108958', 'ticker_sentiment_score': '0.067511', 'ticker_sentiment_label': 'Neutral'}]"
"Nifty to gain above 17,700 or extend losses? Check 7 key things to know before share market opens | The Financial Express",https://www.financialexpress.com/market/nifty-to-gain-above-17700-or-extend-losses-check-7-key-things-to-know-before-share-market-opens/3053224/,20230419T023045,[],Nifty to gain above 17700 or extend losses? Check 7 key things to ... The Financial Express ...,https://www.financialexpress.com/wp-content/uploads/2023/04/Markets-8-7.webp,The Financial Express,n/a,www.financialexpress.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.905476'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.068713,Neutral,"[{'ticker': 'GS', 'relevance_score': '0.064276', 'ticker_sentiment_score': '-0.039581', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.064276', 'ticker_sentiment_score': '-0.039581', 'ticker_sentiment_label': 'Neutral'}]"
"TSLA, NFLX, WAL, DKNG, UAL: Top Trending Stocks - DraftKings  ( NASDAQ:DKNG ) , Netflix  ( NASDAQ:NFLX ) , United Airlines Holdings  ( NASDAQ:UAL ) , Tesla  ( NASDAQ:TSLA ) , Western Alliance  ( NYSE:WAL ) , Bank of America  ( NYSE:BAC ) , Johnson & Johnson  ( NYSE:JNJ ) , Goldman Sachs Gr  ( NYSE:GS ) ",https://www.benzinga.com/markets/equities/23/04/31876886/tesla-netflix-western-alliance-draftkings-united-airlines-why-these-5-stocks-are-drawing-investo,20230419T010851,['Bhavik Nair'],"Major U.S. equity indices closed flat on Tuesday following a mixed set of earnings announcements. While market participants were disappointed with Goldman Sachs Group Inc GS and Johnson & Johnson JNJ earnings, Bank of America Corp BAC results surpassed estimates.",https://cdn.benzinga.com/files/images/story/2023/Stocks_Photo_by_Jirapong_Manustrong_on_Shutterstock_0.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.769861'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.995921'}]",0.092589,Neutral,"[{'ticker': 'DKNG', 'relevance_score': '0.210274', 'ticker_sentiment_score': '-0.015141', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NFLX', 'relevance_score': '0.310843', 'ticker_sentiment_score': '0.157088', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UAL', 'relevance_score': '0.210274', 'ticker_sentiment_score': '0.308837', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.406197', 'ticker_sentiment_score': '0.149428', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.210274', 'ticker_sentiment_score': '-0.146153', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.10607', 'ticker_sentiment_score': '-0.010011', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.210274', 'ticker_sentiment_score': '-0.146153', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.210274', 'ticker_sentiment_score': '-0.146153', 'ticker_sentiment_label': 'Neutral'}]"
"S&P 500 ekes out gain as tech supports, J&J, Goldman disappoint",https://www.moneycontrol.com/news/business/markets/sp-500-ekes-out-gain-as-tech-supports-jj-goldman-disappoint-10435971.html,20230419T002458,[],JJ ( JNJ.N ) shares fell 2.8% after the healthcare conglomerate cautioned investors over the lingering impact of inflation-driven costs this year. Goldman ( GS.N ) shares dropped 1.7% after the Wall Street firm's profit fell 19% as dealmaking and bond trading slumped.,https://images.moneycontrol.com/static-mcnews/2023/03/Wall-Street.jpg?impolicy=website&width=168&height=118,Money Control,Markets,www.moneycontrol.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.769861'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",-0.063101,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.066784', 'ticker_sentiment_score': '-0.04489', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.066784', 'ticker_sentiment_score': '0.255104', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LMT', 'relevance_score': '0.066784', 'ticker_sentiment_score': '-0.078885', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.066784', 'ticker_sentiment_score': '0.089165', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.066784', 'ticker_sentiment_score': '0.089165', 'ticker_sentiment_label': 'Neutral'}]"
US stocks trade mixed as investors assess wave of earnings results from big companies,https://markets.businessinsider.com/news/stocks/stock-market-news-today-bofa-gs-jnj-corporate-earnings-economy-2023-4,20230418T202334,['Jennifer Sor'],Stock Market News Today: US Stocks Mixed Amid Corporate Earnings - Markets Insider ...,https://i.insider.com/5e7cc4132d41c150481afc74?width=1200&format=jpeg,Business Insider,GoogleRSS,markets.businessinsider.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}]",0.0,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.174587', 'ticker_sentiment_score': '0.162467', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UAL', 'relevance_score': '0.087824', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.174587', 'ticker_sentiment_score': '-0.099465', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.087824', 'ticker_sentiment_score': '-0.179008', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.087824', 'ticker_sentiment_score': '-0.179008', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'GS', 'relevance_score': '0.087824', 'ticker_sentiment_score': '-0.179008', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'RDFN', 'relevance_score': '0.087824', 'ticker_sentiment_score': '-0.1414', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.087824', 'ticker_sentiment_score': '-0.1414', 'ticker_sentiment_label': 'Neutral'}]"
ClearPoint Neuro Announces Agreement with NE Scientific to Integrate Gene Therapy Infusion Coverage Tool into ClearPoint Maestro Brain Model - ClearPoint Neuro  ( NASDAQ:CLPT ) ,https://www.benzinga.com/pressreleases/23/04/g31869193/clearpoint-neuro-announces-agreement-with-ne-scientific-to-integrate-gene-therapy-infusion-coverag,20230418T200500,['Globe Newswire'],"SOLANA BEACH, Calif., April 18, 2023 ( GLOBE NEWSWIRE ) -- ClearPoint Neuro, Inc.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",0.135215,Neutral,"[{'ticker': 'NVDA', 'relevance_score': '0.040829', 'ticker_sentiment_score': '0.096008', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CLPT', 'relevance_score': '0.241284', 'ticker_sentiment_score': '0.077916', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.040829', 'ticker_sentiment_score': '0.096008', 'ticker_sentiment_label': 'Neutral'}]"
Stock Market Today: Stocks Waver Amid a Flurry of Quarterly Reports,https://www.kiplinger.com/investing/stocks/stock-market-today-stocks-waver-amid-a-flurry-of-quarterly-reports,20230418T200325,['Dan Burrows'],Equity markets had a hard time making up their minds Tuesday amid a heavy day of earnings reports from big banks and other blue chip stocks. Hawkish commentary from two Fed officials also caused markets to waver.,https://cdn.mos.cms.futurecdn.net/vVb5K9UJPhSVZuMuypmmnC-415-80.jpg,Kiplinger,n/a,www.kiplinger.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Financial Markets', 'relevance_score': '0.972756'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.983783'}]",0.09247,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.105836', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NFLX', 'relevance_score': '0.105836', 'ticker_sentiment_score': '0.036603', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.158173', 'ticker_sentiment_score': '0.10045', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.105836', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.158173', 'ticker_sentiment_score': '-0.016252', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.209819', 'ticker_sentiment_score': '-0.176524', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'UNH', 'relevance_score': '0.105836', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Why Johnson & Johnson Stock Is Slumping Today,https://www.fool.com/investing/2023/04/18/why-johnson-johnson-stock-is-slumping-today/,20230418T195200,['George Budwell'],J&J's ongoing talcum-powder litigation is weighing on its shares.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F728049%2Fan-angry-person-with-hands-outstretched-looking-at-a-computer-monitor.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.222308,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.262522', 'ticker_sentiment_score': '0.240895', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Dow Jones Fades As Goldman Sachs Earnings Drop; These 3 Bill Ackman Stocks Are Near Buy Points,https://www.investors.com/market-trend/stock-market-today/dow-jones-up-as-goldman-sachs-earnings-drop-these-bill-ackman-stocks-are-near-buy-points-netflix-earnings-nflx-stock/,20230418T191400,"[""Investor's Business Daily"", 'MICHAEL LARKIN']",Dow Jones Fades As Goldman Sachs Earnings Drop. These 3 Bill ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2023/04/Snap-BillAckman-0418-news.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.998287'}]",0.053094,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.38489', 'ticker_sentiment_score': '0.071057', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTLT', 'relevance_score': '0.088964', 'ticker_sentiment_score': '-0.328229', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JPM', 'relevance_score': '0.088964', 'ticker_sentiment_score': '0.223372', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CROX', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.111262', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.088964', 'ticker_sentiment_score': '-0.355517', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'SIRI', 'relevance_score': '0.088964', 'ticker_sentiment_score': '-0.36706', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'GS', 'relevance_score': '0.176825', 'ticker_sentiment_score': '-0.108686', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QSR', 'relevance_score': '0.088964', 'ticker_sentiment_score': '0.283107', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LMT', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.059201', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.044551', 'ticker_sentiment_score': '0.116064', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMG', 'relevance_score': '0.088964', 'ticker_sentiment_score': '0.113811', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HD', 'relevance_score': '0.088964', 'ticker_sentiment_score': '0.202448', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BA', 'relevance_score': '0.088964', 'ticker_sentiment_score': '0.202448', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PSHZF', 'relevance_score': '0.044551', 'ticker_sentiment_score': '0.097692', 'ticker_sentiment_label': 'Neutral'}]"
Johnson and Johnson Beats Estimates and Raises Guidance,https://www.zacks.com/stock/news/2080673/johnson-and-johnson-beats-estimates-and-raises-guidance,20230418T184900,['Zacks Investment Research'],"Johnson and Johnson JNJ reported Q1 2023 earnings on Tuesday, April 18 before the market opened ...",https://staticx-tuner.zacks.com/images/articles/main/ff/1612.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.990678'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}]",0.362411,Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.885652', 'ticker_sentiment_score': '0.596653', 'ticker_sentiment_label': 'Bullish'}]"
Anti-abortion group asks Supreme Court to keep mifepristone restrictions,https://www.cnbc.com/2023/04/18/anti-abortion-group-supreme-court-mifepristone-restrictions.html,20230418T180230,['Spencer Kimball'],Supreme Court Justice Samuel Alito on Friday temporarily blocked abortion pill restrictions until 11:59 p.m. Wednesday.,https://image.cnbcfm.com/api/v1/image/107080374-16560830512022-06-24t150153z_1369941590_rc28yu9j16mo_rtrmadp_0_usa-abortion.jpeg?v=1681840950&w=1920&h=1080,CNBC,Business,www.cnbc.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.073434,Neutral,"[{'ticker': 'MRNA', 'relevance_score': '0.050465', 'ticker_sentiment_score': '-0.385732', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'PFE', 'relevance_score': '0.050465', 'ticker_sentiment_score': '-0.17', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.050465', 'ticker_sentiment_score': '0.199342', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"J&J lifts profit forecast as cancer drugs, Stelara buoy pharma unit",https://www.foxbusiness.com/markets/jj-lifts-profit-forecast-cancer-drugs-stelara-buoy-pharma-unit,20230418T173125,[],"Johnson & Johnson beat first-quarter profit estimates and raised its 2023 profit forecast on Tuesday, as cancer drugs such as Erleada and Crohn's disease treatment Stelara boost sales at its large pharmaceuticals unit.",https://static.foxbusiness.com/foxbusiness.com/content/uploads/2023/04/JJ-BOARD.jpg,Fox Business News,n/a,www.foxbusiness.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.036241,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.12165', 'ticker_sentiment_score': '0.12507', 'ticker_sentiment_label': 'Neutral'}]"
"On a Roll: Earnings Season Off To Solid Start, With Strength From Bank Of America, J&J Boosting Market - Bank of America  ( NYSE:BAC ) , Goldman Sachs Gr  ( NYSE:GS ) ",https://www.benzinga.com/news/earnings/23/04/31864600/on-a-roll-earnings-season-off-to-solid-start-with-strength-from-bank-of-america-j-j-boosting-market,20230418T171306,['Alex Coffey'],"( Tuesday market open ) Earnings season accelerates from zero to 60 this week-with 60 S&P 500 companies expected to report between now and Friday. Things are off to a roaring start. Of the names that reported during Week 1, 90% topped EPS estimates, according to Bank of America BAC data.",https://cdn.benzinga.com/files/images/story/2023/04/18/shutterstock_775323931_1.jpg?width=1200&height=800&fit=crop,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Blockchain', 'relevance_score': '0.158519'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.769861'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.028883,Neutral,"[{'ticker': 'UAL', 'relevance_score': '0.078226', 'ticker_sentiment_score': '0.076506', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.03916', 'ticker_sentiment_score': '-0.045012', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.136444', 'ticker_sentiment_score': '0.091441', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDNDF', 'relevance_score': '0.019586', 'ticker_sentiment_score': '0.054606', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VZ', 'relevance_score': '0.03916', 'ticker_sentiment_score': '0.060653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.03916', 'ticker_sentiment_score': '0.060653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.078226', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.058711', 'ticker_sentiment_score': '-0.017119', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.078226', 'ticker_sentiment_score': '-0.147618', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.03916', 'ticker_sentiment_score': '0.060653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HAL', 'relevance_score': '0.03916', 'ticker_sentiment_score': '0.060653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.136444', 'ticker_sentiment_score': '-0.091795', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNP', 'relevance_score': '0.03916', 'ticker_sentiment_score': '0.051924', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.03916', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.03916', 'ticker_sentiment_score': '0.051924', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UPS', 'relevance_score': '0.03916', 'ticker_sentiment_score': '0.060653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FCX', 'relevance_score': '0.03916', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.03916', 'ticker_sentiment_score': '0.060653', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PM', 'relevance_score': '0.03916', 'ticker_sentiment_score': '0.051924', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.019586', 'ticker_sentiment_score': '0.11556', 'ticker_sentiment_label': 'Neutral'}]"
"Stocks making the biggest moves midday: Southwest Airlines, Goldman Sachs, Bellus Health and more",https://www.cnbc.com/2023/04/18/stocks-moving-big-midday-luv-gs-blu-nvda.html,20230418T170229,['Sarah Min'],These are the stocks posting the largest moves in midday trading.,https://image.cnbcfm.com/api/v1/image/106267133-1574803799871gettyimages-103318586.jpeg?v=1681735845,CNBC,Market Insider,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '1.0'}]",0.121371,Neutral,"[{'ticker': 'GOOG', 'relevance_score': '0.064449', 'ticker_sentiment_score': '-0.111115', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.064449', 'ticker_sentiment_score': '0.087072', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.064449', 'ticker_sentiment_score': '0.095656', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.064449', 'ticker_sentiment_score': '0.075572', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.064449', 'ticker_sentiment_score': '-0.01913', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NYT', 'relevance_score': '0.064449', 'ticker_sentiment_score': '-0.111115', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BK', 'relevance_score': '0.064449', 'ticker_sentiment_score': '0.045023', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BLU', 'relevance_score': '0.064449', 'ticker_sentiment_score': '0.145197', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.191675', 'ticker_sentiment_score': '0.13711', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LUV', 'relevance_score': '0.064449', 'ticker_sentiment_score': '-0.061703', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.128478', 'ticker_sentiment_score': '-0.129697', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSNLF', 'relevance_score': '0.064449', 'ticker_sentiment_score': '-0.111115', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.064449', 'ticker_sentiment_score': '0.196375', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
J&J May Need to Defend Baby Powder Cancer Suits After 19-Month Pause,https://www.business-standard.com/world-news/j-j-may-need-to-defend-baby-powder-cancer-suits-after-19-month-pause-123041801131_1.html,20230418T160829,['Business Standard'],J&J May Need to Defend Baby Powder Cancer Suits After 19-Month ... Business Standard ...,"https://bsmedia.business-standard.com/_media/bs/img/article/2023-04/11/full/1681236950-9272.jpg?im=FeatureCrop,width=826,height=465",Business Standard,GoogleRSS,www.business-standard.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.428917,Bearish,"[{'ticker': 'JNJ', 'relevance_score': '0.160633', 'ticker_sentiment_score': '-0.303323', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
Yet Again: Johnson & Johnson Subsidiary Seeks Stay On Thousands Of Cancer Lawsuits Associated With Talc Products - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/23/04/31860039/yet-again-johnson-johnson-subsidiary-seeks-stay-on-thousands-of-cancer-lawsuits-associated-with-t,20230418T155709,['Vandana Singh'],"Johnson & Johnson's JNJ subsidiary, LTL Management, has reportedly requested a U.S. judge to delay 38,000 lawsuits again. These lawsuits accuse their baby powder and other talc products of causing cancer.",https://cdn.benzinga.com/files/images/story/2023/04/18/johnsons-5671315_1920.jpg?optimize=medium&dpr=2&auto=webp&width=3840,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.256568,Somewhat-Bearish,"[{'ticker': 'JNJ', 'relevance_score': '0.362505', 'ticker_sentiment_score': '-0.151939', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
FDA authorizes additional omicron Covid shots for seniors and people with weak immune systems,https://www.cnbc.com/2023/04/18/covid-seniors-immunocompromised-can-receive-additional-omicron-shots.html,20230418T155231,['Spencer Kimball'],"Although the burden of the pandemic has eased substantially, the CDC says Covid continues to kill more than 1,300 people per week.",https://image.cnbcfm.com/api/v1/image/107227080-1681830780801-gettyimages-1422320734-030a3808_392ff3bf-fbb7-4ebc-8fae-0fdfefc71079.jpeg?v=1681833151&w=1920&h=1080,CNBC,Business,www.cnbc.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.076413,Neutral,"[{'ticker': 'MRNA', 'relevance_score': '0.274834', 'ticker_sentiment_score': '-0.194762', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'PFE', 'relevance_score': '0.274834', 'ticker_sentiment_score': '-0.053242', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.093289', 'ticker_sentiment_score': '0.209811', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Club meeting recap: Jim Cramer says Johnson & Johnson's post-earnings sell-off is wrong and a chance to buy,https://www.cnbc.com/2023/04/18/jim-cramer-says-jj-post-earnings-sell-off-is-wrong-and-a-chance-to-buy.html,20230418T153955,['Kevin Stankiewicz'],"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",https://image.cnbcfm.com/api/v1/image/107227034-16818285361681828530-29073951687-1080pnbcnews.jpg?v=1681829616&w=600&h=300&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.928769'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.857896'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.101431,Neutral,"[{'ticker': 'EVR', 'relevance_score': '0.21686', 'ticker_sentiment_score': '0.073031', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.21686', 'ticker_sentiment_score': '0.073031', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.145583', 'ticker_sentiment_score': '0.055012', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.537018', 'ticker_sentiment_score': '0.140657', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.21686', 'ticker_sentiment_score': '0.073031', 'ticker_sentiment_label': 'Neutral'}]"
Recent Report Shows That Rep. Daniel Goldman Bought Up to $100K Worth of Johnson & Johnson Stock - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/government/23/04/31860312/recent-report-shows-that-rep-daniel-goldman-bought-up-to-100k-worth-of-johnson-johnson-stock,20230418T150619,['Benzinga Insights'],"The Office of New York Representative Daniel Goldman has reported a purchase of Johnson & Johnson JNJ stock on April 17, 2023. According to the Periodic Transaction Report the transaction was placed on April 17, 2023.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}]",0.106699,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.580018', 'ticker_sentiment_score': '0.075109', 'ticker_sentiment_label': 'Neutral'}]"
Building Permits Declined in March,https://www.zacks.com/stock/news/2080499/building-permits-declined-in-march,20230418T145900,['Zacks Investment Research'],"We've got a healthy amount of grist for the trading mill ahead of today's opening bell, with fresh Q1 earnings reports from major household firms joining housing data from last month. All major indices are up at this hour, led by the Nasdaq, which is +110 points roughly 40 minutes prior to the ...",https://staticx-tuner.zacks.com/images/articles/main/92/476.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Earnings', 'relevance_score': '0.938238'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.23241,Somewhat-Bullish,"[{'ticker': 'BAC', 'relevance_score': '0.137671', 'ticker_sentiment_score': '0.06875', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.205225', 'ticker_sentiment_score': '0.144057', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.137671', 'ticker_sentiment_score': '0.229245', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Dow Jones Falls; Tesla Chief Musk Founds New AI Company, Offers 100 Million Shares In Private Sale",https://www.investors.com/market-trend/stock-market-today/dow-jones-falls-tesla-chief-musks-new-ai-company-offers-100-million-private-shares-sale/,20230418T145400,"[""Investor's Business Daily"", 'VIDYA RAMAKRISHNAN']","Dow Jones Falls. Tesla Chief Musk Founds New AI Company, Offers ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2020/07/Stock-elonmusk-03-shutt.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.998682'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.857896'}]",0.01227,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.190667', 'ticker_sentiment_score': '0.312592', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GOOG', 'relevance_score': '0.127795', 'ticker_sentiment_score': '0.011754', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.252332', 'ticker_sentiment_score': '0.225038', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UAL', 'relevance_score': '0.127795', 'ticker_sentiment_score': '0.216285', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.127795', 'ticker_sentiment_score': '-0.21276', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CSCO', 'relevance_score': '0.127795', 'ticker_sentiment_score': '-0.21276', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'BAC', 'relevance_score': '0.127795', 'ticker_sentiment_score': '0.125162', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.127795', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CROX', 'relevance_score': '0.127795', 'ticker_sentiment_score': '-0.059118', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.127795', 'ticker_sentiment_score': '-0.203602', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'ABNB', 'relevance_score': '0.127795', 'ticker_sentiment_score': '-0.166934', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'GS', 'relevance_score': '0.127795', 'ticker_sentiment_score': '0.125162', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.190667', 'ticker_sentiment_score': '0.015131', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSNLF', 'relevance_score': '0.064104', 'ticker_sentiment_score': '0.010016', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.127795', 'ticker_sentiment_score': '-0.059118', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.064104', 'ticker_sentiment_score': '0.163224', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMD', 'relevance_score': '0.127795', 'ticker_sentiment_score': '0.195134', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BKNG', 'relevance_score': '0.127795', 'ticker_sentiment_score': '-0.166934', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
"Ericsson, Johnson & Johnson, Goldman Sachs And Other Big Stocks Moving Lower On Tuesday - CBL International  ( NASDAQ:BANL ) , Alignment Healthcare  ( NASDAQ:ALHC ) ",https://www.benzinga.com/news/23/04/31859838/ericsson-johnson-johnson-goldman-sachs-and-other-big-stocks-moving-lower-on-tuesday,20230418T145152,['Lisa Levin'],"U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today's session. Relay Therapeutics, Inc. RLAY fell 11.5% to $16.12. Merus N.V. MRUS dropped 10.8% to $21.35. FiscalNote Holdings, Inc. NOTE declined 10.3% to $2.42.",https://cdn.benzinga.com/files/images/story/2023/04/18/ericsson_-_logo.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",-0.193842,Somewhat-Bearish,"[{'ticker': 'BANL', 'relevance_score': '0.350564', 'ticker_sentiment_score': '-0.535624', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'SLDP', 'relevance_score': '0.350564', 'ticker_sentiment_score': '-0.738961', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'RLAY', 'relevance_score': '0.350564', 'ticker_sentiment_score': '-0.738961', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'NOTE', 'relevance_score': '0.350564', 'ticker_sentiment_score': '-0.738961', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.504646', 'ticker_sentiment_score': '0.555666', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'MRUS', 'relevance_score': '0.350564', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALHC', 'relevance_score': '0.350564', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCRX', 'relevance_score': '0.350564', 'ticker_sentiment_score': '0.012961', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KPTI', 'relevance_score': '0.350564', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVAX', 'relevance_score': '0.350564', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.350564', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SJT', 'relevance_score': '0.350564', 'ticker_sentiment_score': '-0.738961', 'ticker_sentiment_label': 'Bearish'}]"
Housing Data Muted but Decent; JNJ and BAC Beat on Q1 Earnings,https://www.zacks.com/stock/news/2080475/housing-data-muted-but-decent-jnj-and-bac-beat-on-q1-earnings,20230418T142600,['Zacks Investment Research'],Fresh Q1 earnings reports from major household firms join housing data from last month ahead of today's open.,https://staticx-tuner.zacks.com/images/articles/main/21/1122.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Earnings', 'relevance_score': '0.976671'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.223136,Somewhat-Bullish,"[{'ticker': 'BAC', 'relevance_score': '0.131284', 'ticker_sentiment_score': '0.115203', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.195814', 'ticker_sentiment_score': '0.14897', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.131284', 'ticker_sentiment_score': '0.115203', 'ticker_sentiment_label': 'Neutral'}]"
"Morning Update: This ""Hated"" Rally Could Send the S&P 500 to 4,300",https://moneymorning.com/investing/morning-update-this-hated-rally-could-send-the-sp-500-to-4300/,20230418T141157,"['Chris Johnson', 'Kenny Glick', 'Garrett Baldwin', 'gbaldwin3']","Morning Update: This ""Hated"" Rally Could Send the S&P 500 to 4300 Money Morning ...",https://middaymomentum.com/wp-content/uploads/2023/04/Picture38.png,Money Morning,GoogleRSS,moneymorning.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",-0.012177,Neutral,"[{'ticker': 'BAC', 'relevance_score': '0.152499', 'ticker_sentiment_score': '0.265681', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.076602', 'ticker_sentiment_score': '-0.067314', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAM', 'relevance_score': '0.076602', 'ticker_sentiment_score': '-0.139773', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.152499', 'ticker_sentiment_score': '0.265681', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"US Stocks: Wall Street set for gains after upbeat BofA, J&J earnings | The Financial Express",https://www.financialexpress.com/market/us-stocks-wall-street-set-for-gains-after-upbeat-bofa-jampj-earnings/3052724/,20230418T134108,[],"US Stocks: Wall Street set for gains after upbeat BofA, J&J earnings The Financial Express ...",https://www.financialexpress.com/wp-content/uploads/2023/04/1-216.jpg,The Financial Express,n/a,www.financialexpress.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.838487'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",-0.05148,Neutral,"[{'ticker': 'BABA', 'relevance_score': '0.073321', 'ticker_sentiment_score': '-0.098715', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NFLX', 'relevance_score': '0.073321', 'ticker_sentiment_score': '0.190856', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.073321', 'ticker_sentiment_score': '0.362883', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'LMT', 'relevance_score': '0.073321', 'ticker_sentiment_score': '-0.230452', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'BAC', 'relevance_score': '0.146025', 'ticker_sentiment_score': '0.225693', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JPM', 'relevance_score': '0.073321', 'ticker_sentiment_score': '-0.066655', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.073321', 'ticker_sentiment_score': '-0.260917', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.146025', 'ticker_sentiment_score': '0.146897', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.073321', 'ticker_sentiment_score': '-0.260917', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
US stocks climb on strong Chinese economic growth and upbeat earnings,https://markets.businessinsider.com/news/stocks/stock-market-news-today-china-gdp-growth-goldman-sachs-earnings-2023-4,20230418T133350,['Jason Ma'],Stock Market News Today: China's Economic Growth Beats Views - Markets Insider ...,https://i.insider.com/63975699a3bebb0018b40e0e?width=1200&format=jpeg,Business Insider,GoogleRSS,markets.businessinsider.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.017085,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.217834', 'ticker_sentiment_score': '0.010106', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.217834', 'ticker_sentiment_score': '0.010106', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.109956', 'ticker_sentiment_score': '-0.166054', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'BAC', 'relevance_score': '0.217834', 'ticker_sentiment_score': '0.010106', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.109956', 'ticker_sentiment_score': '-0.166054', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.217834', 'ticker_sentiment_score': '0.010106', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.217834', 'ticker_sentiment_score': '0.010106', 'ticker_sentiment_label': 'Neutral'}]"
Jim Cramer's top 10 things to watch in the stock market Tuesday,https://www.cnbc.com/2023/04/18/jim-cramers-top-10-things-to-watch-in-the-stock-market-tuesday.html,20230418T132051,['Jim Cramer'],"The Dow, the S&P 500 and the Nasdaq are set to open higher on strong J&J and BofA earnings.",https://image.cnbcfm.com/api/v1/image/107201360-1677648920081-gettyimages-468166458-84515483.jpeg?v=1681824051&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.99393'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.997405'}]",0.109995,Neutral,"[{'ticker': 'EVR', 'relevance_score': '0.054483', 'ticker_sentiment_score': '0.171839', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NFLX', 'relevance_score': '0.108712', 'ticker_sentiment_score': '0.061776', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.162437', 'ticker_sentiment_score': '0.195311', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BAC', 'relevance_score': '0.108712', 'ticker_sentiment_score': '0.051543', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.162437', 'ticker_sentiment_score': '0.103842', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.108712', 'ticker_sentiment_score': '-0.035255', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EMR', 'relevance_score': '0.162437', 'ticker_sentiment_score': '0.261459', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.108712', 'ticker_sentiment_score': '-0.037183', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NATI', 'relevance_score': '0.108712', 'ticker_sentiment_score': '0.193789', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DHR', 'relevance_score': '0.162437', 'ticker_sentiment_score': '0.073158', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBUX', 'relevance_score': '0.162437', 'ticker_sentiment_score': '0.257486', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WFC', 'relevance_score': '0.054483', 'ticker_sentiment_score': '-0.08002', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.108712', 'ticker_sentiment_score': '-0.174583', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'RXDX', 'relevance_score': '0.108712', 'ticker_sentiment_score': '-0.035255', 'ticker_sentiment_label': 'Neutral'}]"
Tech Futures Lead As Q1 Earnings Heats Up,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-rise-as-goldman-sachs-dives-on-earnings-nvidia-jumps-on-buy-rating/,20230418T130100,"[""Investor's Business Daily"", 'SCOTT LEHTONEN']",Dow Jones Futures Rise As Goldman Sachs Dives On Earnings ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2017/04/stock-wallstreet-shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.999336'}]",0.145928,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.087931', 'ticker_sentiment_score': '0.024683', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.174798', 'ticker_sentiment_score': '0.201838', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.146025', 'ticker_sentiment_score': '0.042276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CSCO', 'relevance_score': '0.117057', 'ticker_sentiment_score': '0.026338', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.087931', 'ticker_sentiment_score': '0.100696', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.146025', 'ticker_sentiment_score': '0.091048', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.087931', 'ticker_sentiment_score': '0.100696', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.146025', 'ticker_sentiment_score': '0.056006', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NKE', 'relevance_score': '0.117057', 'ticker_sentiment_score': '0.090688', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.087931', 'ticker_sentiment_score': '0.100696', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.029363', 'ticker_sentiment_score': '0.105286', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ASML', 'relevance_score': '0.058687', 'ticker_sentiment_score': '0.274081', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.117057', 'ticker_sentiment_score': '0.052497', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LULU', 'relevance_score': '0.058687', 'ticker_sentiment_score': '0.097991', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FIVE', 'relevance_score': '0.203337', 'ticker_sentiment_score': '-0.03466', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.058687', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.087931', 'ticker_sentiment_score': '0.003173', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'V', 'relevance_score': '0.117057', 'ticker_sentiment_score': '0.09857', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WBA', 'relevance_score': '0.058687', 'ticker_sentiment_score': '0.134999', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.058687', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.087931', 'ticker_sentiment_score': '0.139511', 'ticker_sentiment_label': 'Neutral'}]"
Health Care Bellwether Sets Bullish Tone With Beat And Raise,https://www.investors.com/news/technology/jnj-stock-johnson-johnson-earnings-q1-2023/,20230418T130100,"['ALLISON GATLIN', ""Investor's Business Daily""]",JNJ Stock: Health Care Behemoth Sets Bullish First-Quarter Tone Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2017/10/stock-JohnsonANDjohnson-03-shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}]",0.274517,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.862496', 'ticker_sentiment_score': '0.523526', 'ticker_sentiment_label': 'Bullish'}]"
Johnson & Johnson Reports Q1 2023 Results - Investing News Network,https://investingnews.com/johnson-johnson-reports-q1-2023-results-2659871740/,20230418T124219,[],Johnson & Johnson Reports Q1 2023 Results Investing News Network ...,,Investing News Network,n/a,investingnews.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.682689'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.152262,Somewhat-Bullish,"[{'ticker': 'CURN', 'relevance_score': '0.019178', 'ticker_sentiment_score': '0.055515', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.317206', 'ticker_sentiment_score': '0.23109', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FOREX:EUR', 'relevance_score': '0.019178', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
S&P 500 Futures Gain as Bank Earnings Roll In,https://www.wsj.com/articles/global-stocks-markets-dow-update-04-18-2023-e370a36,20230418T123300,['Anna Hirtenstein'],"Stock futures ticked up as results from major banks including Goldman Sachs, Bank of America and Bank of New York Mellon trickled in. Other companies reporting Tuesday included Johnson & Johnson.",https://images.wsj.net/im-765298/social,Wall Street Journal,Markets,www.wsj.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",-0.203914,Somewhat-Bearish,"[{'ticker': 'BK', 'relevance_score': '0.459624', 'ticker_sentiment_score': '-0.211395', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'BAC', 'relevance_score': '0.459624', 'ticker_sentiment_score': '-0.211395', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'GS', 'relevance_score': '0.459624', 'ticker_sentiment_score': '-0.211395', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.459624', 'ticker_sentiment_score': '-0.211395', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
"Bellus Health's stock climbs on GSK deal, while Goldman Sachs is hurt by a revenue miss",https://www.marketwatch.com/story/bellus-healths-stock-climbs-on-gsk-deal-while-goldman-sachs-is-hurt-by-a-revenue-miss-794e522d,20230418T123100,['Anviksha Patel'],Johnson & Johnson's stock rise on estimate-topping results and Bank of America's stock gets an earnings boost.,https://images.mktw.net/im-748531/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}, {'topic': 'Earnings', 'relevance_score': '0.94762'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.157677,Somewhat-Bullish,"[{'ticker': 'BBBY', 'relevance_score': '0.252987', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.371523', 'ticker_sentiment_score': '-0.031985', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.252987', 'ticker_sentiment_score': '-0.176579', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'FRC', 'relevance_score': '0.252987', 'ticker_sentiment_score': '-0.023794', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.252987', 'ticker_sentiment_score': '0.289083', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"J&J sales in US rise 10 per cent, health care giant raises dividend",https://www.business-standard.com/companies/news/j-j-sales-in-us-rise-10-per-cent-health-care-giant-raises-dividend-123041800775_1.html,20230418T123052,['Business Standard'],"Johnson & Johnson beat first-quarter expectations, as growth in the health care giant's home market helped counter another revenue hit overseas from a strong dollar. The health care giant booked a USD 68 million loss on a one-time charge in the quarter, and revenue grew more than 5 per cent to ...","https://bsmedia.business-standard.com/_media/bs/img/article/2020-10/13/full/1602553972-0193.jpg?im=FeatureCrop,width=826,height=465",Business Standard,Companies,www.business-standard.com,"[{'topic': 'Earnings', 'relevance_score': '0.983783'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.305549,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.265378', 'ticker_sentiment_score': '0.346347', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.937735', 'ticker_sentiment_score': '0.459367', 'ticker_sentiment_label': 'Bullish'}]"
Johnson & Johnson Reports Q1 2023 Results - Investing News Network,https://investingnews.com/johnson-johnson-reports-q1-2023-results/,20230418T122532,[],Johnson & Johnson Reports Q1 2023 Results Investing News Network ...,,Investing News Network,n/a,investingnews.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.682689'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.152262,Somewhat-Bullish,"[{'ticker': 'CURN', 'relevance_score': '0.019178', 'ticker_sentiment_score': '0.055515', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.317206', 'ticker_sentiment_score': '0.23109', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FOREX:EUR', 'relevance_score': '0.019178', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
"Stock market today: US futures up on US earns, China growth",https://apnews.com/article/stock-market-today-april-18-c002eafd2651de107efec1ccd3b960ec,20230418T121115,[],"Stock market today: US futures up on US earns, China growth Pedestrians pass by the Hong Kong Stock Exchange electronic screen in Hong Kong, Tuesday, April 18, 2023.",https://storage.googleapis.com/afs-prod/media/2792b7d5a85e480e9088794a599076a3/3000.webp,Associated Press,Markets,apnews.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.955357'}, {'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.085317,Neutral,"[{'ticker': 'STT', 'relevance_score': '0.058903', 'ticker_sentiment_score': '-0.067987', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.117486', 'ticker_sentiment_score': '0.158455', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WFC', 'relevance_score': '0.058903', 'ticker_sentiment_score': '0.234041', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JPM', 'relevance_score': '0.058903', 'ticker_sentiment_score': '0.234041', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.117486', 'ticker_sentiment_score': '0.105675', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:JPY', 'relevance_score': '0.117486', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:EUR', 'relevance_score': '0.058903', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.058903', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
"Stocks making the biggest moves premarket: Johnson & Johnson, Goldman Sachs, Sunrun and more",https://www.cnbc.com/2023/04/18/stocks-making-the-biggest-moves-premarket-jnj-gs-run.html,20230418T120638,['Pia Singh'],Shares of Goldman Sachs shed nearly 4% after missing revenue estimates in its first-quarter earnings released before Tuesday's opening bell.,https://image.cnbcfm.com/api/v1/image/107127411-16645515612022-09-30t152235z_919627036_rc2mrw9uj40w_rtrmadp_0_storm-ian-florida.jpeg?v=1681750302,CNBC,Market Insider,www.cnbc.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.839681'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.312056,Somewhat-Bullish,"[{'ticker': 'BK', 'relevance_score': '0.150592', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.22421', 'ticker_sentiment_score': '0.339649', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LMT', 'relevance_score': '0.075635', 'ticker_sentiment_score': '0.208749', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BAC', 'relevance_score': '0.150592', 'ticker_sentiment_score': '0.227387', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.150592', 'ticker_sentiment_score': '0.101967', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.075635', 'ticker_sentiment_score': '0.160921', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
These 10 Crummy Stocks Already Cost Investors $300 Billion,https://www.investors.com/etfs-and-funds/sectors/sp500-these-crummy-stocks-already-cost-investors-billions/,20230418T120000,"['MATT KRANTZ', ""Investor's Business Daily""]",S&P 500: These 10 Crummy Stocks Already Cost Investors $300 ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2019/08/Stock-FallingMan-07-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",-0.03201,Neutral,"[{'ticker': 'CVS', 'relevance_score': '0.129516', 'ticker_sentiment_score': '0.057968', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FRC', 'relevance_score': '0.129516', 'ticker_sentiment_score': '-0.038041', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.193207', 'ticker_sentiment_score': '0.034072', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.129516', 'ticker_sentiment_score': '0.028812', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPGI', 'relevance_score': '0.064973', 'ticker_sentiment_score': '0.023358', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LPLA', 'relevance_score': '0.064973', 'ticker_sentiment_score': '0.062051', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.255641', 'ticker_sentiment_score': '0.002059', 'ticker_sentiment_label': 'Neutral'}]"
Futures gain as investors cheer resilient earnings,https://www.reuters.com/markets/us/futures-gain-investors-cheer-resilient-earnings-2023-04-18/,20230418T115400,"['Sruthi Shankar', 'Ankika Biswas']","April 18 ( Reuters ) - U.S. stock index futures climbed on Tuesday as Bank of America and Johnson & Johnson reported upbeat earnings, while signs of uneven economic recovery in China and prospects of more Federal Reserve interest rate hikes capped gains.",https://cloudfront-us-east-2.images.arcpublishing.com/reuters/NSZULEHPDRN7LIX4LTMHLNQF4I.jpg,Reuters,Markets,www.reuters.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.918141'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.838487'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.144554,Neutral,"[{'ticker': 'BABA', 'relevance_score': '0.065327', 'ticker_sentiment_score': '-0.097648', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.065327', 'ticker_sentiment_score': '0.359694', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'BAC', 'relevance_score': '0.130217', 'ticker_sentiment_score': '0.318324', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JPM', 'relevance_score': '0.065327', 'ticker_sentiment_score': '-0.065762', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.130217', 'ticker_sentiment_score': '0.096862', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BK', 'relevance_score': '0.065327', 'ticker_sentiment_score': '0.44259', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'GS', 'relevance_score': '0.065327', 'ticker_sentiment_score': '-0.098867', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JBARF', 'relevance_score': '0.065327', 'ticker_sentiment_score': '-0.068325', 'ticker_sentiment_label': 'Neutral'}]"
Tesla Earnings: Why Guidance Is Key,https://www.fool.com/investing/2023/04/18/tesla-earnings-why-guidance-is-key/,20230418T115100,['Daniel Sparks'],Are recent price cuts a sign of trouble?,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F728049%2Fan-angry-person-with-hands-outstretched-looking-at-a-computer-monitor.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",0.101251,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.073773', 'ticker_sentiment_score': '0.037509', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.073773', 'ticker_sentiment_score': '0.037509', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.645516', 'ticker_sentiment_score': '0.139827', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson  ( JNJ )  Q1 Earnings and Revenues Top Estimates,https://www.zacks.com/stock/news/2080100/johnson-johnson-jnj-q1-earnings-and-revenues-top-estimates,20230418T114502,['Zacks Investment Research'],"Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 6.77% and 5.01%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?",https://staticx-tuner.zacks.com/images/default_article_images/default128.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999997'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.168722,Somewhat-Bullish,"[{'ticker': 'PFE', 'relevance_score': '0.137278', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.396052', 'ticker_sentiment_score': '0.144512', 'ticker_sentiment_label': 'Neutral'}]"
Why Johnson & Johnson  ( JNJ )  Shares Are Trading Higher Premarket Today? - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/23/04/31851333/johnson-johnson-q1-beats-street-view-on-strong-performance-across-all-segments-lifts-guidance-div,20230418T113907,['Vandana Singh'],"Johnson & Johnson JNJ has reported Q1 FY23 adjusted earnings of $2.68 per share, up 0.4% Y/Y and beating the consensus of $2.51. Sales increased 5.6% to $24.75 billion, beating the consensus of $23.67 billion, with operational growth of 9.0% and adjusted operational growth of 7.6%.",https://cdn.benzinga.com/files/images/story/2023/04/18/jnj.png?optimize=medium&dpr=2&auto=webp&width=3840,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.157398,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.660632', 'ticker_sentiment_score': '0.175011', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"The daily business briefing: April 18, 2023",https://theweek.com/briefing/business-briefing/1022766/the-daily-business-briefing-april-18-2023,20230418T111625,['Harold Maass'],"China's National Bureau of Statistics reported Tuesday that the Chinese economy expanded 4.5 percent in the first quarter compared to the same period in 2022 as the world's second biggest economy bounced back after lifting its strict ""zero-COVID"" lockdowns.","https://mediacloud.theweek.com/image/upload/f_auto,t_primary-image-mobile@1/v1681816208/GettyImages-1482863321.jpg",The Week News,n/a,theweek.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.769861'}]",0.024177,Neutral,"[{'ticker': 'SCHW', 'relevance_score': '0.063091', 'ticker_sentiment_score': '0.045656', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STT', 'relevance_score': '0.063091', 'ticker_sentiment_score': '0.045656', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.187705', 'ticker_sentiment_score': '0.146633', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.063091', 'ticker_sentiment_score': '0.045656', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBNY', 'relevance_score': '0.063091', 'ticker_sentiment_score': '0.045656', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.063091', 'ticker_sentiment_score': '0.045656', 'ticker_sentiment_label': 'Neutral'}]"
"Johnson & Johnson Posts Higher Quarterly Sales, Raises 2023 Outlook",https://www.wsj.com/articles/johnson-johnson-jnj-q1-earnings-report-2023-8592c66,20230418T111200,['Will Feuer'],First-quarter earnings were wiped out by a $6.9 billion charge tied to litigation and other costs from its Covid-19 vaccine commitments.,https://images.wsj.net/im-764779?width=860&height=573,Wall Street Journal,Business,www.wsj.com,"[{'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.041854,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.674691', 'ticker_sentiment_score': '-0.109681', 'ticker_sentiment_label': 'Neutral'}]"
J&J raises annual profit forecast on cancer drug strength,https://www.reuters.com/business/healthcare-pharmaceuticals/jj-raises-annual-profit-forecast-cancer-drug-strength-2023-04-18/,20230418T110527,['Reuters'],"April 18 ( Reuters ) - Johnson & Johnson ( JNJ.N ) beat first-quarter profit estimates on Tuesday and raised its 2023 profit forecast, as it banks on its newer cancer treatments and multiple myeloma drug Darzalex to soften the blow from declining demand for older drugs.",https://cloudfront-us-east-2.images.arcpublishing.com/reuters/ZF7GS4FDIVLVDENDGG7NR3HDSE.jpg,Reuters,Business,www.reuters.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.051132,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.126784', 'ticker_sentiment_score': '-0.125541', 'ticker_sentiment_label': 'Neutral'}]"
"Why US Stocks Look Poised For A Rally This Earnings Season - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/23/04/31850201/us-stocks-ready-to-rally-amid-earnings-optimism-analyst-sees-upward-momentum-on-outlier-s-p-500-ret,20230418T105848,['Shanthi Rexaline'],"The positive mood seen in late trading on Monday appears to be spilling over into Tuesday's session, with futures pointing to a higher open. A slew of bank earnings, energy prices and a housing market reading are all in the mix, as traders position themselves for the earnings season.",https://cdn.benzinga.com/files/images/story/2023/04/18/shutterstock_1604841298.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.955357'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.838487'}]",0.021331,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.107978', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.107978', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.107978', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.107978', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.107978', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BK', 'relevance_score': '0.107978', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RUN', 'relevance_score': '0.107978', 'ticker_sentiment_score': '-0.175744', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'PLUG', 'relevance_score': '0.107978', 'ticker_sentiment_score': '-0.288064', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'GS', 'relevance_score': '0.107978', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.064785', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FHN', 'relevance_score': '0.107978', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FSLR', 'relevance_score': '0.107978', 'ticker_sentiment_score': '-0.288064', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'LMT', 'relevance_score': '0.107978', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.107978', 'ticker_sentiment_score': '-0.112096', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LPLA', 'relevance_score': '0.054114', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.107978', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
"J&J sales in US rise 10%, health care giant raises dividend",https://apnews.com/article/johnson-first-quarter-stelara-ebbdc0c3a79531b2af4dab8785b5f341,20230418T105423,[],"Johnson & Johnson beat first-quarter expectations, as growth in the health care giant's home market helped counter another revenue hit overseas from a strong dollar. The health care giant booked a $68 million loss on a one-time charge in the quarter, and revenue grew more than 5% to $24.75 ...",https://storage.googleapis.com/afs-prod/media/deccad98f2b84142b94cd9b80fbd05a4/3000.webp,Associated Press,Markets,apnews.com,"[{'topic': 'Earnings', 'relevance_score': '0.983783'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.323266,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.294093', 'ticker_sentiment_score': '0.373106', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.149656', 'ticker_sentiment_score': '0.255212', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Johnson & Johnson beats on earnings and revenue, raises full-year guidance",https://www.cnbc.com/2023/04/18/johnson-johnson-jnj-earnings-q1-2023.html,20230418T105001,['Annika Kim Constantino'],"J&J, whose financial results are considered a bellwether for many health companies, said its first-quarter sales grew 5.6% over the same quarter last year.",https://image.cnbcfm.com/api/v1/image/106833051-1612183344395-gettyimages-1230907713-widak-covid19v210201_np0OG.jpeg?v=1681815001&w=1920&h=1080,CNBC,Earnings,www.cnbc.com,"[{'topic': 'Earnings', 'relevance_score': '0.998287'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.146141,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.137671', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Genmab Announces Net Sales of DARZALEX  ( daratumumab )  for First Quarter of 2023,https://www.globenewswire.com/news-release/2023/04/18/2648749/0/en/Genmab-Announces-Net-Sales-of-DARZALEX-daratumumab-for-First-Quarter-of-2023.html,20230418T102500,['Genmab A/S'],Company Announcement ...,https://ml-eu.globenewswire.com/Resource/Download/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}]",0.047937,Neutral,"[{'ticker': 'GMAB', 'relevance_score': '0.656549', 'ticker_sentiment_score': '0.09263', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.12546', 'ticker_sentiment_score': '0.010322', 'ticker_sentiment_label': 'Neutral'}]"
"Morning Bid: Global pulse picks up, rates creep higher again",https://www.reuters.com/markets/us/global-markets-view-usa-2023-04-18/,20230418T100716,['Reuters'],"A look at the day ahead in U.S. and global markets from Mike Dolan With investors largely assuming recession ahead, an accelerating global economic pulse challenges the narrative and is seeing interest rates tick back higher again as the March banking wobble subsides.",https://fingfx.thomsonreuters.com/gfx/mkt/klvygmrrmvg/Two.PNG,Reuters,Markets,www.reuters.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '0.905476'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.060475,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.096477', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.148864', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WAL', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.096477', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OMC', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.194878', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BK', 'relevance_score': '0.096477', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PLD', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.144275', 'ticker_sentiment_score': '0.119553', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.148864', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STT', 'relevance_score': '0.048327', 'ticker_sentiment_score': '-0.067005', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:GBP', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
The Fed Thinks a Recession Is More Likely: Here Are 3 Great Stocks to Buy Now,https://www.fool.com/investing/2023/04/18/fed-recession-more-likely-stocks-buy-now/,20230418T095200,['Keith Speights'],These stocks should hold up quite well regardless of what happens with the U.S. economy.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F728092%2Ffinancials-3.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.089682,Neutral,"[{'ticker': 'VRTX', 'relevance_score': '0.106541', 'ticker_sentiment_score': '0.078639', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DG', 'relevance_score': '0.312158', 'ticker_sentiment_score': '0.20663', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.211191', 'ticker_sentiment_score': '0.072575', 'ticker_sentiment_label': 'Neutral'}]"
3 Robinhood Stocks to Buy and Hold Forever,https://www.fool.com/investing/2023/04/18/3-robinhood-stocks-to-buy-and-hold-forever/,20230418T091900,['Jim Halley'],There are solid reasons for the trio's popularity with retail investors.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F728049%2Fan-angry-person-with-hands-outstretched-looking-at-a-computer-monitor.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.187509,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.29234', 'ticker_sentiment_score': '0.239724', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HOOD', 'relevance_score': '0.042723', 'ticker_sentiment_score': '0.16401', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.211191', 'ticker_sentiment_score': '0.150778', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.252114', 'ticker_sentiment_score': '0.315626', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Virtualware will start trading in Paris on Thursday, at 27.25 million valuation",https://www.benzinga.com/pressreleases/23/04/g31848161/virtualware-will-start-trading-in-paris-on-thursday-at-27-25-million-valuation,20230418T091015,['Globe Newswire'],"BILBAO, Spain and PARIS, April 18, 2023 ( GLOBE NEWSWIRE ) -- Virtualware, which develops industrial virtual reality platforms for the nuclear, medical, educational and defense industries, will be listed on Euronext Access Paris next Thursday, April 20, at a valuation of 27.25 million euros.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.77141'}]",0.10639,Neutral,"[{'ticker': 'HTHIF', 'relevance_score': '0.129516', 'ticker_sentiment_score': '0.096012', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IBDSF', 'relevance_score': '0.129516', 'ticker_sentiment_score': '0.096012', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AOMFF', 'relevance_score': '0.129516', 'ticker_sentiment_score': '0.096012', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.129516', 'ticker_sentiment_score': '0.096012', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.129516', 'ticker_sentiment_score': '0.096012', 'ticker_sentiment_label': 'Neutral'}]"
"Bank of America, Goldman Sachs, J&J, Netflix, and More Stock Market Movers",https://www.barrons.com/articles/stock-market-movers-da2446ae,20230418T085900,['Joe Woelfel'],"Stock futures pointed mostly higher Tuesday with earnings reports coming from the likes of Bank of America, Goldman Sachs, and Johnson & Johnson, and as China's economy rebounded at a faster-than-expected pace in the first quarter. These stocks were poised to make moves Tuesday:",https://images.barrons.com/im-82859/social,Barrons,n/a,www.barrons.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.261649,Somewhat-Bullish,"[{'ticker': 'BAC', 'relevance_score': '0.716023', 'ticker_sentiment_score': '0.311218', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GS', 'relevance_score': '0.716023', 'ticker_sentiment_score': '0.311218', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.716023', 'ticker_sentiment_score': '0.311218', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Stock futures nudge higher as fresh batch of earnings eyed.,https://www.marketwatch.com/story/stock-futures-nudge-higher-as-fresh-batch-of-earnings-eyed-2f26483,20230418T084600,['Jamie Chisholm'],"Futures firm as traders await results from Goldman Sachs and Bank of America, among others.",https://images.mktw.net/im-734155/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.230091,Somewhat-Bullish,"[{'ticker': 'NFLX', 'relevance_score': '0.179788', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BK', 'relevance_score': '0.179788', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.179788', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.179788', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.179788', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.090474', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
"Goldman Sachs, Bank of America And 3 Stocks To Watch Heading Into Tuesday - Bank of America  ( NYSE:BAC ) , Goldman Sachs Gr  ( NYSE:GS ) ",https://www.benzinga.com/news/earnings/23/04/31847066/goldman-sachs-bank-of-america-and-3-stocks-to-watch-heading-into-tuesday,20230418T080128,['Lisa Levin'],"With US futures trading slightly higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects The Goldman Sachs Group, Inc. GS to post quarterly earnings at $2.51 per share on revenue of $23.67 billion before the opening bell.",https://cdn.benzinga.com/files/images/story/2023/04/18/goldman_sachs_-_logo.jpg?width=1200&height=800&fit=crop,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.986564'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.181988,Somewhat-Bullish,"[{'ticker': 'NFLX', 'relevance_score': '0.514619', 'ticker_sentiment_score': '0.408934', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'BAC', 'relevance_score': '0.514619', 'ticker_sentiment_score': '0.468984', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'GS', 'relevance_score': '0.514619', 'ticker_sentiment_score': '0.387206', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.514619', 'ticker_sentiment_score': '0.127745', 'ticker_sentiment_label': 'Neutral'}]"
Asian Markets Drop But Pare Losses After China Data,https://www.barrons.com/news/asian-markets-drop-but-pare-losses-after-china-data-a7224ed9,20230418T031036,['AFP - Agence France Presse'],Asian markets fell Tuesday but pared early losses after data showed China's economy grew far more than expected in the first quarter as activity resumed after three years of painful zero-Covid measures.,,Barrons,n/a,www.barrons.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.769861'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.05599,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.069697', 'ticker_sentiment_score': '0.091364', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.069697', 'ticker_sentiment_score': '0.139283', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.069697', 'ticker_sentiment_score': '0.091364', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.069697', 'ticker_sentiment_score': '0.091364', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.069697', 'ticker_sentiment_score': '0.139283', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.069697', 'ticker_sentiment_score': '0.091364', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.069697', 'ticker_sentiment_score': '0.091364', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOK', 'relevance_score': '0.069697', 'ticker_sentiment_score': '0.091364', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NAUBF', 'relevance_score': '0.069697', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:JPY', 'relevance_score': '0.20698', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:EUR', 'relevance_score': '0.138863', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
"Stocks Rise, Dollar Drops As China Posts Bumper Growth",https://www.barrons.com/news/asian-markets-drop-but-pare-losses-after-china-data-a7224ed9,20230418T031036,['AFP - Agence France Presse'],Asian Markets Drop But Pare Losses After China Data ...,,Barrons,n/a,www.barrons.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.082768,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.069094', 'ticker_sentiment_score': '0.099363', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.069094', 'ticker_sentiment_score': '0.134108', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.069094', 'ticker_sentiment_score': '0.099363', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.069094', 'ticker_sentiment_score': '0.099363', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.137671', 'ticker_sentiment_score': '0.179986', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MS', 'relevance_score': '0.069094', 'ticker_sentiment_score': '0.099363', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.069094', 'ticker_sentiment_score': '0.099363', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOK', 'relevance_score': '0.069094', 'ticker_sentiment_score': '0.099363', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NAUBF', 'relevance_score': '0.069094', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:JPY', 'relevance_score': '0.205225', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:EUR', 'relevance_score': '0.137671', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.069094', 'ticker_sentiment_score': '-0.086297', 'ticker_sentiment_label': 'Neutral'}]"
Asian Markets Drop As China Growth Data Fails To Impress Traders,https://www.barrons.com/news/asian-markets-drop-but-pare-losses-after-china-data-a7224ed9,20230418T031036,['AFP - Agence France Presse'],Asian Markets Drop But Pare Losses After China Data ...,,Barrons,n/a,www.barrons.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",-0.004928,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.060388', 'ticker_sentiment_score': '0.091001', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.060388', 'ticker_sentiment_score': '0.138182', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.060388', 'ticker_sentiment_score': '0.091001', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.060388', 'ticker_sentiment_score': '0.091001', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.169668', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MS', 'relevance_score': '0.060388', 'ticker_sentiment_score': '0.091001', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.060388', 'ticker_sentiment_score': '0.091001', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOK', 'relevance_score': '0.060388', 'ticker_sentiment_score': '0.091001', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NAUBF', 'relevance_score': '0.060388', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:JPY', 'relevance_score': '0.179788', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:EUR', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Asian Markets Drop As China Growth Data Fails To Impress Traders,https://www.barrons.com/news/asian-markets-drop-but-pare-losses-after-china-data-a7224ed9,20230418T031036,['AFP - Agence France Presse'],Asian Markets Drop But Pare Losses After China Data ...,,Barrons,n/a,www.barrons.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",-0.004928,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.060236', 'ticker_sentiment_score': '0.091', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.060236', 'ticker_sentiment_score': '0.138172', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.060236', 'ticker_sentiment_score': '0.091', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.060236', 'ticker_sentiment_score': '0.091', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.12013', 'ticker_sentiment_score': '0.169479', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MS', 'relevance_score': '0.060236', 'ticker_sentiment_score': '0.091', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.060236', 'ticker_sentiment_score': '0.091', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOK', 'relevance_score': '0.060236', 'ticker_sentiment_score': '0.091', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NAUBF', 'relevance_score': '0.060236', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:JPY', 'relevance_score': '0.179343', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:EUR', 'relevance_score': '0.12013', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
SGK expands APAC network and opens its tenth office in Seoul,https://www.prnewswire.com/apac/news-releases/sgk-expands-apac-network-and-opens-its-tenth-office-in-seoul-301798754.html,20230418T002500,['SGK'],"SGK continues its growth trajectory in the APAC region to shape the future of brand and consumer connection, with the opening of a Seoul office.",https://mma.prnewswire.com/media/2052697/SGK_Seoul_office.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}]",0.352238,Bullish,"[{'ticker': 'AXP', 'relevance_score': '0.196877', 'ticker_sentiment_score': '0.254289', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MATW', 'relevance_score': '0.06623', 'ticker_sentiment_score': '0.19099', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.06623', 'ticker_sentiment_score': '0.157392', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PG', 'relevance_score': '0.06623', 'ticker_sentiment_score': '0.157392', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FOREX:VND', 'relevance_score': '0.06623', 'ticker_sentiment_score': '0.182517', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Wall Street ends higher; investors await earnings, Fed cues",https://www.moneycontrol.com/news/business/markets/wall-street-ends-higher-investors-await-earnings-fed-cues-10429271.html,20230418T002010,[],Markets are gauging the health of corporate profits and the economy after several banks kicked off first-quarter reports with strong results last week.,https://images.moneycontrol.com/static-mcnews/2020/08/wall-street-1.jpg?impolicy=website&width=168&height=118,Money Control,Markets,www.moneycontrol.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}]",0.08819,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.068698', 'ticker_sentiment_score': '-0.008069', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NFLX', 'relevance_score': '0.068698', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSNLF', 'relevance_score': '0.068698', 'ticker_sentiment_score': '-0.008069', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.204072', 'ticker_sentiment_score': '-0.012997', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STT', 'relevance_score': '0.068698', 'ticker_sentiment_score': '-0.105437', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.068698', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.068698', 'ticker_sentiment_score': '0.08828', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.068698', 'ticker_sentiment_score': '0.08828', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.068698', 'ticker_sentiment_score': '0.08828', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.068698', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.068698', 'ticker_sentiment_score': '0.08828', 'ticker_sentiment_label': 'Neutral'}]"
Q1 Earnings Season Kicks Off Better than Expected,https://www.zacks.com/stock/news/2079938/q1-earnings-season-kicks-off-better-than-expected,20230417T215300,['Zacks Investment Research'],"We've got a long way to go, but some key regional banks have already reported and offered some relief to market participants.",https://staticx-tuner.zacks.com/images/articles/main/f3/29961.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.96136'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.064256,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.140896', 'ticker_sentiment_score': '0.034048', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STT', 'relevance_score': '0.140896', 'ticker_sentiment_score': '0.034048', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.140896', 'ticker_sentiment_score': '0.034048', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.140896', 'ticker_sentiment_score': '0.034048', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.140896', 'ticker_sentiment_score': '0.034048', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.140896', 'ticker_sentiment_score': '0.034048', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.140896', 'ticker_sentiment_score': '0.034048', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.140896', 'ticker_sentiment_score': '0.034048', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.140896', 'ticker_sentiment_score': '0.034048', 'ticker_sentiment_label': 'Neutral'}]"
"J&J's Earnings Are Tuesday. Watch for News on Spinoff, Talc Litigation.",https://www.barrons.com/articles/jnj-earnings-stock-price-a9883ad9,20230417T210000,['Josh Nathan-Kazis'],Johnson & Johnson Reports Earnings Tuesday. Here's What to Watch. ...,https://images.barrons.com/im-764695/social,Barrons,n/a,www.barrons.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.014053,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.699089', 'ticker_sentiment_score': '0.030353', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.699089', 'ticker_sentiment_score': '0.030353', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.961451', 'ticker_sentiment_score': '0.025486', 'ticker_sentiment_label': 'Neutral'}]"
"Dow Jones Futures: Netflix, Tesla Earnings On Deck",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-netflix-tesla-earnings-on-deck-what-to-do-now-todays-stock-market/,20230417T205400,"['SCOTT LEHTONEN', ""Investor's Business Daily""]","Dow Jones futures were little changed ahead of Tuesday's open, with first-quarter earnings season set to heat up this week. Netflix ( NFLX ) earnings are out Tuesday, while Tesla ( TSLA ) earnings are set for Wednesday.",https://www.investors.com/wp-content/uploads/2020/12/Stock-Teslalogo-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.988787'}]",0.10629,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.105449', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.105449', 'ticker_sentiment_score': '0.055983', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CSCO', 'relevance_score': '0.14028', 'ticker_sentiment_score': '-0.006255', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.070414', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.14028', 'ticker_sentiment_score': '0.096368', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.070414', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VRTX', 'relevance_score': '0.17484', 'ticker_sentiment_score': '0.062891', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NKE', 'relevance_score': '0.105449', 'ticker_sentiment_score': '0.098205', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.070414', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.105449', 'ticker_sentiment_score': '0.073282', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LULU', 'relevance_score': '0.070414', 'ticker_sentiment_score': '0.098464', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FIVE', 'relevance_score': '0.209064', 'ticker_sentiment_score': '-0.063591', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.070414', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.14028', 'ticker_sentiment_score': '-0.019143', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'V', 'relevance_score': '0.105449', 'ticker_sentiment_score': '0.109059', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WBA', 'relevance_score': '0.070414', 'ticker_sentiment_score': '0.135736', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.070414', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.105449', 'ticker_sentiment_score': '0.146038', 'ticker_sentiment_label': 'Neutral'}]"
Check Out What Whales Are Doing With JNJ - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/04/31840860/check-out-what-whales-are-doing-with-jnj,20230417T200118,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 30 strange trades. If we consider the specifics of each trade, it is accurate to state that 60% of the investors opened trades with ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.192005,Somewhat-Bullish,"[{'ticker': 'MS', 'relevance_score': '0.127456', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.73856', 'ticker_sentiment_score': '0.260004', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Monday's Market Minute: This Week's Primary Focus: Earnings,https://www.benzinga.com/news/earnings/23/04/31838477/mondays-market-minute-this-weeks-primary-focus-earnings,20230417T174815,['TD Ameritrade Network'],The focus for market participants will shift from inflation and the Fed to companies reporting quarterly results and the housing data due out this week.,https://cdn.benzinga.com/files/images/story/2023/04/17/shutterstock_775323931.jpg?width=1200&height=800&fit=crop,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}]",-0.172091,Somewhat-Bearish,"[{'ticker': 'AA', 'relevance_score': '0.199037', 'ticker_sentiment_score': '-0.020277', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NFLX', 'relevance_score': '0.199037', 'ticker_sentiment_score': '-0.020277', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.199037', 'ticker_sentiment_score': '-0.020277', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.199037', 'ticker_sentiment_score': '-0.020277', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.199037', 'ticker_sentiment_score': '-0.020277', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.199037', 'ticker_sentiment_score': '-0.020277', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNP', 'relevance_score': '0.199037', 'ticker_sentiment_score': '-0.020277', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.199037', 'ticker_sentiment_score': '-0.020277', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.199037', 'ticker_sentiment_score': '-0.020277', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRCX', 'relevance_score': '0.199037', 'ticker_sentiment_score': '-0.020277', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.199037', 'ticker_sentiment_score': '-0.020277', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.199037', 'ticker_sentiment_score': '-0.020277', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:EUR', 'relevance_score': '0.100308', 'ticker_sentiment_score': '-0.167729', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.199037', 'ticker_sentiment_score': '-0.243638', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
"Earnings Extravaganza: More Big Banks Report This Week, Along with Tesla, Netflix and Other",https://www.benzinga.com/markets/23/04/31838272/earnings-extravaganza-more-big-banks-report-this-week-along-with-tesla-netflix-and-other,20230417T174044,['Alex Coffey'],"( Monday market open ) Welcome to the first full week of Q1 earnings season. Today's a relatively quiet day on the reporting calendar, but it's the proverbial calm before the storm. Solid earnings from three of the country's largest banks fueled financials sector gains Friday, but the broader ...",https://cdn.benzinga.com/files/images/story/2023/04/17/shutterstock_119647393_1.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Financial Markets', 'relevance_score': '0.998682'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",-0.024157,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.05786', 'ticker_sentiment_score': '0.006998', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.038592', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.20986', 'ticker_sentiment_score': '0.056815', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.038592', 'ticker_sentiment_score': '-0.088654', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.077094', 'ticker_sentiment_score': '0.048524', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.15347', 'ticker_sentiment_score': '-0.073947', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.134482', 'ticker_sentiment_score': '-0.062684', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.15347', 'ticker_sentiment_score': '-0.075914', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.038592', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNP', 'relevance_score': '0.038592', 'ticker_sentiment_score': '0.051814', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.038592', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RTX', 'relevance_score': '0.038592', 'ticker_sentiment_score': '-0.056349', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.038592', 'ticker_sentiment_score': '0.051814', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FCX', 'relevance_score': '0.038592', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PM', 'relevance_score': '0.038592', 'ticker_sentiment_score': '0.051814', 'ticker_sentiment_label': 'Neutral'}]"
Merck's takeover of Prometheus gives it a foothold in immunology,https://www.marketwatch.com/story/mercks-10-8-billion-takeover-of-prometheus-is-a-good-strategic-move-that-gives-it-a-foothold-in-immunology-2f922a41,20230417T161900,['Ciara Linnane'],Merck's acquisition of Prometheus Biosciences will help the drug company diversify and reduce the risk of overreliance on its cancer drug Keytruda.,https://images.mktw.net/im-585127/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.048181,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.118064', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.118064', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MRNA', 'relevance_score': '0.059194', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RXDX', 'relevance_score': '0.118064', 'ticker_sentiment_score': '-0.04911', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ESALF', 'relevance_score': '0.059194', 'ticker_sentiment_score': '-0.322229', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'PFE', 'relevance_score': '0.118064', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.118064', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Rate-hike Fears Keep Stocks Rangebound,https://www.barrons.com/amp/news/rate-hike-fears-keep-stocks-rangebound-e3bc109f,20230417T160121,['AFP - Agence France Presse'],Rate-hike Fears Keep Stocks ...,https://www.barrons.com/asset/external-media/afp/AFP7465877786430879640431658375783229392370---1.jpg,Barrons,n/a,www.barrons.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.029141,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.028762', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOK', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:JPY', 'relevance_score': '0.213674', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:EUR', 'relevance_score': '0.143415', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.168295', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Rate-hike Fears Keep Stocks Rangebound,https://www.barrons.com/news/rate-hike-fears-keep-stocks-rangebound-e3bc109f,20230417T160121,['AFP - Agence France Presse'],Rate-hike Fears Keep Stocks ...,https://www.barrons.com/asset/external-media/afp/AFP7465877786430879640431658375783229392370---1.jpg,Barrons,n/a,www.barrons.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.029141,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.028762', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOK', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:JPY', 'relevance_score': '0.213674', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:EUR', 'relevance_score': '0.143415', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.072', 'ticker_sentiment_score': '0.168295', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Club meeting recap: Cramer applauds Well Fargo's 'amazing' quarter, as the stock jumps",https://www.cnbc.com/2023/04/17/club-meeting-recap-cramer-applauds-well-fargos-amazing-quarter.html,20230417T160051,['Paulina Likos'],"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",https://image.cnbcfm.com/api/v1/image/107226269-16817422241681742219-29059491886-1080pnbcnews.jpg?v=1681743811&w=600&h=300&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.98396'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.110636,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.160099', 'ticker_sentiment_score': '0.063736', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSNLF', 'relevance_score': '0.160099', 'ticker_sentiment_score': '0.063736', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.080458', 'ticker_sentiment_score': '0.047648', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.238133', 'ticker_sentiment_score': '0.085746', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.386477', 'ticker_sentiment_score': '0.124388', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.238133', 'ticker_sentiment_score': '0.085746', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.238133', 'ticker_sentiment_score': '0.085746', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.238133', 'ticker_sentiment_score': '0.085746', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NYT', 'relevance_score': '0.080458', 'ticker_sentiment_score': '0.047648', 'ticker_sentiment_label': 'Neutral'}]"
Surgical Sutures Market to be Worth $4.42 Billion by 2030 - Exclusive Report by Meticulous Research,https://www.benzinga.com/pressreleases/23/04/g31833643/surgical-sutures-market-to-be-worth-4-42-billion-by-2030-exclusive-report-by-meticulous-research,20230417T150000,['Globe Newswire'],"Redding, California, April 17, 2023 ( GLOBE NEWSWIRE ) -- According to a new market research report titled, 'Surgical Sutures Market by Type [Absorbable {Polyglactin, Polydioxanone, Poliglecaprone, Collagen} Nonabsorbable {Polypropylene, Nylon, Silk}] Structure [Monofilament, Multifilament] ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}]",0.195964,Somewhat-Bullish,"[{'ticker': 'ZBH', 'relevance_score': '0.024724', 'ticker_sentiment_score': '0.007192', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNN', 'relevance_score': '0.024724', 'ticker_sentiment_score': '0.007192', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SYK', 'relevance_score': '0.024724', 'ticker_sentiment_score': '0.007192', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSSMY', 'relevance_score': '0.024724', 'ticker_sentiment_score': '0.007192', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BSX', 'relevance_score': '0.024724', 'ticker_sentiment_score': '0.007192', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.024724', 'ticker_sentiment_score': '0.007192', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TFX', 'relevance_score': '0.024724', 'ticker_sentiment_score': '0.007192', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.024724', 'ticker_sentiment_score': '0.007192', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CNMD', 'relevance_score': '0.024724', 'ticker_sentiment_score': '0.007192', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HCSG', 'relevance_score': '0.024724', 'ticker_sentiment_score': '0.197276', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
CRH: 3 Quality and Inexpensive Stocks Above the 100-Day Moving Average,https://stocknews.com/news/crh-egiey-hyw-3-quality-and-inexpensive-stocks-above-the-100-day-moving-average/,20230417T142040,[],CRH: 3 Quality and Inexpensive Stocks Above the 100-Day Moving ... ...,https://stocknews.com/wp-content/uploads/2022/06/shutterstock_204245116-scaled.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.890401'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.99793'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.999999'}]",0.286435,Somewhat-Bullish,"[{'ticker': 'ENGQF', 'relevance_score': '0.051221', 'ticker_sentiment_score': '0.072996', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAYZF', 'relevance_score': '0.025624', 'ticker_sentiment_score': '0.023945', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EGIEY', 'relevance_score': '0.152821', 'ticker_sentiment_score': '0.085371', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HYW', 'relevance_score': '0.227479', 'ticker_sentiment_score': '0.242986', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.051221', 'ticker_sentiment_score': '0.025954', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TMO', 'relevance_score': '0.051221', 'ticker_sentiment_score': '0.025954', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRH', 'relevance_score': '0.347058', 'ticker_sentiment_score': '0.28161', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GSK', 'relevance_score': '0.051221', 'ticker_sentiment_score': '0.025954', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.051221', 'ticker_sentiment_score': '0.025954', 'ticker_sentiment_label': 'Neutral'}]"
"ESG activities correlate to stronger financial performance, reveals new study from Bain & Company and EcoVadis",https://www.prnewswire.com/news-releases/esg-activities-correlate-to-stronger-financial-performance-reveals-new-study-from-bain--company-and-ecovadis-301798933.html,20230417T135000,['Bain & Company'],"ESG activities correlate to stronger financial performance, reveals ... PR ...",,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.504157,Bullish,"[{'ticker': 'LRLCF', 'relevance_score': '0.039811', 'ticker_sentiment_score': '0.242805', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JPM', 'relevance_score': '0.039811', 'ticker_sentiment_score': '0.242805', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BRDCF', 'relevance_score': '0.039811', 'ticker_sentiment_score': '0.242805', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.039811', 'ticker_sentiment_score': '0.242805', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UL', 'relevance_score': '0.039811', 'ticker_sentiment_score': '0.242805', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Will J&J  ( JNJ )  Pharma Unit Outperform Market & Drive Q1 Results?,https://www.zacks.com/stock/news/2079631/will-jj-jnj-pharma-unit-outperform-market-drive-q1-results,20230417T133100,['Zacks Investment Research'],"In J&J's (JNJ) Pharma segment, its oncology drug, Darzalex as well as a psoriasis treatment, Stelara is likely to have driven sales growth in the first quarter ...",https://staticx-tuner.zacks.com/images/articles/main/ff/1612.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.995869'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.171787,Somewhat-Bullish,"[{'ticker': 'INVA', 'relevance_score': '0.230235', 'ticker_sentiment_score': '-0.01981', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.230235', 'ticker_sentiment_score': '0.122503', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.230235', 'ticker_sentiment_score': '0.300558', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SNY', 'relevance_score': '0.230235', 'ticker_sentiment_score': '0.122503', 'ticker_sentiment_label': 'Neutral'}]"
Earnings Season Picks Up Steam,https://www.forbes.com/sites/jjkinahan/2023/04/17/earnings-season-picks-up-steam/,20230417T132758,['JJ Kinahan'],It was a quiet week for stocks with both the S&P 500 and Nasdaq Composite both up less than 1%.,https://imageio.forbes.com/specials-images/imageserve/643d489591fd075fe20ab188/0x0.jpg?format=jpg&width=1200,Forbes,Markets,www.forbes.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.769861'}]",0.157282,Somewhat-Bullish,"[{'ticker': 'NFLX', 'relevance_score': '0.061159', 'ticker_sentiment_score': '0.055126', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.061159', 'ticker_sentiment_score': '0.044', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.061159', 'ticker_sentiment_score': '0.044', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.121959', 'ticker_sentiment_score': '0.056391', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.061159', 'ticker_sentiment_score': '0.182077', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CTLT', 'relevance_score': '0.121959', 'ticker_sentiment_score': '0.084242', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.121959', 'ticker_sentiment_score': '0.089172', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.061159', 'ticker_sentiment_score': '-0.048135', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALGN', 'relevance_score': '0.061159', 'ticker_sentiment_score': '0.044', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.121959', 'ticker_sentiment_score': '0.139295', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSM', 'relevance_score': '0.061159', 'ticker_sentiment_score': '-0.048135', 'ticker_sentiment_label': 'Neutral'}]"
Is Johnson & Johnson a Buy After Its Proposed $8.9 Billion Talc Settlement?,https://www.fool.com/investing/2023/04/17/is-johnson-johnson-a-buy-after-proposed-89-billion/,20230417T123600,['Justin Pope'],The controversial company could soon take a big step forward.,https://media.ycharts.com/charts/8b6b0b001e28da43d43d0c7f8053bbb0.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.967321'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.184816,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.489163', 'ticker_sentiment_score': '0.237213', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Regeneron Announces Retirement of Board Chair, Dr. P. Roy Vagelos, Accomplished Physician-Businessman and Industry Luminary",https://www.globenewswire.com/news-release/2023/04/17/2647803/0/en/Regeneron-Announces-Retirement-of-Board-Chair-Dr-P-Roy-Vagelos-Accomplished-Physician-Businessman-and-Industry-Luminary.html,20230417T113000,"['Regeneron Pharmaceuticals', 'Inc.']",Dr. Leonard S. Schleifer and Dr. George D. Yancopoulos to become Co-Chairs of the Board and Christine A. Poon to be named Lead Independent Director Dr. Leonard S. Schleifer and Dr. George D. Yancopoulos to become Co-Chairs of the Board and Christine A. Poon to be named Lead Independent ...,https://ml.globenewswire.com/Resource/Download/add5ebc7-88c9-49dc-8834-abbb07c622d1,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.262679,Somewhat-Bullish,"[{'ticker': 'REGN', 'relevance_score': '0.205807', 'ticker_sentiment_score': '0.074563', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.069294', 'ticker_sentiment_score': '0.154735', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Regeneron Announces Retirement of Board Chair, Dr. P. Roy Vagelos, Accomplished Physician-Businessman and Industry Luminary - Regeneron Pharmaceuticals  ( NASDAQ:REGN ) ",https://www.benzinga.com/pressreleases/23/04/g31826057/regeneron-announces-retirement-of-board-chair-dr-p-roy-vagelos-accomplished-physician-businessman-,20230417T113000,['Globe Newswire'],"TARRYTOWN, N.Y., April 17, 2023 ( GLOBE NEWSWIRE ) -- Regeneron Pharmaceuticals, Inc. REGN today announced that P. Roy Vagelos, M.D., will retire from his role as Chair of the Company's Board of Directors and will not stand for reelection at the Company's 2023 Annual Meeting of Shareholders.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.253818,Somewhat-Bullish,"[{'ticker': 'REGN', 'relevance_score': '0.201244', 'ticker_sentiment_score': '0.073268', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.067727', 'ticker_sentiment_score': '0.154425', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Lack of Volatility, Weak Macro, Mixed Fed Messages, Earnings, Charting Markets",https://realmoney.thestreet.com/investing/lack-of-volatility-weak-macro-mixed-fed-messages-earnings-charting-markets-16121271,20230417T112808,['Stephen Guilfoyle'],"Lack of Volatility, Weak Macro, Mixed Fed Messages, Earnings ... ...",https://s.thestreet.com/files/tsc/v2008/photos/contrib/uploads/b94de534-dd08-11ed-85d3-89a410cb95fc.png,The Street,GoogleRSS,realmoney.thestreet.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.972193'}, {'topic': 'Financial Markets', 'relevance_score': '0.999982'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.999336'}]",0.055045,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.035929', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.035929', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.035929', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.035929', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.05387', 'ticker_sentiment_score': '0.027012', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.035929', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.035929', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.035929', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRCX', 'relevance_score': '0.035929', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.035929', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DAL', 'relevance_score': '0.035929', 'ticker_sentiment_score': '0.047589', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.035929', 'ticker_sentiment_score': '0.047589', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.035929', 'ticker_sentiment_score': '-0.058146', 'ticker_sentiment_label': 'Neutral'}]"
"JPMorgan, Citigroup and even Wells Fargo are part of Zacks Earnings Preview",https://www.zacks.com/stock/news/2079476/jpmorgan-citigroup-and-even-wells-fargo-are-part-of-zacks-earnings-preview,20230417T110000,['Zacks Investment Research'],"JPMorgan, Citigroup and Wells Fargo are highlights of Zacks Earnings Preview article.",https://staticx-tuner.zacks.com/images/articles/main/59/80.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.004832,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.029691', 'ticker_sentiment_score': '-0.039501', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.205557', 'ticker_sentiment_score': '0.144802', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.029691', 'ticker_sentiment_score': '-0.039501', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.029691', 'ticker_sentiment_score': '-0.083923', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.205557', 'ticker_sentiment_score': '0.144802', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.176717', 'ticker_sentiment_score': '0.083193', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.029691', 'ticker_sentiment_score': '-0.039501', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.029691', 'ticker_sentiment_score': '-0.039501', 'ticker_sentiment_label': 'Neutral'}]"
Global Markets: European stocks touch fresh highs ahead of US earnings | The Financial Express,https://www.financialexpress.com/market/global-markets-european-stocks-touch-fresh-highs-ahead-of-us-earnings/3050511/,20230417T094737,[],Global Markets: European stocks touch fresh highs ahead of US ... The Financial Express ...,https://www.financialexpress.com/wp-content/uploads/2023/04/1-208.jpg,The Financial Express,n/a,www.financialexpress.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.769861'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.818451'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.904684'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.126363,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.051774', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.051774', 'ticker_sentiment_score': '0.108022', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.051774', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.103331', 'ticker_sentiment_score': '-0.050087', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.051774', 'ticker_sentiment_score': '0.108022', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.051774', 'ticker_sentiment_score': '0.108022', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.051774', 'ticker_sentiment_score': '0.094521', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.051774', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.051774', 'ticker_sentiment_score': '0.094521', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:JPY', 'relevance_score': '0.154455', 'ticker_sentiment_score': '0.111019', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.154455', 'ticker_sentiment_score': '0.152551', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
1 Warren Buffett Index Fund Could Turn $100 Per Week into $1 Million,https://www.fool.com/investing/2023/04/17/1-warren-buffett-index-fund-turn-100-to-1-million/,20230417T091500,['Trevor Jennewine'],Warren Buffett believes this strategy can help the average investor outperform professional money managers.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F728088%2Fartificial-intelligence-ai-on-circuit-board.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.9996'}]",0.219875,Somewhat-Bullish,"[{'ticker': 'SPGI', 'relevance_score': '0.060085', 'ticker_sentiment_score': '0.097035', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.060085', 'ticker_sentiment_score': '0.216073', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.060085', 'ticker_sentiment_score': '0.036997', 'ticker_sentiment_label': 'Neutral'}]"
U.S. stock futures near highs of the year as earnings season eyed,https://www.marketwatch.com/story/u-s-stock-futures-near-highs-of-the-year-as-earnings-season-eyed-f30a4a9b,20230417T091100,['Jamie Chisholm'],"The S&P 500 is in line to begin Monday near the top of the 3,800 to 4,200 range within which it has vacillated for about five months.",https://images.mktw.net/im-763159/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",-0.007248,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.152983', 'ticker_sentiment_score': '0.069151', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.152983', 'ticker_sentiment_score': '0.069151', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HRGLF', 'relevance_score': '0.076847', 'ticker_sentiment_score': '0.182311', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BAC', 'relevance_score': '0.152983', 'ticker_sentiment_score': '0.069151', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.152983', 'ticker_sentiment_score': '0.069151', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.152983', 'ticker_sentiment_score': '0.069151', 'ticker_sentiment_label': 'Neutral'}]"
2 Best Biotech Stocks to Buy for the Long Haul,https://www.fool.com/investing/2023/04/17/2-best-biotech-stocks-to-buy-for-the-long-haul/,20230417T091000,['Kody Kester'],These two are among the largest pharma companies in the world.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F728172%2Fa-doctor-and-patient-talk-to-each-other-during-an-appointment.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}]",0.287943,Somewhat-Bullish,"[{'ticker': 'BMY', 'relevance_score': '0.07157', 'ticker_sentiment_score': '0.099916', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.212425', 'ticker_sentiment_score': '-0.082507', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.07157', 'ticker_sentiment_score': '0.084311', 'ticker_sentiment_label': 'Neutral'}]"
The Fed Expects a Recession: 2 Warren Buffett Stocks to Buy Now and 1 to Avoid Like the Plague,https://www.fool.com/investing/2023/04/17/fed-recession-2-warren-buffett-stocks-buy-1-avoid/,20230417T090600,['Sean Williams'],"Two Berkshire Hathaway holdings are well positioned for a possible economic downturn, while another Buffett favorite is best avoided.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F728241%2Fwarren-buffett-brka-brkb-berkshire-hathaway-motley-fool5.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.838487'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999499'}, {'topic': 'Earnings', 'relevance_score': '0.744043'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.032095,Neutral,"[{'ticker': 'OXY', 'relevance_score': '0.236684', 'ticker_sentiment_score': '0.005646', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVX', 'relevance_score': '0.17868', 'ticker_sentiment_score': '-0.025223', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'V', 'relevance_score': '0.34851', 'ticker_sentiment_score': '0.109906', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.06001', 'ticker_sentiment_score': '-0.017233', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.149285', 'ticker_sentiment_score': '0.06077', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPGI', 'relevance_score': '0.030026', 'ticker_sentiment_score': '0.15576', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HCSG', 'relevance_score': '0.030026', 'ticker_sentiment_score': '-0.041097', 'ticker_sentiment_label': 'Neutral'}]"
Appointment of new CEO,https://www.globenewswire.com/news-release/2023/04/17/2647616/0/en/Appointment-of-new-CEO.html,20230417T080000,['Chemometec A/S'],ANNOUNCEMENT NO. ...,https://ml-eu.globenewswire.com/Resource/Download/dda6d08e-1d43-433e-bc7b-b1e84b4963be,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}]",0.238177,Somewhat-Bullish,"[{'ticker': 'MDT', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.099731', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.046311', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.238133', 'ticker_sentiment_score': '0.131175', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.120431', 'ticker_sentiment_score': '0.046311', 'ticker_sentiment_label': 'Neutral'}]"
FMCG market size to grow by USD 310.5 billion from 2021 to 2026; Growth driven by growing preference for e-commerce online distribution - Technavio,https://www.prnewswire.com/news-releases/fmcg-market-size-to-grow-by-usd-310-5-billion-from-2021-to-2026-growth-driven-by-growing-preference-for-e-commerce-online-distribution---technavio-301798236.html,20230417T043000,['Technavio'],FMCG market size to grow by USD 310.5 billion from 2021 to 2026 ... PR ...,https://mma.prnewswire.com/media/2054982/Technavio_Logo_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",0.233148,Somewhat-Bullish,"[{'ticker': 'KMB', 'relevance_score': '0.109242', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.093714', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KDP', 'relevance_score': '0.109242', 'ticker_sentiment_score': '0.022822', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.109242', 'ticker_sentiment_score': '0.157685', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KHC', 'relevance_score': '0.015654', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UL', 'relevance_score': '0.062556', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.062556', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'K', 'relevance_score': '0.015654', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRLCF', 'relevance_score': '0.031302', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NSRGF', 'relevance_score': '0.031302', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Wall Street ticks higher ahead of another busy earnings week,https://apnews.com/article/inflation-federal-reserve-system-financial-markets-business-f2678ffc2c6a9f415a652c6b5ebf3968,20230417T034817,[],"Asian shares mixed over economic growth, rate worries The Associated Press ...",https://storage.googleapis.com/afs-prod/media/bcad6f196df3400ba0e7a9d69fa63853/3000.webp,Associated Press,Markets,apnews.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.838487'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",-0.118196,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.063258', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.063258', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.063258', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RXDX', 'relevance_score': '0.063258', 'ticker_sentiment_score': '0.066021', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.063258', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:JPY', 'relevance_score': '0.126119', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:EUR', 'relevance_score': '0.063258', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.063258', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Stocks drift to open first full week of earnings season,https://apnews.com/article/inflation-federal-reserve-system-financial-markets-business-f2678ffc2c6a9f415a652c6b5ebf3968,20230417T034817,[],"Asian shares mixed over economic growth, rate worries The Associated Press ...",https://storage.googleapis.com/afs-prod/media/bcad6f196df3400ba0e7a9d69fa63853/3000.webp,Associated Press,Markets,apnews.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.875462'}]",-0.012221,Neutral,"[{'ticker': 'STT', 'relevance_score': '0.051774', 'ticker_sentiment_score': '-0.174326', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TSLA', 'relevance_score': '0.051774', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.051774', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.103331', 'ticker_sentiment_score': '0.047571', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.051774', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.051774', 'ticker_sentiment_score': '-0.060061', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.051774', 'ticker_sentiment_score': '-0.071023', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RXDX', 'relevance_score': '0.051774', 'ticker_sentiment_score': '0.105505', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBNY', 'relevance_score': '0.051774', 'ticker_sentiment_score': '-0.038027', 'ticker_sentiment_label': 'Neutral'}]"
Wall Street holds steady as earnings season kicks into gear,https://apnews.com/article/inflation-federal-reserve-system-financial-markets-business-f2678ffc2c6a9f415a652c6b5ebf3968,20230417T034817,[],"Asian shares mixed over economic growth, rate worries The Associated Press ...",https://storage.googleapis.com/afs-prod/media/bcad6f196df3400ba0e7a9d69fa63853/3000.webp,Associated Press,Markets,apnews.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.875462'}]",-0.007347,Neutral,"[{'ticker': 'STT', 'relevance_score': '0.049629', 'ticker_sentiment_score': '-0.173929', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TSLA', 'relevance_score': '0.049629', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.049629', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.099066', 'ticker_sentiment_score': '-0.010982', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.049629', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.049629', 'ticker_sentiment_score': '0.013015', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.049629', 'ticker_sentiment_score': '-0.071001', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RXDX', 'relevance_score': '0.049629', 'ticker_sentiment_score': '0.107191', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBNY', 'relevance_score': '0.049629', 'ticker_sentiment_score': '-0.093984', 'ticker_sentiment_label': 'Neutral'}]"
Wall Street drifts lower as earnings season kicks into gear,https://apnews.com/article/inflation-federal-reserve-system-financial-markets-business-f2678ffc2c6a9f415a652c6b5ebf3968,20230417T034817,[],"Asian shares mixed over economic growth, rate worries The Associated Press ...",https://storage.googleapis.com/afs-prod/media/bcad6f196df3400ba0e7a9d69fa63853/3000.webp,Associated Press,Markets,apnews.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.875462'}]",-0.019594,Neutral,"[{'ticker': 'STT', 'relevance_score': '0.049322', 'ticker_sentiment_score': '-0.173878', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TSLA', 'relevance_score': '0.049322', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.049322', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.098456', 'ticker_sentiment_score': '-0.010957', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.049322', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.049322', 'ticker_sentiment_score': '0.013013', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.049322', 'ticker_sentiment_score': '-0.071', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RXDX', 'relevance_score': '0.049322', 'ticker_sentiment_score': '0.10714', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBNY', 'relevance_score': '0.049322', 'ticker_sentiment_score': '-0.093976', 'ticker_sentiment_label': 'Neutral'}]"
Wall Street drifts as earnings season kicks into gear,https://apnews.com/article/inflation-federal-reserve-system-financial-markets-business-f2678ffc2c6a9f415a652c6b5ebf3968,20230417T034817,[],"Asian shares mixed over economic growth, rate worries The Associated Press ...",https://storage.googleapis.com/afs-prod/media/bcad6f196df3400ba0e7a9d69fa63853/3000.webp,Associated Press,Markets,apnews.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.875462'}]",0.0,Neutral,"[{'ticker': 'STT', 'relevance_score': '0.048523', 'ticker_sentiment_score': '-0.173752', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TSLA', 'relevance_score': '0.048523', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.048523', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.096866', 'ticker_sentiment_score': '-0.0109', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.048523', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.048523', 'ticker_sentiment_score': '0.013009', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.048523', 'ticker_sentiment_score': '-0.070998', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RXDX', 'relevance_score': '0.048523', 'ticker_sentiment_score': '0.107', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBNY', 'relevance_score': '0.048523', 'ticker_sentiment_score': '-0.093951', 'ticker_sentiment_label': 'Neutral'}]"
Stocks drift higher as earnings season kicks into gear,https://apnews.com/article/inflation-federal-reserve-system-financial-markets-business-f2678ffc2c6a9f415a652c6b5ebf3968,20230417T034817,[],"Asian shares mixed over economic growth, rate worries The Associated Press ...",https://storage.googleapis.com/afs-prod/media/bcad6f196df3400ba0e7a9d69fa63853/3000.webp,Associated Press,Markets,apnews.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Financial Markets', 'relevance_score': '0.980922'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.875462'}]",0.036641,Neutral,"[{'ticker': 'STT', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.001003', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.096477', 'ticker_sentiment_score': '-0.010886', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.012006', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.048327', 'ticker_sentiment_score': '-0.070997', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RXDX', 'relevance_score': '0.048327', 'ticker_sentiment_score': '0.106964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBNY', 'relevance_score': '0.048327', 'ticker_sentiment_score': '-0.093943', 'ticker_sentiment_label': 'Neutral'}]"
Stocks Mixed As Rate-hike Fears Resurface,https://www.barrons.com/news/asian-markets-mixed-as-wary-traders-weigh-latest-data-9aa1db,20230417T031106,['AFP - Agence France Presse'],Asian Markets Mixed As Wary Traders Weigh Latest Data ...,,Barrons,n/a,www.barrons.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.0,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.084722', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.084722', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.084722', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.084722', 'ticker_sentiment_score': '0.029673', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.084722', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.084722', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOK', 'relevance_score': '0.084722', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:JPY', 'relevance_score': '0.250386', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:EUR', 'relevance_score': '0.16849', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.084722', 'ticker_sentiment_score': '0.171654', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Asia stocks on edge for earnings, China data | The Financial Express",https://www.financialexpress.com/market/asia-stocks-on-edge-for-earnings-china-data/3049805/,20230417T024621,[],"Asia stocks on edge for earnings, China data The Financial Express ...",https://www.financialexpress.com/wp-content/uploads/2023/04/asian-stocks-2.jpg,The Financial Express,n/a,www.financialexpress.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.769861'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.857896'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.714479'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.102986,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.059488', 'ticker_sentiment_score': '0.024004', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.059488', 'ticker_sentiment_score': '0.024004', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.059488', 'ticker_sentiment_score': '0.024004', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.059488', 'ticker_sentiment_score': '0.024004', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.059488', 'ticker_sentiment_score': '0.024004', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:JPY', 'relevance_score': '0.118647', 'ticker_sentiment_score': '0.179764', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.17715', 'ticker_sentiment_score': '0.224825', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Tesla, AT&T, Goldman Sachs, Netflix, Charles Schwab, and More Stocks to Watch This Week",https://www.barrons.com/articles/stocks-to-watch-this-week-tesla-att-goldman-sachs-netflix-charles-schwab-9d157291,20230416T235100,['Nicholas Jasinski'],It will be a busy week of first-quarter earnings reports and with several of the latest indicators on the U.S. economy and housing market on deck. Charles Schwab and J.B.,https://images.barrons.com/im-764111/social,Barrons,n/a,www.barrons.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.0,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.546745', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.546745', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.546745', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.546745', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.546745', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.546745', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.546745', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
"Tesla, AT&T, Goldman Sachs, Netflix, Charles Schwab, and More Stocks to Watch This Week",https://www.barrons.com/articles/tesla-at-t-goldman-sachs-netflix-charles-schwab-and-more-stocks-to-watch-this-week-9d157291,20230416T190000,['Nicholas Jasinski'],It will be a busy week of first-quarter earnings reports and with several of the latest indicators on the U.S. economy and housing market on deck. Charles Schwab and J.B.,https://images.barrons.com/im-764111/social,Barrons,n/a,www.barrons.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.0,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.546745', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.546745', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.546745', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.546745', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.546745', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.546745', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.546745', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
"Tesla, Netflix earnings and Apple's India debut top week ahead",https://www.foxbusiness.com/markets/tesla-netflix-earnings-apple-india-debut-top-week-ahead,20230416T174845,[],"Investors head into a busy week as earnings season continues with tech and bank companies on the docket. Additionally, Apple is set to make a big splash in India. notched weekly gains, led by the Dow Jones Industrial Average, while the S&P 500 and Nasdaq Composite posted smaller increases.",https://cf-images.us-east-1.prod.boltdns.net/v1/static/854081161001/29f659f7-6e92-444d-8e0d-e911e78503b8/0d06a229-1cab-4834-ba0d-d3f9a26edf52/1280x720/match/image.jpg,Fox Business News,n/a,www.foxbusiness.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Blockchain', 'relevance_score': '0.451494'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.890401'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.744043'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.769861'}]",-0.002345,Neutral,"[{'ticker': 'ALK', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CFG', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PPG', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BK', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'COIN', 'relevance_score': '0.049939', 'ticker_sentiment_score': '-0.003996', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STT', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KNX', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BX', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EFX', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPGI', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UBER', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NFLX', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IBKR', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OMC', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALLY', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HCA', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SIG', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RF', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.049939', 'ticker_sentiment_score': '-0.050798', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FCX', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HD', 'relevance_score': '0.049939', 'ticker_sentiment_score': '-0.461929', 'ticker_sentiment_label': 'Bearish'}, {'ticker': 'PM', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.049939', 'ticker_sentiment_score': '-0.031897', 'ticker_sentiment_label': 'Neutral'}]"
2 of the Lowest-Risk Dividend Stocks in the World,https://www.fool.com/investing/2023/04/16/2-of-the-lowest-risk-dividend-stocks-in-the-world/,20230416T143100,['Matthew DiLallo'],The companies backing these dividends generate massive cash flows and have fortress-like balance sheets.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F728088%2Fartificial-intelligence-ai-on-circuit-board.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.99977'}]",0.293215,Somewhat-Bullish,"[{'ticker': 'ATVI', 'relevance_score': '0.116067', 'ticker_sentiment_score': '0.304602', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.577979', 'ticker_sentiment_score': '0.385371', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.488777', 'ticker_sentiment_score': '0.285198', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Tesla, Netflix earnings due: Cheaper cars, cheaper content, more workout videos, as 'earnings recession' seems likely",https://www.marketwatch.com/story/tesla-netflix-earnings-due-cheaper-cars-cheaper-content-more-workout-videos-as-earnings-recession-seems-likely-bf4ebc54,20230416T140100,['Bill Peters'],"Netflix, Tesla, banks and credit-card companies report in the week ahead.",https://images.mktw.net/im-764247/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.838487'}]",-0.050638,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.332211', 'ticker_sentiment_score': '0.158415', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UAL', 'relevance_score': '0.068404', 'ticker_sentiment_score': '-0.119409', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.068404', 'ticker_sentiment_score': '-0.119409', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.068404', 'ticker_sentiment_score': '-0.119409', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.068404', 'ticker_sentiment_score': '-0.119409', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.068404', 'ticker_sentiment_score': '-0.119409', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CSX', 'relevance_score': '0.068404', 'ticker_sentiment_score': '-0.074458', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.068404', 'ticker_sentiment_score': '-0.119409', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DFS', 'relevance_score': '0.068404', 'ticker_sentiment_score': '-0.109668', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.23615', 'ticker_sentiment_score': '0.028999', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'T', 'relevance_score': '0.034233', 'ticker_sentiment_score': '-0.115197', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.102449', 'ticker_sentiment_score': '-0.117939', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.068404', 'ticker_sentiment_score': '-0.119409', 'ticker_sentiment_label': 'Neutral'}]"
Three investors on how to protect your portfolio | Business,https://www.cnn.com/2023/04/16/business/stocks-week-ahead/index.html,20230416T113500,['Krystal Hur'],Three investors on how to protect your portfolio ...,"https://media.cnn.com/api/v1/images/stellar/prod/230317083900-nyse-0316.jpg?c=16x9&q=w_800,c_fill",CNN,Markets,www.cnn.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.990678'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.980716'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.999476'}]",0.0,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.089797', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.089797', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.04497', 'ticker_sentiment_score': '0.149993', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WAL', 'relevance_score': '0.089797', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.134339', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PNC', 'relevance_score': '0.04497', 'ticker_sentiment_score': '0.149993', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CFG', 'relevance_score': '0.089797', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.089797', 'ticker_sentiment_score': '0.102568', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.134339', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.089797', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.134339', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AN', 'relevance_score': '0.04497', 'ticker_sentiment_score': '-0.033842', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.089797', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IBM', 'relevance_score': '0.089797', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.04497', 'ticker_sentiment_score': '0.149993', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.089797', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WBD', 'relevance_score': '0.04497', 'ticker_sentiment_score': '0.04994', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.089797', 'ticker_sentiment_score': '-0.035964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.134339', 'ticker_sentiment_score': '0.162647', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SBNY', 'relevance_score': '0.04497', 'ticker_sentiment_score': '-0.065795', 'ticker_sentiment_label': 'Neutral'}]"
Why Johnson & Johnson Is Such an Impressive Dividend Stock,https://www.fool.com/investing/2023/04/15/why-johnson-johnson-is-such-an-impressive-dividend/,20230415T135000,['David Jagielski'],"For dividend investors, this stock can be a solid pillar to build your portfolio around.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F727516%2Fstock-market-person-looking-at-computer-charts.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}]",0.298787,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.405651', 'ticker_sentiment_score': '0.28873', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WBA', 'relevance_score': '0.070725', 'ticker_sentiment_score': '0.185241', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Farallon steps up activism at biotech company Exelixis. Here's what could happen next,https://www.cnbc.com/2023/04/15/-farallon-steps-up-activism-at-biotech-company-exelixis-heres-what-could-happen-next.html,20230415T112607,['Kenneth Squire'],"Farallon isn't an activist investor, but it won't shy away from a battle if necessary.",https://image.cnbcfm.com/api/v1/image/107225857-1681511347626-gettyimages-1327624070-pi-2204527.jpeg?v=1681557967&w=1920&h=1080,CNBC,Investing,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Economy - Fiscal', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.998962'}, {'topic': 'Earnings', 'relevance_score': '0.538269'}]",0.176171,Somewhat-Bullish,"[{'ticker': 'EXEL', 'relevance_score': '0.217834', 'ticker_sentiment_score': '0.136812', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.027571', 'ticker_sentiment_score': '0.091125', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson Stock: Bear vs. Bull,https://www.fool.com/investing/2023/04/15/johnson-johnson-stock-bear-vs-bull/,20230415T112000,['Alex Carchidi'],"The stock's proponents are facing upcoming uncertainty, but its detractors aren't as much.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F727516%2Fstock-market-person-looking-at-computer-charts.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}]",0.14947,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.282777', 'ticker_sentiment_score': '0.141795', 'ticker_sentiment_label': 'Neutral'}]"
3 Dividend Stocks to Buy and Hold for the Next Decade,https://www.fool.com/investing/2023/04/15/3-dividend-stocks-to-buy-and-hold-for-the-next-dec/,20230415T101400,"['David Jagielski', 'and Prosper Junior Bakiny', 'Keith Speights']",Long-term investors looking for income should especially like these stocks.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F727606%2Fwarren-buffett-brka-brkb-berkshire-hathaway-motley-fool2.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}]",0.208251,Somewhat-Bullish,"[{'ticker': 'ABBV', 'relevance_score': '0.324673', 'ticker_sentiment_score': '0.093828', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GILD', 'relevance_score': '0.165883', 'ticker_sentiment_score': '0.125557', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.286002', 'ticker_sentiment_score': '0.192414', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Analyzing Q1 Bank Earnings: Good or Bad?,https://www.zacks.com/commentary/2079235/analyzing-q1-bank-earnings-good-or-bad,20230414T221600,['Zacks Investment Research'],"There was plenty to like in these quarterly results, with higher interest rates helping these big players expand their margins while demand for loans remained strong, helping loan portfolios grow.",https://staticx-tuner.zacks.com/images/articles/main/ae/82.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.019257,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.027508', 'ticker_sentiment_score': '-0.036258', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.163909', 'ticker_sentiment_score': '0.128444', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.027508', 'ticker_sentiment_score': '-0.036258', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.027508', 'ticker_sentiment_score': '-0.083151', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.163909', 'ticker_sentiment_score': '0.128444', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.075594', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.027508', 'ticker_sentiment_score': '-0.036258', 'ticker_sentiment_label': 'Neutral'}]"
"Investing Action Plan: Tesla, Netflix, Goldman Sachs Earnings Amid Young Uptrend",https://www.investors.com/research/investing-action-plan/stock-trading-action-plan-tesla-netflix-goldman-sachs-earnings-amid-young-uptrend/,20230414T220300,"[""Investor's Business Daily"", 'ALAN R. ELLIOTT']","Investing Action Plan: Tesla, Netflix, Goldman Sachs Earnings Amid ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2019/11/stock-NYSE-exterior-04-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '1.0'}]",0.102536,Neutral,"[{'ticker': 'XPEV', 'relevance_score': '0.042762', 'ticker_sentiment_score': '0.123163', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WAL', 'relevance_score': '0.042762', 'ticker_sentiment_score': '-0.056626', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.042762', 'ticker_sentiment_score': '0.093831', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.042762', 'ticker_sentiment_score': '0.093831', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SLB', 'relevance_score': '0.042762', 'ticker_sentiment_score': '0.097777', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.042762', 'ticker_sentiment_score': '0.093831', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ASML', 'relevance_score': '0.064104', 'ticker_sentiment_score': '0.113235', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.148863', 'ticker_sentiment_score': '0.057581', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMA', 'relevance_score': '0.042762', 'ticker_sentiment_score': '-0.056626', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRCX', 'relevance_score': '0.042762', 'ticker_sentiment_score': '-0.001973', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPGI', 'relevance_score': '0.021388', 'ticker_sentiment_score': '-0.017343', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DKNG', 'relevance_score': '0.042762', 'ticker_sentiment_score': '0.050026', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NFLX', 'relevance_score': '0.148863', 'ticker_sentiment_score': '0.088158', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.042762', 'ticker_sentiment_score': '-0.056626', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.042762', 'ticker_sentiment_score': '-0.056626', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HCA', 'relevance_score': '0.064104', 'ticker_sentiment_score': '0.061032', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BKR', 'relevance_score': '0.064104', 'ticker_sentiment_score': '0.075667', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.0854', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IOT', 'relevance_score': '0.042762', 'ticker_sentiment_score': '0.050026', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.064104', 'ticker_sentiment_score': '0.051023', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NIO', 'relevance_score': '0.042762', 'ticker_sentiment_score': '0.123163', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.042762', 'ticker_sentiment_score': '0.093831', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.042762', 'ticker_sentiment_score': '0.093831', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCHW', 'relevance_score': '0.042762', 'ticker_sentiment_score': '-0.056626', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FCX', 'relevance_score': '0.064104', 'ticker_sentiment_score': '-0.075161', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.042762', 'ticker_sentiment_score': '0.136375', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LI', 'relevance_score': '0.064104', 'ticker_sentiment_score': '0.125286', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KEY', 'relevance_score': '0.042762', 'ticker_sentiment_score': '-0.056626', 'ticker_sentiment_label': 'Neutral'}]"
"Time of the Season: Banks Get Quarterly Reporting Off to Strong Start, but Retail Sales Disappoint",https://www.benzinga.com/markets/23/04/31810522/time-of-the-season-banks-get-quarterly-reporting-off-to-strong-start-but-retail-sales-disappoint,20230414T165710,['Alex Coffey'],"( Friday market open ) The biggest U.S. banks have a reputation for beating Wall Street's earnings estimates, and they lived up to it again Friday morning.",https://cdn.benzinga.com/files/images/story/2023/04/14/shutterstock_119647393.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Financial Markets', 'relevance_score': '0.999999'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",-0.007255,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.038499', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.038499', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.096052', 'ticker_sentiment_score': '0.096834', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.038499', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.096052', 'ticker_sentiment_score': '0.100269', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.038499', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.038499', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.038499', 'ticker_sentiment_score': '0.091634', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.096052', 'ticker_sentiment_score': '-0.011691', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STT', 'relevance_score': '0.038499', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.096052', 'ticker_sentiment_score': '-0.010624', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.11514', 'ticker_sentiment_score': '0.067725', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNP', 'relevance_score': '0.076909', 'ticker_sentiment_score': '0.02424', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXP', 'relevance_score': '0.076909', 'ticker_sentiment_score': '0.02424', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CME', 'relevance_score': '0.038499', 'ticker_sentiment_score': '-0.08031', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PM', 'relevance_score': '0.076909', 'ticker_sentiment_score': '0.02424', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:EUR', 'relevance_score': '0.019255', 'ticker_sentiment_score': '-0.113307', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.038499', 'ticker_sentiment_score': '-0.123079', 'ticker_sentiment_label': 'Neutral'}]"
"Spencer Breithaupt Joins PetVivo Holdings, Inc. Board of Directors",https://www.globenewswire.com/news-release/2023/04/14/2647269/0/en/Spencer-Breithaupt-Joins-PetVivo-Holdings-Inc-Board-of-Directors.html,20230414T163500,"['Inc.', 'PetVivo Holdings']","MINNEAPOLIS, MN, US, April 14, 2023 ( GLOBE NEWSWIRE ) -- PetVivo Holdings, Inc. ( NASDAQ: PETV & PETVW ) ( the ""Company"" ) an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for companion animals and animal athletes is pleased to announce ...",https://ml.globenewswire.com/Resource/Download/3650e342-de03-4b6b-9361-77521907301c,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.614606'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.242534,Somewhat-Bullish,"[{'ticker': 'ABC', 'relevance_score': '0.049835', 'ticker_sentiment_score': '0.121196', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PETV', 'relevance_score': '0.426225', 'ticker_sentiment_score': '0.421603', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.049835', 'ticker_sentiment_score': '0.121196', 'ticker_sentiment_label': 'Neutral'}]"
StockNews.com Issues Imperative Report on Heska Corporation's Healthcare Stock,https://beststocks.com/stocknews-com-issues-imperative-report-on-heska-co/,20230414T151447,['Ronald Kaufman'],StockNews.com Issues Imperative Report on Heska Corporation's ... Best Stocks ...,https://beststocks.com/wp-content/uploads/2023/02/business-news-today-750x375.jpg,Stocknews.com,n/a,beststocks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.980922'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.222288,Somewhat-Bullish,"[{'ticker': 'HSKA', 'relevance_score': '0.588294', 'ticker_sentiment_score': '0.360433', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'MS', 'relevance_score': '0.059488', 'ticker_sentiment_score': '0.150004', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.059488', 'ticker_sentiment_score': '0.175014', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ZTS', 'relevance_score': '0.059488', 'ticker_sentiment_score': '0.046143', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GLP', 'relevance_score': '0.059488', 'ticker_sentiment_score': '0.150004', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ALGGF', 'relevance_score': '0.059488', 'ticker_sentiment_score': '0.150004', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.118647', 'ticker_sentiment_score': '0.132212', 'ticker_sentiment_label': 'Neutral'}]"
Drug manufacturer Catalent's stock tumbles 25% after profit warning and CFO departure,https://www.marketwatch.com/story/catalent-issues-profit-warning-for-fiscal-q3-after-manufacturing-and-cost-issues-at-three-plants-sending-stock-down-20-120d0af5,20230414T145700,['Ciara Linnane'],Drug manufacturer Catalent said higher-than-expected costs and productivity issues at three plants would have a material adverse impact on fiscal third-quarter earnings.,https://images.mktw.net/im-258428/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Earnings', 'relevance_score': '0.839681'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",-0.004765,Neutral,"[{'ticker': 'MRNA', 'relevance_score': '0.28305', 'ticker_sentiment_score': '0.063239', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SRPT', 'relevance_score': '0.143843', 'ticker_sentiment_score': '0.053048', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CTLT', 'relevance_score': '0.585334', 'ticker_sentiment_score': '-0.076393', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.143843', 'ticker_sentiment_score': '0.053048', 'ticker_sentiment_label': 'Neutral'}]"
FDA Strikes Down Eli Lilly's Application Seeking Approval For Ulcerative Colitis Drug - Eli Lilly  ( NYSE:LLY ) ,https://www.benzinga.com/general/biotech/23/04/31803789/fda-strikes-down-eli-lillys-application-seeking-approval-for-ulcerative-colitis-drug,20230414T133350,['Vandana Singh'],"The FDA has issued a complete response letter for Eli Lilly And Co's LLY mirikizumab biologic license application ( BLA ) for ulcerative colitis ( UC ) . In the letter, the FDA cited issues related to the proposed manufacturing of mirikizumab, with no concerns about the clinical data ...",https://cdn.benzinga.com/files/images/story/2023/04/14/abbvie.jpg?optimize=medium&dpr=2&auto=webp&width=3840,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.093177,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.713164', 'ticker_sentiment_score': '0.194515', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MORN', 'relevance_score': '0.140896', 'ticker_sentiment_score': '-0.021003', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.277433', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.277433', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.277433', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
J&J  ( JNJ )  to Initiate Q1 Earnings Season for Pharma Sector,https://www.zacks.com/stock/news/2078827/jj-jnj-to-initiate-q1-earnings-season-for-pharma-sector,20230414T131500,['Zacks Investment Research'],"Growth in J&J's (JNJ) Pharma unit is expected to have been driven by drugs like Darzalex and Stelara. In the MedTech segment, continued recovery in worldwide procedure volume should drive sales.",https://staticx-tuner.zacks.com/images/articles/main/7d/1177.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999973'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.11281,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.247838', 'ticker_sentiment_score': '-0.039123', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.247838', 'ticker_sentiment_score': '0.065892', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.199447', 'ticker_sentiment_score': '0.05386', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.100518', 'ticker_sentiment_score': '0.07225', 'ticker_sentiment_label': 'Neutral'}]"
Wall Street: All eyes on earnings announcements as recession fears take centre stage | The Financial Express,https://www.financialexpress.com/business/investing-abroad-wall-street-all-eyes-on-earnings-announcements-as-recession-fears-take-centre-stage-3047210/,20230414T125700,[],Wall Street: All eyes on earnings announcements as recession fears ... The Financial Express ...,https://www.financialexpress.com/wp-content/uploads/2023/04/19-8.jpg,The Financial Express,n/a,www.financialexpress.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.94762'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.96136'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",-0.135995,Neutral,"[{'ticker': 'C', 'relevance_score': '0.080728', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.080728', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.080728', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.080728', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.080728', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Why Johnson & Johnson Paying $8.9 Billion to Settle Its Talc Lawsuits Would Be Good News,https://www.fool.com/investing/2023/04/14/why-johnson-johnson-paying-89-billion-for-talc-law/,20230414T124500,['David Jagielski'],Is now the time to buy the stock?,https://media.ycharts.com/charts/a2b0fc349ad5bb7728fa7f9a780c8ee2.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.103545,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.665714', 'ticker_sentiment_score': '0.15239', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Take Five: How bad is it?,https://www.reuters.com/business/take-five/global-markets-themes-takealook-2023-04-14/,20230414T062500,['Reuters'],"LONDON, April 14 ( Reuters ) - Earnings season gets into full swing, while the first snapshot of business activity in April could provide a sense of how much pain the turmoil in the banking sector has inflicted on the world economy.",https://graphics.reuters.com/GLOBAL-MARKETS/THEMES/lbvggwwjgvq/chart.png,Reuters,Business,www.reuters.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.9973'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",-0.146525,Neutral,"[{'ticker': 'NFLX', 'relevance_score': '0.044801', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSCDF', 'relevance_score': '0.044801', 'ticker_sentiment_score': '-0.207869', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TSLA', 'relevance_score': '0.044801', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.044801', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.044801', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.044801', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.044801', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
"Sri Balaji University, Pune invites applications for UG, PG programmes | The Financial Express",https://www.financialexpress.com/education-2/sri-balaji-university-pune-invites-applications-for-ug-pg-programmes/3046543/,20230414T053011,[],"Sri Balaji University, Pune invites applications for UG, PG programmes The Financial Express ...",https://www.financialexpress.com/wp-content/uploads/2023/04/law.webp,The Financial Express,n/a,www.financialexpress.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.216663,Somewhat-Bullish,"[{'ticker': 'GOOG', 'relevance_score': '0.109455', 'ticker_sentiment_score': '0.242917', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'INFY', 'relevance_score': '0.109455', 'ticker_sentiment_score': '0.242917', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'COUR', 'relevance_score': '0.109455', 'ticker_sentiment_score': '0.140318', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.109455', 'ticker_sentiment_score': '0.242917', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Acne Drugs Market size to grow by USD 907.11 million from 2022 to 2027, Driven by the emergence of improved diagnostic modalities - Technavio",https://www.prnewswire.com/news-releases/acne-drugs-market-size-to-grow-by-usd-907-11-million-from-2022-to-2027--driven-by-the-emergence-of-improved-diagnostic-modalities---technavio-301795679.html,20230414T033000,['Technavio'],Acne Drugs Market size to grow by USD 907.11 million from 2022 to ... PR ...,https://mma.prnewswire.com/media/2052644/Technavio_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}]",0.164381,Somewhat-Bullish,"[{'ticker': 'DERM', 'relevance_score': '0.025325', 'ticker_sentiment_score': '0.034283', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCK', 'relevance_score': '0.025325', 'ticker_sentiment_score': '0.034283', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAYZF', 'relevance_score': '0.050625', 'ticker_sentiment_score': '0.036953', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.050625', 'ticker_sentiment_score': '0.060964', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VTRS', 'relevance_score': '0.025325', 'ticker_sentiment_score': '0.034283', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALPMF', 'relevance_score': '0.050625', 'ticker_sentiment_score': '0.036953', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CPHRF', 'relevance_score': '0.025325', 'ticker_sentiment_score': '0.034283', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TEVA', 'relevance_score': '0.025325', 'ticker_sentiment_score': '0.034283', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PRTK', 'relevance_score': '0.025325', 'ticker_sentiment_score': '0.034283', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XBIT', 'relevance_score': '0.025325', 'ticker_sentiment_score': '0.034283', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RBGPF', 'relevance_score': '0.025325', 'ticker_sentiment_score': '0.034283', 'ticker_sentiment_label': 'Neutral'}]"
Congestive Heart Failure Drugs Market Size to Cross USD 13.5 Bn Revenue by 2031 | TMR Study,https://www.benzinga.com/pressreleases/23/04/g31798962/congestive-heart-failure-drugs-market-size-to-cross-usd-13-5-bn-revenue-by-2031-tmr-study,20230413T213000,['Globe Newswire'],"Wilmington, Delaware, United States, April 14, 2023 ( GLOBE NEWSWIRE ) -- The global congestive heart failure drugs market was valued at USD 6.7 Bn in 2022 and is estimated to reach USD 13.5 Bn by 2031, expanding at a CAGR of 7.6% between 2023 and 2031.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.233632,Somewhat-Bullish,"[{'ticker': 'HCSG', 'relevance_score': '0.041466', 'ticker_sentiment_score': '0.258638', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BMY', 'relevance_score': '0.041466', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.041466', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Anika Enters Into Cooperation Agreement with Caligan Partners - Anika Therapeutics  ( NASDAQ:ANIK ) ,https://www.benzinga.com/pressreleases/23/04/g31797973/anika-enters-into-cooperation-agreement-with-caligan-partners,20230413T210025,['Globe Newswire'],"BEDFORD, Mass., April 13, 2023 ( GLOBE NEWSWIRE ) -- Anika Therapeutics, Inc. ANIK ( ""Anika"" or the ""Company"" ) , a global joint preservation company in early intervention orthopedics, today announced that it has entered into a cooperation agreement with Caligan Partners LP ( ""Caligan"" ) .",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.875462'}]",0.302292,Somewhat-Bullish,"[{'ticker': 'ANIK', 'relevance_score': '0.084127', 'ticker_sentiment_score': '0.156623', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CFMS', 'relevance_score': '0.028089', 'ticker_sentiment_score': '0.004561', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.028089', 'ticker_sentiment_score': '0.004561', 'ticker_sentiment_label': 'Neutral'}]"
Anika Enters Into Cooperation Agreement with Caligan Partners,https://www.globenewswire.com/news-release/2023/04/13/2646752/28467/en/Anika-Enters-Into-Cooperation-Agreement-with-Caligan-Partners.html,20230413T210000,['Anika Therapeutics Inc.'],Gary Fischetti Joins Anika Board ...,https://ml.globenewswire.com/Resource/Download/96da9ec1-6e87-4b15-af19-e816e4737796,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.795202'}]",0.315452,Somewhat-Bullish,"[{'ticker': 'ANIK', 'relevance_score': '0.11537', 'ticker_sentiment_score': '0.182607', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CFMS', 'relevance_score': '0.028937', 'ticker_sentiment_score': '0.004584', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.028937', 'ticker_sentiment_score': '0.004584', 'ticker_sentiment_label': 'Neutral'}]"
The Largest Companies by Market Cap in 2023,https://www.fool.com/research/largest-companies-by-market-cap/,20230413T180833,['Lyle Daly'],"Apple, Microsoft, and Saudi Aramco are the biggest companies measured by market cap.",https://m.foolcdn.com/media/dubs/images/women-investing-stock-graphs.width-880.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}]",0.057769,Neutral,"[{'ticker': 'GOOG', 'relevance_score': '0.154125', 'ticker_sentiment_score': '0.100568', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.154125', 'ticker_sentiment_score': '-0.224438', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NVDA', 'relevance_score': '0.051663', 'ticker_sentiment_score': '-0.169939', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'AAPL', 'relevance_score': '0.395792', 'ticker_sentiment_score': '0.066121', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.103109', 'ticker_sentiment_score': '-0.185627', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'BRK-A', 'relevance_score': '0.051663', 'ticker_sentiment_score': '-0.169939', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.051663', 'ticker_sentiment_score': '-0.169939', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TCTZF', 'relevance_score': '0.103109', 'ticker_sentiment_score': '0.026494', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.051663', 'ticker_sentiment_score': '-0.169939', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'TSM', 'relevance_score': '0.103109', 'ticker_sentiment_score': '0.026494', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.302553', 'ticker_sentiment_score': '0.054091', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.051663', 'ticker_sentiment_score': '-0.169939', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'MA', 'relevance_score': '0.154125', 'ticker_sentiment_score': '-0.224438', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'V', 'relevance_score': '0.051663', 'ticker_sentiment_score': '-0.169939', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'AMZN', 'relevance_score': '0.349857', 'ticker_sentiment_score': '0.060458', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.051663', 'ticker_sentiment_score': '-0.169939', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
"Jeff Bezos, George Soros, Mark Cuban, and Ray Dalio All Have One Thing in Common: They're Making a Big Bet on This Industry - Horizon Therapeutics  ( NASDAQ:HZNP ) , Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/news/23/04/31792814/jeff-bezos-george-soros-mark-cuban-and-ray-dalio-all-have-one-thing-in-common-theyre-making-a-big-be,20230413T163320,['Caleb Naysmith'],"When billionaires jump on the same trend, it's important for investors to take notice. The pieces often don't come together immediately, but these investors have millions of dollars in resources dedicated to getting the most up-to-date information as quickly as possible.",https://cdn.benzinga.com/files/images/story/2023/04/13/piccccccccccccccccccccc.png?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.858979'}]",0.169882,Somewhat-Bullish,"[{'ticker': 'HZNP', 'relevance_score': '0.155954', 'ticker_sentiment_score': '0.020134', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.155954', 'ticker_sentiment_score': '-0.027918', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.155954', 'ticker_sentiment_score': '-0.027918', 'ticker_sentiment_label': 'Neutral'}]"
Don't Celebrate Yet: Lower Wholesale Inflation Data Mainly Reflected Drop in Energy Prices,https://www.benzinga.com/markets/23/04/31791322/dont-celebrate-yet-lower-wholesale-inflation-data-mainly-reflected-drop-in-energy-prices,20230413T152733,['Alex Coffey'],"( Thursday market open ) More signs emerged early Thursday of cooler inflation, as the March Producer Price Index ( PPI ) fell 0.5%. It was the first monthly slide in PPI since December, and while it reflected a big drop in volatile energy prices, other areas also showed progress.",https://cdn.benzinga.com/files/images/story/2023/04/13/shutterstock_1016430565_5.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.998626'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",-0.082006,Neutral,"[{'ticker': 'BLK', 'relevance_score': '0.034831', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UAL', 'relevance_score': '0.069596', 'ticker_sentiment_score': '0.057777', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.034831', 'ticker_sentiment_score': '-0.021304', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.053526', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.104228', 'ticker_sentiment_score': '0.062622', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PNC', 'relevance_score': '0.034831', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.155786', 'ticker_sentiment_score': '0.070673', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.069596', 'ticker_sentiment_score': '0.038116', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.034831', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAL', 'relevance_score': '0.034831', 'ticker_sentiment_score': '0.066701', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.069596', 'ticker_sentiment_score': '0.038116', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.034831', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.034831', 'ticker_sentiment_score': '-0.021304', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LMT', 'relevance_score': '0.069596', 'ticker_sentiment_score': '-0.009099', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'STT', 'relevance_score': '0.034831', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.034831', 'ticker_sentiment_score': '-0.021304', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.138663', 'ticker_sentiment_score': '0.083916', 'ticker_sentiment_label': 'Neutral'}]"
Will Q1 Earnings Fuel a Rally in Dow ETF?,https://www.zacks.com/stock/news/2078322/will-q1-earnings-fuel-a-rally-in-dow-etf,20230413T151500,['Zacks Investment Research'],"As the index is closely tied to the cyclical sectors, the banking turmoil hit hard the Dow last month. Recession fears have added to the woes.",https://staticx-tuner.zacks.com/images/default_article_images/default270.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.999174'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '1.0'}]",0.019198,Neutral,"[{'ticker': 'DOW', 'relevance_score': '0.130689', 'ticker_sentiment_score': '0.040755', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IBM', 'relevance_score': '0.173645', 'ticker_sentiment_score': '0.048521', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.130689', 'ticker_sentiment_score': '0.040755', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.173645', 'ticker_sentiment_score': '0.048521', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.130689', 'ticker_sentiment_score': '0.040755', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.130689', 'ticker_sentiment_score': '0.040755', 'ticker_sentiment_label': 'Neutral'}]"
Earnings season guidance will give recession clues,https://www.investorideas.com/news/2023/main/04131Earnings-Season-Guidance.asp,20230413T135338,[],"April 13, 2023 ( Investorideas.com Newswire ) Investor focus is set to shift from inflation to earnings season, which starts on Friday, as it will give us more insight about a forthcoming recession, says the CEO of one of the world's largest independent financial advisory, asset management and ...",,Investor Ideas,n/a,www.investorideas.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.858979'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.96136'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",-0.117012,Neutral,"[{'ticker': 'C', 'relevance_score': '0.075874', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.075874', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.075874', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.075874', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.075874', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
Buy These 3 PIMCO Mutual Funds for Amazing Returns,https://www.zacks.com/stock/news/2078001/buy-these-3-pimco-mutual-funds-for-amazing-returns,20230413T101100,['Zacks Investment Research'],"Below, we share with you three PIMCO mutual funds, namely PKAPX, PZRAX and PQICX. Each has earned a Zacks Mutual Fund Rank #1.",https://staticx-tuner.zacks.com/images/articles/main/ba/154.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}]",0.279824,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.085022', 'ticker_sentiment_score': '0.054226', 'ticker_sentiment_label': 'Neutral'}]"
Can Pfizer Beat GSK and Moderna in This $10 Billion Market?,https://www.fool.com/investing/2023/04/13/can-pfizer-beat-gsk-and-moderna-in-this-10-billion/,20230413T095200,['Keith Speights'],There's such a big need in preventing RSV that multiple companies should be big winners.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F727597%2Fperson-holding-cash-bills-money-hundred-dollar-fifty-dividend-income-invest-retire-spend-getty.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",-0.028945,Neutral,"[{'ticker': 'MRNA', 'relevance_score': '0.396798', 'ticker_sentiment_score': '0.082489', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.585975', 'ticker_sentiment_score': '-0.003544', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.059194', 'ticker_sentiment_score': '0.021009', 'ticker_sentiment_label': 'Neutral'}]"
Can AI answer your money questions? We put chatbots to the test,https://www.reuters.com/markets/wealth/can-ai-answer-your-money-questions-we-put-chatbots-test-2023-04-13/,20230413T041336,['Chris Taylor'],"NEW YORK, April 13 ( Reuters ) - Face it, we could all use a little help with our money. So who better to ask for personal finance advice than a couple of the most powerful chatbots on the planet?",https://cloudfront-us-east-2.images.arcpublishing.com/reuters/6MNDBJBVCJPERL5YH7JPGBIFLI.jpg,Reuters,Markets,www.reuters.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.27551,Somewhat-Bullish,"[{'ticker': 'GOOG', 'relevance_score': '0.050465', 'ticker_sentiment_score': '0.056985', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.050465', 'ticker_sentiment_score': '0.056985', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VZ', 'relevance_score': '0.050465', 'ticker_sentiment_score': '0.086378', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.050465', 'ticker_sentiment_score': '0.086378', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.050465', 'ticker_sentiment_score': '0.086378', 'ticker_sentiment_label': 'Neutral'}]"
Check Out What Whales Are Doing With JNJ - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/04/31769989/check-out-what-whales-are-doing-with-jnj,20230412T141557,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://cdn.benzinga.com/files/images/story/2023/movers_image_6941.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.189212,Somewhat-Bullish,"[{'ticker': 'MS', 'relevance_score': '0.107495', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.720339', 'ticker_sentiment_score': '0.308543', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Jim Cramer's top 10 things to watch in the stock market Wednesday,https://www.cnbc.com/2023/04/12/jim-cramers-top-10-things-to-watch-in-the-stock-market-wednesday-.html,20230412T131005,['Jim Cramer'],Club holding Emerson Electric (EMR) announced an $8.2 billion deal to acquire National Instruments (NATI) - and other market developments Cramer's watching.,https://image.cnbcfm.com/api/v1/image/107113453-NUP_198430_00764r.jpg?v=1681305005&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.99393'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}]",0.264653,Somewhat-Bullish,"[{'ticker': 'HON', 'relevance_score': '0.187221', 'ticker_sentiment_score': '0.097239', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.12546', 'ticker_sentiment_score': '-0.04715', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.12546', 'ticker_sentiment_score': '-0.04715', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.187221', 'ticker_sentiment_score': '0.053241', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WYNN', 'relevance_score': '0.12546', 'ticker_sentiment_score': '0.125941', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EMR', 'relevance_score': '0.12546', 'ticker_sentiment_score': '0.122453', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.187221', 'ticker_sentiment_score': '0.045936', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NATI', 'relevance_score': '0.12546', 'ticker_sentiment_score': '0.122453', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.12546', 'ticker_sentiment_score': '0.245639', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LMT', 'relevance_score': '0.187221', 'ticker_sentiment_score': '0.218522', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BCS', 'relevance_score': '0.12546', 'ticker_sentiment_score': '0.01281', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.062926', 'ticker_sentiment_score': '0.035109', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMA', 'relevance_score': '0.12546', 'ticker_sentiment_score': '-0.04715', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RTX', 'relevance_score': '0.12546', 'ticker_sentiment_score': '0.376689', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'KEY', 'relevance_score': '0.12546', 'ticker_sentiment_score': '-0.04715', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.187221', 'ticker_sentiment_score': '0.288827', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Will Johnson & Johnson Stock Rise Post Q1?,https://www.forbes.com/sites/greatspeculations/2023/04/12/will-johnson--johnson-stock-rise-post-q1/,20230412T130007,['Trefis Team'],"We expect J&J to report revenues and earnings slightly above the consensus estimate, and JNJ stock appears to have more room for growth.",https://imageio.forbes.com/specials-images/imageserve/6436667dcca2ec50c416b4c5/0x0.jpg?format=jpg&width=1200,Forbes,Markets,www.forbes.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}, {'topic': 'Earnings', 'relevance_score': '0.995921'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.5'}]",0.154728,Somewhat-Bullish,"[{'ticker': 'AWON', 'relevance_score': '0.065685', 'ticker_sentiment_score': '0.086489', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FDX', 'relevance_score': '0.065685', 'ticker_sentiment_score': '0.136343', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.716023', 'ticker_sentiment_score': '0.247286', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Is Vanguard Dividend Appreciation ETF  ( VIG )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2077293/is-vanguard-dividend-appreciation-etf-vig-a-strong-etf-right-now,20230412T102009,['Zacks Investment Research'],Smart Beta ETF report for VIG ...,https://staticx-tuner.zacks.com/images/default_article_images/default61.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999687'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.289408,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.113062', 'ticker_sentiment_score': '0.059546', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MORN', 'relevance_score': '0.056674', 'ticker_sentiment_score': '0.201064', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UNH', 'relevance_score': '0.113062', 'ticker_sentiment_score': '0.059546', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.113062', 'ticker_sentiment_score': '0.059546', 'ticker_sentiment_label': 'Neutral'}]"
Which Healthcare Company Will Be the First to Get to a $1 Trillion Market Cap?,https://www.fool.com/investing/2023/04/12/which-healthcare-stock-first-trillion-market-cap/,20230412T092000,['David Jagielski'],These businesses all show promise and should get much bigger in the future.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F727604%2Fgrowth-5.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.108179'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.279089,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.29234', 'ticker_sentiment_score': '0.234794', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.29234', 'ticker_sentiment_score': '0.300911', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UNH', 'relevance_score': '0.370296', 'ticker_sentiment_score': '0.216309', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.211191', 'ticker_sentiment_score': '0.185587', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Home Healthcare Market to Expand at a 10.5% CAGR from 2021-2028, Globally: TMR Report",https://www.benzinga.com/pressreleases/23/04/g31758515/home-healthcare-market-to-expand-at-a-10-5-cagr-from-2021-2028-globally-tmr-report,20230411T213000,['Globe Newswire'],"Wilmington, Delaware, United States, April 12, 2023 ( GLOBE NEWSWIRE ) -- According to the recent study by Transparency Market Research, the global home healthcare market is anticipated to flourish at a staggering 10.5% CAGR from 2021 to 2028.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}]",0.241129,Somewhat-Bullish,"[{'ticker': 'CVS', 'relevance_score': '0.113597', 'ticker_sentiment_score': '0.091863', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OMRNF', 'relevance_score': '0.03798', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAYZF', 'relevance_score': '0.03798', 'ticker_sentiment_score': '0.102767', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.03798', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVCRQ', 'relevance_score': '0.03798', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAH', 'relevance_score': '0.03798', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HCSG', 'relevance_score': '0.261117', 'ticker_sentiment_score': '0.110769', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.03798', 'ticker_sentiment_score': '0.143447', 'ticker_sentiment_label': 'Neutral'}]"
Carrier plots separation of fire unit,https://www.foxbusiness.com/markets/carrier-plots-separation-fire-unit,20230411T182426,[],"Carrier Global Corp. is working on a plan to sell or spin off its Fire & Security business segment, which accounts for about 17% of the air-conditioning company's sales, according to people familiar with the matter. The process is in an early stage, the people said, and there is no guarantee the ...",https://cf-images.us-east-1.prod.boltdns.net/v1/static/854081161001/638cca3d-af20-4b7b-8440-f4e0197a51fc/30c6a196-ec7b-4bf5-ac37-29cf416b0c59/1280x720/match/image.jpg,Fox Business News,n/a,www.foxbusiness.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",-0.097247,Neutral,"[{'ticker': 'CARR', 'relevance_score': '0.107978', 'ticker_sentiment_score': '0.021227', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BX', 'relevance_score': '0.107978', 'ticker_sentiment_score': '0.072757', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.107978', 'ticker_sentiment_score': '-0.086945', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GEHC', 'relevance_score': '0.107978', 'ticker_sentiment_score': '0.067948', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EMR', 'relevance_score': '0.107978', 'ticker_sentiment_score': '0.072757', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'K', 'relevance_score': '0.107978', 'ticker_sentiment_score': '-0.086945', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GE', 'relevance_score': '0.213988', 'ticker_sentiment_score': '0.103068', 'ticker_sentiment_label': 'Neutral'}]"
Club meeting recap: Jim Cramer says stick with health care stocks in uncertain times,https://www.cnbc.com/2023/04/11/club-meeting-recap-jim-cramer-says-stick-with-health-care-stocks.html,20230411T160052,['Paulina Likos'],"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",https://image.cnbcfm.com/api/v1/image/107223220-1681224866175-1681224317318-3ED4-REQ-041123-CramersMorningMeeting.jpg?v=1681225603&w=600&h=300&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.998333'}, {'topic': 'Earnings', 'relevance_score': '0.77141'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.222786,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.227007', 'ticker_sentiment_score': '0.166886', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HUM', 'relevance_score': '0.369319', 'ticker_sentiment_score': '0.242076', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MS', 'relevance_score': '0.076602', 'ticker_sentiment_score': '0.097012', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAT', 'relevance_score': '0.499102', 'ticker_sentiment_score': '0.293919', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DHR', 'relevance_score': '0.499102', 'ticker_sentiment_score': '0.293919', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.227007', 'ticker_sentiment_score': '0.166886', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Analysts Estimate Johnson & Johnson  ( JNJ )  to Report a Decline in Earnings: What to Look Out for,https://www.zacks.com/stock/news/2076955/analysts-estimate-johnson-johnson-jnj-to-report-a-decline-in-earnings-what-to-look-out-for,20230411T140020,['Zacks Investment Research'],Johnson & Johnson (JNJ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,https://staticx-tuner.zacks.com/images/default_article_images/default253.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.152637,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.295273', 'ticker_sentiment_score': '0.002206', 'ticker_sentiment_label': 'Neutral'}]"
"Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow - BeiGene  ( NASDAQ:BGNE ) , Bristol-Myers Squibb  ( NYSE:BMY ) ",https://www.benzinga.com/general/biotech/23/04/31741766/hillstream-biopharmas-drug-candidate-hsb-1216-could-be-one-to-watch-as-global-oncology-market-con,20230411T122809,['Ernest Dela Aglanu'],"A surge in oncology drug development, coupled with increased patient access and early diagnosis, has resulted in a massive increase in global spending on cancer treatments. Due to this, the global oncology market has been growing at an unprecedented pace over the past few years.",https://cdn.benzinga.com/files/images/story/2023/04/11/shutterstock_1526469227.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.06929,Neutral,"[{'ticker': 'DD', 'relevance_score': '0.156461', 'ticker_sentiment_score': '0.071429', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSTK', 'relevance_score': '0.052455', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BGNE', 'relevance_score': '0.104683', 'ticker_sentiment_score': '-0.151137', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'ILMN', 'relevance_score': '0.104683', 'ticker_sentiment_score': '-0.151137', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.104683', 'ticker_sentiment_score': '-0.151137', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CRMD', 'relevance_score': '0.104683', 'ticker_sentiment_score': '0.05909', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HILS', 'relevance_score': '0.207571', 'ticker_sentiment_score': '0.084366', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.104683', 'ticker_sentiment_score': '0.05909', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.104683', 'ticker_sentiment_score': '0.05909', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.104683', 'ticker_sentiment_score': '-0.151137', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
"Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow - BeiGene  ( NASDAQ:BGNE ) , Bristol-Myers Squibb  ( NYSE:BMY ) ",https://www.benzinga.com/general/biotech/23/04/31741764/hillstream-biopharmas-drug-candidate-hsb-1216-could-be-one-to-watch-as-global-oncology-market-con,20230411T122808,['Ernest Dela Aglanu'],"A surge in oncology drug development, coupled with increased patient access and early diagnosis, has resulted in a massive increase in global spending on cancer treatments. Due to this, the global oncology market has been growing at an unprecedented pace over the past few years.",https://cdn.benzinga.com/files/images/story/2023/04/11/shutterstock_1526469227.jpg?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.06929,Neutral,"[{'ticker': 'DD', 'relevance_score': '0.156461', 'ticker_sentiment_score': '0.071429', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSTK', 'relevance_score': '0.052455', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BGNE', 'relevance_score': '0.104683', 'ticker_sentiment_score': '-0.151137', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'ILMN', 'relevance_score': '0.104683', 'ticker_sentiment_score': '-0.151137', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.104683', 'ticker_sentiment_score': '-0.151137', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CRMD', 'relevance_score': '0.104683', 'ticker_sentiment_score': '0.05909', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HILS', 'relevance_score': '0.207571', 'ticker_sentiment_score': '0.084366', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GS', 'relevance_score': '0.104683', 'ticker_sentiment_score': '0.05909', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.104683', 'ticker_sentiment_score': '0.05909', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.104683', 'ticker_sentiment_score': '-0.151137', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
Best Inverse/Leveraged ETFs of Last Week,https://www.zacks.com/stock/news/2076739/best-inverseleveraged-etfs-of-last-week,20230411T120000,['Zacks Investment Research'],"Wall Street put up a mixed show in the holiday-shortened last week. Leveraged gold miners, healthcare, utilities and energy ETFs/ETNs were among the winning investing areas.",https://staticx-tuner.zacks.com/images/default_article_images/default100.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.744043'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",-0.014902,Neutral,"[{'ticker': 'UNH', 'relevance_score': '0.063091', 'ticker_sentiment_score': '0.270538', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.063091', 'ticker_sentiment_score': '0.270538', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.063091', 'ticker_sentiment_score': '-0.129752', 'ticker_sentiment_label': 'Neutral'}]"
Is Johnson & Johnson About to Put Its Talc Lawsuits to Bed?,https://www.fool.com/investing/2023/04/11/is-johnson-johnson-about-to-put-its-talc-lawsuits/,20230411T100000,['Prosper Junior Bakiny'],The company took an important step toward that goal.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F727730%2Fdown-90-buy-buy-buy.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}, {'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.110936,Neutral,"[{'ticker': 'CURN', 'relevance_score': '0.061315', 'ticker_sentiment_score': '0.070073', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.682689', 'ticker_sentiment_score': '0.191802', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Hywin Holdings, Leonteq AG, and ARTA TechFin jointly launch principal-protected note linked to FactSet Hywin Global Health Care Index",https://www.globenewswire.com/news-release/2023/04/11/2644010/0/en/Hywin-Holdings-Leonteq-AG-and-ARTA-TechFin-jointly-launch-principal-protected-note-linked-to-FactSet-Hywin-Global-Health-Care-Index.html,20230411T000000,"['LTD', 'HYWIN WEALTH MANAGEMENT CO.']","HONG KONG, April 11, 2023 ( GLOBE NEWSWIRE ) -- Hywin Holdings Ltd. ( ""Hywin Wealth"" or ""Hywin"" ) ( NASDAQ: HYW ) , a leading independent wealth management service provider in China, Leonteq Securities AG ( ""Leonteq"" ) , a Swiss fintech company with a leading marketplace for structured ...",https://ml.globenewswire.com/Resource/Download/eebfe6ef-c4e1-4e0d-9624-245a4d14588f,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Blockchain', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.999606'}]",0.363132,Bullish,"[{'ticker': 'LNTQF', 'relevance_score': '0.073659', 'ticker_sentiment_score': '0.113229', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAYZF', 'relevance_score': '0.036869', 'ticker_sentiment_score': '0.079891', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HCA', 'relevance_score': '0.036869', 'ticker_sentiment_score': '0.079891', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HYW', 'relevance_score': '0.620205', 'ticker_sentiment_score': '0.603026', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.036869', 'ticker_sentiment_score': '0.079891', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SKXJF', 'relevance_score': '0.036869', 'ticker_sentiment_score': '0.079891', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSKYF', 'relevance_score': '0.036869', 'ticker_sentiment_score': '0.079891', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GSK', 'relevance_score': '0.036869', 'ticker_sentiment_score': '0.079891', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.036869', 'ticker_sentiment_score': '0.079891', 'ticker_sentiment_label': 'Neutral'}]"
"Hywin Holdings, Leonteq AG, and ARTA TechFin jointly launch principal-protected note linked to FactSet Hywin Global Health Care Index - Hywin Holdings  ( NASDAQ:HYW ) ",https://www.benzinga.com/pressreleases/23/04/g31736283/hywin-holdings-leonteq-ag-and-arta-techfin-jointly-launch-principal-protected-note-linked-to-facts,20230411T000000,['Globe Newswire'],"HONG KONG, April 11, 2023 ( GLOBE NEWSWIRE ) -- Hywin Holdings Ltd. ( ""Hywin Wealth"" or ""Hywin"" ) HYW, a leading independent wealth management service provider in China, Leonteq Securities AG ( ""Leonteq"" ) , a Swiss fintech company with a leading marketplace for structured investment solutions, ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Blockchain', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.999862'}]",0.350428,Bullish,"[{'ticker': 'LNTQF', 'relevance_score': '0.072108', 'ticker_sentiment_score': '0.113009', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAYZF', 'relevance_score': '0.036091', 'ticker_sentiment_score': '0.079702', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HCA', 'relevance_score': '0.036091', 'ticker_sentiment_score': '0.079702', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HYW', 'relevance_score': '0.634523', 'ticker_sentiment_score': '0.59402', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.036091', 'ticker_sentiment_score': '0.079702', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SKXJF', 'relevance_score': '0.036091', 'ticker_sentiment_score': '0.079702', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSKYF', 'relevance_score': '0.036091', 'ticker_sentiment_score': '0.079702', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GSK', 'relevance_score': '0.036091', 'ticker_sentiment_score': '0.079702', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.036091', 'ticker_sentiment_score': '0.079702', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson  ( JNJ )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2076534/johnson-johnson-jnj-stock-sinks-as-market-gains-what-you-should-know,20230410T214525,['Zacks Investment Research'],"In the latest trading session, Johnson & Johnson (JNJ) closed at $164.32, marking a -0.5% move from the previous day.",https://staticx-tuner.zacks.com/images/default_article_images/default304.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.976913'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.202426,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.606946', 'ticker_sentiment_score': '0.222507', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
An Investor's View of Johnson & Johnson's Talc Settlement,https://www.fool.com/investing/2023/04/10/an-investors-view-of-johnson-johnsons-talc-settlem/,20230410T193740,"['Dylan Lewis', 'Emily Flippen', 'Tim Beyers', 'and Ricky Mulvey']",We also take a look at Chewy's growth initiatives.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F727338%2Fpaper-certificate-shares-invest-stock-split-market-reverse-getty.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.961735'}, {'topic': 'Earnings', 'relevance_score': '0.87644'}]",0.107399,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.008644', 'ticker_sentiment_score': '0.069011', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.043201', 'ticker_sentiment_score': '-0.094575', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'W', 'relevance_score': '0.008644', 'ticker_sentiment_score': '-0.075761', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ATVI', 'relevance_score': '0.077677', 'ticker_sentiment_score': '0.086077', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CHWY', 'relevance_score': '0.213498', 'ticker_sentiment_score': '0.114173', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.025929', 'ticker_sentiment_score': '-0.061089', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TRUP', 'relevance_score': '0.008644', 'ticker_sentiment_score': '0.049143', 'ticker_sentiment_label': 'Neutral'}]"
Looking At Johnson & Johnson's Recent Unusual Options Activity - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/04/31732168/looking-at-johnson-johnsons-recent-unusual-options-activity,20230410T184609,['Benzinga Insights'],"A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 15 strange trades. If we consider the specifics of each trade, it is accurate to state that 46% of the investors opened trades with ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.132301,Neutral,"[{'ticker': 'MS', 'relevance_score': '0.126784', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.736015', 'ticker_sentiment_score': '0.046453', 'ticker_sentiment_label': 'Neutral'}]"
Raydiant Launches Task Management Feature on Employee Experience  ( EX )  Platform to Better Engage Brick-and-Mortar Workers,https://www.prnewswire.com/news-releases/raydiant-launches-task-management-feature-on-employee-experience-ex-platform-to-better-engage-brick-and-mortar-workers-301793367.html,20230410T154500,"['Inc.', 'Raydiant']",Raydiant Launches Task Management Feature on Employee ... PR ...,,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.305049,Somewhat-Bullish,"[{'ticker': 'NSRGF', 'relevance_score': '0.073321', 'ticker_sentiment_score': '0.132793', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.073321', 'ticker_sentiment_score': '0.132793', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UL', 'relevance_score': '0.073321', 'ticker_sentiment_score': '0.132793', 'ticker_sentiment_label': 'Neutral'}]"
3 Things About Johnson & Johnson Smart Investors Know,https://www.fool.com/investing/2023/04/10/things-about-johnson-johnson-smart-investors-know/,20230410T153937,['Alex Carchidi'],The healthcare giant's stock is looking like less of a safe bet than it was in the past.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F727498%2Fbuffett19-tmf.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}, {'topic': 'Earnings', 'relevance_score': '0.650727'}]",0.029273,Neutral,"[{'ticker': 'ABBV', 'relevance_score': '0.044304', 'ticker_sentiment_score': '0.025984', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.175859', 'ticker_sentiment_score': '-0.016275', 'ticker_sentiment_label': 'Neutral'}]"
Pfizer CEO signs letter in support of FDA after federal judge suspends approval of abortion pill,https://www.cnbc.com/2023/04/10/abortion-pill-ruling-pfizer-ceo-signs-letter-in-support-of-fda.html,20230410T153402,['Annika Kim Constantino'],Pfizer's CEO was among the more than 200 pharmaceutical company executives who signed the letter after a federal judge's controversial ruling on mifepristone.,https://image.cnbcfm.com/api/v1/image/107222561-1681140107886-gettyimages-1240924830-SWITZERLAND-DAVOS-WORLD_ECONOMIC_FORUM.jpeg?v=1681140842&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.123516,Neutral,"[{'ticker': 'MRNA', 'relevance_score': '0.155451', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.155451', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.155451', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
"AbbVie  ( ABBV ) , J&J to Withdraw 2 Blood Cancer Nods for Imbruvica",https://www.zacks.com/stock/news/2076361/abbvie-abbv-jj-to-withdraw-2-blood-cancer-nods-for-imbruvica,20230410T150300,['Zacks Investment Research'],AbbVie (ABBV)/J&J's (JNJ) decision to withdraw the FDA's accelerated approval for Imbruvica in two blood cancer treatments is based on confirmatory studies data that do not support full approval.,https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.246193,Somewhat-Bullish,"[{'ticker': 'ABBV', 'relevance_score': '0.368773', 'ticker_sentiment_score': '0.213726', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AZN', 'relevance_score': '0.127119', 'ticker_sentiment_score': '0.169459', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVO', 'relevance_score': '0.251032', 'ticker_sentiment_score': '0.145678', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.251032', 'ticker_sentiment_score': '0.061028', 'ticker_sentiment_label': 'Neutral'}]"
3 Sector ETFs to Play as Recession Fears Are on the Rise,https://www.zacks.com/stock/news/2076344/3-sector-etfs-to-play-as-recession-fears-are-on-the-rise,20230410T144100,['Zacks Investment Research'],"With recession fears on the rise, look into some sectors that can shield from market volatility.",https://staticx-tuner.zacks.com/images/articles/main/c5/13179.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.986564'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.007373,Neutral,"[{'ticker': 'KO', 'relevance_score': '0.116914', 'ticker_sentiment_score': '0.086039', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.116914', 'ticker_sentiment_score': '-0.021983', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.116914', 'ticker_sentiment_score': '0.086039', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.116914', 'ticker_sentiment_score': '-0.021983', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.116914', 'ticker_sentiment_score': '0.086039', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SBNY', 'relevance_score': '0.058615', 'ticker_sentiment_score': '-0.198359', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'PFE', 'relevance_score': '0.116914', 'ticker_sentiment_score': '-0.021983', 'ticker_sentiment_label': 'Neutral'}]"
Can You Still Buy the Dow Jones' Best-Performing April Stocks?,https://www.fool.com/investing/2023/04/10/can-you-still-buy-the-dow-jones-best-performing-ap/,20230410T130500,['James Brumley'],"Each is benefiting from recent good news, but there's also a theme-based tailwind brewing that could last a while.",https://media.ycharts.com/charts/a951e302e2ff029f776945e0fd682cd0.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}, {'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.196096,Somewhat-Bullish,"[{'ticker': 'AMGN', 'relevance_score': '0.079656', 'ticker_sentiment_score': '0.279936', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'UNH', 'relevance_score': '0.235823', 'ticker_sentiment_score': '0.117732', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.158519', 'ticker_sentiment_score': '0.117766', 'ticker_sentiment_label': 'Neutral'}]"
Investors Heavily Search Johnson & Johnson  ( JNJ ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2076171/investors-heavily-search-johnson-johnson-jnj-here-is-what-you-need-to-know,20230410T130013,['Zacks Investment Research'],"Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",https://staticx-tuner.zacks.com/images/default_article_images/default33.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.999999'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}]",0.228278,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.47672', 'ticker_sentiment_score': '0.15377', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
How Johnson & Johnson's Attempt At A $9 Billion Baby Powder Settlement Impacts Black Women,https://www.forbes.com/sites/korihale/2023/04/10/how-johnson--johnsons-attempt-at-a-9-billion-baby-powder-settlement-impacts-black-women/,20230410T124634,['Kori Hale'],"Pharmaceutical giant Johnson & JohnsonJNJ wants to do a one-time lump sum payment of at least $8.9 billion to thousands of talc-powder claimants. For Black women, who were selected by J&J as ""the right place"" to sell more baby powder to,"" this is perhaps an opportunity for financial reciprocity.",https://imageio.forbes.com/specials-images/imageserve/643404e1d7bd6767a2eb47f1/0x0.jpg?format=jpg&width=1200,Forbes,Money,www.forbes.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.072515,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.306963', 'ticker_sentiment_score': '-0.016151', 'ticker_sentiment_label': 'Neutral'}]"
Northpass Launches First of a Kind Resources to Help Companies Scale Customer Success Through Digital Customer Education,https://www.prnewswire.com/news-releases/northpass-launches-first-of-a-kind-resources-to-help-companies-scale-customer-success-through-digital-customer-education-301793165.html,20230410T121400,['Northpass'],Northpass Launches First of a Kind Resources to Help Companies ... PR ...,https://mma.prnewswire.com/media/2050520/1_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}]",0.429251,Bullish,"[{'ticker': 'ICNB', 'relevance_score': '0.063763', 'ticker_sentiment_score': '0.251543', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.063763', 'ticker_sentiment_score': '0.251543', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WMT', 'relevance_score': '0.063763', 'ticker_sentiment_score': '0.251543', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"The European Patent Office announced U.S. companies and inventors filed more patent applications in Europe in 2022, buoyed by innovation in digital communication and semiconductors",https://www.prnewswire.com/news-releases/the-european-patent-office-announced-us-companies-and-inventors-filed-more-patent-applications-in-europe-in-2022-buoyed-by-innovation-in-digital-communication-and-semiconductors-301793057.html,20230410T110000,['European Patent Office'],The European Patent Office announced U.S. companies and ... PR ...,,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",0.212783,Somewhat-Bullish,"[{'ticker': 'CETY', 'relevance_score': '0.100729', 'ticker_sentiment_score': '0.146187', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'QCOM', 'relevance_score': '0.199859', 'ticker_sentiment_score': '0.257082', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.100729', 'ticker_sentiment_score': '0.082971', 'ticker_sentiment_label': 'Neutral'}]"
2 Warren Buffett Favorites to Buy on the Dip,https://www.fool.com/investing/2023/04/10/2-warren-buffett-favorites-to-buy-on-the-dip/,20230410T093000,['Adria Cimino'],These stocks have what it takes to perform over the long term.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F727338%2Fpaper-certificate-shares-invest-stock-split-market-reverse-getty.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.54554'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.858979'}]",0.226976,Somewhat-Bullish,"[{'ticker': 'RIVN', 'relevance_score': '0.060236', 'ticker_sentiment_score': '-0.035394', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.594159', 'ticker_sentiment_score': '0.146822', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.12013', 'ticker_sentiment_score': '0.155535', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
2 Top Stocks to Buy in April and Hold Forever,https://www.fool.com/investing/2023/04/08/2-top-stocks-to-buy-in-april-and-hold-forever/,20230408T113900,['Kody Kester'],The need for healthcare goods and/or services is here to stay.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F727401%2Fa-customer-shops-at-a-pharmacy.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.28274,Somewhat-Bullish,"[{'ticker': 'SYK', 'relevance_score': '0.246582', 'ticker_sentiment_score': '0.118589', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.062597', 'ticker_sentiment_score': '-0.0756', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.186259', 'ticker_sentiment_score': '0.173', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.062597', 'ticker_sentiment_score': '0.142085', 'ticker_sentiment_label': 'Neutral'}]"
S&P 500 Volatility Continues As Investors Digest Latest Labor Market Data - SPDR S&P 500  ( ARCA:SPY ) ,https://www.benzinga.com/news/23/04/31714148/s-p-500-volatility-continues-as-investors-digest-latest-labor-market-data,20230407T192033,['Wayne Duggan'],"The SPDR S&P 500 ETF Trust SPY snapped a three-week winning streak as the latest economic data suggests the U.S. labor market is cooling. On Friday, the Labor Department reported the U.S. economy added 236,000 jobs in March, just shy of economist estimates of 240,000 new jobs.",https://cdn.benzinga.com/files/images/story/2023/04/07/shutterstock_176534375.jpg?width=1200&height=800&fit=crop,Benzinga,News,www.benzinga.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.769861'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",-0.007095,Neutral,"[{'ticker': 'EDR', 'relevance_score': '0.28442', 'ticker_sentiment_score': '0.16151', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'C', 'relevance_score': '0.191929', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.191929', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WWE', 'relevance_score': '0.372912', 'ticker_sentiment_score': '0.198883', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WFC', 'relevance_score': '0.191929', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'F', 'relevance_score': '0.191929', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.28442', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.191929', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.28442', 'ticker_sentiment_score': '-0.29254', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
Unemployment Report Out Today: Here's The Latest On The Job Market,https://www.forbes.com/sites/qai/2023/04/07/unemployment-report-out-today-heres-the-latest-on-the-job-market/,20230407T143341,['Q.ai - Powering a Personal Wealth Movement'],"This follows on from the ADP private payrolls report and the jobless claims data from earlier in the week, giving us a solid overview of where the job market is at right now.",https://imageio.forbes.com/specials-images/imageserve/634025a027eb5db2d7bec1e4/0x0.jpg?format=jpg&width=1200,Forbes,Markets,www.forbes.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.928139'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}]",0.041224,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.032825', 'ticker_sentiment_score': '0.050541', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.032825', 'ticker_sentiment_score': '0.050541', 'ticker_sentiment_label': 'Neutral'}]"
2 Supercharged Dividend Stocks to Buy If There's a Stock Market Sell-Off,https://www.fool.com/investing/2023/04/07/2-supercharged-dividend-stocks-to-buy-if-theres-a/,20230407T140000,['Sushree Mohanty'],These two pharma stocks have kept their businesses stable and have steadily paid dividends.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F727111%2Fmoney-in-jar-with-plant-growing.jpeg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.961735'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}]",0.213618,Somewhat-Bullish,"[{'ticker': 'MDT', 'relevance_score': '0.32478', 'ticker_sentiment_score': '0.353225', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.1331', 'ticker_sentiment_score': '0.046135', 'ticker_sentiment_label': 'Neutral'}]"
"B2B start-up ElasticRun takes a step back, to focus on core strategy",https://www.business-standard.com/companies/start-ups/b2b-startup-elasticrun-takes-a-step-back-refocuses-on-core-strategy-123040700638_1.html,20230407T132632,['Business Standard'],ElasticRun extends the reach of a brand's direct distribution network to deep rural markets ...,"https://bsmedia.business-standard.com/_media/bs/img/article/2021-12/27/full/1640546890-55.jpg?im=FeatureCrop,width=826,height=465",Business Standard,Companies,www.business-standard.com,"[{'topic': 'Earnings', 'relevance_score': '0.360215'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.042455,Neutral,"[{'ticker': 'PROSY', 'relevance_score': '0.086556', 'ticker_sentiment_score': '-0.046725', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.086556', 'ticker_sentiment_score': '0.105998', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RBGPF', 'relevance_score': '0.086556', 'ticker_sentiment_score': '0.105998', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SFTBF', 'relevance_score': '0.086556', 'ticker_sentiment_score': '-0.046725', 'ticker_sentiment_label': 'Neutral'}]"
This Industry Leader Will Have to Spend Big if It Wants to Keep Growing,https://www.fool.com/investing/2023/04/07/industry-leader-spend-big-growing-realty-income/,20230407T095700,['Reuben Gregg Brewer'],"Realty Income is a giant in the net-lease REIT space, but investors need to understand this can be both good and bad.",https://media.ycharts.com/charts/f048d078180cf6bb0ccc011ef458b575.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}]",0.27152,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.055621', 'ticker_sentiment_score': '0.046097', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NNN', 'relevance_score': '0.110973', 'ticker_sentiment_score': '0.045718', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'O', 'relevance_score': '0.514619', 'ticker_sentiment_score': '0.341822', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PG', 'relevance_score': '0.055621', 'ticker_sentiment_score': '0.046097', 'ticker_sentiment_label': 'Neutral'}]"
Lanier Law Firm Responds to Proposed Plan to Resolve Talc Litigation,https://www.prnewswire.com/news-releases/lanier-law-firm-responds-to-proposed-plan-to-resolve-talc-litigation-301792283.html,20230407T021600,['The Lanier Law Firm'],Lanier Law Firm Responds to Proposed Plan to Resolve Talc ... PR ...,,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.049553,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.16849', 'ticker_sentiment_score': '-0.085165', 'ticker_sentiment_label': 'Neutral'}]"
Build a Unique Portfolio with 3 Top Ranked ETFs,https://www.zacks.com/commentary/2075769/build-a-unique-portfolio-with-3-top-ranked-etfs,20230406T193800,['Zacks Investment Research'],The universe of ETFs these days is practically as diverse as the whole stock market ...,https://staticx-tuner.zacks.com/images/articles/main/40/26137.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.996718'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}]",0.235654,Somewhat-Bullish,"[{'ticker': 'JPM', 'relevance_score': '0.099683', 'ticker_sentiment_score': '0.05826', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.099683', 'ticker_sentiment_score': '0.068892', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.099683', 'ticker_sentiment_score': '0.068892', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.049939', 'ticker_sentiment_score': '0.03661', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.099683', 'ticker_sentiment_score': '0.068892', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.099683', 'ticker_sentiment_score': '0.05826', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FTNT', 'relevance_score': '0.099683', 'ticker_sentiment_score': '0.039151', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.099683', 'ticker_sentiment_score': '0.05826', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.099683', 'ticker_sentiment_score': '0.05826', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ATVI', 'relevance_score': '0.099683', 'ticker_sentiment_score': '0.039151', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CDNS', 'relevance_score': '0.099683', 'ticker_sentiment_score': '0.039151', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RBLX', 'relevance_score': '0.099683', 'ticker_sentiment_score': '0.039151', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EA', 'relevance_score': '0.099683', 'ticker_sentiment_score': '0.039151', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HD', 'relevance_score': '0.099683', 'ticker_sentiment_score': '0.05826', 'ticker_sentiment_label': 'Neutral'}]"
Will Bristol Myers  ( BMY )  Gain From New Drugs' Label Expansion?,https://www.zacks.com/stock/news/2075733/will-bristol-myers-bmy-gain-from-new-drugs-label-expansion,20230406T164400,['Zacks Investment Research'],Label expansion of Bristol Myers' (BMY) new drugs should help it somewhat combat the decline in Revlimid sales due to generic competition.,https://staticx-tuner.zacks.com/images/articles/main/b7/2106.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}, {'topic': 'Earnings', 'relevance_score': '0.857896'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.108179'}]",0.247791,Somewhat-Bullish,"[{'ticker': 'NVO', 'relevance_score': '0.107736', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.265089', 'ticker_sentiment_score': '0.099382', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.053992', 'ticker_sentiment_score': '-0.023887', 'ticker_sentiment_label': 'Neutral'}]"
2 Elite Dividend Stocks That Won't Wilt in a Recessionary Environment,https://www.fool.com/investing/2023/04/06/2-elite-dividend-stocks-that-wont-wilt-in-a-recess/,20230406T134500,['George Budwell'],"Johnson & Johnson and Ford have resilient businesses, stellar dividend programs, and wide economic moats.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F727199%2Fno-crisis_man-under-umbrella.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.962106'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}]",0.179427,Somewhat-Bullish,"[{'ticker': 'F', 'relevance_score': '0.199037', 'ticker_sentiment_score': '0.083224', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.13347', 'ticker_sentiment_score': '0.323483', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Boston Scientific  ( BSX )  Hits 52-Week High: What's Driving It?,https://www.zacks.com/stock/news/2075403/boston-scientific-bsx-hits-52-week-high-whats-driving-it,20230406T130500,['Zacks Investment Research'],Boston Scientific (BSX) outperforms the industry and the S&P 500 due to several new acquisitions and the long-term growth prospects of the WATCHMAN device.,https://staticx-tuner.zacks.com/images/articles/main/45/26891.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.938238'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}]",0.240344,Somewhat-Bullish,"[{'ticker': 'EW', 'relevance_score': '0.045482', 'ticker_sentiment_score': '0.069733', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OFIX', 'relevance_score': '0.135857', 'ticker_sentiment_score': '0.069177', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNN', 'relevance_score': '0.045482', 'ticker_sentiment_score': '0.069733', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DSSMY', 'relevance_score': '0.045482', 'ticker_sentiment_score': '0.069733', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'APEN', 'relevance_score': '0.045482', 'ticker_sentiment_score': '0.229133', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BSX', 'relevance_score': '0.431554', 'ticker_sentiment_score': '0.357838', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.045482', 'ticker_sentiment_score': '0.069733', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PODD', 'relevance_score': '0.135857', 'ticker_sentiment_score': '0.034407', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.045482', 'ticker_sentiment_score': '0.069733', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VMD', 'relevance_score': '0.18046', 'ticker_sentiment_score': '0.039792', 'ticker_sentiment_label': 'Neutral'}]"
Here's Why Chevron Is a No-Brainer Dividend Stock,https://www.fool.com/investing/2023/04/06/heres-why-chevron-is-a-no-brainer-dividend-stock/,20230406T124500,['Reuben Gregg Brewer'],The integrated oil giant has proven it knows how to handle adversity while continuing to grow its dividend.,https://media.ycharts.com/charts/6365d21f0e781d5e667ee80c7ef3ee30.png,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.658903'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}]",0.227322,Somewhat-Bullish,"[{'ticker': 'EMR', 'relevance_score': '0.060236', 'ticker_sentiment_score': '0.033248', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVX', 'relevance_score': '0.550151', 'ticker_sentiment_score': '0.339664', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KO', 'relevance_score': '0.060236', 'ticker_sentiment_score': '0.033248', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TTE', 'relevance_score': '0.060236', 'ticker_sentiment_score': '-0.02719', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.060236', 'ticker_sentiment_score': '0.033248', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.060236', 'ticker_sentiment_score': '-0.02719', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson  ( JNJ )  Soars 4.5%: Is Further Upside Left in the Stock?,https://www.zacks.com/stock/news/2075276/johnson-johnson-jnj-soars-45-is-further-upside-left-in-the-stock,20230406T080500,['Zacks Investment Research'],Johnson & Johnson (JNJ) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.,https://staticx-tuner.zacks.com/images/default_article_images/default261.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.976913'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.316726'}]",0.25383,Somewhat-Bullish,"[{'ticker': 'ABBV', 'relevance_score': '0.390396', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.47672', 'ticker_sentiment_score': '0.440368', 'ticker_sentiment_label': 'Bullish'}]"
Asian shares mostly fall amid worries about slowing economy,https://apnews.com/article/stock-markets-banks-rates-recession-b123b54a2436b2afd62fb2a9fad26149,20230406T070559,[],"A man walks near a sign of foreign currency outside a money exchange office at a shopping district in Seoul, South Korea, Thursday, April 6, 2023. Asian shares were trading mostly lower Thursday as investors turned their attention to upcoming earnings reports and other economic indicators. ( AP ...",https://storage.googleapis.com/afs-prod/media/508df9df0a644c54821e3346f98c5329/3000.webp,Associated Press,Markets,apnews.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.990999'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",-0.043641,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.05387', 'ticker_sentiment_score': '-0.018058', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:JPY', 'relevance_score': '0.107495', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:EUR', 'relevance_score': '0.05387', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.05387', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
S&P 500 ends lower as recession fears take center stage,https://www.moneycontrol.com/news/business/markets/sp-500-ends-lower-as-recession-fears-take-center-stage-10369971.html,20230406T003425,[],Nvidia Corp ( NVDA.O ) dropped 2.1% and was among the stocks weighing most on the SP 500 after Alphabet Inc's ( GOOGL.O ) Google unit said the supercomputers it uses to train its artificial intelligence models were faster and more power-efficient than comparable components made by the chipmaker.,https://images.moneycontrol.com/static-mcnews/2023/01/asset-monetisation-rep-378x213.jpg?impolicy=website&width=168&height=118,Money Control,Markets,www.moneycontrol.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}]",-0.153109,Somewhat-Bearish,"[{'ticker': 'GOOG', 'relevance_score': '0.058047', 'ticker_sentiment_score': '0.129989', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.058047', 'ticker_sentiment_score': '0.129989', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'C', 'relevance_score': '0.058047', 'ticker_sentiment_score': '0.081972', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.058047', 'ticker_sentiment_score': '0.038468', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.058047', 'ticker_sentiment_score': '0.081972', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.058047', 'ticker_sentiment_score': '0.181129', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FDX', 'relevance_score': '0.058047', 'ticker_sentiment_score': '0.082139', 'ticker_sentiment_label': 'Neutral'}]"
"Look to 3 'great American companies' in this market, Jim Cramer says",https://www.cnbc.com/2023/04/05/look-to-3-great-american-companies-in-this-market-jim-cramer-says.html,20230405T224553,['Rohan Goswami'],"There are three companies that Cramer thinks have compelling stories and strength: Johnson & Johnson, Eli Lilly, and Procter & Gamble.",https://image.cnbcfm.com/api/v1/image/107116754-1662978855859-gettyimages-1236243165-RAFAPRESS_30102021-1664.jpeg?v=1680631890,CNBC,Top News,www.cnbc.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.918141'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.10021,Neutral,"[{'ticker': 'META', 'relevance_score': '0.109956', 'ticker_sentiment_score': '-0.099934', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.217834', 'ticker_sentiment_score': '-0.165418', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'PG', 'relevance_score': '0.109956', 'ticker_sentiment_score': '0.19234', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"J&J, Walmart Lift Dow In Down Day For US Stocks",https://www.barrons.com/news/j-j-walmart-lift-dow-in-down-day-for-us-stocks-cdb4b0c4,20230405T203057,['AFP - Agence France Presse'],"Wall Street stocks mostly fell on Wednesday following data that showed a weakening US economy, but the Dow advanced on gains by Johnson & Johnson and Walmart.",,Barrons,n/a,www.barrons.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}]",-0.083169,Neutral,"[{'ticker': 'META', 'relevance_score': '0.136888', 'ticker_sentiment_score': '-0.033226', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MORN', 'relevance_score': '0.136888', 'ticker_sentiment_score': '-0.033226', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FDX', 'relevance_score': '0.136888', 'ticker_sentiment_score': '-0.033226', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.269776', 'ticker_sentiment_score': '-0.033677', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.269776', 'ticker_sentiment_score': '-0.033677', 'ticker_sentiment_label': 'Neutral'}]"
Cash Is 'In Jeopardy': World's Largest Hedge Fund Founder Ray Dalio Says but Sees an Unexpected Solution,https://www.benzinga.com/markets/cryptocurrency/23/04/31688001/cash-is-in-jeopardy-worlds-largest-hedge-fund-founder-ray-dalio-says-but-sees-an-unexpecte,20230405T203053,['Caleb Naysmith'],"Inflation has been a massive issue for nearly every major country for the past year or so. Consumers and corporations alike have felt the pain, with the previous four quarters of earnings proving to be relatively lackluster. While inflation is slowly declining, it has caused the debt of the U.S. ...",https://cdn.benzinga.com/files/images/story/2023/04/05/0000web_summit_2018_-_forum_-_day_2_november_7_hm1_7481_44858045925.jpg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.858979'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Blockchain', 'relevance_score': '0.451494'}]",-0.11305,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.109956', 'ticker_sentiment_score': '0.076502', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.510588', 'ticker_sentiment_score': '0.137925', 'ticker_sentiment_label': 'Neutral'}]"
How major US stock indexes fared Wednesday 4/5/2023,https://apnews.com/article/business-johnson-and-stocks-bonds-financial-markets-4a7e173a96d68514a8ebc2bc7a7dd35b,20230405T201735,[],Stocks closed lower on Wall Street Wednesday and Treasury yields fell following the latest signals that the U.S. economy is slowing. The S&P 500 slid 0.2% and the Nasdaq lost 1.1%. Reports on both services industries and the jobs market came in weaker than expected.,https://storage.googleapis.com/afs-prod/media/afs:Medium:751921853724/700.png,Associated Press,Business,apnews.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.223659,Somewhat-Bearish,"[{'ticker': 'JNJ', 'relevance_score': '0.245339', 'ticker_sentiment_score': '-0.102909', 'ticker_sentiment_label': 'Neutral'}]"
Stock Market Today: Weak Economic Data Weighs on Stocks,https://www.kiplinger.com/investing/stocks/stock-market-today-weak-economic-data-weighs-on-stocks,20230405T201525,['Karee Venema'],Weakness in the tech sector and strength in healthcare stocks resulted in a mixed finish for the major indexes Wednesday. It's already been a shaky week for stocks as recent economic data elevated worries about a potential recession this year.,https://cdn.mos.cms.futurecdn.net/vVb5K9UJPhSVZuMuypmmnC-415-80.jpg,Kiplinger,n/a,www.kiplinger.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.451494'}, {'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.94762'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.12342,Neutral,"[{'ticker': 'GOOG', 'relevance_score': '0.053749', 'ticker_sentiment_score': '0.021008', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.160277', 'ticker_sentiment_score': '0.029215', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BCS', 'relevance_score': '0.053749', 'ticker_sentiment_score': '0.125119', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMA', 'relevance_score': '0.053749', 'ticker_sentiment_score': '-0.065', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.107255', 'ticker_sentiment_score': '-0.026347', 'ticker_sentiment_label': 'Neutral'}]"
Why Johnson & Johnson Stock Was Climbing Today,https://www.fool.com/investing/2023/04/05/why-johnson-johnson-stock-was-climbing-today/,20230405T193842,['Jeremy Bowman'],The healthcare giant reached a $8.9 billion settlement over allegations that its baby powder caused cancer.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F726787%2Fa-person-standing-in-front-of-digitally-enhanced-shelving-in-a-large-factory.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.132046,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.560594', 'ticker_sentiment_score': '0.238591', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
JNJ: Investors Are Keeping This Healthcare Stock Long-Term,https://stocknews.com/news/jnj-nvo-nvs-bmy-abmd-investors-are-keeping-this-healthcare-stock-long-term/,20230405T192540,[],JNJ: Investors Are Keeping This Healthcare Stock ...,https://stocknews.com/wp-content/uploads/2021/10/shutterstock_370500485-1-scaled.jpg,Stocknews.com,n/a,stocknews.com,"[{'topic': 'Earnings', 'relevance_score': '0.999896'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.999967'}]",0.297283,Somewhat-Bullish,"[{'ticker': 'NVS', 'relevance_score': '0.069697', 'ticker_sentiment_score': '0.07528', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.069697', 'ticker_sentiment_score': '0.07528', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.069697', 'ticker_sentiment_score': '0.07528', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.488161', 'ticker_sentiment_score': '0.405846', 'ticker_sentiment_label': 'Bullish'}]"
This portfolio manager's frugality and eye for income protected her fund from the worst of 2022's tumult,https://www.cnbc.com/2023/04/05/this-portfolio-managers-eye-for-income-protected-her-fund-from-2022s-tumult.html,20230405T185107,"['Darla Mercado', 'CFP']","Ramona Persaud manages the Fidelity Equity-Income Fund (FEQIX). The fund posted a total return of -5.07% in 2022, avoiding the worst of last year's turmoil.",https://image.cnbcfm.com/api/v1/image/107220196-1680622016395-Persaud_Ramona_July2021-USE-FOR-MARKETING.jpg?v=1680720667&w=1920&h=1080,CNBC,Investing,www.cnbc.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.858979'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.224912,Somewhat-Bullish,"[{'ticker': 'MORN', 'relevance_score': '0.096477', 'ticker_sentiment_score': '0.006385', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.048327', 'ticker_sentiment_score': '-0.010026', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.096477', 'ticker_sentiment_score': '0.031609', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.048327', 'ticker_sentiment_score': '-0.010026', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.048327', 'ticker_sentiment_score': '-0.010026', 'ticker_sentiment_label': 'Neutral'}]"
J&J's $8.9 Billion Agreement Doesn't End Its Talc Worries,https://www.barrons.com/articles/johnson-johnson-talc-lawsuit-settlement-bc2d3aea,20230405T184100,['Josh Nathan-Kazis'],Will J&J's $8.9 Billion Talc Agreement Make It Through the Courts? ...,https://images.barrons.com/im-757921/social,Barrons,n/a,www.barrons.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.283157,Somewhat-Bearish,"[{'ticker': 'JNJ', 'relevance_score': '0.795061', 'ticker_sentiment_score': '-0.451557', 'ticker_sentiment_label': 'Bearish'}]"
Stock Market Posts Mixed Results; Health Care Stocks Lead The Day,https://www.investors.com/market-trend/stock-market-today/stock-market-posts-mixed-results-health-care-stocks-lead/,20230405T175000,"['KIMBERLEY KOENIG', ""Investor's Business Daily""]",Stock Market Posts Mixed Results. Health Care Stocks Lead The Day Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2022/10/stock-unh-minnetonka-shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.999981'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}]",0.10935,Neutral,"[{'ticker': 'SMPL', 'relevance_score': '0.144708', 'ticker_sentiment_score': '-0.223096', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'GOOG', 'relevance_score': '0.072655', 'ticker_sentiment_score': '0.1118', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.144708', 'ticker_sentiment_score': '0.138028', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HCA', 'relevance_score': '0.284696', 'ticker_sentiment_score': '0.291839', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.215574', 'ticker_sentiment_score': '0.003466', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FDX', 'relevance_score': '0.144708', 'ticker_sentiment_score': '0.14928', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IVZ', 'relevance_score': '0.072655', 'ticker_sentiment_score': '-0.18562', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CRYPTO:BTC', 'relevance_score': '0.072655', 'ticker_sentiment_score': '-0.140712', 'ticker_sentiment_label': 'Neutral'}]"
"Stocks making the biggest moves midday: Nvidia, Palantir, Western Alliance, Johnson & Johnson and more",https://www.cnbc.com/2023/04/05/stocks-moving-big-midday-nvda-pltr-wal-jnj.html,20230405T165759,['Samantha Subin'],These are the stocks posting the largest moves in midday trading.,https://image.cnbcfm.com/api/v1/image/107208179-1678794119001-gettyimages-1248150503-arriens-concerns230313_npRkE.jpeg?v=1680713879&w=1920&h=1080,CNBC,Market Insider,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}]",0.150515,Somewhat-Bullish,"[{'ticker': 'GOOG', 'relevance_score': '0.068698', 'ticker_sentiment_score': '0.192949', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.232205', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BAC', 'relevance_score': '0.068698', 'ticker_sentiment_score': '-0.090975', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MKTX', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.051052', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.068698', 'ticker_sentiment_score': '-0.092778', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BBBY', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.101564', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CAG', 'relevance_score': '0.068698', 'ticker_sentiment_score': '0.135533', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.328109', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MSFT', 'relevance_score': '0.136888', 'ticker_sentiment_score': '-0.017184', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALB', 'relevance_score': '0.136888', 'ticker_sentiment_score': '-0.112201', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CZBS', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.064891', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FIZN', 'relevance_score': '0.136888', 'ticker_sentiment_score': '0.064891', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FDX', 'relevance_score': '0.068698', 'ticker_sentiment_score': '0.090732', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CLNE', 'relevance_score': '0.068698', 'ticker_sentiment_score': '0.305112', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PLTR', 'relevance_score': '0.068698', 'ticker_sentiment_score': '-0.014091', 'ticker_sentiment_label': 'Neutral'}]"
IBD Stock Of The Day: Why 2024 Could Be A Game-Changer,https://www.investors.com/research/ibd-stock-of-the-day/isrg-stock-why-2024-could-be-a-game-changer-for-robotic-surgery/,20230405T162800,"['ALLISON GATLIN', ""Investor's Business Daily""]",ISRG Stock: Why 2024 Could Be A Game-Changer For Robotic ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2023/04/ISRG-SOTD-chart1.png,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999365'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.173841,Somewhat-Bullish,"[{'ticker': 'EVR', 'relevance_score': '0.068306', 'ticker_sentiment_score': '0.097295', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MDT', 'relevance_score': '0.136113', 'ticker_sentiment_score': '0.026971', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.068306', 'ticker_sentiment_score': '0.138353', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.734843', 'ticker_sentiment_score': '0.231238', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.202932', 'ticker_sentiment_score': '0.028709', 'ticker_sentiment_label': 'Neutral'}]"
Club meeting recap: Jim Cramer says 'the existential threat is gone for J&J',https://www.cnbc.com/2023/04/05/jim-cramer-says-the-existential-threat-is-gone-for-jj-.html,20230405T162316,['Paulina Likos'],"The Investing Club holds its ""Morning Meeting"" every weekday at 10:20 a.m. ET.",https://image.cnbcfm.com/api/v1/image/107220991-16807053831680705378-28888179594-1080pnbcnews.jpg?v=1680706277&w=600&h=300&vtcrop=y,CNBC,Top News,www.cnbc.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.891286'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.10456,Neutral,"[{'ticker': 'LLY', 'relevance_score': '0.422661', 'ticker_sentiment_score': '0.125264', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.147366', 'ticker_sentiment_score': '0.057003', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.147366', 'ticker_sentiment_score': '0.057003', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.219477', 'ticker_sentiment_score': '0.075777', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.219477', 'ticker_sentiment_score': '0.075777', 'ticker_sentiment_label': 'Neutral'}]"
Dow Jones Rises But Big Tech Gets Sold; Gold Holds $2000; Johnson & Johnson Settles Baby Powder Claims,https://www.investors.com/market-trend/stock-market-today/dow-jones-rises-but-big-tech-gets-sold-gold-holds-2000-johnson-johnson-settles-baby-powder-claims/,20230405T145000,"['VIDYA RAMAKRISHNAN', ""Investor's Business Daily""]",Dow Jones Rises But Big Tech Gets Sold. Gold Holds $2000 ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2017/10/stock-JohnsonANDjohnson-02-shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.967645'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.166667'}]",0.019489,Neutral,"[{'ticker': 'GOOG', 'relevance_score': '0.130217', 'ticker_sentiment_score': '0.198199', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.194242', 'ticker_sentiment_score': '0.254488', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AAPL', 'relevance_score': '0.130217', 'ticker_sentiment_score': '0.125808', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.194242', 'ticker_sentiment_score': '-0.161784', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'AZN', 'relevance_score': '0.130217', 'ticker_sentiment_score': '0.225322', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'GM', 'relevance_score': '0.194242', 'ticker_sentiment_score': '-0.161784', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'MS', 'relevance_score': '0.065327', 'ticker_sentiment_score': '0.027148', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.256989', 'ticker_sentiment_score': '-0.07716', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FDX', 'relevance_score': '0.130217', 'ticker_sentiment_score': '0.081933', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RGLD', 'relevance_score': '0.130217', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AEP', 'relevance_score': '0.130217', 'ticker_sentiment_score': '0.225322', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'XEL', 'relevance_score': '0.130217', 'ticker_sentiment_score': '0.225322', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Johnson & Johnson to pay $8.9B to resolve claims baby powder, talc products caused cancer",https://www.foxbusiness.com/retail/johnson-johnson-to-pay-resolve-claims-baby-powder-talc-products-caused-cancer,20230405T144813,[],Johnson & Johnson announced Tuesday that it would pay $8.9 billion to resolve all allegations that talc in its baby powder and other products caused cancer. That amount was more than quadruple what the company previously set aside to pay for its potential liability.,https://static.foxbusiness.com/foxbusiness.com/content/uploads/2022/02/JJ-Talc-A.jpg,Fox Business News,n/a,www.foxbusiness.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.090093,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.264897', 'ticker_sentiment_score': '-0.219463', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
Johnson & Johnson shares rise after company proposes baby powder cancer settlement,https://www.cnbc.com/2023/04/05/johnson-and-johnson-shares-rise-talc-settlement.html,20230405T144629,['Annika Kim Constantino'],Wall Street analysts were encouraged by J&J's proposal to pay $8.9 billion to settle claims that its baby powder and other talc products caused cancer.,https://image.cnbcfm.com/api/v1/image/107121163-16636733462022-09-20t110046z_916998079_rc2ykw94dd2c_rtrmadp_0_usa-sec-morganstanley.jpeg?v=1680633514,CNBC,Business,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.099995,Neutral,"[{'ticker': 'BAC', 'relevance_score': '0.092927', 'ticker_sentiment_score': '-0.038111', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.092927', 'ticker_sentiment_score': '0.142167', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MS', 'relevance_score': '0.092927', 'ticker_sentiment_score': '0.157951', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.092927', 'ticker_sentiment_score': '-0.073817', 'ticker_sentiment_label': 'Neutral'}]"
J&J Sweetens Its Talc Deal By $7 Billion And Shares Pop,https://www.investors.com/news/technology/jnj-stock-rises-after-sweetening-its-talc-settlement/,20230405T141900,"[""Investor's Business Daily"", 'ALLISON GATLIN']",JNJ Stock Rises After Sweetening Its Talc Settlement By $6.9 Billion ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2017/10/stock-JohnsonANDjohnson-01-shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.995077'}]",0.13648,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.731269', 'ticker_sentiment_score': '-0.140861', 'ticker_sentiment_label': 'Neutral'}]"
US Stocks Mixed As Data Suggests Slowing Economy,https://www.barrons.com/news/us-stocks-mixed-as-data-suggests-slowing-economy-4f7078ac,20230405T135659,['AFP - Agence France Presse'],"Wall Street stocks were mixed Wednesday as markets digested employment and trade data that suggest a slowing in the economy. Employers added 145,000 jobs last month, according to payroll firm ADP, much below the February level and weaker than analysts expected.",,Barrons,n/a,www.barrons.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}]",-0.110024,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.192694', 'ticker_sentiment_score': '0.003186', 'ticker_sentiment_label': 'Neutral'}]"
J&J  ( JNJ )  Offers $8.9B Settlement for Talc Cancer Lawsuits,https://www.zacks.com/stock/news/2074891/jj-jnj-offers-89b-settlement-for-talc-cancer-lawsuits,20230405T135300,['Zacks Investment Research'],"To completely resolve its cosmetic talc litigation, J&J (JNJ) offers a settlement amount of $8.9 billion payable over a period of 25 years.",https://staticx-tuner.zacks.com/images/articles/main/7d/1177.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.9545'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",-0.012357,Neutral,"[{'ticker': 'INVA', 'relevance_score': '0.214462', 'ticker_sentiment_score': '-0.01521', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.214462', 'ticker_sentiment_score': '0.096198', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.108222', 'ticker_sentiment_score': '-0.129435', 'ticker_sentiment_label': 'Neutral'}]"
"Farallon Capital Might Undertake Proxy Fight Against Exelixis, Nominates Three Directors - Exelixis  ( NASDAQ:EXEL ) ",https://www.benzinga.com/general/biotech/23/04/31674132/farallon-capital-might-undertake-proxy-fight-against-exelixis-nominates-three-directors,20230405T131713,['Vandana Singh'],"Farallon Capital Management is planning to start a proxy battle at Exelixis Inc EXEL and has nominated three director candidates, it signaled in an SEC filing. The firm hadn't decided to move forward with a proxy fight, Wall Street Journal reported and was still trying to work with the company.",https://cdn.benzinga.com/files/images/story/2023/04/05/exel.png?optimize=medium&dpr=2&auto=webp&width=3840,Benzinga,General,www.benzinga.com,"[{'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.158519'}]",-0.071328,Neutral,"[{'ticker': 'EXEL', 'relevance_score': '0.785986', 'ticker_sentiment_score': '-0.280381', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.277433', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
What's Going On With Johnson & Johnson Stock? - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/news/23/04/31677727/whats-going-on-with-johnson-johnson-stock,20230405T131503,['Adam Eckert'],Johnson & Johnson JNJ shares are trading higher Wednesday after the company's subsidiary LTL Management re-filed for bankruptcy to resolve all talc-based baby powder claims.,https://cdn.benzinga.com/files/images/story/2023/04/05/26190158994_907af2d12e_k.jpg?width=1200&height=800&fit=crop,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.214378'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.13862,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.77688', 'ticker_sentiment_score': '-0.049042', 'ticker_sentiment_label': 'Neutral'}]"
Better Dividend Stock: AbbVie vs. Johnson & Johnson,https://www.fool.com/investing/2023/04/05/better-dividend-stock-abbvie-vs-johnson-johnson/,20230405T125500,['Prosper Junior Bakiny'],Both companies have a lot to offer income-seekers.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F726985%2Finvesting-screen-analysis-investor-growth-stocks.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.999491'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.328065,Somewhat-Bullish,"[{'ticker': 'ABBV', 'relevance_score': '0.457977', 'ticker_sentiment_score': '0.436571', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'ABT', 'relevance_score': '0.048621', 'ticker_sentiment_score': '0.092464', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.416844', 'ticker_sentiment_score': '0.393482', 'ticker_sentiment_label': 'Bullish'}]"
"J&J's on the Rise, but This Fintech Stock Is Falling Hard",https://www.fool.com/investing/2023/04/05/jjs-on-the-rise-but-this-fintech-stock-is-falling/,20230405T125251,['Dan Caplinger'],Investors looked prepared for a quiet stock market open on Wednesday morning.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F726985%2Finvesting-screen-analysis-investor-growth-stocks.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.891286'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.992549'}]",0.125661,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.310843', 'ticker_sentiment_score': '0.207908', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Jim Cramer's top 10 things to watch in the stock market Wednesday: New dawn for JNJ, Disney push, Meta upgrade",https://www.cnbc.com/2023/04/05/cramers-things-to-watch-in-stock-market-wednesday.html,20230405T125153,['Jim Cramer'],"Big victory for an embattled Club name, positive analyst calls for META and Apple.",https://image.cnbcfm.com/api/v1/image/106019622-1563210739694gettyimages-837182306.jpeg?v=1680699113&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.744043'}, {'topic': 'Earnings', 'relevance_score': '0.839681'}]",0.190567,Somewhat-Bullish,"[{'ticker': 'HUM', 'relevance_score': '0.127456', 'ticker_sentiment_score': '0.406802', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'META', 'relevance_score': '0.127456', 'ticker_sentiment_score': '0.148853', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BAC', 'relevance_score': '0.063933', 'ticker_sentiment_score': '0.18227', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WFC', 'relevance_score': '0.063933', 'ticker_sentiment_score': '0.015428', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.063933', 'ticker_sentiment_score': '0.093064', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.25168', 'ticker_sentiment_score': '0.031223', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.190167', 'ticker_sentiment_score': '0.138419', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.127456', 'ticker_sentiment_score': '0.406802', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'BIIB', 'relevance_score': '0.127456', 'ticker_sentiment_score': '0.108139', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.127456', 'ticker_sentiment_score': '0.122422', 'ticker_sentiment_label': 'Neutral'}]"
Futures Turn Mixed After ADP Jobs Data,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-ahead-of-adp-jobs-data-c3-ai-extends-losses-after-short-seller-letter/,20230405T122100,"['SCOTT LEHTONEN', ""Investor's Business Daily""]",Dow Jones Futures Fall On Weak ADP Jobs Data. C3.ai Extends ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2020/12/Stock-WallSt-Flags-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.744043'}]",0.083732,Neutral,"[{'ticker': 'AAPL', 'relevance_score': '0.119383', 'ticker_sentiment_score': '0.105772', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CSCO', 'relevance_score': '0.089685', 'ticker_sentiment_score': '0.100682', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.089685', 'ticker_sentiment_score': '-0.193354', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'AXON', 'relevance_score': '0.089685', 'ticker_sentiment_score': '0.068879', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NKE', 'relevance_score': '0.119383', 'ticker_sentiment_score': '0.173378', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'IVZ', 'relevance_score': '0.029951', 'ticker_sentiment_score': '-0.035026', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.17824', 'ticker_sentiment_score': '0.116145', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SMPL', 'relevance_score': '0.089685', 'ticker_sentiment_score': '-0.104616', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.089685', 'ticker_sentiment_score': '-0.012512', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOW', 'relevance_score': '0.05986', 'ticker_sentiment_score': '0.092058', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SCCO', 'relevance_score': '0.148915', 'ticker_sentiment_score': '0.17259', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FDX', 'relevance_score': '0.119383', 'ticker_sentiment_score': '-0.059614', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BA', 'relevance_score': '0.148915', 'ticker_sentiment_score': '0.08494', 'ticker_sentiment_label': 'Neutral'}]"
"Global Non-Invasive Surgical Wound Closure Market Size and Share Revenue to Surpass $25.64 Billion by 2030, Exhibit a CAGR of 7.2%",https://www.benzinga.com/pressreleases/23/04/g31676572/global-non-invasive-surgical-wound-closure-market-size-and-share-revenue-to-surpass-25-64-billion-,20230405T120834,['Globe Newswire'],"Boston, MA, April 05, 2023 ( GLOBE NEWSWIRE ) -- Zion Market Research has published a new research report titled ""Non-Invasive Surgical Wound Closure Market By Product Type ( Adhesive, Natural, Synthetic, , Hemostats, Mechanical Active, Flowable, Sealants, Fibrin, And Surgical ) , By Application ...",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.214378'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",-0.009966,Neutral,"[{'ticker': 'BAX', 'relevance_score': '0.017394', 'ticker_sentiment_score': '0.126508', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MMM', 'relevance_score': '0.017394', 'ticker_sentiment_score': '-0.008523', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.017394', 'ticker_sentiment_score': '-0.033482', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RSSS', 'relevance_score': '0.017394', 'ticker_sentiment_score': '0.360315', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'TFX', 'relevance_score': '0.017394', 'ticker_sentiment_score': '0.126508', 'ticker_sentiment_label': 'Neutral'}]"
J&J rises as $8.9 bln talc lawsuit settlement eases overhang on consumer unit spinoff,https://www.reuters.com/business/healthcare-pharmaceuticals/jj-rises-89-bln-talc-lawsuit-settlement-eases-overhang-consumer-unit-spinoff-2023-04-05/,20230405T120100,['Reuters'],J&J rises as $8.9 bln talc lawsuit settlement eases overhang on ... ...,https://cloudfront-us-east-2.images.arcpublishing.com/reuters/CNFUTHK2XJOWDDZ6I7Z74W3PVI.jpg,Reuters,Business,www.reuters.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.158519'}]",0.190084,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.116914', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
2 Dividend Kings That Are Likely to Raise Their Payouts This Month,https://www.fool.com/investing/2023/04/05/2-dividend-kingsthat-are-likely-to-raise-their-pay/,20230405T120000,['David Jagielski'],These companies have been increasing their dividends for a combined 126 years.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F726985%2Finvesting-screen-analysis-investor-growth-stocks.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.929393'}, {'topic': 'Earnings', 'relevance_score': '0.310843'}]",0.304948,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.353562', 'ticker_sentiment_score': '0.244493', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PG', 'relevance_score': '0.28636', 'ticker_sentiment_score': '0.32141', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Stocks making the biggest moves premarket: Johnson & Johnson, FedEx, Zions and more",https://www.cnbc.com/2023/04/05/stocks-making-the-biggest-moves-premarket-jnj-fdx-zion.html,20230405T115948,['Pia Singh'],FedEx's shares gained more than 2% before the bell after announcing a dividend hike and a corporate reorganization.,https://image.cnbcfm.com/api/v1/image/107177733-1673525179983-gettyimages-1246171353-AA_12012023_1021333.jpeg?v=1680695988&w=1920&h=1080,CNBC,Market Insider,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",0.108336,Neutral,"[{'ticker': 'BAC', 'relevance_score': '0.234684', 'ticker_sentiment_score': '-0.021665', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ALB', 'relevance_score': '0.345674', 'ticker_sentiment_score': '-0.282449', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.118647', 'ticker_sentiment_score': '-0.122099', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ZIONL', 'relevance_score': '0.234684', 'ticker_sentiment_score': '0.378278', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'EXEL', 'relevance_score': '0.234684', 'ticker_sentiment_score': '-0.13382', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FDX', 'relevance_score': '0.345674', 'ticker_sentiment_score': '0.259757', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'LW', 'relevance_score': '0.234684', 'ticker_sentiment_score': '0.162829', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CLNE', 'relevance_score': '0.234684', 'ticker_sentiment_score': '0.513046', 'ticker_sentiment_label': 'Bullish'}]"
"The daily business briefing: April 5, 2023",https://theweek.com/briefing/business-briefing/1022410/the-daily-business-briefing-april-5-2023,20230405T114320,['Harold Maass'],Johnson & Johnson said Tuesday it had agreed to pay $8.9 billion over the next 25 years to settle tens of thousands of lawsuits over claims its iconic Baby Powder and other talc products caused cancer. The company originally offered $2 billion.,"https://mediacloud.theweek.com/image/upload/f_auto,t_primary-image-mobile@1/v1680694134/GettyImages-1441388302.jpg",The Week News,n/a,theweek.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Blockchain', 'relevance_score': '0.158519'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}]",-0.160179,Somewhat-Bearish,"[{'ticker': 'SBNY', 'relevance_score': '0.068306', 'ticker_sentiment_score': '0.00102', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GM', 'relevance_score': '0.068306', 'ticker_sentiment_score': '0.042351', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.268294', 'ticker_sentiment_score': '-0.213558', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.068306', 'ticker_sentiment_score': '-0.113414', 'ticker_sentiment_label': 'Neutral'}]"
These are the only stocks that matter right now | Business,https://www.cnn.com/2023/04/05/investing/premarket-stocks-trading/index.html,20230405T113300,['Nicole Goodkind'],These are the only stocks that matter right now ...,"https://media.cnn.com/api/v1/images/stellar/prod/230330114859-wall-street-0328-restricted.jpg?c=16x9&q=w_800,c_fill",CNN,Markets,www.cnn.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.576289'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}]",0.00485,Neutral,"[{'ticker': 'APO', 'relevance_score': '0.036255', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.036255', 'ticker_sentiment_score': '0.120113', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.072435', 'ticker_sentiment_score': '0.049276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.108466', 'ticker_sentiment_score': '0.149601', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVX', 'relevance_score': '0.072435', 'ticker_sentiment_score': '0.049276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.072435', 'ticker_sentiment_score': '0.049276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.036255', 'ticker_sentiment_score': '0.04654', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.072435', 'ticker_sentiment_score': '0.049276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UNH', 'relevance_score': '0.072435', 'ticker_sentiment_score': '0.049276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.108466', 'ticker_sentiment_score': '0.149601', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.072435', 'ticker_sentiment_score': '0.156235', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MA', 'relevance_score': '0.036255', 'ticker_sentiment_score': '0.04654', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'V', 'relevance_score': '0.072435', 'ticker_sentiment_score': '0.049276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.072435', 'ticker_sentiment_score': '0.049276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.072435', 'ticker_sentiment_score': '0.049276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.072435', 'ticker_sentiment_score': '0.049276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WBD', 'relevance_score': '0.108466', 'ticker_sentiment_score': '-0.039882', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HD', 'relevance_score': '0.072435', 'ticker_sentiment_score': '0.049276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.108466', 'ticker_sentiment_score': '0.149601', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WMT', 'relevance_score': '0.072435', 'ticker_sentiment_score': '0.049276', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:GBP', 'relevance_score': '0.144275', 'ticker_sentiment_score': '-0.010219', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.036255', 'ticker_sentiment_score': '0.093803', 'ticker_sentiment_label': 'Neutral'}]"
"J&J firmer on hopes for talc deal, but Western Alliance Bancorp slides as regional bank fears revive",https://www.marketwatch.com/story/j-j-firmer-on-hopes-for-talc-deal-but-western-alliance-bancorp-slides-as-regional-bank-fears-revive-2fa90cc8,20230405T113100,['Jamie Chisholm'],C3.ai extends its slide after attack from short seller Kerrisdale Capital.,https://images.mktw.net/im-757874/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",-0.109207,Neutral,"[{'ticker': 'BROS', 'relevance_score': '0.388879', 'ticker_sentiment_score': '0.395677', 'ticker_sentiment_label': 'Bullish'}, {'ticker': 'WAL', 'relevance_score': '0.388879', 'ticker_sentiment_score': '-0.264866', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JPM', 'relevance_score': '0.200688', 'ticker_sentiment_score': '-0.161253', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.554365', 'ticker_sentiment_score': '-0.239447', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'WMT', 'relevance_score': '0.388879', 'ticker_sentiment_score': '-0.178952', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
"The commodity supercycle is still young, these strategists say. Here's why.",https://www.marketwatch.com/story/the-commodity-supercycle-is-still-young-these-strategists-say-heres-why-e84f5496,20230405T103100,['Steve Goldstein'],"Strategists at Wells Fargo investment Institute argue it's year three of a commodity supercycle, which they say has plenty more room to run.",https://images.mktw.net/im-757872?width=700&height=457,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '0.977154'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}]",0.081766,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.082535', 'ticker_sentiment_score': '-0.222007', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'GOOG', 'relevance_score': '0.041323', 'ticker_sentiment_score': '0.271618', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVDA', 'relevance_score': '0.082535', 'ticker_sentiment_score': '0.28244', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BCS', 'relevance_score': '0.041323', 'ticker_sentiment_score': '0.074068', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WAL', 'relevance_score': '0.082535', 'ticker_sentiment_score': '-0.049403', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WFC', 'relevance_score': '0.041323', 'ticker_sentiment_score': '0.013899', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.082535', 'ticker_sentiment_score': '-0.161677', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'WMT', 'relevance_score': '0.082535', 'ticker_sentiment_score': '0.088799', 'ticker_sentiment_label': 'Neutral'}]"
Should Vanguard Value ETF  ( VTV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2074662/should-vanguard-value-etf-vtv-be-on-your-investing-radar,20230405T102005,['Zacks Investment Research'],Style Box ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default128.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Finance', 'relevance_score': '0.5'}]",0.25634,Somewhat-Bullish,"[{'ticker': 'UNH', 'relevance_score': '0.125134', 'ticker_sentiment_score': '0.069019', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.062761', 'ticker_sentiment_score': '0.060012', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.125134', 'ticker_sentiment_score': '0.069019', 'ticker_sentiment_label': 'Neutral'}]"
Futures fall as investors await key economic data amid recession fears,https://www.reuters.com/markets/us/futures-fall-investors-await-key-economic-data-amid-recession-fears-2023-04-05/,20230405T095900,['Reuters'],"April 5 ( Reuters ) - U.S. stock index futures slipped on Wednesday in the run up to a fresh batch of economic data, expected to give more clarity on the state of the U.S. economy amid worries that rapid rate hikes by the Federal Reserve may trigger a steep downturn. At 5:03 a.m.",https://cloudfront-us-east-2.images.arcpublishing.com/reuters/EOYDT7Q7SBL7LIOLXW5OMSLNUM.jpg,Reuters,Markets,www.reuters.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.77141'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",-0.188717,Somewhat-Bearish,"[{'ticker': 'MSFT', 'relevance_score': '0.081552', 'ticker_sentiment_score': '-0.006339', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.081552', 'ticker_sentiment_score': '0.101758', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.081552', 'ticker_sentiment_score': '0.101758', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.081552', 'ticker_sentiment_score': '-0.006339', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.081552', 'ticker_sentiment_score': '-0.006339', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WAL', 'relevance_score': '0.081552', 'ticker_sentiment_score': '-0.025155', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.081552', 'ticker_sentiment_score': '-0.194394', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'SPGI', 'relevance_score': '0.081552', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BFC', 'relevance_score': '0.081552', 'ticker_sentiment_score': '-0.025155', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson to pay $8.9 billion to settle talc-cancer lawsuits | The Financial Express,https://www.financialexpress.com/healthcare/news-healthcare/johnson-johnson-to-pay-8-9-billion-to-settle-talc-cancer-lawsuits/3034671/,20230405T071600,[],Johnson & Johnson to pay $8.9 billion to settle talc-cancer lawsuits The Financial Express ...,https://www.financialexpress.com/wp-content/uploads/2023/04/TM5IO554ZJLY7CIKGFOQ2PYUPU.jpg,The Financial Express,n/a,www.financialexpress.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.231674,Somewhat-Bearish,"[{'ticker': 'JNJ', 'relevance_score': '0.080458', 'ticker_sentiment_score': '-0.010787', 'ticker_sentiment_label': 'Neutral'}]"
"Futures: AI Stock Keeps Sliding, Dow Giant Rises",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-ai-stock-keeps-sliding-johnson-and-johnson-rises/,20230405T020900,"['ED CARSON', ""Investor's Business Daily""]",Dow Jones Futures: AI Stock Keeps Sliding. Johnson & Johnson ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2023/03/Stock-AIservercontrol-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}]",-0.164299,Somewhat-Bearish,"[{'ticker': 'MSFT', 'relevance_score': '0.126918', 'ticker_sentiment_score': '-0.041018', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.076358', 'ticker_sentiment_score': '-0.042114', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.101689', 'ticker_sentiment_score': '-0.013195', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.101689', 'ticker_sentiment_score': '-0.012288', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.152018', 'ticker_sentiment_score': '-0.078376', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ATKR', 'relevance_score': '0.076358', 'ticker_sentiment_score': '-0.071986', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.101689', 'ticker_sentiment_score': '-0.201335', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CAT', 'relevance_score': '0.050948', 'ticker_sentiment_score': '-0.094077', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.152018', 'ticker_sentiment_score': '-0.067845', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOW', 'relevance_score': '0.076358', 'ticker_sentiment_score': '0.095858', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RIO', 'relevance_score': '0.050948', 'ticker_sentiment_score': '-0.094077', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NUE', 'relevance_score': '0.050948', 'ticker_sentiment_score': '-0.094077', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.025487', 'ticker_sentiment_score': '-0.230518', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
"TSLA, AI, JNJ, CDLX, BFRG: Top Trending Stocks - Cardlytics  ( NASDAQ:CDLX ) , Tesla  ( NASDAQ:TSLA ) , Bullfrog AI Hldgs  ( NASDAQ:BFRG ) , Johnson & Johnson  ( NYSE:JNJ ) , C3.ai  ( NYSE:AI ) ",https://www.benzinga.com/news/23/04/31672113/tesla-c3-ai-johnson-amp-johnson-cardlytics-bullfrog-ai-holdings-why-these-5-stocks-are-drawing-inves,20230405T010014,['Bhavik Nair'],Major Wall Street indices closed in the red on Monday after U.S. job openings in February declined to the lowest level in about two years while factory orders dropped for a second straight month.,https://cdn.benzinga.com/files/images/story/2023/Stocks_Photo_by_Phongphan_on_Shutterstock.jpeg?width=1200&height=800&fit=crop,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}]",-0.026655,Neutral,"[{'ticker': 'CDLX', 'relevance_score': '0.220809', 'ticker_sentiment_score': '0.258965', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TSLA', 'relevance_score': '0.220809', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BFRG', 'relevance_score': '0.220809', 'ticker_sentiment_score': '0.227927', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JPM', 'relevance_score': '0.111488', 'ticker_sentiment_score': '-0.215005', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'JNJ', 'relevance_score': '0.220809', 'ticker_sentiment_score': '0.144829', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson is again trying to use bankruptcy to settle talc cases for $8.9 billion | Business,https://www.cnn.com/2023/04/04/investing/johnson-and-johnson-talc-bankruptcy/index.html,20230404T220000,['David Goldman'],Johnson & Johnson is again trying to use bankruptcy to settle talc cases for $8.9 billion ...,"https://media.cnn.com/api/v1/images/stellar/prod/230404174208-johnson-baby-powder-file-040423.jpg?c=16x9&q=w_800,c_fill",CNN,Markets,www.cnn.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.0,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.246582', 'ticker_sentiment_score': '-0.15722', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
Johnson & Johnson  ( JNJ )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2074520/johnson-johnson-jnj-gains-as-market-dips-what-you-should-know,20230404T214522,['Zacks Investment Research'],"Johnson & Johnson (JNJ) closed the most recent trading day at $158.49, moving +1.05% from the previous trading session.",https://staticx-tuner.zacks.com/images/default_article_images/default261.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.976913'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.156909,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.546745', 'ticker_sentiment_score': '0.123205', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson offers to pay $8.9B in talc baby powder lawsuit over cancer claims,https://www.axios.com/2023/04/04/jnj-talc-lawsuit-payment-cancer,20230404T211451,"['Nathan Bomey', 'https://www.axios.com/authors/nbomey']",Johnson & Johnson offers to pay $8.9B in talc baby powder lawsuit ... ...,https://images.axios.com/AhM2Pks3Y9VsnJAJqIfRIp19BnE=/0x0:1920x1080/1920x1080/2023/04/04/1680642139638.jpg?w=1920,Axios,Business,www.axios.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.119748,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.113597', 'ticker_sentiment_score': '-0.343183', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
Johnson & Johnson sets aside $8.9 billion to settle talc claims; stock up 3%,https://www.marketwatch.com/story/johnson-johnson-stock-up-nearly-3-after-talc-litigation-unit-re-files-for-bankruptcy-bc258245,20230404T210500,['Claudia Assis'],Johnson & Johnson stock rises more than 3% in the extended session Tuesday after the company proposes to pay up to $8.9 billion to settle claims connected with cosmetic-talc litigation.,https://images.mktw.net/im-346630/social,MarketWatch,Top Stories,www.marketwatch.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.019668,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.701875', 'ticker_sentiment_score': '-0.031196', 'ticker_sentiment_label': 'Neutral'}]"
Why Johnson & Johnson Stock Is Moving Higher After Hours - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/news/23/04/31668369/why-johnson-johnson-stock-is-moving-higher-after-hours,20230404T210221,['Adam Eckert'],Johnson & Johnson JNJ shares are trading higher in Tuesday's after-hours session after the company's subsidiary LTL Management re-filed for bankruptcy to resolve all talc-based baby powder claims.,https://cdn.benzinga.com/files/images/story/2023/04/04/26728263791_c6f707a60c_k.jpg?width=1200&height=800&fit=crop,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.160697,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.887767', 'ticker_sentiment_score': '0.131888', 'ticker_sentiment_label': 'Neutral'}]"
"Dow Jones Falls On Recession Fears; AI Stock Crashes, Many Groups Sell Off",https://www.investors.com/market-trend/stock-market-today/dow-jones-falls-on-recession-fears-ai-stock-crashes-many-groups-sell-off/,20230404T205500,"['ED CARSON', ""Investor's Business Daily""]","Dow Jones Falls On Recession Fears. AI Stock Crashes, Many ... Investor's Business Daily ...",https://www.investors.com/wp-content/uploads/2023/03/Stock-AIservercontrol-01-adobe.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.25'}, {'topic': 'Technology', 'relevance_score': '0.25'}, {'topic': 'Finance', 'relevance_score': '0.25'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.25'}, {'topic': 'Earnings', 'relevance_score': '0.158519'}]",-0.164357,Somewhat-Bearish,"[{'ticker': 'MSFT', 'relevance_score': '0.128272', 'ticker_sentiment_score': '-0.041241', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.077177', 'ticker_sentiment_score': '-0.042184', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.102778', 'ticker_sentiment_score': '-0.013243', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.102778', 'ticker_sentiment_score': '-0.012336', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.153634', 'ticker_sentiment_score': '-0.078907', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ATKR', 'relevance_score': '0.077177', 'ticker_sentiment_score': '-0.072109', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JPM', 'relevance_score': '0.102778', 'ticker_sentiment_score': '-0.202022', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'CAT', 'relevance_score': '0.051496', 'ticker_sentiment_score': '-0.094098', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.153634', 'ticker_sentiment_score': '-0.081745', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOW', 'relevance_score': '0.077177', 'ticker_sentiment_score': '0.026925', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'RIO', 'relevance_score': '0.051496', 'ticker_sentiment_score': '-0.094098', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NUE', 'relevance_score': '0.051496', 'ticker_sentiment_score': '-0.094098', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:USD', 'relevance_score': '0.025761', 'ticker_sentiment_score': '-0.230771', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
Johnson & Johnson to Settle Talc Claims for $8.9 Billion. The Stock Is Jumping.,https://www.barrons.com/articles/jnj-stock-price-talc-cancer-14ee8132,20230404T204400,['Ben Levisohn'],"JNJ to Settle Talc Claims for $8.9 Billion, Stock Jumps ...",https://images.barrons.com/im-473510/social,Barrons,n/a,www.barrons.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",-0.064921,Neutral,"[{'ticker': 'JNJ', 'relevance_score': '0.699089', 'ticker_sentiment_score': '-0.103305', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson Proposes Paying $9 Billion to Settle Talc Lawsuits,https://www.wsj.com/articles/johnson-johnson-proposes-paying-9-billion-to-settle-talc-lawsuits-2fcc672a,20230404T203600,['Peter Loftus and Andrew Scurria'],A unit of the health-products company is also refiling for bankruptcy protection to seek approval for the settlement plan.,https://images.wsj.net/im-757634?width=860&height=573,Wall Street Journal,Business,www.wsj.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.15871,Somewhat-Bearish,"[{'ticker': 'JNJ', 'relevance_score': '0.636698', 'ticker_sentiment_score': '-0.609214', 'ticker_sentiment_label': 'Bearish'}]"
"2 Biotech Stocks That Could Soar by 130% and 92%, According to Wall Street",https://www.fool.com/investing/2023/04/04/2-biotech-stocks-that-could-soar-by-130-and-92-acc/,20230404T203000,['George Budwell'],"Arrowhead Pharmaceuticals and Seres Therapeutics are screaming buys, according to some Wall Street analysts.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F727011%2Fblood-sample.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.161647'}]",0.197207,Somewhat-Bullish,"[{'ticker': 'ARWR', 'relevance_score': '0.148731', 'ticker_sentiment_score': '-0.114718', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MCRB', 'relevance_score': '0.148731', 'ticker_sentiment_score': '0.079196', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NSRGF', 'relevance_score': '0.074692', 'ticker_sentiment_score': '0.163277', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.074692', 'ticker_sentiment_score': '0.090087', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson Subsidiary LTL Management LLC Re-Files for Voluntary Chapter 11 to Equitably Resolve All Current and Future Talc Claims,https://investingnews.com/johnson-johnson-subsidiary-ltl-management-llc-re-files-for-voluntary-chapter-11-to-equitably-resolve-all-current-and-future-talc-claims/,20230404T202749,[],LTL's Reorganization Plan Has Significant Support From Claimants The Plan Includes LTL's Present Value Commitment of $8.9 Billion Payable Over 25 Years For Complete Resolution,https://investingnews.com/media-library/eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJpbWFnZSI6Imh0dHBzOi8vYXNzZXRzLnJibC5tcy8yNTg1ODg1NS9vcmlnaW4ucG5nIiwiZXhwaXJlc19hdCI6MTcwODY4MTIxOX0.Phin9ClvosnPNpkGRdBWHz_VFepTco5fqEYZcXCsZIQ/image.png?width=210,Investing News Network,n/a,investingnews.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.495866'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.24193,Somewhat-Bullish,"[{'ticker': 'CURN', 'relevance_score': '0.029914', 'ticker_sentiment_score': '-0.000971', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.207064', 'ticker_sentiment_score': '0.153044', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
J&J will pay $8.9 billion to settle claims cosmetic talc products caused cancer,https://www.cnbc.com/2023/04/04/jj-will-pay-8point9-billion-to-settle-claims-cosmetic-talc-products-caused-cancer.html,20230404T202538,['Annika Kim Constantino'],Johnson & Johnson said it would pay an $8.9 billion settlement over claims that its talc-based baby powder caused cancer.,https://image.cnbcfm.com/api/v1/image/105636810-1545227621135gettyimages-998014428.jpeg?v=1680640158&w=1920&h=1080,CNBC,Business,www.cnbc.com,"[{'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.406929,Bearish,"[{'ticker': 'JNJ', 'relevance_score': '0.269776', 'ticker_sentiment_score': '-0.447193', 'ticker_sentiment_label': 'Bearish'}]"
Oncternal  ( ONCT )  Down on Restructuring Plan to Extend Runway,https://www.zacks.com/stock/news/2074388/oncternal-onct-down-on-restructuring-plan-to-extend-runway,20230404T160200,['Zacks Investment Research'],Oncternal (ONCT) closes the development program for zilovertamab to extend its cash runway into 2025. Shares are down on the same.,https://staticx-tuner.zacks.com/images/default_article_images/default202.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.682689'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}]",0.019148,Neutral,"[{'ticker': 'ABBV', 'relevance_score': '0.062761', 'ticker_sentiment_score': '0.095187', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BGNE', 'relevance_score': '0.062761', 'ticker_sentiment_score': '0.095187', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AZN', 'relevance_score': '0.125134', 'ticker_sentiment_score': '0.07093', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ONCT', 'relevance_score': '0.521465', 'ticker_sentiment_score': '-0.15386', 'ticker_sentiment_label': 'Somewhat-Bearish'}, {'ticker': 'NVO', 'relevance_score': '0.125134', 'ticker_sentiment_score': '0.057472', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.062761', 'ticker_sentiment_score': '0.095187', 'ticker_sentiment_label': 'Neutral'}]"
This Is What Whales Are Betting On Johnson & Johnson - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/markets/options/23/04/31657740/this-is-what-whales-are-betting-on-johnson-johnson,20230404T140106,['Benzinga Insights'],"Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson JNJ. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Markets,www.benzinga.com,"[{'topic': 'Earnings', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}]",0.189443,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.691995', 'ticker_sentiment_score': '0.343654', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
3 Top Healthcare Stocks to Buy for April,https://www.fool.com/investing/2023/04/04/3-top-healthcare-stocks-to-buy-for-april/,20230404T131200,['Jim Halley'],"These pharmaceutical companies' shares are down, but their prospects are rising.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F726723%2Fsenior-man-laptop-covering-face-gettyimages-1472263927.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.796627'}, {'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.158519'}]",0.182051,Somewhat-Bullish,"[{'ticker': 'LLY', 'relevance_score': '0.120885', 'ticker_sentiment_score': '0.126787', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABBV', 'relevance_score': '0.030331', 'ticker_sentiment_score': '0.196409', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.120885', 'ticker_sentiment_score': '0.142034', 'ticker_sentiment_label': 'Neutral'}]"
David Gabriel Joins Warburg Pincus as Senior Advisor,https://www.prnewswire.com/news-releases/david-gabriel-joins-warburg-pincus-as-senior-advisor-301788835.html,20230404T130000,['Warburg Pincus'],"Former CEO of Sonepar USA and COO of Sonepar SAS to Support Industrials Investment Opportunities NEW YORK, April 4, 2023 /PRNewswire/ -- Warburg Pincus, a leading global growth investor, today announced the appointment of David Gabriel as a Senior Advisor working with its Industrials group.",,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",0.411864,Bullish,"[{'ticker': 'PEP', 'relevance_score': '0.065866', 'ticker_sentiment_score': '0.091135', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TDG', 'relevance_score': '0.065866', 'ticker_sentiment_score': '0.018095', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.065866', 'ticker_sentiment_score': '0.091135', 'ticker_sentiment_label': 'Neutral'}]"
Biogen Appoints Adam Keeney as Head of Corporate Development,https://www.globenewswire.com/news-release/2023/04/04/2640516/0/en/Biogen-Appoints-Adam-Keeney-as-Head-of-Corporate-Development.html,20230404T113000,['Biogen Inc.'],"CAMBRIDGE, Mass., April 04, 2023 ( GLOBE NEWSWIRE ) -- Biogen Inc. ( Nasdaq: BIIB ) today announced the appointment of Adam Keeney, Ph.D., as Executive Vice President, Head of Corporate Development effective 17 April 2023. Dr. Keeney will be a member of Biogen's Executive Committee reporting to ...",https://ml.globenewswire.com/Resource/Download/80f9c524-3da2-4583-a763-0dad931fa182,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.684621'}, {'topic': 'Technology', 'relevance_score': '0.5'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.083135,Neutral,"[{'ticker': 'CURN', 'relevance_score': '0.043186', 'ticker_sentiment_score': '-0.018', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.043186', 'ticker_sentiment_score': '0.068329', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.043186', 'ticker_sentiment_score': '0.068329', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.254751', 'ticker_sentiment_score': '0.296309', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.043186', 'ticker_sentiment_score': '0.122623', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.086245', 'ticker_sentiment_score': '0.128671', 'ticker_sentiment_label': 'Neutral'}]"
Biogen Appoints Adam Keeney as Head of Corporate Development - Biogen  ( NASDAQ:BIIB ) ,https://www.benzinga.com/pressreleases/23/04/g31651697/biogen-appoints-adam-keeney-as-head-of-corporate-development,20230404T113000,['Globe Newswire'],"CAMBRIDGE, Mass., April 04, 2023 ( GLOBE NEWSWIRE ) -- Biogen Inc. BIIB today announced the appointment of Adam Keeney, Ph.D., as Executive Vice President, Head of Corporate Development effective 17 April 2023. Dr. Keeney will be a member of Biogen's Executive Committee reporting to Christopher A.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.87644'}, {'topic': 'Technology', 'relevance_score': '0.5'}, {'topic': 'Economy - Macro', 'relevance_score': '0.158519'}]",0.077881,Neutral,"[{'ticker': 'CURN', 'relevance_score': '0.039033', 'ticker_sentiment_score': '-0.017974', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.039033', 'ticker_sentiment_score': '0.067424', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.039033', 'ticker_sentiment_score': '0.067424', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.268084', 'ticker_sentiment_score': '0.242802', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.039033', 'ticker_sentiment_score': '0.121225', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SNY', 'relevance_score': '0.077972', 'ticker_sentiment_score': '0.126808', 'ticker_sentiment_label': 'Neutral'}]"
4 Best Stocks to Set You Up for Early Retirement,https://www.fool.com/investing/2023/04/04/4-best-stocks-to-set-you-up-for-early-retirement/,20230404T095500,['Leo Sun'],"Cloudflare, ServiceNow, The Trade Desk, and Airbnb are all long-term winners.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F726810%2Fretiree-financial-advisor.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.972756'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",0.188851,Somewhat-Bullish,"[{'ticker': 'GOOG', 'relevance_score': '0.051221', 'ticker_sentiment_score': '0.160883', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'META', 'relevance_score': '0.051221', 'ticker_sentiment_score': '0.160883', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'KO', 'relevance_score': '0.051221', 'ticker_sentiment_score': '-0.01601', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TTD', 'relevance_score': '0.20279', 'ticker_sentiment_score': '0.166919', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.051221', 'ticker_sentiment_score': '-0.01601', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NOW', 'relevance_score': '0.20279', 'ticker_sentiment_score': '0.139931', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ABNB', 'relevance_score': '0.347058', 'ticker_sentiment_score': '0.253073', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NET', 'relevance_score': '0.152821', 'ticker_sentiment_score': '0.065506', 'ticker_sentiment_label': 'Neutral'}]"
3 Dow Stocks That Are Screaming Buys in April,https://www.fool.com/investing/2023/04/04/3-dow-stocks-that-are-screaming-buys-in-april/,20230404T090600,['Sean Williams'],"Among the Dow Jones Industrial Average's 30 components, there are three plain-as-day bargains.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F726766%2Fnyse-wall-street-trading-new-york-financial-stock-market-getty.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}, {'topic': 'Earnings', 'relevance_score': '0.988787'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.176973,Somewhat-Bullish,"[{'ticker': 'NFLX', 'relevance_score': '0.033421', 'ticker_sentiment_score': '0.120935', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPGI', 'relevance_score': '0.033421', 'ticker_sentiment_score': '0.151978', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VZ', 'relevance_score': '0.293897', 'ticker_sentiment_score': '0.21778', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HCSG', 'relevance_score': '0.033421', 'ticker_sentiment_score': '0.020513', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.16594', 'ticker_sentiment_score': '0.031572', 'ticker_sentiment_label': 'Neutral'}]"
Group steers Swiss billionaire's money to liberal causes,https://apnews.com/article/dark-money-democrats-wyss-politics-elections-601d40cd01569190559d545418afe396,20230403T225859,[],"WASHINGTON ( AP ) - The Berger Action Fund is a nondescript name for a group with a rather specific purpose: steering the wealth of Hansjrg Wyss, a Swiss billionaire, into the world of American politics and policy. As a foreign national, Wyss is prohibited from donating to candidates or ...",https://storage.googleapis.com/afs-prod/media/242a9c94e14942f6a39412b44fdefa0d/3000.webp,Associated Press,Business,apnews.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}]",0.083718,Neutral,"[{'ticker': 'NYT', 'relevance_score': '0.029691', 'ticker_sentiment_score': '-0.115979', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.029691', 'ticker_sentiment_score': '0.121739', 'ticker_sentiment_label': 'Neutral'}]"
Novartis  ( NVS )  Gets CHMP Positive Opinion for Entresto Approval,https://www.zacks.com/stock/news/2073837/novartis-nvs-gets-chmp-positive-opinion-for-entresto-approval,20230403T155500,['Zacks Investment Research'],Novartis (NVS) receives a positive opinion from the CHMP for Entresto (sacubitril/valsartan) for a new indication in pediatric patients.,https://staticx-tuner.zacks.com/images/articles/main/71/1337.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.928139'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}]",0.17695,Somewhat-Bullish,"[{'ticker': 'INVA', 'relevance_score': '0.301315', 'ticker_sentiment_score': '0.163599', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NVS', 'relevance_score': '0.228431', 'ticker_sentiment_score': '0.130302', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVO', 'relevance_score': '0.301315', 'ticker_sentiment_score': '0.232106', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.301315', 'ticker_sentiment_score': '0.211232', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Is It Time to Buy the Dow Jones' 3 Worst-Performing Stocks This Year?,https://www.fool.com/investing/2023/04/03/is-it-time-to-buy-the-dow-jones-3-worst-performing/,20230403T131700,['Jeremy Bowman'],These blue chips are down. Is it time to buy?,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F726630%2Fbear-market-stocks-down-loss-chart.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.980922'}, {'topic': 'Manufacturing', 'relevance_score': '0.333333'}, {'topic': 'Earnings', 'relevance_score': '0.999919'}, {'topic': 'Technology', 'relevance_score': '0.333333'}]",-0.068046,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.061003', 'ticker_sentiment_score': '0.17406', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CURN', 'relevance_score': '0.061003', 'ticker_sentiment_score': '0.066165', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPGI', 'relevance_score': '0.061003', 'ticker_sentiment_score': '0.17406', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'HON', 'relevance_score': '0.240489', 'ticker_sentiment_score': '-0.057814', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.240489', 'ticker_sentiment_score': '-0.127518', 'ticker_sentiment_label': 'Neutral'}]"
"Nium Names Payments Veteran, Volker Steinle, as Senior Vice President and General Manager Americas",https://www.prnewswire.com/news-releases/nium-names-payments-veteran-volker-steinle-as-senior-vice-president-and-general-manager-americas-301788332.html,20230403T130100,['Nium'],"Nium Names Payments Veteran, Volker Steinle, as Senior Vice ... PR ...",https://mma.prnewswire.com/media/1678669/Nium_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Earnings', 'relevance_score': '0.538269'}, {'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.28008,Somewhat-Bullish,"[{'ticker': 'TMOAF', 'relevance_score': '0.076847', 'ticker_sentiment_score': '0.047497', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INFY', 'relevance_score': '0.076847', 'ticker_sentiment_score': '0.047497', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ADYYF', 'relevance_score': '0.227716', 'ticker_sentiment_score': '0.177689', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.076847', 'ticker_sentiment_score': '0.047497', 'ticker_sentiment_label': 'Neutral'}]"
Peering Into Johnson & Johnson's Recent Short Interest - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/short-sellers/23/04/31632670/peering-into-johnson-johnsons-recent-short-interest,20230403T130058,['Benzinga Insights'],"Johnson & Johnson's JNJ short percent of float has fallen 15.56% since its last report. The company recently reported that it has 11.72 million shares sold short, which is 0.38% of all regular shares that are available for trading.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,Trading,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.365926'}]",0.237013,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.221819', 'ticker_sentiment_score': '0.081322', 'ticker_sentiment_label': 'Neutral'}]"
Reunion Neuroscience Appoints Dr. Fred Grossman to Board of Directors,https://www.globenewswire.com/news-release/2023/04/03/2639431/0/en/Reunion-Neuroscience-Appoints-Dr-Fred-Grossman-to-Board-of-Directors.html,20230403T113000,['Reunion Neuroscience Inc.'],"- Seasoned Psychiatrist and Global Pharmaceutical R&D Executive with Over Two Decades of Experience in Clinical Development, Including at Eli Lilly, Johnson & Johnson, Bristol Myers Squibb and Sunovion Pharmaceuticals ...",https://ml.globenewswire.com/Resource/Download/0446e058-6399-48c6-a279-a8c703bf1bd7,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.744043'}]",0.176128,Somewhat-Bullish,"[{'ticker': 'FTHWF', 'relevance_score': '0.037329', 'ticker_sentiment_score': '0.035131', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MESO', 'relevance_score': '0.037329', 'ticker_sentiment_score': '-0.051559', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'REUN', 'relevance_score': '0.11166', 'ticker_sentiment_score': '0.113416', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSOI', 'relevance_score': '0.074576', 'ticker_sentiment_score': '0.123016', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.074576', 'ticker_sentiment_score': '0.001012', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.074576', 'ticker_sentiment_score': '0.001012', 'ticker_sentiment_label': 'Neutral'}]"
Reunion Neuroscience Appoints Dr. Fred Grossman to Board of Directors - Reunion Neuroscience  ( NASDAQ:REUN ) ,https://www.benzinga.com/pressreleases/23/04/g31629773/reunion-neuroscience-appoints-dr-fred-grossman-to-board-of-directors,20230403T113000,['Globe Newswire'],"- Seasoned Psychiatrist and Global Pharmaceutical R&D Executive with Over Two Decades of Experience in Clinical Development, Including at Eli Lilly, Johnson & Johnson, Bristol Myers Squibb and Sunovion Pharmaceuticals TORONTO, April 03, 2023 ( GLOBE NEWSWIRE ) -- Reunion Neuroscience Inc.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.839681'}]",0.164318,Somewhat-Bullish,"[{'ticker': 'FTHWF', 'relevance_score': '0.035821', 'ticker_sentiment_score': '0.034949', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MESO', 'relevance_score': '0.035821', 'ticker_sentiment_score': '-0.051237', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'REUN', 'relevance_score': '0.107175', 'ticker_sentiment_score': '0.132397', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSOI', 'relevance_score': '0.07157', 'ticker_sentiment_score': '0.119385', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.07157', 'ticker_sentiment_score': '0.001008', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.07157', 'ticker_sentiment_score': '0.001008', 'ticker_sentiment_label': 'Neutral'}]"
3 Dow Stocks With Above-Average Dividends Yields to Buy in April,https://www.fool.com/investing/2023/04/03/3-dow-stocks-with-above-average-dividends-yields-t/,20230403T093900,['Cory Renauer'],Income-seeking investors are going to love the annual payout raises and yields of 2.9% or better that these legendary dividend payers offer right now.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F726477%2Fbear-market-stock-chart-quarter-report-financial-metrics-invest-getty.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.266143'}, {'topic': 'Manufacturing', 'relevance_score': '0.5'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}]",0.176434,Somewhat-Bullish,"[{'ticker': 'KO', 'relevance_score': '0.269776', 'ticker_sentiment_score': '0.128025', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMGN', 'relevance_score': '0.217346', 'ticker_sentiment_score': '0.137049', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HZNP', 'relevance_score': '0.054983', 'ticker_sentiment_score': '0.183894', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.109705', 'ticker_sentiment_score': '0.032261', 'ticker_sentiment_label': 'Neutral'}]"
3 Top S&P 500 Stocks Near 52-Week Lows That Look Like Bargains Now,https://www.fool.com/investing/2023/04/03/3-top-sp-500-stocks-near-52-week-lows-that-look-li/,20230403T092700,['Cory Renauer'],Now's a great time to buy some shares of these highly reliable dividend-payers.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F726543%2Fa-digital-rendering-of-a-circuit-board-with-a-chip-in-the-center-with-ai-inscribed-on-it.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.5855'}, {'topic': 'Earnings', 'relevance_score': '0.576289'}, {'topic': 'Mergers & Acquisitions', 'relevance_score': '0.108179'}]",0.246437,Somewhat-Bullish,"[{'ticker': 'MDT', 'relevance_score': '0.269776', 'ticker_sentiment_score': '0.274401', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'CVS', 'relevance_score': '0.269776', 'ticker_sentiment_score': '0.162398', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.109705', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
3 Warren Buffett Stocks That Are No-Brainer Buys in April,https://www.fool.com/investing/2023/04/03/3-warren-buffett-stocks-no-brainer-buys-in-april/,20230403T090600,['Sean Williams'],"Out of Berkshire Hathaway's more than four dozen holdings, there are three stocks that stand out as absolute steals right now.",https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F726487%2Fwarren-buffett-brka-brkb-berkshie-hathaway-motley-fool3.jpg&op=resize&w=700,Motley Fool,n/a,www.fool.com,"[{'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '0.999355'}, {'topic': 'Earnings', 'relevance_score': '0.795202'}, {'topic': 'Technology', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.149256,Neutral,"[{'ticker': 'SPGI', 'relevance_score': '0.031079', 'ticker_sentiment_score': '0.166855', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'SBNY', 'relevance_score': '0.06211', 'ticker_sentiment_score': '-0.06648', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PARA', 'relevance_score': '0.123844', 'ticker_sentiment_score': '-0.00357', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HCSG', 'relevance_score': '0.031079', 'ticker_sentiment_score': '-0.040141', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.031079', 'ticker_sentiment_score': '0.068978', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.244723', 'ticker_sentiment_score': '0.1841', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Virtual Reality company Virtualware to start trading in Euronext Paris on April 20,https://www.benzinga.com/pressreleases/23/04/g31626457/virtual-reality-company-virtualware-to-start-trading-in-euronext-paris-on-april-20,20230403T082336,['Globe Newswire'],"BILBAO, Spain and PARIS, April 03, 2023 ( GLOBE NEWSWIRE ) -- European company Virtualware, one of the European leaders in the Virtual Reality industry, will start trading on Euronext Paris on April 20.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,News,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'IPO', 'relevance_score': '0.158519'}, {'topic': 'Financial Markets', 'relevance_score': '0.858979'}]",0.053241,Neutral,"[{'ticker': 'HTHIF', 'relevance_score': '0.136113', 'ticker_sentiment_score': '0.098444', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IBDSF', 'relevance_score': '0.136113', 'ticker_sentiment_score': '0.098444', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AOMFF', 'relevance_score': '0.136113', 'ticker_sentiment_score': '0.098444', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BIIB', 'relevance_score': '0.136113', 'ticker_sentiment_score': '0.098444', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.136113', 'ticker_sentiment_score': '0.098444', 'ticker_sentiment_label': 'Neutral'}]"
Could This Move by Johnson & Johnson Equal Billions for Moderna?,https://www.fool.com/investing/2023/04/02/could-this-j-and-j-move-equal-billions-for-moderna/,20230402T093000,['Adria Cimino'],An RSV vaccine could be a driver of blockbuster revenue.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F726477%2Fbear-market-stock-chart-quarter-report-financial-metrics-invest-getty.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.360215'}]",0.207388,Somewhat-Bullish,"[{'ticker': 'MRNA', 'relevance_score': '0.711131', 'ticker_sentiment_score': '0.33237', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.238133', 'ticker_sentiment_score': '0.211911', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.179788', 'ticker_sentiment_score': '0.019279', 'ticker_sentiment_label': 'Neutral'}]"
Value Investing Is Back,https://www.kiplinger.com/investing/stocks/value-investing-is-back,20230401T133000,['James K. Glassman'],"It looks like value investing is making a comeback. Growth stocks clobbered value for about a decade. In 2020, they beat value by more than 30 percentage points - the widest margin since at least 1927. Then, in 2022, growth took a sickening dive.",https://cdn.mos.cms.futurecdn.net/7WU5N4XfczKKEFQJhfP8LE-415-80.jpg,Kiplinger,n/a,www.kiplinger.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.166667'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.166667'}, {'topic': 'Technology', 'relevance_score': '0.166667'}, {'topic': 'Finance', 'relevance_score': '0.166667'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.166667'}, {'topic': 'Financial Markets', 'relevance_score': '0.99999'}, {'topic': 'Manufacturing', 'relevance_score': '0.166667'}, {'topic': 'Earnings', 'relevance_score': '0.682689'}]",0.372933,Bullish,"[{'ticker': 'META', 'relevance_score': '0.076277', 'ticker_sentiment_score': '0.17671', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'TGNA', 'relevance_score': '0.050894', 'ticker_sentiment_score': '0.027888', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CVX', 'relevance_score': '0.050894', 'ticker_sentiment_score': '-0.054961', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KO', 'relevance_score': '0.050894', 'ticker_sentiment_score': '-0.054961', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'VZ', 'relevance_score': '0.050894', 'ticker_sentiment_score': '0.038871', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.02546', 'ticker_sentiment_score': '0.109786', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.050894', 'ticker_sentiment_score': '0.066862', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KHC', 'relevance_score': '0.050894', 'ticker_sentiment_score': '0.119369', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSFT', 'relevance_score': '0.101582', 'ticker_sentiment_score': '0.157982', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'WFC', 'relevance_score': '0.050894', 'ticker_sentiment_score': '0.038871', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.050894', 'ticker_sentiment_score': '0.066862', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CMC', 'relevance_score': '0.050894', 'ticker_sentiment_score': '0.027888', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PEP', 'relevance_score': '0.050894', 'ticker_sentiment_score': '0.066862', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMZN', 'relevance_score': '0.076277', 'ticker_sentiment_score': '0.14864', 'ticker_sentiment_label': 'Neutral'}]"
3 Surprisingly Underrated Stocks to Buy in April,https://www.fool.com/investing/2023/04/01/3-surprisingly-underrated-stocks-to-buy-in-april/,20230401T101400,"['and Prosper Junior Bakiny', 'David Jagielski', 'Keith Speights']",These drugmakers could deliver greater gains than many investors expect.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F726546%2Fbuy-gettyimages-986757634.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.77141'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.623304'}]",0.091931,Neutral,"[{'ticker': 'SGEN', 'relevance_score': '0.034984', 'ticker_sentiment_score': '0.083678', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.339046', 'ticker_sentiment_score': '0.11804', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AXSM', 'relevance_score': '0.339046', 'ticker_sentiment_score': '0.051858', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.306963', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
9 Best Index Funds for Long-Term Investors,https://www.fool.com/investing/how-to-invest/index-funds/best-index-funds/,20230331T222140,"['Robin Hartill', 'CFP']","Here are the nine best index funds to add to your portfolio for steady, low-cost growth.",https://m.foolcdn.com/media/dubs/images/original_imageshttpsg.foolcdn.comeditorialimag.width-880_ywXz1Zp.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.158519'}, {'topic': 'Retail & Wholesale', 'relevance_score': '0.2'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Real Estate & Construction', 'relevance_score': '0.2'}]",0.157139,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.043421', 'ticker_sentiment_score': '0.115452', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'GOOG', 'relevance_score': '0.043421', 'ticker_sentiment_score': '0.115452', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.043421', 'ticker_sentiment_score': '0.115452', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'TSLA', 'relevance_score': '0.043421', 'ticker_sentiment_score': '0.115452', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'IBM', 'relevance_score': '0.043421', 'ticker_sentiment_score': '0.068979', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.043421', 'ticker_sentiment_score': '0.115452', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'WBA', 'relevance_score': '0.043421', 'ticker_sentiment_score': '0.068979', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SPGI', 'relevance_score': '0.043421', 'ticker_sentiment_score': '0.006945', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NNN', 'relevance_score': '0.043421', 'ticker_sentiment_score': '0.068979', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'O', 'relevance_score': '0.021718', 'ticker_sentiment_score': '0.063041', 'ticker_sentiment_label': 'Neutral'}]"
Investing in Johnson & Johnson Stock,https://www.fool.com/investing/how-to-invest/stocks/how-to-invest-in-johnson-and-johnson-stock/,20230331T213525,['Matthew DiLallo'],"Johnson & Johnson ( NYSE:JNJ ) is an iconic global healthcare company. It was originally formed in 1866 when three brothers ( Robert, Edward, and James Johnson ) founded the company to focus on producing bandages and baby products.",https://m.foolcdn.com/media/dubs/images/Johnson_and_Johnson_logo_--_source_Johnson_and.width-880.jpg,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.614606'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}]",0.305682,Somewhat-Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.932935', 'ticker_sentiment_score': '0.511008', 'ticker_sentiment_label': 'Bullish'}]"
Here are our 4 best stocks - and 4 worst stocks - of the first quarter,https://www.cnbc.com/2023/03/31/first-quarter-2023-best-and-worst-stocks-investing-club.html,20230331T211411,"['Jeff Marks', 'Kevin Stankiewicz']","Club holding Nvidia (NVDA) has soared more than 90% this year, while Halliburton (HAL) and other energy stocks slid.",https://image.cnbcfm.com/api/v1/image/105394258-1534194817403gettyimages-902403114.jpeg?v=1680297251&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.2'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.2'}, {'topic': 'Technology', 'relevance_score': '0.2'}, {'topic': 'Finance', 'relevance_score': '0.2'}, {'topic': 'Economy - Monetary', 'relevance_score': '0.310843'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Manufacturing', 'relevance_score': '0.2'}, {'topic': 'Earnings', 'relevance_score': '0.857896'}]",0.138959,Neutral,"[{'ticker': 'MSFT', 'relevance_score': '0.021718', 'ticker_sentiment_score': '0.069859', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HUM', 'relevance_score': '0.043421', 'ticker_sentiment_score': '-0.081063', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.065091', 'ticker_sentiment_score': '0.035103', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVDA', 'relevance_score': '0.129749', 'ticker_sentiment_score': '0.095001', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HAL', 'relevance_score': '0.172404', 'ticker_sentiment_score': '0.015995', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HON', 'relevance_score': '0.108271', 'ticker_sentiment_score': '0.010027', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'INTC', 'relevance_score': '0.043421', 'ticker_sentiment_score': '0.158818', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.065091', 'ticker_sentiment_score': '-0.002014', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AMD', 'relevance_score': '0.193551', 'ticker_sentiment_score': '0.075332', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LLY', 'relevance_score': '0.043421', 'ticker_sentiment_score': '-0.081063', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DVN', 'relevance_score': '0.043421', 'ticker_sentiment_score': '0.035906', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'DHR', 'relevance_score': '0.043421', 'ticker_sentiment_score': '-0.081063', 'ticker_sentiment_label': 'Neutral'}]"
Johnson & Johnson unit loses bid to stay in bankruptcy during Supreme Court appeal,https://www.reuters.com/business/healthcare-pharmaceuticals/johnson-johnson-unit-loses-bid-stay-bankruptcy-during-supreme-court-appeal-2023-03-31/,20230331T195259,['Dietrich Knauth'],Johnson & Johnson unit loses bid to stay in bankruptcy during ... ...,https://cloudfront-us-east-2.images.arcpublishing.com/reuters/TM5IO554ZJLY7CIKGFOQ2PYUPU.jpg,Reuters,Business,www.reuters.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.295027,Somewhat-Bearish,"[{'ticker': 'JNJ', 'relevance_score': '0.183895', 'ticker_sentiment_score': '-0.158064', 'ticker_sentiment_label': 'Somewhat-Bearish'}]"
Johnson & Johnson  ( JNJ )  Could Be a Great Choice,https://www.zacks.com/stock/news/2073104/johnson-johnson-jnj-could-be-a-great-choice,20230331T154512,['Zacks Investment Research'],"Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.",https://staticx-tuner.zacks.com/images/default_article_images/default115.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.938238'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.998356'}]",0.399761,Bullish,"[{'ticker': 'JNJ', 'relevance_score': '0.448316', 'ticker_sentiment_score': '0.479986', 'ticker_sentiment_label': 'Bullish'}]"
Personal care market size to grow by USD 169.7 billion between 2022 and 2027; Offline segment to account for maximum growth - Technavio,https://www.prnewswire.com/news-releases/personal-care-market-size-to-grow-by-usd-169-7-billion-between-2022-and-2027-offline-segment-to-account-for-maximum-growth---technavio-301784571.html,20230331T153000,['Technavio'],Personal care market size to grow by USD 169.7 billion between ... PR ...,https://mma.prnewswire.com/media/2043168/Technavio_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.230737,Somewhat-Bullish,"[{'ticker': 'GOOG', 'relevance_score': '0.01329', 'ticker_sentiment_score': '0.101476', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'META', 'relevance_score': '0.01329', 'ticker_sentiment_score': '0.101476', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BDRFF', 'relevance_score': '0.079612', 'ticker_sentiment_score': '0.025343', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'KAOCF', 'relevance_score': '0.039855', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SSDOF', 'relevance_score': '0.066377', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'REVRQ', 'relevance_score': '0.026576', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.092824', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PG', 'relevance_score': '0.092824', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'UL', 'relevance_score': '0.066377', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'HENKY', 'relevance_score': '0.092824', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'CL', 'relevance_score': '0.092824', 'ticker_sentiment_score': '0.04578', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'LRLCF', 'relevance_score': '0.039855', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
"J&J Drops Out Of A Key Race With Pfizer, GSK, Moderna",https://www.investors.com/research/ibd-industry-themes/jnj-stock-johnson-johnson-drops-out-of-rsv-vaccine-race-pfizer-gsk-moderna-duke-it-out/,20230331T124800,"['ALLISON GATLIN', ""Investor's Business Daily""]",JNJ Stock: Johnson & Johnson Drops Out Of RSV Vaccine Race ... Investor's Business Daily ...,https://www.investors.com/wp-content/uploads/2019/10/stock-JohnsonANDjohnson-05-shutter.jpg,Investors Business Daily,n/a,www.investors.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.503496'}]",0.13849,Neutral,"[{'ticker': 'MRNA', 'relevance_score': '0.527969', 'ticker_sentiment_score': '0.109365', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.462395', 'ticker_sentiment_score': '0.175833', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.527969', 'ticker_sentiment_score': '-0.10458', 'ticker_sentiment_label': 'Neutral'}]"
Minimally Invasive Surgical Instruments Market to Hit USD 71.6 Bn by 2032 | TMR,https://www.benzinga.com/pressreleases/23/03/g31607356/minimally-invasive-surgical-instruments-market-to-hit-usd-71-6-bn-by-2032-tmr,20230331T123000,['Globe Newswire'],"Wilmington, Delaware, United States, March 31, 2023 ( GLOBE NEWSWIRE ) -- The global minimally invasive surgical instruments market is forecast to expand at a value CAGR of 14.8% from 2022 to 2032. As per Transparency Market Research's findings, global sales stood at USD 15.7 Bn as of 2021.",https://www.benzinga.com/next-assets/images/schema-image-default.png,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.108179'}]",0.103545,Neutral,"[{'ticker': 'SEMHF', 'relevance_score': '0.04303', 'ticker_sentiment_score': '0.150372', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'MDT', 'relevance_score': '0.085936', 'ticker_sentiment_score': '0.149282', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'SYK', 'relevance_score': '0.085936', 'ticker_sentiment_score': '0.072693', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.085936', 'ticker_sentiment_score': '0.126754', 'ticker_sentiment_label': 'Neutral'}]"
"Nexcella, an Immix Biopharma Subsidiary, Announces 2023 Haematologica Editorial Highlighting NXC-201 Efficacy In The Context of U.S. Food And Drug Administration Approved BCMA CAR T Cells",https://www.globenewswire.com/news-release/2023/03/31/2638581/0/en/Nexcella-an-Immix-Biopharma-Subsidiary-Announces-2023-Haematologica-Editorial-Highlighting-NXC-201-Efficacy-In-The-Context-of-U-S-Food-And-Drug-Administration-Approved-BCMA-CAR-T-C.html,20230331T120000,"['Immix Biopharma', 'Inc.']","LOS ANGELES, March 31, 2023 ( GLOBE NEWSWIRE ) -- Nexcella, Inc., a subsidiary of Immix Biopharma, Inc. ( Nasdaq: IMMX ) ( ""ImmixBio"", ""Company"", ""We"" or ""Us"" ) today announced that an editorial written by Maria Sjstrand and Michel Sadelain of Memorial Sloan Kettering Cancer Center was ...",https://ml.globenewswire.com/Resource/Download/b46d5687-65de-44df-81d5-e36f2665d8e7,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Technology', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}]",-0.007124,Neutral,"[{'ticker': 'IMMX', 'relevance_score': '0.154125', 'ticker_sentiment_score': '-0.008006', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BMY', 'relevance_score': '0.025845', 'ticker_sentiment_score': '0.055979', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.025845', 'ticker_sentiment_score': '0.055979', 'ticker_sentiment_label': 'Neutral'}]"
Should iShares Russell 1000 Value ETF  ( IWD )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2072825/should-ishares-russell-1000-value-etf-iwd-be-on-your-investing-radar,20230331T102009,['Zacks Investment Research'],Style Box ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default110.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.23226,Somewhat-Bullish,"[{'ticker': 'BLK', 'relevance_score': '0.063594', 'ticker_sentiment_score': '0.117088', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.063594', 'ticker_sentiment_score': '-0.019067', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.126784', 'ticker_sentiment_score': '-0.022599', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.126784', 'ticker_sentiment_score': '-0.022599', 'ticker_sentiment_label': 'Neutral'}]"
Why Is Fate Therapeutics  ( FATE )  Down 8.9% Since Last Earnings Report?,https://www.zacks.com/stock/news/2072512/why-is-fate-therapeutics-fate-down-89-since-last-earnings-report,20230330T153040,['Zacks Investment Research'],Fate Therapeutics (FATE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,https://staticx-tuner.zacks.com/images/default_article_images/default16.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Earnings', 'relevance_score': '0.857896'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.413559'}]",0.063855,Neutral,"[{'ticker': 'APLS', 'relevance_score': '0.338582', 'ticker_sentiment_score': '0.045171', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FATE', 'relevance_score': '0.415927', 'ticker_sentiment_score': '0.186554', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.087185', 'ticker_sentiment_score': '0.050374', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'OPHLF', 'relevance_score': '0.087185', 'ticker_sentiment_score': '0.050374', 'ticker_sentiment_label': 'Neutral'}]"
Amyotrophic Lateral Sclerosis Treatment Market Size to Hit USD 436.17 Million by 2027 at 5.52% CAGR Reported by Brandessence Market Research,https://www.prnewswire.com/news-releases/amyotrophic-lateral-sclerosis-treatment-market-size-to-hit-usd-436-17-million-by-2027-at-5-52-cagr-reported-by-brandessence-market-research-301785993.html,20230330T142000,['Brandessence Market Research And Consulting Private Limited'],Amyotrophic Lateral Sclerosis Treatment Market Size to Hit USD ... PR ...,https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}, {'topic': 'Earnings', 'relevance_score': '0.161647'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.266646,Somewhat-Bullish,"[{'ticker': 'BHVN', 'relevance_score': '0.030759', 'ticker_sentiment_score': '0.049455', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MJNA', 'relevance_score': '0.030759', 'ticker_sentiment_score': '0.160638', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'AMLX', 'relevance_score': '0.030759', 'ticker_sentiment_score': '0.049455', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.030759', 'ticker_sentiment_score': '0.160638', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'IONS', 'relevance_score': '0.030759', 'ticker_sentiment_score': '0.049455', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'MSBHF', 'relevance_score': '0.030759', 'ticker_sentiment_score': '0.049455', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'NVS', 'relevance_score': '0.030759', 'ticker_sentiment_score': '0.160638', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'PFE', 'relevance_score': '0.030759', 'ticker_sentiment_score': '0.160638', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'BIIB', 'relevance_score': '0.061473', 'ticker_sentiment_score': '0.156123', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'FOREX:UZS', 'relevance_score': '0.030759', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}]"
2 Unstoppable Stocks to Buy Without Hesitation Right Now,https://www.fool.com/investing/2023/03/30/2-unstoppable-stocks-to-buy-this-month/,20230330T132000,['Rachel Warren'],These industry giants are going from strength to strength in a volatile market.,https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F725910%2Fstack-of-one-hundred-dollar-bills-cash-money-invest-retire-getty.jpg&op=resize&h=340,Motley Fool,n/a,www.fool.com,"[{'topic': 'Earnings', 'relevance_score': '0.796627'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.538269'}]",0.196036,Somewhat-Bullish,"[{'ticker': 'ABNB', 'relevance_score': '0.244518', 'ticker_sentiment_score': '0.159535', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.204763', 'ticker_sentiment_score': '0.068822', 'ticker_sentiment_label': 'Neutral'}]"
EDAP Reports Record Fourth Quarter and Full-Year 2022 Results and Announces Leadership Succession Plan to Develop Global Group Strategy,https://www.globenewswire.com/news-release/2023/03/30/2637451/9622/en/EDAP-Reports-Record-Fourth-Quarter-and-Full-Year-2022-Results-and-Announces-Leadership-Succession-Plan-to-Develop-Global-Group-Strategy.html,20230330T103000,['EDAP TMS S.A.'],"LYON, France, March 30, 2023 -- EDAP TMS SA ( Nasdaq: EDAP ) ( the ""Company"" ) , a global leader in robotic energy-based therapies, announced today unaudited financial results for the fourth quarter and full-year 2022 and announced a change in its leadership, effective May 1, 2023.",https://ml-eu.globenewswire.com/Resource/Download/3e934184-5c25-44fd-880b-e10deb63e6e1,GlobeNewswire,n/a,www.globenewswire.com,"[{'topic': 'Earnings', 'relevance_score': '1.0'}, {'topic': 'Life Sciences', 'relevance_score': '1.0'}, {'topic': 'Financial Markets', 'relevance_score': '0.714479'}]",0.174893,Somewhat-Bullish,"[{'ticker': 'VERO', 'relevance_score': '0.020491', 'ticker_sentiment_score': '0.114063', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'ISRG', 'relevance_score': '0.020491', 'ticker_sentiment_score': '0.114063', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'EDAP', 'relevance_score': '0.280846', 'ticker_sentiment_score': '0.285709', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.020491', 'ticker_sentiment_score': '0.114063', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'FOREX:EUR', 'relevance_score': '0.772642', 'ticker_sentiment_score': '0.246071', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
Should Schwab U.S. Large-Cap Value ETF  ( SCHV )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2072228/should-schwab-us-large-cap-value-etf-schv-be-on-your-investing-radar,20230330T102010,['Zacks Investment Research'],Style Box ETF report for ...,https://staticx-tuner.zacks.com/images/default_article_images/default298.jpg,Zacks Commentary,n/a,www.zacks.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.333333'}, {'topic': 'Financial Markets', 'relevance_score': '1.0'}, {'topic': 'Earnings', 'relevance_score': '0.451494'}, {'topic': 'Energy & Transportation', 'relevance_score': '0.333333'}, {'topic': 'Finance', 'relevance_score': '0.333333'}]",0.252465,Somewhat-Bullish,"[{'ticker': 'SCHW', 'relevance_score': '0.059636', 'ticker_sentiment_score': '0.117', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'BRK-A', 'relevance_score': '0.059636', 'ticker_sentiment_score': '-0.022031', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.11894', 'ticker_sentiment_score': '-0.025465', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'XOM', 'relevance_score': '0.11894', 'ticker_sentiment_score': '-0.025465', 'ticker_sentiment_label': 'Neutral'}]"
Best Blue Chip Stocks To Invest In Right Now? 3 To Know,https://stockmarket.com/featured/best-blue-chip-stocks-to-invest-in-right-now-3-to-know-2023-03-29,20230329T200457,['Josh Dylan'],"Blue chip stocks are the metaphorical gold standard of the investing world. Generally, they represent well-established, financially stable, and consistently profitable companies that have demonstrated a long track record of success. These stocks are typically issued by large-cap companies.",https://u3j7m9h7.rocketcdn.me/wp-content/uploads/2023/03/aapl-stock.jpg,StockMarket.com,n/a,stockmarket.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.999999'}, {'topic': 'Earnings', 'relevance_score': '0.495866'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.281972,Somewhat-Bullish,"[{'ticker': 'MSFT', 'relevance_score': '0.293741', 'ticker_sentiment_score': '0.141895', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'AAPL', 'relevance_score': '0.40225', 'ticker_sentiment_score': '0.311523', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'DSSMY', 'relevance_score': '0.060085', 'ticker_sentiment_score': '0.00603', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.293741', 'ticker_sentiment_score': '0.09992', 'ticker_sentiment_label': 'Neutral'}]"
"Johnson & Johnson Pulls Plug On Large Late-Stage Study Of RSV Vaccine Candidate; GSK, Pfizer Shots Are Under FDA Review - Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/general/biotech/23/03/31556135/johnson-johnson-pulls-plug-on-large-late-stage-study-of-rsv-vaccine-candidate-gsk-pfizer-shots-ar,20230329T184137,['Vandana Singh'],"After reviewing its portfolio to prioritize and assessing the respiratory syncytial virus ( RSV ) vaccine landscape, Janssen, a unit of Johnson & Johnson JNJ, will exit its investigational RSV adult vaccine program and discontinue its Phase 3 EVERGREEN study.",https://cdn.benzinga.com/files/images/story/2023/03/29/jnj.png?width=1200&height=800&fit=crop,Benzinga,General,www.benzinga.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.047041,Neutral,"[{'ticker': 'GSK', 'relevance_score': '0.358152', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.514619', 'ticker_sentiment_score': '0.0', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.514619', 'ticker_sentiment_score': '-0.045064', 'ticker_sentiment_label': 'Neutral'}]"
"Grant Weinstein joins Performio as Head of Sales, APAC -- Performio Strengthens Global Sales Leadership Team",https://www.prnewswire.com/apac/news-releases/grant-weinstein-joins-performio-as-head-of-sales-apac--performio-strengthens-global-sales-leadership-team-301784328.html,20230329T180000,['Performio'],"Grant Weinstein joins Performio as Head of Sales, APAC ... PR ...",,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}, {'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.513158,Bullish,"[{'ticker': 'TTRAF', 'relevance_score': '0.071784', 'ticker_sentiment_score': '0.226851', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VOD', 'relevance_score': '0.071784', 'ticker_sentiment_score': '0.218563', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABT', 'relevance_score': '0.071784', 'ticker_sentiment_score': '0.218563', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'EFX', 'relevance_score': '0.071784', 'ticker_sentiment_score': '0.226851', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NWSAL', 'relevance_score': '0.071784', 'ticker_sentiment_score': '0.218563', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.071784', 'ticker_sentiment_score': '0.218563', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
"Grant Weinstein joins Performio as Head of Sales, APAC -- Performio Strengthens Global Sales Leadership Team",https://www.prnewswire.com/news-releases/grant-weinstein-joins-performio-as-head-of-sales-apac--performio-strengthens-global-sales-leadership-team-301784161.html,20230329T180000,['Performio'],"Grant Weinstein joins Performio as Head of Sales, APAC ... PR ...",https://mma.prnewswire.com/media/1439716/Performio_Logo.jpg?p=facebook,PR Newswire,n/a,www.prnewswire.com,"[{'topic': 'Life Sciences', 'relevance_score': '0.5'}, {'topic': 'Financial Markets', 'relevance_score': '0.158519'}, {'topic': 'Earnings', 'relevance_score': '0.108179'}, {'topic': 'Technology', 'relevance_score': '0.5'}]",0.513158,Bullish,"[{'ticker': 'TTRAF', 'relevance_score': '0.071784', 'ticker_sentiment_score': '0.226851', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'VOD', 'relevance_score': '0.071784', 'ticker_sentiment_score': '0.218563', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'ABT', 'relevance_score': '0.071784', 'ticker_sentiment_score': '0.218563', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'EFX', 'relevance_score': '0.071784', 'ticker_sentiment_score': '0.226851', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'NWSAL', 'relevance_score': '0.071784', 'ticker_sentiment_score': '0.218563', 'ticker_sentiment_label': 'Somewhat-Bullish'}, {'ticker': 'JNJ', 'relevance_score': '0.071784', 'ticker_sentiment_score': '0.218563', 'ticker_sentiment_label': 'Somewhat-Bullish'}]"
J&J backs out of RSV vaccine race with rivals Pfizer and GSK,https://www.cnbc.com/2023/03/29/jj-backs-out-of-rsv-vaccine-race-with-rivals-pfizer-and-gsk-.html,20230329T162806,['Annika Kim Constantino'],"J&J lagged behind rival drugmakers Pfizer and GSK, both of which made major strides toward U.S. approval of their RSV vaccines in the last month.",https://image.cnbcfm.com/api/v1/image/106097408-1566846750350rtsx61s.jpg?v=1680107286&w=1920&h=1080,CNBC,Top News,www.cnbc.com,"[{'topic': 'Life Sciences', 'relevance_score': '1.0'}]",-0.07084,Neutral,"[{'ticker': 'MRNA', 'relevance_score': '0.080458', 'ticker_sentiment_score': '0.132418', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'PFE', 'relevance_score': '0.160099', 'ticker_sentiment_score': '-0.129643', 'ticker_sentiment_label': 'Neutral'}, {'ticker': 'JNJ', 'relevance_score': '0.160099', 'ticker_sentiment_score': '0.039934', 'ticker_sentiment_label': 'Neutral'}]"
